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Abstract 
Parasitic gastroenteritis is the primary production limiting disease of sheep in 
the UK and is a considerable welfare concern. A global problem, it is caused by 
nematode parasites and mixed species infections can be common. In the UK, the 
primary pathogen in growing lambs is Teladorsagia circumcincta, an abomasal 
parasite of small ruminants, causing severe pathology and reduced weight gain. 
T. circumcincta is expertly adapted to both the host and the farming year and 
control is extremely difficult. The majority of UK farmers will use anthelmintics 
to manage parasitic gastroenteritis. Nevertheless, anthelmintic resistance is 
increasing, reducing control options. Many farmers will now dose sheep with a 
macrocyclic lactone (e.g. ivermectin) to treat T. circumcincta as this species has 
developed resistance to multiple anthelmintic classes. Unfortunately, over fifty 
percent of farms in recent UK studies had detectable ivermectin resistance.  
There is a pressing need to conserve anthelmintics for future use. However, the 
mechanism of ivermectin resistance is unknown, and the lack of a sensitive test 
for ivermectin resistance limits research into resistance spread and 
development. Many excellent studies have investigated ivermectin resistance in 
nematode parasites, however mutations responsible for ivermectin resistance 
remain elusive. The purpose of this PhD was to perform a genome wide 
association study to identify genomic regions under ivermectin selection within 
UK T. circumcincta field populations. L3 progeny were sequenced pre- and post-
ivermectin treatment using next generation sequencing techniques (ddRAD-Seq 
and Pool-Seq) and population genetics analyses were performed.  
Multiple loci were genetically differentiated between pre- and post-ivermectin 
populations. However, the reference genomes used were highly fragmented and 
the number of loci under selection cannot be concluded. Genes identified 
included those with neuronal functions, metabolic and regulatory genes. Many 
genes had associations with pharyngeal structures and chemosensory behaviour. 
Nevertheless, multiple copies of genes expected to be single copy were detected 
in both reference genomes and these may have affected read alignment and 
results. The work performed here provides an important basis for future studies, 
and has generated high quality next generation sequenced resources from two 
UK field populations of T. circumcincta.  
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1 Introduction 
1.1 Sheep Farming Systems 
Sheep and goats are farmed worldwide, with New Zealand and Australia, in 
particular, being known for their high levels of sheep production. There is no 
one-size-fits-all approach, and sheep farming methods, breeds and outputs vary 
widely across the globe. In the UK, sheep farming is predominantly for meat, 
although in the past, wool was also a considerable production output, so much 
so that the Romney was exported from the UK to NZ, as a hardy, efficient dual-
purpose breed (http://romneysuk.com). The UK sheep industry is divided into 
three main strata: hill, upland and lowland farms (Figure 1.1). Sheep move 
between and within these strata, enabling spread of parasites and anthelmintic 
resistance. 
 
Figure 1.1: Diagram of the UK sheep industry. In the UK, the sheep industry is stratified. 
Three separate farming ‘regions’ are present; hill, upland and lowland. 
The summer national flock in the UK consists of about 33.7 million sheep 
(DEFRA, 2018). Flocks can range in size from several thousand sheep down to 
only a handful, which may be kept as a hobby, or to conserve a rare breed. 
Generally speaking, flocks lamb in the late winter/early spring, and lambs are 
either finished for the meat market in late summer/early autumn, or sold for 
breeding. Those lambs which have failed to attain their market weight may be 
Lowland
Upland
Hill
Pure bred sheep for breeding. Excess females and males are sent as 
store lambs to upland/lowland farms for finishing. Old ewes sent to 
upland farms.
Produce pure and 
cross-bred ewes 
for lowland farms.
Finish lambs from 
upland and hill 
farms, and older 
ewes.
Produce lambs for 
the meat market 
using terminal 
sires 
Male and excess 
female lambs are 
sent to lowland 
farms for finishing.  
May be able to 
finish lambs on 
arable crops, or 
dairy farms.
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sold as ‘stores’ and finished more slowly over winter in areas of the country 
which have sufficient pasture or arable crops. Some lambs may be retained by 
the breeder for a longer period of time before being sold. Traditionally, ewe 
lambs have been bred so as to lamb at two years of age, however, it is now 
encouraged to mate ewe lambs when they are about eight months of age, if they 
are ready, in a bid to reduce greenhouse gas emissions by up to 9.4% per kg of 
meat produced over their six-year lifetime (Rees and Phillips, 2016). This means 
that ewe lambs for breeding, which once were retained on their farm of origin 
until adulthood, may be increasingly sold when only five to six months old, at an 
age when they are unlikely to have developed robust immunity against parasites 
and may have high faecal egg counts (FECs) (Smith et al., 1985). Very few, if 
any, UK farms are truly closed, with almost all farmers buying in male breeding 
stock each year, predominantly in the autumn. Although most lambing occurs in 
the spring, the climatic conditions within the UK ensure that the coming of 
spring varies across the country, and as a result, lambing is usually earlier, 
sometimes by several months, in southern England compared to northern 
Scotland, adding yet another level of complexity to the overall management of 
the national flock.  
Farmers generally try to aim for a lamb about 40 kg liveweight, as the consumer 
market is such that lamb at this weight achieves optimal price, with lambs 
under- or overweight potentially selling for less per kg that those within the 
specified weight bracket. In addition, lamb price varies week to week and month 
to month, so farmers must plan ahead to determine when they wish to lamb and 
how quickly they want to finish their lambs to sell. In this system, many external 
factors including both weather conditions and disease, can seriously affect the 
potential profit farmers make each year. The majority of farms receive subsidy 
payments from the government, and for many sheep farms these payments are 
the means of providing income for the farm over and above that required to 
break-even (AHDB, 2017). In the future, dependent on trade deals with Europe 
and the rest of the world, and subsidies following BREXIT, the economics of 
farming in the UK may change dramatically and it is possible that many farmers 
will struggle to stay in business (AHDB, 2017). It is therefore essential that 
production-limiting diseases are managed effectively with a view to reducing 
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their impact, both in terms of management costs and detrimental effect on 
sheep production.  
1.2 Parasitic Gastroenteritis 
The Agricultural and Horticultural Development Board (AHDB) Beef and Lamb 
estimated that parasitic gastroenteritis (PGE), a severe production limiting 
disease, reduced the price per lamb by £10 (Lovatt and Stubbings, 2018). This is 
a considerable amount given that the price per 40 kg lamb averaged £74.84 in 
2017, with store lambs (those finished more slowly overwinter), reaching only 
£54.15 on average (AHDB, 2018). These costs include the increased feed 
consumed by a lamb to reach the same final weight, the cost of treatment 
(anthelmintics), increased labour required to raise a lamb and reduced 
availability of pasture for other purposes (Lovatt and Stubbings, 2018). PGE has 
consistently been the commonest cause of death diagnosed by the Animal and 
Plant Health Agency (APHA) in both sheep and goats (APHA, 2018). Although the 
presentation varies, PGE is considered ubiquitous in sheep farming, and is a 
worldwide concern of farmers (Kaplan and Vidyashankar, 2012). With both 
clinical and sub-clinical presentations, PGE manifests with various clinical signs, 
including: poor weight gain, anorexia, diarrhoea, low milk yield, death and 
pallor (Durham and Elliott, 1975). Pathology includes gastroenteritis, with the 
recruitment of mast cells, eosinophils, neutrophils and lymphocytes to the 
mucosal and submucosal layers (Durham and Elliott, 1975; Balic et al., 2003). 
Dehydration, hypoproteinaemia, poor digestion of the diet and anaemia are 
evident (Baker et al., 1959; Lawton et al., 1996). PGE is caused by a wide range 
of parasites including: Nematodirus battus, predominantly in the spring in the 
UK, in young lambs, which can manifest as severe sudden onset diarrhoea and/or 
death; Trichostrongylus spp. cause most disease (known as ‘black scours’) during 
the autumn and winter months; Haemonchus contortus, responsible for 
Haemonchosis, is haematophagus, and although diarrhoea is not usually a clinical 
sign, anaemia is common and can be fatal; and Teladorsagia circumcincta, the 
‘brown stomach worm’, responsible for Teladorsagiosis, and the commonest 
cause of PGE in growing lambs over the summer in the UK (Burgess et al., 2012; 
Mitchell, 2016). Other nematode species are also potentially involved in small 
ruminant PGE, however they are generally considered less pathogenic than those 
mentioned above and usually contribute to, rather than primarily cause, PGE. 
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Each of these strongyle species have slight differences in their lifecycles 
affecting the timing, presentation, management and severity of PGE. Farm 
management practices can impact upon which species survive and thrive on a 
holding. This is perhaps most evident when considering the differences seen in 
the abundance of species in unmanaged wild flocks (Wimmer et al., 2004; 
Sinclair et al., 2016), and the comparative lack of diversity noted on some 
commercially managed farms (Redman et al., 2015).  
1.3 Teladorsagiosis 
T. circumcincta is an abomasal trichostrongylid nematode of sheep and goats. 
Previously known as Ostertagia circumcincta, it was thought to be related to the 
cattle parasite Ostertagia ostertagi. However, it was determined to belong to a 
separate genus in the 1980s by morphological differences of the lateral rays in 
the bursa and an absence of the proconus of the male (Gibbons and Khalil, 1982; 
Lichtenfels et al., 1988; Lichtenfels and Hoberg, 1993). Following ingestion of 
the infective L3 stage from pasture the larva exsheaths within the rumen 
(Bekelaar et al., 2018), passes to the abomasum and enters the gastric glands of 
the abomasal wall. There it causes a severe inflammatory reaction, provoking a 
small raised lesion surrounding the gland and grossly visible on examination, 
providing the classic ‘Moroccan leather’ appearance (McKellar, 1993). It 
undergoes two moults to become an immature adult, and emerges to complete 
development on the mucosal surface of the abomasal wall. Once fully developed 
it mates, producing eggs, roughly 100-200 per female per day (Cole, 1986). The 
pre-patent period from ingestion to first appearance of eggs in the faeces is 
about 17-21 days, but can be shorter with one study recording eggs in the faeces 
of infected sheep at just 14 days post-infection (Barrett et al., 1998). As a 
consequence of infection, the serum pepsinogen and gastrin increase, and in the 
initial stages pre-patency, the abomasal pH increases, although it returns to 
normal levels once patency is established in experimentally infected sheep 
(Lawton et al., 1996).      
T. circumcincta is ubiquitous on UK sheep farms, being present on all farms 
tested in Scotland, England, Wales and Northern Ireland in a recent study 
(Burgess et al., 2012), and in several independent studies of farms in Wales 
(Hybu Cig Cymru, 2015), Northern Ireland (McMahon et al., 2013b), Scotland 
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(Bartley et al., 2003), and southeast England (Glover et al., 2017). Although it is 
found worldwide (Kaplan, 2004), T. circumcincta is predominantly a parasite of 
small ruminants in temperate climates (O'Connor et al., 2006). 
T. circumcincta is a particular problem for UK farmers as it is expertly adapted 
to both the sheep host and the farming year. The parasite is present within all 
sheep on a holding, but the egg output attributable to T. circumcincta is very 
low in non-pregnant adult sheep. Nevertheless, in late pregnancy immunity 
against T. circumcincta, and other strongyles (excluding N. battus) is reduced 
and egg output from all strongyles, but especially T. circumcincta, increases 
dramatically (Gibson, 1973; Jansen, 1987). This phenomenon is known as the 
peri-parturient rise (PPR) and is key to the maintenance of disease-inducing and 
production-limiting levels of T. circumcincta on farm (Coop et al., 1982). 
Following lambing, the PPR continues for six weeks, before the ewe’s immune 
system reasserts itself leading to a reduction in egg output (Gibson, 1973). 
Lambs initially eat very little grass, but over time begin to ingest greater 
quantities, increasing their intake of L3 from the pasture. Due to the nature of 
the PPR, and the time taken for eggs to develop to L3 in the UK spring, pasture 
infectivity is usually high at the time at which lambs begin feeding on grass in 
earnest (Gibbs, 1986b). Lambs take between four to six months to develop 
immunity to T. circumcincta (Smith et al., 1985), and during this time they 
greatly multiply the number of larvae residing on pasture. This lack of immunity 
towards parasites causing PGE severely impacts on lamb growth rate if PGE is 
not appropriately managed within the flock (Coop et al., 1982). Unlike most 
other species, T. circumcincta is able to develop at very low temperatures (Salih 
and Grainger, 1982), and can survive on pasture overwinter, with infective L3 
still found as late as 16-18 months following egg deposition (Gibson, 1973). 
These overwintered larvae also contribute to the PPR, as they are ingested by 
ewes in early lactation, and thus contribute to the subsequent pasture 
population during the later spring and summer (Sargison et al., 2002). T. 
circumcincta is capable of hypobiosis, arresting development overwinter within 
the host, ensuring both that adults emerge when ewes experience low immunity 
and are less effective at supressing fecundity of parasites, and also when eggs 
are more likely to successfully develop to L3 than at the start of winter (Gibbs, 
1986b). 
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In the faeces, T. circumcincta develops from an egg to an infective L3, taking 
between 14 days to 10 weeks dependent on weather conditions (Gibson and 
Everett, 1972). The L3 migrate onto pasture in response to moisture (van Dijk 
and Morgan, 2011). Nevertheless, unlike other strongyle parasites, such as H. 
contortus and Trichostrongylus colubriformis, this migration occurs slowly over 
many months, as a trickle, rather than en mass (Gibson and Everett, 1972; Wang 
et al., 2014). This allows the maintenance of a sub-population within the 
relative safety of the faeces, ensuring pasture levels of infectivity remain higher 
for longer (Gibson and Everett, 1972). L3 are able to survive on pasture for a 
year or longer, but are more exposed and are prone to desiccation (Gibson and 
Everett, 1972; van Dijk et al., 2009). In addition, the survival of eggs developing 
to L3 appears linked to the time of year at which they are shed, with those laid 
in winter providing lower yields of L3, and these only surviving for a maximum of 
five months on pasture in a UK study (Gibson and Everett, 1972).  
1.4 Management of Parasitic Gastroenteritis 
Management options for PGE vary, and not all practices will be available to all 
farmers. Almost all farmers rely to a greater or lesser extent on anthelmintics 
(Burgess et al., 2012). These drugs are a diverse set of products, which are 
available without the requirement for veterinary input as they can all be 
obtained via a suitably qualified person (an SQP). SQPs are legally designated 
animal medicine advisors, who have been trained in the prescription or supply of 
certain medications, but are not necessarily medically trained. There are five 
anthelmintic classes which can be used to treat T. circumcincta in sheep in the 
UK (Table 1.1) (Abbott et al., 2012). Briefly, the earliest modern anthelmintic 
class introduced in 1961 was the benzimidazole class (1-BZ), with the product 
thiabendazole (Gordon, 1961). This compound, although still widely used in 
research, is no longer used on farm, but there are several other BZ anthelmintics 
licensed in the UK for sheep, namely: albendazole, fenbendazole, mebendazole, 
oxfendazole and ricobendazole (SCOPS, 2019). The second class of anthelmintic 
is the imidazothiazoles (2-LV), of which only the anthelmintic levamisole (LEV) is 
licensed for use in UK sheep. The third class are the macrocyclic lactones (3-
ML), which consist of two sub-classes: avermectins and milbemycin oximes. 
Avermectins include ivermectin (IVM), doramectin, eprinomectin and abamectin, 
the latter only sold as a combined product with derquantel. IVM is increasingly 
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used by sheep farmers in the UK specifically to treat PGE in lambs, with 
moxidectin (MOX), a milbemycin oxime, also commonly used at the time of the 
PPR (Burgess et al., 2012). MOX is marketed in both 0.1% oral and 1% injectable 
formulations with five weeks persistency against re-infection with T. 
circumcincta, and a 2% injectable formulation with over 13 weeks persistency 
(Kerboeuf et al., 1995; Abbott et al., 2012). Macrocyclic lactones are also used 
to treat the ectoparasite Psoroptes ovis, both prophylactically and reactively, 
simultaneously affecting the strongyle population within the host (Doherty et 
al., 2018). MOX was introduced onto the UK market in 1991 but no new 
anthelmintics were developed from that time until 2009, when monepantel 
(MPTL) (an amino-acetonitrile derivative, class 4-AD) was released onto the 
market in NZ and Australia and a year later in the UK (Hosking et al., 2009; 
Bartley et al., 2019). In 2011, derquantel (a spiroindole, class 5-SI) was 
developed, and released as a combined product with abamectin (Little et al., 
2011). Two final anthelmintics available to farmers are also flukicides (active 
against Fasciola hepatica): closantel and nitroxynil, both of which have narrow 
spectrum efficacy against H. contortus (Abbott et al., 2012). Farmers vary in 
their use of anthelmintics, both in frequency of dosing and choice of 
anthelmintic used for sheep by age, and time of year (Burgess et al., 2012). In 
the UK, the presence of N. battus requires many farmers to treat their lambs 
monthly in mid- to late-spring and the BZ anthelmintics are recommended for 
this (Abbott et al., 2012). However, recent reports indicate that resistance is 
developing and, furthermore, that many farmers choose to use other 
anthelmintic classes for nematodirosis treatments (Morrison et al., 2014; 
McMahon et al., 2017).  
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Table 1.1: Anthelmintic classes licensed to treat Teladorsagia circumcincta in sheep in the UK.  
Anthelmintic class Anthelmintics licensed in the 
UK for sheep 
Date first introduced First reports of resistance 
1-BZ (benzimidazoles, ‘white 
drenches’) 
Albendazole, fenbendazole, 
mebendazole, oxfendazole and 
ricobendazole 
1961 (thiabendazole, no longer 
used to treat sheep) (Gordon, 
1961) 
(Drudge et al., 1964; Smeal et 
al., 1968; Britt, 1982) 
2-LEV (imidazothiazoles, 
‘yellow drench’) 
Levamisole c.1970 (Thienpont et al., 1966; 
Kaplan, 2004) 
(Sangster et al., 1979; Hong et 
al., 1994, 1996) 
3-ML (macrocyclic lactones, 
‘clear drenches’, also 
injectable forms); sub-class 
avermectins 
Ivermectin, doramectin, 
eprinomectin and abamectin 
1981(Chabala et al., 1980; 
Campbell et al., 1983) 
(van Wyk and Malan, 1988; 
Jackson et al., 1992a) 
3-ML (macrocyclic lactones, 
‘clear drenches’, also 
injectable forms); sub-class 
milbemycin oximes 
Moxidectin 1991 (Kerboeuf et al., 1995) (Sargison et al., 2005; Sargison 
et al., 2010) 
4-AD (amino-acetonitrile 
derivative, orange) 
Monepantel 2009 (2010 in UK) (Hosking et 
al., 2009; Kaminsky et al., 
2009; Abbott et al., 2012) 
(Scott et al., 2013; Van den 
Brom et al., 2015; Hamer et 
al., 2018) 
5-SI (spiroindole, purple) Derquantel (only available as a 
combination product with 
abamectin) 
2011 (Little et al., 2011) (Lamb et al., 2017)1 
The anthelmintics available within each class are shown, and an indication of the first introduction of the anthelmintic class into the UK is provided, with 
early reports of anthelmintic resistance both worldwide and in the UK. 1This may be due to the presence of Haemonchus contortus L4 achieving patency, 
rather than adult resistance and the authors advised further follow-up work was required to fully diagnose resistance.
27 
 
Introduction 
Advice on management of PGE is provided to farmers by the knowledge transfer 
group, ‘Sustainable Control of Parasites in Sheep’ (SCOPS) and the levy board 
AHDB Beef and Lamb, (in addition to other levy boards, organisations and vets). 
Research has assessed both the uptake and effect of the SCOPS 
recommendations. SCOPS guidelines are followed by some farmers, however a 
significant proportion of farmers still use traditional practices (McMahon et al., 
2013c). One study compared the effect of using SCOPS guidelines to treat sheep 
with anthelmintics, to traditional treatment management practices. No 
significant difference was noted in worm burden or lamb weight gain over three 
years between the farms monitored, however SCOPS farmers used significantly 
less anthelmintic than traditional farmers (Learmount et al., 2016b). Other than 
the use of anthelmintics, management options include; (i) using cattle as 
biological ‘hoovers’, effectively reducing the pasture larval contamination of 
sheep specific strongyle nematodes, including T. circumcincta. Cattle could be 
used in rotation with sheep, or alongside sheep, which may have an added 
benefit of increasing the overall nematode diversity (Giudici et al., 1999). (ii) 
Using arable crop rotation to effectively clean up a pasture, which can be 
subsequently re-seeded with grass. (iii) Alternatively, silage production, several 
cuts likely being better than a single cut, can be used. (iv) Growing certain 
forage crops, such as chicory, which may reduce the ability of larvae to develop 
on pasture (Marley et al., 2003), and (v) using nematophagus fungi, although this 
varies in its efficacy (da Silveira et al., 2017). In addition, copper has been 
investigated as a means of reducing parasite burden in sheep infected with H. 
contortus (Knox, 2002; Leal et al., 2014), and lastly, vaccination against 
nematode parasites is becoming an increasing possibility. Already, an H. 
contortus vaccine based on nematode gut proteases is in use in Australia and 
South Africa (Smith et al., 2001), although it is not available in the UK. A vaccine 
for a cattle pulmonary nematode, Dictyocaulus viviparous, based on irradiated 
L3, has been available and in use since the 1960s (Jarrett et al., 1960; Strube et 
al., 2015). Ongoing work at the Moredun Research Institute (MRI) aims to 
develop a recombinant subunit vaccine for T. circumcincta (Nisbet et al., 2016a) 
and H. contortus (Nisbet et al., 2016b; Sallé et al., 2018). While it is not 
possible to eliminate parasites from sheep flocks, it is possible to reduce the 
infective larval burden, or breed resilient or nematode-resistant animals 
reducing the impact of PGE on production losses (Fairlie-Clarke et al., 2019). Of 
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key importance in managing anthelmintics wisely is the maintenance of a 
susceptible population of worms in refugia (van Wyk, 2001), within which any 
resistant alleles will be diluted, prolonging the effectiveness of an anthelmintic 
in a flock. This population will be, by definition, unexposed to the anthelmintic 
and will include pre-parasitic stages on pasture, worms in untreated animals 
(both domestic and wild) and lifecycle stages within a treated animal, which are 
not affected by the anthelmintic. However, all classes of modern anthelmintics 
for sheep are active against both immature and adult strongyles, with many also 
capable of killing inhibited larval stages within the host. The population in 
refugia will not include free-living stages affected by anthelmintic, which reside 
within faeces containing anthelmintics. Nor will it apply in animals which are 
untreated by the farmer but which obtain anthelmintics through other means; 
for example by consuming milk from treated animals (Dever and Kahn, 2015), or 
licking anthelmintic from animals treated using a pour-on product (Laffont et 
al., 2001). 
1.5 Anthelmintic Resistance 
Resistance is defined as the ability of an individual to survive concentrations of 
an anthelmintic which are higher than that which might be expected to be 
therapeutic, or which some individuals within a normal, heterogeneous 
population, with natural tolerance towards the anthelmintic might be expected 
to survive (Le Jambre et al., 1976). On farm, and also in many research studies, 
anthelmintic efficacy is tested using a faecal egg count reduction test (FECRT) 
(Coles et al., 2006). This involves the collection of faeces from a group of 
animals both before and after treatment with an anthelmintic. FECs are 
performed at each sampling time point and the percentage reduction in egg 
output is calculated (Coles et al., 2006). For older anthelmintics, efficacy was 
not expected to be 100%, however, modern anthelmintics can provide close to 
100% efficacy against strongyles (Wood et al., 1995). Anthelmintic resistance is 
thus generally considered when tests show that the anthelmintic is less than 95% 
effective, with the 95% lower confidence interval calculated at 90% reduction in 
egg output or less (Coles et al., 1992). If only one of these two conditions is met, 
resistance is suspected but cannot be confirmed (Coles et al., 1992).  
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Other means of determining anthelmintic efficacy are also used in research, 
with the gold standard being a Controlled Efficacy Test (CET) (Wood et al., 
1995). To test a field population using a CET, faeces are collected from the 
farm, and L3 cultured and harvested. Worm-free sheep are then infected with a 
set number of these L3, and following establishment of patency, are treated 
with the anthelmintic under consideration. A FECRT is performed and the sheep 
are sacrificed, following which the number of adults surviving treatment are 
identified to species level, quantified and compared with an untreated control 
sheep (Wood et al., 1995; Bartley et al., 2019).   
1.6 In vitro tests of anthelmintic sensitivity 
In vitro bioassays allow determination of the effect of an anthelmintic on the 
free-living stages (Table 1.2). Perhaps the commonest assay in active use is the 
Egg Hatch Test (EHT), used primarily to determine BZ efficacy by the prevention 
of development to, and hatching of, L1 larvae (Le Jambre, 1976). This can also 
be used to determine LEV efficacy (Dobson et al., 1986), and for MPTL (Bartley 
et al., 2016), however it cannot be used to determine the efficacy of IVM as this 
is not ovicidal except at extremely high concentrations (Patel, 1997). Eggs must 
be harvested and the EHT set up within 3 hours of collection (or stored 
anaerobically), otherwise results are unreliable (Coles et al., 2006). Culture of 
larvae from eggs through to L3 over the course of a week can also be performed, 
as a Larval Development Test (LDT), with the anthelmintic (BZ, LEV or a ML), 
added at either the start of the test, or after 24 hours (Taylor, 1990). Several 
variations on the LDT set-up are possible, and variation is also apparent in the 
development of different strongyle species within the assay (Hubert and 
Kerboeuf, 1992; Gill et al., 1995; Heim et al., 2015). LDTs can be liquid based 
(Varady et al., 1996) or agar based (Gill et al., 1995). Each has different benefits 
and drawbacks, and neither test type appears to work well for all species.  
In the presence of genetically modified E. coli producing GFP, the ability of LEV 
or MLs to inhibit pharyngeal pumping, and thus feeding, can be determined, 
known as a Larval Feeding Inhibition Test (LFIT). In practice, this requires 
harvesting and hatching eggs, incubating L1 larvae in varying concentrations of 
either LEV or IVM for two hours before further incubation with GFP labelled E. 
coli for an additional two hours (Alvarez-Sanchez et al., 2005b). The assay 
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performs better for IVM than for LEV, with resistance ratios (RR) of 
approximately 7.5 for both IVM resistant H. contortus and T. circumcincta 
isolates tested, compared to ratios of only 2.7 for LEV resistant H. contortus 
compared to susceptible isolates. Importantly, the sensitivity of L1 to IVM or LEV 
appears to vary over the time-course of an infection, and so it would be 
important to age match both the resistant and sensitive strains whenever the 
assay was performed, which may limit its application in the field (Alvarez-
Sanchez et al., 2005b).   
Using the infective L3 stage, the effect of IVM on somatic musculature can be 
determined using a Larval Migration Inhibition Test (LMIT) (Demeler et al., 
2010a). Briefly, following incubation in the anthelmintic, larvae are tested for 
their ability to migrate vertically down through a fine mesh sieve over time 
(Demeler et al., 2010b). However, a more recent study assessing both motility 
(using the ‘Worminator’, a video capture technology (Storey et al., 2014)) and 
migration of field isolates of H. contortus and Cooperia oncophora found both 
tests to be unhelpful in determining resistance status to avermectins (George et 
al., 2017).     
A common issue with all of the above-mentioned assays is the presence of mixed 
species populations, as between-species differences may impact upon assay 
interpretation. These include differences in development time and in natural 
tolerance of the species to the anthelmintic and other reagents used in the 
assay. This confounding effect is of concern in field populations, which often 
contain a mix of strongyle species (Boag and Thomas, 1977; Redman et al., 
2015). Further complications arise when one species within a population is 
sensitive to an anthelmintic and another is resistant (Calvete et al., 2014). In 
addition, differences are apparent between different lifecycle stages (Sangster 
et al., 1988; Sangster and Bjorn, 1995; Varady and Corba, 1999), age of L3 
(Geerts et al., 1989) and throughout the patency period of an infection (Varady 
and Corba, 1999) even within a single species. Within a field sample collected at 
any given point in time, it is expected that eggs will have been shed by parasites 
of different ages, as sheep continually graze infective pasture. Lastly, it has 
been shown that the ability to detect BZ resistance in a population using either a 
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FECRT or an EHT lacks sensitivity until at least 25% of the population is resistant 
(Martin et al., 1989).   
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Table 1.2: Tests described to detect anthelmintic resistance in ruminant strongyle nematodes.  
Test 1-BZ 2-LEV 3-ML 4-AD 5-SI 
CET (Wood et al., 1995) (Wood et al., 
1995) 
(Wood et al., 
1995) 
(Wood et al., 
1995) 
(Wood et al., 1995) 
FECRT (Coles et al., 2006) (Coles et al., 
2006) 
(Coles et al., 2006) (Raza et al., 
2016c) 
(Geurden et al., 2012) 
EHT (Le Jambre, 1976; von 
Samson-Himmelstjerna et 
al., 2009a) 
(Dobson et al., 
1986) 
 (Bartley et al., 
2016) 
 
LDT (Kotze et al., 2012)  (Hubert and 
Kerboeuf, 1992) 
(Gill et al., 1995) (Raza et al., 
2016c) 
 
LMIT   (Demeler et al., 
2010a) 
  
LFIT   (Alvarez-Sanchez 
et al., 2005b) 
  
Allele-specific PCR (Silvestre and Humbert, 
2000; Rufener et al., 
2009a) 
    
Allele-specific qPCR (Alvarez-Sanchez et al., 
2005a) 
    
Pyrosequencing (Skuce et al., 2010)     
An indication of whether a particular test is available for each of the five anthelmintic classes is provided. In vivo tests: CET – Controlled efficacy test, 
FECRT – Faecal egg count reduction test. In vitro tests:  EHT – Egg hatch test, LDT – Larval development test, LMIT – Larval migration inhibition test, LFIT 
– Larval feeding inhibition test. Molecular tests: Allele-specific PCR, Allele-specific qPCR and Pyrosequencing. 
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1.7 Prevalence of Anthelmintic Resistance 
The reported prevalence of anthelmintic resistance varies between studies and 
is likely partially dependent on the method used to detect it. In some parts of 
the world, particularly in South America, anthelmintic resistance is highly 
prevalent, to the extent that many farms have been diagnosed with multiple 
anthelmintic resistance (Kaplan and Vidyashankar, 2012). Within Europe, 
prevalence of anthelmintic resistance appears to vary between countries and 
host species (Rose et al., 2015). In 2012, a UK study surveyed farmers, who were 
asked whether resistance had been diagnosed in their flock by a veterinary 
surgeon (Burgess et al., 2012). Farmers reported known resistance to BZ and LEV 
anthelmintics only. However, both previous and subsequent studies within the 
UK and Ireland have identified larger numbers of farms with resistance to BZ, 
LEV and the macrocyclic lactones than were reported in that study (Table 1.3). 
Not all studies have diagnosed resistance to species level, and this likely has an 
impact on the interpretation of results reported (McMahon et al., 2013b). The 
time of year at which a study is performed also impacts on the prevalence 
detected (Hybu Cig Cymru, 2015), probably mostly due to species composition, 
although host age, and stage of infection may also play a role. Multi-drug 
resistant populations have been increasingly reported, following the first 
European diagnosis in Scotland in 2001 (Sargison et al., 2001; Sargison et al., 
2010; Hybu Cig Cymru, 2015).  Worryingly, few farmers appear to regularly test 
for anthelmintic efficacy (Morgan et al., 2012). Nevertheless, the use of 
macrocyclic lactones is increasing, which suggests a perceived lack of efficacy of 
older anthelmintics more commonly used previously, or a general increase in 
treatment frequency (Keegan et al., 2017b). Some will also be choosing to use 
macrocyclic lactones to treat P. ovis more frequently than previously, or may be 
buying combination flukicide and nematocide products, which can contain 
macrocyclic lactones.  
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Table 1.3: Prevalence of anthelmintic resistance on farms in the British Isles.  
Study Location Prevalence (percentage) of Anthelmintic Resistance  
(Total number of farms tested) 
Method used 
BZ LEV IVM MOX MON 
(Cawthorne and Cheong, 1984) SE England 13.5% (52) 0% (52) ND ND ND FECRT1 
(Grimshaw et al., 1994) S England 100% (5) 40% (5) 0% (5) ND ND FECRT 
(Hong et al., 1996) England and 
Wales 
32.6% (138) 1 farm 
(total 
tested 
unclear) 
0% (26) ND ND FECRT/EHT/LDT/ 
Lab sheep infected1 
(Bartley et al., 2003) Scotland 64.4% (90) ND ND ND ND EHT 
(Bartley et al., 2006) Scotland ND ND 35.3% 
(17) 
ND ND FECRT 
(Fraser et al., 2006) SW England 28% (90)2 ? ? ? ND Survey 
(Mitchell et al., 2010) Wales 56.3% (122) 36% (122) ND ND ND LDT 
(Burgess et al., 2012) UK 17.5% (118) 3.4%(118) ND ND ND Survey 
(Good et al., 2012) Ireland 88.2% (17) 38.9% (18) ND3 ND ND FECRT 
(McMahon et al., 2013b) N Ireland 81% (26) 14% (7) 50% (14) 62% (21) 0% (3) FECRT4 
(Keane et al., 2014) Ireland 70% (155) 48% (82) 24% (132) ND FECRT 
(Hybu Cig Cymru, 2015) Wales 94% (47) 68% (47) 51% (47) 19% (47) ND FECRT 
(Kenyon et al., 2016) S Scotland 100% (4) 75% (4) 100% (4) 100% (1) ND FECRT (Mini-
FLOTAC) 
(Glover et al., 2017) SW England 96% (25) 60% (25) 67% (27) ND ND FECRT 
(Keegan et al., 2017b) Ireland 68.5% (550)5 48.1% 
(316)5 
37.5% 
(405)5,6 
16% 
(163)5 
ND FECRT 
For each study included, data are shown in terms of the percentage of farms with detectable anthelmintic resistance, as defined by the study authors. For 
each anthelmintic, the percentage of farms with resistance is provided, in addition to the total number of farms tested or surveyed in the study. The 
method used to determine prevalence is provided. In some studies multiple methods were used, and not all are provided here. 1Note post-drench check at 
day 7, potential for under-estimation. 2Two tests used combination products. 3Suspected by LDT.  4Excluded combination product results. 5Number of 
tests, not farms. 6Avermectins. ND = Not Done.
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1.8 Ivermectin Resistance 
IVM is a macrocyclic lactone, released onto the market in 1981 after being 
discovered by Omura and Campbell (Campbell et al., 1983). IVM induces a 
flaccid paralysis (Arena et al., 1995), leading to worm expulsion from the host. 
One of the most common anthelmintics in use by farmers, IVM is increasingly 
used in both the UK and Ireland (Burgess et al., 2012; Keane et al., 2014). There 
is a considerable prevalence of IVM resistance worldwide (Kaplan and 
Vidyashankar, 2012), and in the UK, over 50% of farms tested had detectable IVM 
resistance in recent studies (McMahon et al., 2013b; Hybu Cig Cymru, 2015). 
1.8.1 IVM resistance is inherited as a fully or partially dominant 
trait 
Several studies have investigated the aetiology of IVM resistance using genetic 
crosses between sensitive and resistant isolates to produce heterozygous 
offspring (F1 generation). One study suggested that, for T. circumcincta 
developing larvae, IVM resistance is partially dominant (Sutherland et al., 
2003b). A multi-drug resistant (BZ, LEV, IVM, MOX) field isolate was exposed to 
intense selection pressure with BZ, LEV and IVM. The original population when 
tested was less resistant to IVM than the highly selected resistant strain, but 
equally resistant to MOX (Sutherland et al., 2003b). Females of this strain were 
then crossed with males of a sensitive isolate. IVM-continuous release capsules 
(CRC), which release a low concentration of IVM, prevented establishment of L3 
of the sensitive isolate. In contrast, the selected resistant strain was able to 
establish infection. The F1 generation was capable of partial establishment of 
infection, based on FEC and worm burden data. Although this may suggest that 
IVM resistance in T. circumcincta is partially dominant, as the authors inferred, 
the potential for side-resistance to IVM conferred by MOX resistance mechanisms 
cannot be ruled out. Side-resistance occurs when resistance mutations 
associated with an anthelmintic confer resistance to other anthelmintics in the 
same class (Sangster, 1999). In addition, the resistant strain could contain 
heterozygous individuals. If so, there could be an increased proportion of 
homozygous susceptible individuals within the F1 generation compared to 
offspring derived from the resistant strain alone. The authors also used the same 
parasite strains to infect sheep subsequently treated with IVM. IVM resistance in 
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adult T. circumcincta appeared to be a dominant trait based on FEC and worm 
burden (Sutherland et al., 2002). 
A separate study investigating the inheritance of IVM resistance in H. contortus, 
established a laboratory cross between an IVM resistant CAVR strain (CAVRS) and 
an IVM sensitive isolate (VRSG) (Le Jambre et al., 2000). The authors found that 
IVM resistance appeared to be autosomal and dominant in larvae (based on a LDT 
using avermectin B2). There was no difference in larval development in vitro in 
the presence of IVM between the F1 generation (offspring of the cross) and 
larvae of the resistant parental isolate (CAVRS) (Le Jambre et al., 2000). This 
was observed whether males or females of the resistant isolate were used in the 
cross. Nevertheless, following infection of sheep with the F1 generation of the 
cross, and in vivo treatment with IVM, 50% fewer males than females were found 
at post-mortem, suggesting some advantage of adult females exposed to IVM, 
and potentially a difference in resistance mechanisms between sexes (Le Jambre 
et al., 2000). More recently, a laboratory cross between males of the BZ, LEV 
and IVM resistant H. contortus isolate, MHco18(UGA), and females of the 
sensitive isolate, MHco3(ISE), found IVM resistance to be semi-dominant. A 
FECRT performed on a sheep infected with the F1 generation of the cross found 
that the adults were more resistant than MHco3(ISE), although less so than 
MHco18(UGA) (Laing, pers comm).  
1.8.2 IVM affects motility, fecundity and reproduction 
IVM is known to affect the motility of nematodes when applied in micromolar 
concentrations (LMIT) (Demeler et al., 2010a), and to alter feeding behaviour by 
acting on the pharynx (LFIT, LDT) when free-living stages of nematodes are 
exposed to nanomolar concentrations (Gill et al., 1995; Bartley et al., 2009). 
The latter causes cessation of pharyngeal pumping and can induce starvation 
(Laing et al., 2012).  
Evidence from field studies indicates that in vivo treatment with IVM also affects 
the reproductive system. Significantly increased mean numbers of eggs within 
adult H. contortus females were noted in sheep infected with an IVM resistant 
population at seven days post-IVM treatment compared with pre-treatment 
adults, and simultaneously lower FEC (Scott et al., 1991), suggestive of egg 
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retention. This followed an initial reduction in eggs within adult females at 48 
hours post-treatment. This could indicate that IVM may have both an 
embryostatic effect and, in addition, affect egg expulsion in H. contortus. This 
could be by separate modes of action. However, it should be noted that this 
study only evaluated ten H. contortus females at each sampling time point (via 
an abomasal cannula), and the reduced FEC was not followed up with an overall 
worm count post-treatment. In addition to suppression of egg output by IVM, 
eggs collected post-IVM treatment from adult females were also found to larvate 
within 48 hours at 27 °C but to remain unhatched (Scott et al., 1991). Although 
hatching appeared delayed in the study by Scott et al. (1991), a second study 
found that IVM resistant H. contortus eggs were capable of developing to L3 
providing they were first removed from faeces containing IVM (Tyrrell et al., 
2002). A similar experiment using T. circumcincta infection of seven month old 
lambs dosed with IVM-CRC found that the number of eggs per adult female was 
significantly higher in those treated with IVM than in control sheep (Sutherland 
et al., 2003a). However there was no overall difference in the FEC (although 
adult worm burden was still reduced, on average, compared to the control, but 
not significantly). Neither was any difference identified in the ability of eggs to 
hatch or develop to L3 in faeces (Sutherland et al., 2003a). IVM has also been 
shown to reduce fecundity by an unknown embryostatic mechanism in the filarial 
nematode Onchocerca volvulus (Duke et al., 1991) and in mosquitoes (Deus et 
al., 2012; Ng'habi et al., 2018). 
1.8.3 IVM interacts with ligand gated ion channels, but the cause 
of resistance is unknown 
The molecular basis of IVM resistance is likely to be multi-genic, and genes or 
mutations conferring resistance may vary between populations (Kotze et al., 
2014). Although many studies have been conducted to date, there has been no 
consensus of a single dominant gene or single nucleotide polymorphism (SNP) 
conferring IVM resistance. In contrast, studies have found strong associations 
between non-synonymous SNPs or indels present within target genes and 
anthelmintic resistance for both BZ (Kwa et al., 1995) and LEV (Barrère et al., 
2014; Blanchard et al., 2018). The model nematode, Caenorhabditis elegans, is 
used to study anthelmintic resistance within laboratory settings as it is easily 
manipulated and maintained, unlike ruminant parasitic nematodes. IVM was 
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shown to irreversibly activate a C. elegans glutamate gated chloride channel 
subunit, (GluCl), glc-1 (GluClα) expressed in Xenopus oocytes (Cully et al., 
1994), but a second GluCl tested (glc-2, GluClβ) was insensitive. These channels 
have been identified in invertebrates but not in the mammalian host 
(Wolstenholme, 2012). Initially, these target genes received much attention, and 
it was shown using C. elegans that IVM potentiated the effect of glutamate, 
causing paralysis of worms. The action of IVM was correlated with the presence 
of bound IVM in membrane fractions, suggesting that the channels were 
expressed in the cell membranes of C. elegans (Arena et al., 1995). A further 
GluCl gene was identified, which was post-synaptically expressed on the muscles 
of the pharynx and some head and anal motor neurons, and which was necessary 
for the pharynx muscles to respond to glutamate (Dent et al., 1997). The authors 
found that mutations in this gene alone, avr-15, were not sufficient to induce 
IVM resistance, but that worms with mutations in this gene could be further 
selected with IVM to produce resistant individuals carrying mutations in both 
avr-15 and a second unknown gene (Dent et al., 1997). They suggested that the 
main nematocidal property of IVM was its ability to paralyse the pharynx of 
worms, inducing starvation and preventing development to the next lifecycle 
stage. They observed that somatically paralysed adults of C. elegans were still 
viable, and hypothesised that the importance of somatic paralysis in a parasitic 
nematode would depend on its location in the host (Dent et al., 1997). Just 
three years later, the authors published information showing that, in C. elegans, 
IVM resistance increases 4000 fold following null mutations (variants which result 
in loss of function of the gene), in three GluCl genes; glc-1, avr-14 and avr-15 
(Dent et al., 2000).  
Early studies investigating the avr-14 orthologue in the cattle parasitic nematode 
C. oncophora, identified three SNPs (E114G, V235A and L256F) (Njue and 
Prichard, 2004). Following expression of these IVM sensitive and IVM resistance-
associated haplotypes in Xenopus oocytes, resistance-associated haplotypes were 
shown to be less sensitive to glutamate and to IVM. However, the fold changes 
were small, (2.6 fold increase in the EC50), and were predominantly related to 
the L256F SNP (Njue et al., 2004). Consistent with Dent et al. (2000), this would 
suggest that mutations in single genes confer little or no resistance. Both Cully 
et al. (1994) and Njue et al. (2004) found increased sensitivity to glutamate 
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when heteromeric channels (glc-1 and glc-2; avr-14 and glc-2) were expressed in 
Xenopus oocytes rather than homomeric channels, and this may partially 
underlie the requirement for multiple gene mutations. In 2011, a study using IVM 
resistant Belgian isolates of C. oncophora and O. ostertagi failed to detect the 
L256F polymorphism, but they did note that the avr-14 gene was highly 
polymorphic, with 32 alleles in a 190 bp region identified in a sensitive isolate 
and reduced allele diversity in resistant isolates. Additionally, reduced 
expression of both avr-14A and avr-14B in IVM resistant adults of C. oncophora 
was observed (El-Abdellati et al., 2011). In contrast, a study by Martinez-
Valladares et al. (2012b) searched for the presence of the L256F SNP within the 
T. circumcincta avr-14 gene. They failed to find either significant evidence of 
selection by IVM, or the presence of the SNP, and concluded that it was unlikely 
that avr-14 played a significant role in IVM resistance in T. circumcincta. One 
allele was significantly increased in frequency within an MTci5 adult population 
following IVM treatment compared to the IVM susceptible MTci1 population. 
Although non-synonymous SNPs were identified within avr-14B, all were at a low 
frequency (Martinez-Valladares et al., 2012b).  
In the parasitic nematode H. contortus, GluCl genes include avr-14, avr-15, glc-
2, glc-3, glc-4, glc-5 and glc-6 (McCavera et al., 2007; Glendinning et al., 2011). 
However, no orthologue of glc-1 is present (Laing et al., 2013). A few studies 
have shown associations between changes in GluCls and IVM phenotype, however 
others have not identified differences. For example, Blackhall et al. (1998) 
selected two H. contortus IVM resistant strains, using sub-optimal dosing over 17 
generations, from two parental isolates. The resistant strains survived 
approximately 10-fold higher IVM concentrations than that required to kill 95% of 
the parental isolates. These selected strains were compared to un-selected, 
sensitive strains derived from the same parental isolates. Following SSCP 
analysis, one GluCl allele was significantly increased in frequency in the 
resistant strain compared to the corresponding susceptible strain for one pair. 
However, no significant change was noted for the other strain (Blackhall et al., 
1998). The gene was later identified as Hco-glc-5 (Beech et al., 2010).  
In a similar way, differences were noted in allele frequency in some candidate 
IVM resistance genes in a study comparing four UK farm populations of H. 
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contortus but these were not associated with IVM resistance (Laing et al., 2016). 
No significant differences were noted between UGA/2004, a resistant isolate, 
and US/HcS, a susceptible isolate (Williamson et al., 2011). Neither were Hco-
glc-5 haplotypes linked with IVM resistance in backcrosses between the inbred 
susceptible strain MHco3(ISE), and two resistant isolates, MHco4(WRS) and 
MHco10(CAVR) (Rezansoff et al., 2016). Such changes more likely reflect 
diversity at this locus between populations therefore, rather than IVM selection. 
However, a 0.59 fold reduction in mRNA expression of Hco-glc-5 in UGA/2004 
compared with the US/HcS isolate was determined to be significant (Williamson 
et al., 2011), but, again, could reflect differences between isolates rather than 
IVM selection. Using the triple null mutant, IVM resistant C. elegans strain 
DA1316 (Dent et al., 2000), Glendinning et al. (2011) were able to demonstrate 
rescue of IVM induced paralysis using transgenic expression of Hco-avr-14b and 
partial rescue with Hco-glc-5, indicating IVM sensitivity of these channel 
subunits. Nevertheless, neither Laing et al. (2016), nor Rezansoff et al. (2016), 
found associations between Hco-avr-14b haplotypes and IVM resistance 
phenotype. Collectively, although GluCls are targets of IVM, studies to date do 
not suggest a major or consistent role for GluCls in mediating IVM resistance in 
parasitic nematodes of ruminants either in laboratory isolates or in field 
populations.  
Other possible candidate IVM resistance genes include those of the ATP-binding 
cassette transporter family (ABC transporters), of which the most frequently 
investigated in parasitic nematodes are the P-glycoproteins (P-gp). These are a 
family of multi-drug transporters which are involved in efflux of xenobiotics 
from cells (Lespine et al., 2012). Originally identified in multi-drug resistant 
cancer cells (Juliano and Ling, 1976), interaction of IVM with P-gps has been 
shown in both mammalian cell expression systems and in C. elegans (Godoy et 
al., 2015; Janssen et al., 2015; Godoy et al., 2016; Mani et al., 2016). 
Transgenic expression of parasitic nematode P-gps in mammalian cells, including 
Dirofilaria immitis PGP-11 (Mani et al., 2016) and H. contortus PGP-2 and PGP-
9.1 (Godoy et al., 2015, 2016), demonstrated inhibition of fluorophore 
accumulation by IVM. Parascaris pgp-11, transgenically expressed in a pgp-11 
deficient C. elegans, was shown to confer a 3.2 - 4.6 fold increase in IVM 
resistance relative to the deficient strain in a thrashing assay (Janssen et al., 
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2015). A thrashing assay is used in C. elegans to measure the effect of a drug or 
a mutation on the ability of the worms to move in liquid – the number of lateral 
movements of the body are counted and compared to controls. In C. elegans, 15 
P-gps are present (Sheps et al., 2004). Selective culture of an IVM resistant C. 
elegans strain on gradually increasing IVM concentrations up to 10 ng/ml, 
resulted in increased expression of P-gps, especially pgp-1, and another multi-
drug transporter, mrp-1 (James and Davey, 2009). In contrast, rapid selection of 
a H. contortus resistant strain (parental isolate MHco3(ISE)), did not identify 
changes in P-gp expression (Williamson and Wolstenholme, 2012). Different P-
gps may be important in anthelmintic resistance in different parasitic species, 
including pgp-2 in H. contortus (Lloberas et al., 2013), pgp-9 in T. circumcincta 
(Dicker et al., 2011b), and pgp-11 in Parascaris (Janssen et al., 2015). Several 
studies have found associations between constitutive and induced mRNA 
expression levels of P-gp genes and IVM resistance phenotypes in H. contortus 
(Xu et al., 1998; Prichard and Roulet, 2007; Williamson et al., 2011; Lloberas et 
al., 2013). Time dependent differences in P-gp expression have been observed 
(Lloberas et al., 2013), and 14 days post-IVM no differences were noted in a 
resistant H. contortus strain between untreated, treated worms or worms 
treated at ten times the recommended dose (Alvarez et al., 2015).  
In T. circumcincta, 11 partial P-gp sequences have been detected (Dicker et al., 
2011b). Upregulated expression of pgp-9 but downregulated expression of pgp-2 
was associated with the BZ, LEV and IVM resistant MTci5 isolate, compared with 
the sensitive isolate, MTci2 (Dicker et al., 2011b). Significantly reduced (0.12 to 
0.17 fold) expression of pgp-2 was identified in eggs, L1, ex-sheathed L3 and L4, 
but not in adults of MTci5 compared with MTci2 (Dicker et al., 2011b). In 
contrast, expression levels of pgp-9 were significantly increased (5.06 to 55.27 
fold) in all life stages of MTci5 compared with MTci2, most noticeably in eggs 
(Dicker et al., 2011b).  
Both synonymous and non-synonymous SNPs have been found within the Tci-pgp-
9 gene, and changes in haplotype frequencies have been noted, although the 
significance of these in relation to resistance has yet to be conclusively shown 
(Choi et al., 2017; Turnbull et al., 2018). Comparing the full-length pgp-9 cDNA 
(~3.8 kb) of MTci2 and MTci5, nine non-synonymous SNPs, corresponding to six 
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amino acid changes, were identified (Turnbull et al., 2018). A further four amino 
acid changes within the same region had been previously identified by Bisset 
(2007). Of these ten amino acid substitutions, only four were consistently 
identified with an IVM resistant phenotype (A662T, T663A, A664T, R697S) 
(Turnbull et al., 2018). Using individual worm gDNA qPCR, and pooled read 
counts, Turnbull et al. (2018), and Choi et al. (2017) found evidence for a 
potential increase in copy number of Tci-pgp-9 over and above that expected for 
a single copy gene in a diploid, heterozygous individual. Overall, Turnbull et al. 
(2018) identified a high level of within-population diversity at the Tci-pgp-9 
locus. Up to ten, seven and five pgp-9 haplotypes were identified in individuals 
of MTci2, MTci5 and post-IVM MTci5 populations, respectively (Turnbull et al., 
2018). The authors concluded that these results could indicate selection at the 
pgp-9 locus both by anthelmintics in general and IVM in particular. 
Studies investigating the potency of IVM in vitro with T. circumcincta and H. 
contortus L1, found IVM to be more effective against both susceptible (MTci3 
and MHco3(ISE)) and resistant (MTci4 and MHco4(WRS)) isolates, when worms 
were exposed to P-gp inhibitors (Bartley et al., 2009). Despite these findings, 
fold changes associated with P-gps are often small, with several studies unable 
to detect associations between P-gps and IVM resistance (Dicker et al., 2011a; 
Williamson and Wolstenholme, 2012; Alvarez et al., 2015; Rezansoff et al., 
2016). 
Other genes have also been investigated for their role in IVM resistance in 
nematodes. In the study by Dent et al. (2000), loss of wild type innexins (unc-7 
and unc-9, molecules forming gap junctions and involved in cell to cell 
transmission), was found to enhance IVM resistance in C. elegans. An amphidial, 
dye-filling defective gene (i.e. reduced uptake of Dil stain in amphids), osm-1, 
was also associated with resistance in C. elegans (Dent et al., 2000). In several 
laboratory H. contortus isolates a specific haplotype of Hco-dyf-7, another dye-
filling defective gene, containing 15 SNPs, was found to be associated with an 
IVM resistance phenotype (Urdaneta-Marquez et al., 2014). Nevertheless, no 
association of dyf-7 genotype and IVM selection was found in four H. contortus 
field populations within the UK (Laing et al., 2016). Recently, a study 
investigating the association between reduced Dil uptake by C. elegans 
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amphidial neurons and IVM resistance identified 17 mutants in a forward genetic 
screen which were able to survive on 10 nM IVM agar plates (Page, 2018). Of 
these, just two had variable filling of the amphids (the rest were dye-filling 
defective) and these were identified to contain mutations in dynein heavy chain 
genes, che-3 and dhc-3. IVM resistance in the wild type sensitive strain, N2, was 
induced by RNAi of either gene (Page, 2018). By screening previously identified 
dye-filling defective mutant strains, Page (2018) was able to confirm resistance 
to 10 nM IVM in ten strains, including a strain defective for dyf-7, but not a 
strain defective for osm-1. Finally, other ligand gated ion channels (LGIC) may 
also be important in IVM resistance, as IVM is known to antagonise Ascaris GABA 
receptors in L1 muscle cells (Holden-Dye and Walker, 1990). 
Since the advent of next generation sequencing (NGS) technologies, the 
opportunity to conduct genome wide association studies (GWAS) has become 
increasingly available as sequencing prices have reduced (Park and Kim, 2016). 
In 2017, the first GWAS in T. circumcincta investigating BZ, LEV and IVM 
resistance was published (Choi et al., 2017). A susceptible and a resistant NZ 
strain were used. The multi-drug (BZ, LEV and IVM) resistant strain had been 
isolated from the field and then subsequently selected in the lab for five 
generations, in an attempt to reduce diversity and increase homozygosity of 
resistance alleles. Backcrossing of these strains with in vivo anthelmintic 
selection had been carried out and both whole genome re-sequencing (WGS) and 
double-digest restriction-site-associated DNA sequencing (ddRAD-Seq) was 
performed (Choi et al., 2017). A separate study, using 2b-RAD, investigated IVM 
resistance in two laboratory isolates of H. contortus (Luo et al., 2017). Recently, 
WGS of backcrosses of two resistant H. contortus isolates to a susceptible 
isolate, with IVM selection at each of four generations has also been performed 
(Doyle et al., 2019). Importantly, none of these studies have found associations 
between any of the previously studied ‘candidate’ genes and IVM resistance, 
with the exception of pgp-9 in T. circumcincta. Here, there was a weak 
correlation between Tci-pgp-9 and IVM resistance, with increased copy number 
and distinct haplotypes detected within the multi-drug resistant population 
compared to the susceptible inbred strain (Choi et al., 2017). Instead, various 
genes, including a LGIC, Tci-lgc-54 (Choi et al., 2017) and Tci-mrp-6 (an ABC 
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transporter) (Choi et al., 2017) were implicated in IVM resistance in T. 
circumcincta. 
It is important to note that most studies have investigated IVM resistance using 
multi-drug resistant isolates. For example, MTci5 is resistant to BZ, LEV and IVM. 
These factors may impact on the outcome of a study, as mechanisms identified 
may be equally beneficial to the nematode in resisting the effect of multiple 
anthelmintic classes. This is especially true of the P-gps, recognised as a method 
of multi-drug resistance in cancer studies (Lehne, 2000). In addition, many 
studies compare isolates and parasite populations obtained from discrete 
geographical regions or hosts, both of which will impact on genetic selection 
pressures, leading to differences in genotype which may have little bearing on 
IVM sensitivity (Sallé et al., 2019). Lastly, nematode parasite populations are 
highly diverse and sub-populations of drug resistant worms may exist within the 
overall multi-drug resistant population (Sarai et al., 2014). This phenomenon 
may confound results if not accounted for, however it can also be exploited to 
detect regions of the genome specifically under selection by IVM (Doyle et al., 
2019). 
1.9 Benzimidazole Resistance  
At the time of writing, molecular detection of polymorphisms is only established 
for BZ resistance, with the understanding that non-synonymous SNPs in the β-
tubulin isotype-1 gene are capable of conferring resistance in parasitic 
strongyles (Coles et al., 2006; Beech et al., 2011). These include SNPs in codons 
F167Y (tTc > tAc) (Silvestre and Cabaret, 2002), E198A/L (gAa > gCa or GAa/GAG 
> TTa) (Ghisi et al., 2007; Rufener et al., 2009a; Redman et al., 2015) and, most 
commonly, in codon F200Y (tTc > tAc) (Kwa et al., 1995). Computer modelling 
has suggested that the presence of tyrosine at codon 200 prevents BZ from 
binding β-tubulin isotype-1, and is the amino acid found at this position in 
mammalian β-tubulin isotype-1 (Robinson et al., 2004).  
None of the molecular methods commonly in use allow interpretation of all 
three codons at once, necessitating at least two PCRs. In addition, some 
methods are more limited in their interpretation than others. Pyrosequencing 
conditions for both H. contortus (von Samson-Himmelstjerna et al., 2009b) and 
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T. circumcincta (Skuce et al., 2010) have been published, in which all SNPs are 
sequenced in two separate reactions; these and similar assays have been 
employed in several field studies (von Samson-Himmelstjerna et al., 2009b; 
Skuce et al., 2010; Martinez-Valladares et al., 2012a; Ramünke et al., 2016). In 
contrast, allele-specific PCRs have been reported for codon 200 (Elard and 
Humbert, 1999; Silvestre and Humbert, 2000), and for alanine at codon 198 
(Rufener et al., 2009a) but not for codon 167, requiring separate PCRs and 
limiting interpretation of results. Furthermore the allele-specific PCRs are fickle 
and require highly stringent lab techniques, with accurate primer 
concentrations, and fresh L3 (Coles et al., 2006). As for the in vivo and in vitro 
tests, molecular tests on pools of larvae can be confounded by species identity. 
One particular allele-specific PCR, including a speciation step in the protocol, 
was described by Silvestre and Humbert (2000). Species identity was determined 
using a restriction fragment length polymorphism PCR, prior to detection of the 
codon 200 SNP allele using β-tubulin isotype-1 species-specific primers. 
However, this can be difficult to interpret due to the presence of multiple bands 
in the speciation PCR. NGS is now being used to swiftly diagnose and investigate 
BZ resistance in pools of mixed species individuals (Avramenko et al., 2019), 
which can be comparatively easy to set-up, but expensive to perform. A 
potential inexpensive molecular test for field use may be the Loop-mediated 
isothermal amplification (LAMP) assay which has the ability to detect three 
alleles of a SNP that confers resistance to the BZ fungicide carbendazim (Duan et 
al., 2018). These fungal LAMP assays appear to be both sensitive and specific, 
even in the presence of large amounts of non-organismal DNA (Duan et al., 
2016). It is likely that other BZ resistance mechanisms exist (Sangster et al., 
1998; Beech et al., 2011; Kotze et al., 2014; Hahnel et al., 2018), but detection 
of these has been limited. 
1.10 Levamisole Resistance 
LEV induces a spastic paralysis in nematodes by binding to acetylcholine 
receptors (AChR) on nematode somatic muscle cells (Lewis et al., 1980). There 
are many types of AChR, which vary between species (Qian et al., 2008; Neveu 
et al., 2010; Boulin et al., 2011) and there is inherent variability in their ligand 
sensitivity and specificity (Qian et al., 2006). There also appears to be a degree 
of plasticity or redundancy within the nAChR subunit gene family, which may 
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complicate the understanding of LEV resistance. In C. elegans, the LEV sensitive 
AChR is pentameric, composed of three α-subunits: LEV-8, UNC-38 and UNC-63 
(Culetto et al., 2004; Towers et al., 2005), and two non-α subunits, LEV-1 and 
UNC-29 (Fleming et al., 1997). Three ancillary factors, RIC-3, UNC-50 and UNC-
74 are required for functional expression in Xenopus oocytes (Boulin et al., 
2008). However, in the parasitic nematodes, H. contortus and T. circumcincta, 
no lev-8 orthologue has been identified (Neveu et al., 2010; Blanchard et al., 
2018). A functional LEV sensitive receptor was produced in Xenopus oocytes 
using Hco-unc-38, Hco-unc-63, Hco-unc-29, and Hco-acr-8 (Boulin et al., 2011). 
Additional expression of Hco-lev-1 made little difference to the current detected 
following application of LEV to the cells. The absence of Hco-acr-8 greatly 
reduced the current response, but did not eliminate it (Boulin et al., 2011). 
Homologues of these genes have been identified in T. circumcincta, although 
functional expression has not yet been performed (Walker et al., 2001; Neveu et 
al., 2010; Boulin et al., 2011). Transgenically expressed Hco-unc-38 cDNA, was 
sufficient to fully rescue the LEV resistant phenotype (with associated 
behavioural abnormalities) of a C. elegans null mutant, but Hco-unc-29 was only 
able to partially rescue a Cel-unc-29 null mutant (Sloan et al., 2015). However, 
the authors used only one isotype of Hco-unc-29, while four isotypes of unc-29 
are recognised in both H. contortus and T. circumcincta (Neveu et al., 2010). 
Finally, Blanchard et al. (2018) produced evidence that the transgenic 
expression of Hco-acr-8 in body wall muscle was able to restore LEV sensitivity in 
a C. elegans mutant strain lacking Cel-lev-8 and resistant to LEV. This indicates 
that Cel-acr-8 may not naturally form functional LEV sensitive receptors in C. 
elegans in the absence of Cel-lev-8, despite the formation of such receptors in 
Xenopus oocytes. Or, if it does, that it is less responsive to LEV than when 
expressed in Xenopus oocytes (Blanchard et al., 2018). Finally, knock-down of 
acr-8 using siRNA in H. contortus L2 induced a LEV resistance phenotype 
compared to control larvae (Blanchard et al., 2018). 
LEV resistance in parasitic nematodes has been predominantly associated with 
truncated forms of alpha-subunits of AChRs. A truncated isoform of acr-8, 
termed acr-8b in H. contortus (Fauvin et al., 2010) and also a truncated isoform 
of unc-63, termed unc-63b in H. contortus, T. circumcincta and Trichostrongylus 
colubriformis (Neveu et al., 2010) have been identified. Again using Xenopus 
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oocytes as an expression system, the presence of Hco-unc-63 was shown to be 
required for a functional receptor, however the co-expression of Hco-unc-63b 
was found to have a dominant negative effect, greatly reducing the response of 
the receptor (Boulin et al., 2011). The presence of an indel within the second 
intron of Hco-acr-8 has since been associated with the Hco-acr-8b truncated 
transcript in various isolates, recognising that the transcript is formed from 
exons 1 and 2 of Hco-acr-8, with an additional third exon formed from sequence 
found within intron 2 (Barrère et al., 2014). Nonetheless, resistance appears 
complex, with both LEV-resistant and LEV-susceptible isolates containing the 
deletion (Barrère et al., 2014). Also, expression patterns of the various subunits, 
including Hco-acr-8b and Hco-unc-63b, and the three ancillary factor genes vary 
between lifecycle stages within an isolate and between isolates (Sarai et al., 
2013, 2014). In addition, the relative expression of these subunits is not 
conserved in three separate H. contortus multi-drug resistant isolates compared 
to a susceptible isolate (Sarai et al., 2013). Some of this variation may be 
explained by sub-populations of worms with different LEV phenotype within an 
overall population. Higher level in vitro resistance of H. contortus Wallangra L3 
was associated with more consistently reduced expression of AChR subunits and 
ancillary genes compared to the whole population (Sarai et al., 2014). Various 
amino acid changes have been identified in AChR subunits in H. contortus, 
although prevalence between three resistant isolates varied (Sarai et al., 2013). 
In T. circumcincta, differences in frequency of Tci-unc-38 (tca-1) alleles 
between a resistant isolate and two susceptible isolates were observed, 
including amino acid changes, but no association of any particular allele with 
LEV resistance was identified (Walker et al., 2001). Interestingly, in C. elegans, 
a single basepair change in the first intron of Cel-lev-8 corresponds to the 
presence of two alternatively spliced isoforms, with premature stop codons 
(Towers et al., 2005). lev-8 mutant worms are partially resistant to LEV, and can 
be partially rescued to wildtype sensitivity by extrachromosomal expression of 
Cel-lev-8 (Towers et al., 2005). LEV resistance is therefore potentially complex, 
with at least 11 genes originally identified in early C. elegans studies associated 
with variation in resistance phenotype between mutants (Fleming et al., 1997). 
Furthermore, a considerable number of genes are involved in the pathway 
enabling functional responses to ACh and LEV (Martin et al., 2012). Although 
there is good evidence for the correlation of indels in acr-8 with LEV sensitivity 
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in H. contortus (Fauvin et al., 2010; Blanchard et al., 2018), the deletion 
appears to vary between isolates and has not been identified in other strongyle 
species. 
1.11 Monepantel Resistance 
Before its release onto the market, Kaminsky et al. (2008) determined the genes 
associated with MPTL resistance in C. elegans (acr-23) and H. contortus (des-2 
and acr-23). Subsequently, acr-23 was renamed Hco-mptl-1 (Rufener et al., 
2009b). MPTL resistant T. circumcincta strains have also been generated at the 
MRI: MTci2-11, MTci5-13 and MTci7-12, with sub-therapeutic dosing (Bartley et 
al., 2015). Of concern was the observation that the MPTL resistant T. 
circumcincta strain, MTci7-12 appeared to establish patency more rapidly and to 
be more fecund, than the parental strain (MTci7) from which it was derived 
(Bartley et al., 2015). In another study, rapid selection of a resistant H. 
contortus strain was possible in the laboratory after isolation of a field isolate 
obtained following a FECRT, which showed an efficacy of 99.2%, from which 
offspring of the survivors were used to infect a single sheep (Raza et al., 2016c). 
A FECRT was performed and MPTL efficacy was found to be only 15% effective 
(Raza et al., 2016c). Interestingly, LDTs demonstrated the presence of at least 
two separate sub-populations. This may indicate two or more mechanisms of 
resistance, conferring low and high level (more than 1000-fold increase of the 
ED50 compared to a susceptible isolate) resistance to MPTL in vitro (Raza et al., 
2016c). Sequencing of the resistance-associated gene, Tci-mptl-1, in both lab 
and field populations, has confirmed positive selection at this locus, noting a 
reduction in allele frequency from many haplotypes pre-treatment, to just one 
major haplotype post-treatment (Turnbull et al., 2019). However the causative 
polymorphism is unknown, and the alleles under selection differed between 
isolates, suggesting multiple genetic backgrounds are associated with resistance. 
Work is still ongoing, but it may be that a diagnostic test of MPTL resistance will 
need to encompass more than one variant. Recently a GWAS using a H. contortus 
genetic cross confirmed a single region surrounding Hco-mptl-1 is under 
selection by MPTL (Niciura et al., 2019). 
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Table 1.4: Mechanisms of resistance in parasitic strongyles.  
Anthelmintic Mechanism of resistance in parasitic strongyles Potential mechanisms of 
resistance 
BZ 
 
β-tubulin isotype-1 SNPs; F167Y, 
E198A/L, F200Y (Kwa et al., 1995; 
Silvestre and Cabaret, 2002; Rufener et 
al., 2009a) 
β-tubulin isotype-2 (Kwa et al., 
1993) 
Other loci (Hahnel et al., 2018) 
LEV 
 
AChR truncated proteins; acr-8/acr-8b, 
unc-63/unc-63b (Fauvin et al., 2010; 
Neveu et al., 2010; Boulin et al., 2011; 
Barrère et al., 2014) 
Other AChRs or genes involved 
in the LEV sensitive AChR 
pathway (Fleming et al., 1997; 
Walker et al., 2001; Towers et 
al., 2005; Martin et al., 2012) 
IVM   Unknown 
 
Gene(s) within a region on Chromosome V 
in H. contortus (Doyle et al., 2019) 
GluCls (Dent et al., 2000) 
Amphidial genes (Dent et al., 
2000; Urdaneta-Marquez et al., 
2014; Page, 2018)  
Innexins (Dent et al., 2000) 
MON 
 
AChRs, mechanism unknown; mptl-1/acr-
23, des-2 (Kaminsky et al., 2008; Rufener 
et al., 2009b)  
AChR deg-3 (Rufener et al., 
2009b)  
 
Multi-drug 
resistance 
 
P-glycoproteins (Blackhall et al., 2008; 
Bartley et al., 2009; Dicker et al., 2011b; 
Raza et al., 2016b; Turnbull et al., 2018) 
Tolerance; transcription factors 
(Ménez et al., 2019), lipid 
metabolism (Laing et al., 2012), 
drug metabolism (Fontaine and 
Choe, 2018; Stuchlikova et al., 
2018). Amphids (Page, 2018) 
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1.12 What factors affect the genetic footprint of 
resistance? 
Anthelmintic resistance can arise by one of two methods. Either resistance 
conferring mutations are already present within a population and these are 
selected for by treatment, or mutations arise de novo during active anthelmintic 
use on a farm. A study by Redman et al. (2015), sequencing a region of the β-
tubulin isotype-1 gene, noted that mutations arose independently on several 
farms, as had also been found in another study of BZ resistance (Skuce et al., 
2010). In addition, Redman et al. (2015) demonstrated the spread of BZ 
resistance between several UK farms, likely due to sheep movement, which was 
particularly obvious for the less common mutation noted at codon E198L. 
Strongyles are sexually reproducing, and H. contortus has been shown to be 
polyandrous, with occasional fully or partially triploid individuals (Doyle et al., 
2018). Mutation rates are expected to be high, despite comparatively low 
recombination rates (Doyle et al., 2018). These traits are reflected in the 
relatively high nucleotide diversity (π) estimates of 0.022 to 0.038 identified for 
autosomes of H. contortus isolates (Doyle et al., 2019). These stand in contrast 
to nucleotide diversity estimates for the hermaphrodite C. elegans, which are 
much lower and were calculated to be only 0.00068 for one sample population 
(Cutter, 2006), despite a recombination rate almost double that of H. contortus 
(Barnes et al., 1995). This high nucleotide diversity, the probability that two 
sequences will differ at a given genomic site, provides the potential for dilution 
of resistance SNPs within the population as a whole, in the absence of drug 
selection as new mutations occur. However, it also increases the chance of a 
resistance-conferring SNP arising de novo. In the presence of drug, positive 
selection occurs, and the number of alleles within the population decreases 
(Lubega et al., 1994; Redman et al., 2012). Dependent on the number of 
independent origins of resistance, the number of alleles retained will vary. If 
there is a hard sweep, just one or two genetic backgrounds carrying the resistant 
allele will be selected (Barnes et al., 2017). In contrast, a soft sweep will occur 
when many genetic backgrounds contain the resistant allele (Redman et al., 
2015). However, with a high mutation rate, and a high recombination rate, the 
time since the variant arose will greatly affect how easy it is to detect such a 
selection pressure. For example, ancient mutations are likely to now be present 
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on many different genetic backgrounds and a hard sweep could resemble a soft 
sweep. As the rate of recombination varies between different chromosomes of 
H. contortus (Doyle et al., 2018), the position of a variant within the genome is 
also important as to how rapidly the genetic background surrounding the variant 
will diversify. Recombination rate also varies along individual chromosomes, in 
both H. contortus (Doyle et al., 2018) and C. elegans (Rockman and Kruglyak, 
2009), such that the position within a chromosome may also effect the size of 
the genetic footprint identified. Whether a resistance conferring mutation is 
dominant or recessive will also affect the selection pressure seen (Smith and 
Haigh, 1974). Finally, the potential for dilution of resistance alleles will be 
impacted upon by the size of the population unexposed to drug, known as the 
population in refugia (Martin et al., 1981; van Wyk, 2001).  
1.13 Why might anthelmintic resistance have arisen so 
rapidly? 
Nematode parasites of sheep are generally highly fecund, with each T. 
circumcincta adult able to lay about 100-200 eggs per day (Cole, 1986), and each 
H. contortus female capable of producing approximately 5000 eggs per day 
(Coyne and Smith, 1992). Large parasite population sizes, and the delay between 
treatment of a host with an anthelmintic and patency of new infection, could 
rapidly increase the prevalence of resistance alleles on pasture. In the past, 
farmers were advised to ‘treat and move’ their sheep onto clean pasture, a 
management practice which likely exacerbated development of resistance. All 
farmers are currently advised to quarantine and treat new stock on pasture not 
routinely grazed by other animals on the farm, or indoors (especially for the first 
48 hours) (Abbott et al., 2012). However, there is no guarantee that this will be 
performed (Jack et al., 2017), nor that multi-drug resistant parasites are not 
present, allowing resistant parasites to be introduced to the flock. The practice 
of under-dosing sheep, by inaccurate estimation of an animal’s weight, poor 
calibration of a dosing gun, or following inefficient dosing such that an animal 
swallows only part of the required dose, is also thought to be a major factor in 
the development and spread of resistance (McMahon et al., 2013c). It has been 
proposed that the use of sub-optimal doses allows for more rapid development 
of resistance, but by the selection of genetic mutations which may not confer 
full resistance against the correct dose. For example, in C. elegans, generational 
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selection of worms using increasing doses of IVM identified selection of P-gps   
(James and Davey, 2009), in contrast to GluCls. Alternatively, sub-optimal dosing 
may allow parasites heterozygous for a recessive resistance-conferring mutation, 
to survive and contribute towards the next generation of parasites. In the UK, 
where we have a stratified sheep industry, the spread of resistance alleles 
between farms appears to be inevitable. 
1.14 What are the concerns with anthelmintic resistance?  
PGE raises both welfare and economic concerns. For UK farmers, as for many 
others, the inability to control PGE calls into question the sustainability of sheep 
farming (Lovatt and Stubbings, 2018). Some farms have already closed due to a 
lack of control options in the face of multiple anthelmintic resistance (Sargison 
et al., 2005). Following BREXIT, it is likely that many farmers will fail to make a 
profit unless they are able to make considerable changes to their farm 
management and production costs/outgoings (AHDB, 2017). Although other 
production diseases obviously impact flocks, PGE is ubiquitous and most farmers 
rely heavily on anthelmintics to control parasites and maintain reasonable 
weight gains on farm (Burgess et al., 2012). Whilst in the UK the cost of rising 
anthelmintic resistance will predominantly be felt by individual farmers, their 
families and their flocks, on a worldwide scale the sustainability of food 
production is a key concern (Fitzpatrick, 2013; Morgan et al., 2013). Many 
subsistence farmers rely on small ruminants to provide both milk and meat 
(Alary et al., 2011) and PGE has been shown to considerably affect both these 
production traits (Mavrot et al., 2015). Anthelmintic resistance in these 
conditions contributes to human malnutrition and subsequently a rise in endemic 
diseases of both livestock and humans.  
As anthelmintic resistance increases within strongyle populations on a holding, 
the benefit of using these products reduces until clinically apparent anthelmintic 
resistance is seen (Sargison, 2011). In addition, although for the BZ, LEV and 
macrocyclic lactones, no apparent benefit has been noted for anthelmintic 
resistant parasites, there are also no reports of a fitness cost of anthelmintic 
resistance (Elard et al., 1998; Leathwick, 2013). In contrast, one MPTL resistant 
T. circumcincta laboratory strain did appear to have enhanced parasite fitness 
traits compared to its MPTL sensitive parental population (Bartley et al., 2015). 
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These differences however were not seen in two other selected strains and may 
be related to genetic drift, or genetic hitch-hiking of fitness traits which are 
isolate specific, rather than a change directly related to anthelmintic resistance 
(Maingi et al., 1990). Anthelmintic resistance is not only present in sheep 
nematodes but is also a serious problem in: Fasciola hepatica populations (Kelley 
et al., 2016), cattle nematodes (O. ostertagi, C. oncophora) (Kaplan and 
Vidyashankar, 2012), human nematodes (sub-optimal responses noted to IVM in 
Onchocerca volvulus) (Awadzi et al., 2004), canine heartworm (D. immitis) 
(Bourguinat et al., 2015), equine strongyles (Nielsen et al., 2014), and P. ovis, 
where macrocyclic lactones are used (Sturgess-Osborne et al., 2019). Overall this 
trend highlights the capability of these parasites to survive and adapt to 
changing circumstances. Although livestock farming is still possible in the face of 
anthelmintic resistance, productivity will fall and, for many, this may make 
commercial farming and production of food for the human population untenable. 
1.15 Is there hope in the face of anthelmintic resistance?  
Although no studies have yet shown that anthelmintic resistance associated 
genotypes may be lost from the population, several have demonstrated 
improvement in anthelmintic efficacy within a flock over time (Kenyon et al., 
2013; Leathwick et al., 2015). This has followed use of newer and combination 
products over the use of older, single class anthelmintics (Leathwick et al., 
2015), and the use of targeted selective treatment within a flock (Kenyon et al., 
2013). In the study of Leathwick et al. (2015), no improvement in drug efficacy 
was observed for BZ anthelmintics, perhaps relating to fixation of BZ resistance 
within the population. Potentially, improvements for other anthelmintics might 
have arisen from a decrease in the prevalence of anthelmintic resistant 
genotypes within the parasite population as a whole, or from reduced 
proportions of these genotypes contributing to resistant phenotypes. For 
example, dilution by a susceptible in refugia population could lead to the 
presence of heterozygotes. Alternatively, improvement may simply be due to 
increased within host strongyle diversity with sensitive species (Melville et al., 
2016), without any change in the prevalence of the resistance alleles within the 
resistant species population. If anthelmintic resistance is conferred by recessive 
alleles then the presence of a sensitive in refugia population may help to 
mitigate selection pressure by anthelmintic treatments. However, it will need to 
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be carefully managed as, without a fitness cost, any anthelmintic use will 
prioritise the survival of resistant genotypes over sensitive genotypes (van Wyk, 
2001). This is true for either dominant or recessive genotypes. The former will 
confer a resistance phenotype in both heterozygotes and homozygotes. In 
contrast, recessive genotypes, unless there is sufficient refugia, will rapidly 
increase in the population to fixation as only homozygotes survive treatment. 
However, anthelmintic resistance is not, by itself, a disease but merely a 
constraint to one management option of PGE (Sargison, 2014). With other 
management practices, such as co-grazing or rotational grazing with cattle 
(Jordan et al., 1988), or the judicious use of alternative forages and arable crops 
(Marley et al., 2003), it may be possible to better control larval numbers and 
strongyle diversity reducing the severity of PGE (Learmount et al., 2016b). 
Selective breeding of sheep enables selection for those resilient (high egg 
output, mild clinical signs) or resistant (low egg output), to T. circumcincta, by 
the use of recording on farm and through sire/maternal offspring monitoring 
(Morris et al., 2010). One such method, which may increase in use for this 
purpose, is that of monitoring the levels of lamb salivary IgA, with affinity for T. 
circumcincta L3 antigen in vitro (Fairlie-Clarke et al., 2019). As lambs are the 
main drivers of the multiplication of pasture larvae during the summer months, 
the ability to rapidly finish lambs earlier in the year is another way to better 
mitigate the effects of PGE. AHDB Beef and Lamb estimate that it is possible to 
finish lambs within 12 weeks, however in order for this to occur excellent 
pasture management is required to ensure the availability of sufficient, high 
quality feed (Laws and Genever, 2015). Some farmers choose to bring lambing 
forward, ensuring that lambs are finished before the warmer weather arrives. 
This avoids grazing young, susceptible lambs, at a time when eggs laid will 
rapidly develop to infective L3. Alternatively, it is possible to extend finishing 
time considerably, expecting lambs to remain on the farm far longer than 
normal, within a low input, slow output type system (van Wyk et al., 2003). 
Although this may not alleviate the effects of PGE, it can help to mitigate the 
production costs.  
The use of vaccines (such as Barbervax® available for H. contortus 
http://barbervax.com.au/) and any future novel anthelmintics may assist with 
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the management of PGE (Smith et al., 2001). Although the H. contortus vaccine 
can greatly reduce reliance on anthelmintics, multiple doses are required over a 
breeding season (six for lambs and three to five for ewes) and some worms can 
survive the vaccine (Sallé et al., 2018). It is thus possible that any vaccine 
developed will still have a limited lifespan and/or will always require to be used 
alongside additional management tools. Furthermore, all vaccines to date are 
species specific, requiring management of other strongyle species contributing 
to PGE. The use of combination anthelmintic products may assist in reducing 
clinical disease, however the presence of dual-resistant parasites within a 
population limits the effectiveness of this strategy (Sargison et al., 2001). The 
proportion of strongyles within the overall population carrying resistance 
genotypes will ultimately depend on a vast multitude of factors. These include: 
the initial presence of the resistance genotypes within the population (Silvestre 
et al., 2000), the accuracy and frequency of dosing (Leathwick et al., 2015), the 
presence and size of the in refugia population (Martin et al., 1981), management 
factors (Sargison et al., 2007), host immune responses (Ahmed et al., 2015) and 
climatic conditions (Kenyon et al., 2009b; Rose et al., 2016) which may all 
impact parasite survival.     
1.16 Investigating the genetic basis of drug resistance 
using next generation sequencing 
In 1977, Sanger sequencing was developed wherein the addition of 
complementary nucleotide bases (dNTPs) occurred until the addition of a ddNTP 
prevented further elongation of the strand. Identification of sequence lengths 
generated for each ddNTP base reaction allowed identification of the order of 
bases within a DNA sequence (Sanger et al., 1977). In 1990 this process was 
greatly improved through the use of capillary electrophoresis to separate and 
determine the size of the sequenced strands (Swerdlow and Gesteland, 1990). 
Although a significant advancement for understanding genetic mechanisms and 
allowing sequencing of genomes, the Sanger sequencing technique was slow and 
expensive, costing about $300 million to sequence the human genome over 
several years (Bentley et al., 2008). Subsequently, NGS, also referred to as 
second generation sequencing, was developed. A range of NGS platforms are 
available, of which the Illumina is perhaps the most widely adopted (Bentley et 
al., 2008). These ‘massively parallel’ technologies have greatly increased the 
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potential for sequencing entire genomes and the cost per megabase sequenced 
has considerably reduced over the last decade, from approximately $10,000 in 
2001, to $10 in 2008, and by 2017, human DNA could be sequenced for just $0.01 
per megabase (Wetterstrand, 2019). In addition, the Illumina sequencing method 
was considerably quicker than first generation sequencing methods, taking just 
eight weeks to sequence a human genome to a depth of 40x coverage (Bentley 
et al., 2008).  
GWAS allow investigation into the genotype conferring a particular phenotype, 
without specifically targeting a single region or gene family. Instead, using an 
unbiased approach, GWAS look for regions of selection (or association) across the 
entire genome. These studies provide the means by which to identify novel 
regions under selection, without the constraint of pre-supposed theories as to 
the genetic basis of a trait. GWAS can be conducted using relatively few markers 
(SNPs or microsatellites, for example) spread across the genome. Alternatively, 
using whole genome sequencing techniques, the entire genome can be used to 
identify smaller regions of differentiation between two sample populations. 
GWAS have successfully identified regions and genes associated with drug 
resistance in trematodes (e.g. Schistosoma mansoni and oxamniquine resistance, 
Valentim et al. (2013)), nematodes (e.g. H. contortus and IVM resistance, Doyle 
et al. (2019)), protozoa (e.g. Plasmodium falciparum and artemisinin resistance, 
Cheeseman et al. (2012)) and insects (e.g. Anopheles funestus and pyrethroid 
resistance, Barnes et al. (2017)). While some studies have identified novel 
regions under selection by a drug (Cheeseman et al., 2012; Takala-Harrison et 
al., 2013; Valentim et al., 2013; Doyle et al., 2019), others have aimed to 
confirm mechanisms already identified as the cause of drug resistance (Niciura 
et al., 2019), reducing the probability of the existence of additionally selected 
regions.  
Several studies have been performed on parasites where clonal expansion within 
a host occurs. Clonal expansion has the major advantage of enabling a large 
number of identical parasites to be produced from a single resistant or 
susceptible individual as was recently demonstrated using F. hepatica 
(Hodgkinson et al., 2018). This provides a sufficient quantity of DNA for NGS 
from, essentially, a single individual, avoiding the use of error-inducing DNA 
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amplification methods. In contrast, mixed populations contain inherent 
diversity, which can complicate investigation of drug resistance. This is true 
both for sexually reproducing species, such as H. contortus (Sallé et al., 2019) 
and T. circumcincta (Choi et al., 2017), and for those capable of clonal 
expansion in addition to sexual reproduction, such as F. hepatica (Beesley et al., 
2017). Although lab isolates of sexually reproducing parasites can be inbred, as 
has been performed with both H. contortus (Sargison et al., 2017) and T. 
circumcincta (Choi et al., 2017), diversity can still remain – often to a significant 
extent. In addition, resistance conferring variants identified in lab isolates may 
not reflect field population mutations or mechanisms. An ongoing study 
investigating triclabendazole resistance in F. hepatica has produced clonal 
populations of both resistant and susceptible field individuals (Hodgkinson et al., 
2018). These have been used to generate field-derived genetic crosses to study 
triclabendazole resistance (Hodgkinson et al., 2013). This has provided both 
reduced diversity in addition to introgression and selection of resistance 
associated mutations, enhanced by knowledge of differences in parental SNPs 
between the resistant and susceptible clones. Others have used a genetic cross 
between susceptible and resistant lab isolates of the sexually reproducing H. 
contortus (Redman et al., 2012), or T. circumcincta (Choi et al., 2017) to 
introgress regions associated with anthelmintic resistance into a sensitive 
genetic background. However, Doyle et al. (2017) successfully used field 
populations of Onchocerca volvulus, without crossing or inbreeding of parasites, 
to identify novel regions of genetic differentiation based on IVM phenotype.  
Often, additional testing using more outbred populations, or finer mapping with 
SNPs or microsatellites is employed to refine a region identified during a GWAS. 
One such example of this was by Valentim et al. (2013) investigating 
oxamniquine resistance in the trematode S. mansoni. A genetic cross was 
performed to identify a region under selection containing 184 genes. Following 
WGS to identify SNPs between the resistant and susceptible parental isolates 
within this region, a subset of these SNPs and additional microsatellites were 
utilised to refine the region. Having a list of just 16 potential candidates, they 
employed further genome-wide NGS (RNA-Seq) and additional experiments to 
identify the causative gene of oxamniquine resistance (Valentim et al., 2013). 
Using the knowledge that oxamniquine must be metabolised to its active form to 
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kill S. mansoni, they identified suitable genes by predicted function. Production 
of recombinant proteins and the use of a biochemical complementation assay 
confirmed a single sulfotransferase as the most likely gene candidate conferring 
oxamniquine resistance (Valentim et al., 2013). Subsequent studies used this 
information to further investigate oxamniquine resistance in the field (Chevalier 
et al., 2016; Chevalier et al., 2019). Hence, for the recessive oxamniquine 
resistance trait a GWAS using a genetic cross between clonal sample populations 
enabled identification of the region containing the gene responsible. However, 
identification of the gene itself relied on additional knowledge of how parasites 
mediate resistance to oxamniquine, which had been previously identified (Pica-
Mattoccia et al., 2006).         
There is a current need to identify markers of anthelmintic resistance in 
parasites for the macrocyclic lactones, in particular IVM, which is widely used as 
a broad-spectrum endectocide in both animals and humans (Campbell, 1985, 
1991). Research investigating single genes has failed to find consistent evidence 
of a genetic marker within or between species (Kotze et al., 2014), and the 
mechanism of IVM resistance is unknown. Many studies are confounded by the 
use of isolates or strains originating from different geographic regions, or by 
comparing a susceptible isolate with a multi-drug resistant isolate (Laing et al., 
2016).  
Recent studies have used surgical techniques in sheep to generate genetic 
crosses between susceptible and resistant laboratory isolates of H. contortus, 
introgressing resistance markers into a sensitive genetic background. An initial 
study backcrossed MHco4(WRS) and MHco10(CAVR), two drug-resistant isolates 
from differing geographical origins, to MHco3(ISE), a susceptible isolate used in 
the genome project (Redman et al., 2012). The study identified a microsatellite 
marker, Hc_8a20, which appeared to be linked to IVM resistance, and which has 
been identified in subsequent studies (Laing et al., 2016; Rezansoff et al., 2016). 
Recently, WGS of parental isolates and offspring of these H. contortus genetic 
crosses to investigate IVM resistance identified selection over a large region of 
Chromosome V (Doyle et al., 2019), which contained the Hc_8a20 microsatellite. 
A third H. contortus genetic cross, using MHco3(ISE) crossed with MHco18(UGA), 
performed as part of work of the BUG Consortium 
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(https://bugconsortium.wordpress.com/) identified the same region on 
Chromosome V (Laing, pers comm).  
Only a single GWAS investigating anthelmintic resistance in T. circumcincta has 
been performed. This employed NGS and backcrossed a triple resistant strain 
into a sensitive inbred strain (Choi et al., 2017). The study identified the β-
tubulin isotype-1 locus (likely due to BZ selection), Tci-pgp-9 and various LGICs 
in addition to other genes potentially involved in LEV or IVM resistance. 
However, the genome used (PRJNA72569, (Choi et al., 2017)), was highly 
fragmented and whether a few or many loci were under selection was not clear. 
In addition, it was not possible to determine genes solely related to IVM 
selection (Choi et al., 2017). Importantly, none of these studies have found 
candidate genes to be strongly associated with IVM resistant phenotypes. In 
contrast, introgression of MPTL resistance into a sensitive background confirmed 
the region around Hco-mptl-1 to be under selection (Niciura et al., 2019).  
Such GWAS have excellent potential and can clearly identify regions under 
selection specific to IVM through comparison with parental isolates or untreated 
progeny of the genetic cross. However, they can suffer two main limitations. 
Firstly, it is unknown whether the genetic basis of resistance is the same in field 
populations as in lab isolates. Also, generational selection of helminths in the lab 
takes considerable time, restricting the number of generations included in these 
studies. Thus the genetic footprints of selection can be quite large, containing 
many potentially important genes, such as was found with IVM resistance in H. 
contortus (Doyle et al., 2019).  
To date many studies have investigated IVM resistance in both lab and field 
populations of sheep parasitic strongyles. However, despite rising prevalence of 
IVM resistance and decreasing efficacy of IVM and other anthelmintics on 
individual farms, no conclusion has been drawn as to the genetic basis of IVM 
resistance. For this reason studying how resistant genotypes increase in 
prevalence within a field population, and whether management practices are 
able to constrain development of resistance, is difficult. The need to identify 
genetic markers of IVM resistance in outbred field populations of T. circumcincta 
is the focus of this PhD. Such markers could potentially be used as diagnostic 
tests on farm, or within research studies to monitor IVM resistance in the field. 
60 
 
Introduction 
Initially a farm was closely monitored over a year to assess factors affecting 
detection of anthelmintic resistance using currently available methods (Farm 1, 
chapter 3). Following the identification of two appropriately resistant field 
populations (Farms 2 and 3), FECRTs were used to select progeny pre- and post-
treatment of IVM treated adults. NGS techniques were employed to identify 
regions of genetic differentiation between these sampled populations. A new 
draft reference genome, of similar size to the published genome, PRJNA72569, 
but one tenth as fragmented was used for analysis of reads. It was expected that 
resistance-associated alleles would be enriched in the sample populations 
following treatment of the adults. Initially Farm 2 individuals were sequenced 
using ddRAD-Seq (chapter 4). Following this, Pool-Seq was used to identify 
regions of genetic differentiation between pre- and post-IVM populations 
sampled from Farms 2 and 3 (chapters 5 and 6). Each farm was individually 
analysed and, based on the hypothesis of a common genetic locus conferring IVM 
resistance (based on work in H. contortus), farm results were compared. 
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2 Materials and Methods 
2.1 Parasite material  
2.1.1 Laboratory isolates  
MTci2 (Moredun T. circumcincta 2)  
MTci2 was obtained by the Moredun Research Institute (MRI) in 2000 from the 
Central Veterinary Laboratories, Weybridge and is susceptible to most 
anthelmintic classes. However, there is the possibility of low levels of resistance 
to BZ (Skuce et al., 2010). 
MTci5 (Moredun T. circumcincta 5) 
MTci5 is a multi-drug resistant isolate, isolated in 2002 from a UK field 
population following detection of multidrug resistance on the farm the previous 
year (Sargison et al., 2001) and is resistant to BZ, LEV and IVM (Bartley et al., 
2004; Skuce et al., 2010).  
2.1.2 Farm 1 
A lowland sheep farm in southeast Scotland was visited between March 2016 and 
March 2017, every three weeks, with the agreement of the shepherd and 
knowledge of the presence of anthelmintic resistance. Ethical consent was 
obtained under the guidance of the University of Glasgow. Farm 1 was used to 
assess current methods available for monitoring anthelmintic resistance. Results 
are described in Chapter 3.  
2.1.3 Farm 2 
A Faecal egg count reduction test (FECRT) was performed on a farm in southwest 
England in August 2016, coordinated by colleagues from the University of Bristol 
(Prof E. Morgan, Dr H. Vineer and Miss K. Bull), who provided coprocultured L3 
pre- and post-IVM treatment. Farm 2 was used for both ddRAD-Seq and Pool-Seq 
(Chapters 4, 5 and 6). 
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2.1.4 Farm 3 
A FECRT was performed on a farm in southeast Scotland in July 2015, 
coordinated by colleagues at the MRI and coprocultured L3 were provided for use 
in this study. Farm 3 was used for Pool-Seq (Chapters 5 and 6). 
2.2 Sample Collection and Processing 
2.2.1 Collection of faecal samples  
The strongyle population on Farm 1 was monitored over time, in both ewes and 
lambs. Other than for FECRTs, the identity of individual sheep varied between 
sampling time points. In line with farm management practices, the same pasture 
groups were sampled each time. Additional information is provided in 3.3. 
Starting in March 2016, faecal samples were collected from ten ewes every three 
weeks until March 2017. From May 2016 until November 2016, samples were also 
collected from lambs; the first samples were from only four lambs, but after this 
time point at least ten lambs were sampled every three weeks. Samples were 
collected as soon as possible after voiding by sheep, and care was taken to 
minimise contamination with free-living species. Samples were taken quickly to 
the lab for immediate processing. When egg hatch tests (EHTs) were to be 
performed, if a delay was likely, such that the estimated start time of the assay 
was three hours or later from collection, a subsample of faeces was stored 
anaerobically preventing development of the eggs (Coles et al., 1992). EHTs 
were always set up the same day.  
2.2.2 Faecal egg counts 
A cuvette method, sensitive to 1 egg per gram (epg) was used to perform 
strongyle faecal egg counts (FECs) (Christie and Jackson, 1982). Briefly, faeces 
were weighed and water was added in a ratio of 10 ml to 1 g, following which 
10 ml was strained through a coarse sieve (1 mm aperture). After centrifugation 
at 234 × g for 2 min, the supernatant was aspirated, and the egg pellet re-
suspended in saturated NaCl solution (specific gravity 1.2) with a further 
centrifugation step as above. The meniscus was isolated using artery forceps and 
tipped into a cuvette, which was filled with saturated NaCl solution for counting. 
Strongyle epg and Nematodirus epg were quantified (as described in Figure 2.1), 
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and other species were noted if present. Strongyle epg were analysed using 
Minitab (Minitab® 17.1.0, Microsoft). Group arithmetic means were calculated, 
with 95% confidence intervals (CIs).  
 
Figure 2.1: Cuvette method for faecal egg counts. Each of A, B and C represent a cuvette, 
containing eggs (yellow ovals). Due to the specific gravity of the NaCl solution all eggs 
floated to the top of the cuvette for counting (Rinaldi et al., 2011). As the equivalent of one 
gram of faeces was used, each total count is equivalent to the epg. D represents a Miller 
eyepiece graticule, which can be placed in the microscope eyepiece to enable counting of 
moderate to high numbers of eggs. A. Low number of eggs present – counted all eggs 
present within the surface area. For both moderate (e.g. > 50, B) and high (e.g. >300, C) 
numbers of eggs two rows (shown in blue) were counted using the graticule. Eggs were 
counted if they were fully within the upper and lower boundaries of the square. In addition, 
eggs partially covering one of either the upper or the lower boundary were also counted. 
For moderate egg counts (B), the larger graticule square was used and the sum of both 
rows multiplied by three. For high egg counts (C), the smaller graticule square was used, 
and the sum of both rows multiplied by nine.  
2.2.3 Coprocultures and Baermannisation of L3 
Individual faecal samples were pooled separately by age group (ewes or lambs) 
for culturing. If faeces were too moist, vermiculite was added and faeces formed 
into small balls for culture at 25 °C for 10 days. Following culture, faeces were 
immersed in warm water for 6 h before a modified Baermannisation method was 
used to collect L3. Briefly, the water was poured over a fine muslin mesh, which 
was placed in a jar containing warm water and left for 24 h, following which the 
L3 could be collected from the bottom of the jar. L3 were stored in culture 
flasks in water at 8 °C. Spare L3 were snap frozen in liquid nitrogen and stored 
at -80 °C.  
 
 
 
 
 
Moderate egg count: 
multiply by 3 
High egg 
count: 
multiply by 
9 
A 
B 
C 
D 
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2.2.4 Morphological examination of L3 
Larvae were killed with dilute iodine and examined at low magnification, 
increasing as needed. Sheath tail length was measured, morphological 
differences in tails and heads were noted (e.g. flat, rounded, tapered, refractile 
bodies) and intestinal cells counted if needed. If required for identification the 
entire larval length was measured. This was performed as an initial screen with 
the help of Mr J. McGoldrick (University of Glasgow) to identify species present 
for PCR primer selection.  
2.2.5 Faecal egg count reduction test 
A FECRT was performed on Farm 1 in September 2016 (see section 3.3.2.1). 
Thirty-five, five-and-a-half month old lambs were set aside by the farmer and 
from these, animals were selected randomly for use in the FECRT, but with the 
aim of balancing gender. Faeces were collected per rectum for FECs pre-
treatment, with additional material gathered for further analysis, if voided 
immediately following treatment. Ten lambs were allocated to the albendazole 
(BZ) treatment group (5 mg/kg body weight (BW), Albex™ 2.5% w/v SC oral 
suspension, Chanelle UK), ten lambs to the LEV treatment group (7.5 mg/kg BW, 
Levacide Drench 3% Oral solution, Norbrook) and twelve lambs to the IVM 
treatment group (0.2 mg/kg BW, Noromectin® 0.08% w/v Drench Oral Solution, 
Norbrook). All were weighed individually, using the shepherd’s weigh scales (EID 
weigh crate, Shearwell), and dosed per os according to their individual weights 
using a syringe. Repeat faecal samples were collected on days 7 and 14 post-
treatment and faeces transferred anaerobically to the laboratory. The FECR 
percentage and Bayesian CIs were calculated using R Shiny ‘eggCounts’ web 
interface (Wang and Paul, 2017; Wang et al., 2017). 
2.3 Bioassays 
Strongyle eggs were harvested within three hours of faecal collection for 
immediate use in bioassays as described in 2.2.2, but with the following 
modifications; emulsified faeces were strained through a series of sieves, 
(215 μm, 125 μm and 63 μm), with eggs collected from a 38 μm sieve. 
Centrifugation steps were performed as described above, and the meniscus was 
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poured back onto a small, 38 μm sieve. Eggs were washed with tap water to 
remove salt and collected. A 200 μl aliquot of egg suspension was counted to 
determine the total number of eggs/ml. The egg concentration was adjusted to 
1 egg/μl for the EHT and 2 eggs/μl for the larval development test (LDT). 
Bioassay results are described in section 3.3.2.2. 
2.3.1 Egg hatch test 
An EHT was set up to measure BZ efficacy, essentially as described previously 
(Coles et al., 2006). Stock solutions of thiabendazole (TBZ) (Sigma) were 
prepared by diluting 1 mg/ml of TBZ/DMSO solution into DMSO and stored in 
opaque tubes at room temperature. Briefly, a 24 well plate was set up with a 
range of final TBZ concentrations as follows: 0.05 μg/ml, 0.1 μg/ml, 0.2 μg/ml, 
0.3 μg/ml, 0.4 μg/ml, 0.5 μg/ml, 1 μg/ml and 0.5% DMSO control (Sigma Aldrich). 
To each well was added: 10 μl of TBZ/DMSO solution, 1890 μl deionised water 
(Acros Organics) and 100 μl of egg suspension, giving approximately 100 
eggs/well. 
EHTs were performed throughout the season on Farm 1, with three replicate 
wells for each concentration tested. In addition, eggs collected as part of the 
September BZ and IVM FECRTs on Farm 1 were tested as follows. Four EHTs were 
performed using pre-treatment samples for each of the BZ and IVM treated lamb 
groups. For each of the eight tests, all concentrations were repeated in 
triplicate, when sufficient eggs were available. Plates were incubated in a humid 
environment at 25 °C for 48 h and the number of unhatched eggs and L1 
recorded at 48 h. 
On day 14 post-treatment a reduced EHT was performed for the BZ treated 
population as follows: all TBZ concentrations were incorporated but a reduced 
quantity of eggs restricted replicate numbers. Two replicates were carried out 
for each of 0.05 μg/ml, 0.1 μg/ml and 0.2 μg/ml. The rest were single wells. Due 
to a paucity of eggs post-IVM treatment of lambs, it was not possible to perform 
a full EHT and only two replicates of the ‘definitive dose’ wells (0.1 μg/ml) were 
included. 
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The ED50, the effective dose at which 50% of larvae fail to hatch, was calculated 
using a binomial (probit) general linear model (GLM) in R Studio (version 1.1.383 
– © 2009–2017 RStudio, Inc; R version 3.4.3 © 2017). All data were first corrected 
for the percentage hatch in the DMSO control wells and the TBZ concentrations 
were log10 transformed. If the ED50 was greater than 0.1 μg/ml TBZ, then the 
sample population was considered resistant to BZ (Coles et al., 1992; von 
Samson-Himmelstjerna et al., 2009a). The script used for the GLM is available on 
GitHub (https://github.com/SheepwormJM). 
2.3.2 Larval development test 
The LDT was performed at the time of the September FECRT on strongyle 
populations obtained pre- and post-IVM treatment (day 0 and day 14) and pre-BZ 
treatment. In total, two tests were performed for each FECRT pre-treatment 
(total four), and one test was performed post-IVM treatment. Insufficient eggs 
were recovered post-BZ treatment to allow a LDT to be carried out. A method 
adapted from Varady et al. (1996) was used to ascertain the ability of larvae to 
develop in the following concentrations of IVM: 0.57 nM, 1.14 nM, 2.29 nM, 
4.54 nM, 9.14 nM, 18.29 nM and 36.58 nM, water only (control), and 2% DMSO 
(control). Pre-treatment each concentration was included in triplicate in each 
assay, but post-IVM treatment each concentration was included only twice due 
to fewer eggs being available. Stock solutions of IVM (22,23 dihydroavermectin 
B1, primarily IVMB1a, catalogue number I8898, Sigma Aldrich) were prepared by 
diluting a 0.001 M IVM/DMSO solution into DMSO and were stored in opaque tubes 
at room temperature. Briefly, a 48 well plate was set up, each well containing 
6 μl of IVM/DMSO solution, 239 μl deionised water and 5 μl of a highly 
concentrated, reconstituted, lyophilised E. coli OP50 as a food source for the 
developing larvae (Heim et al., 2015). 50 μl of strongyle eggs were added 
(concentration of 2 eggs/μl), giving approximately 100 eggs/well. No 
antimicrobials were used. Wells surrounding those used for the assay were filled 
with deionised water and the plate sealed with an adhesive plastic seal (Sigma 
Aldrich). The assay was incubated for 7 days at 25 °C in a humid environment. 
Eggs, L1/L2 and L3 larvae were counted. Those with obvious failure (e.g. no 
development, fungal or bacterial overgrowth) were discarded. Following 
correction for development in the control wells, an ED50 for each sample was 
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calculated using a GLM constructed in R Studio as above. The script used for the 
GLM is available on GitHub (https://github.com/SheepwormJM). 
2.4 Molecular Biology 
2.4.1 Lysate protocol 
Lysates were made from individual strongyle eggs, L1 or L3 in 96 well plates. 
Briefly, a master mix per 100 wells was prepared as follows: 1000 μl DirectPCR 
Lysis Reagent (Cell; Viagen Biotech), 50 μl 1 M DTT (Thermofisher Scientific) and 
10 μl Proteinase K (Fungal; Invitrogen), which had been reconstituted at 
100 mg/ml in DEPC treated water (Ambion). 10 μl was dispensed per well and a 
single egg or larva added to each in ≤ 1 μl of water/PCR Lysis Reagent. After 
incubation at 60 °C for 2 h, followed by 85 °C for 45 min to denature the 
proteinase K, lysates were aliquoted in 1:20 dilutions using DEPC treated water. 
All lysates were stored at −80 °C. 
2.4.2 Speciation of strongyles by PCR 
Individual eggs, L1 or L3, lysed as described in 2.4.1, were identified by PCR to 
species level using the ITS2 region (Wimmer et al., 2004; Redman et al., 2008; 
Burgess et al., 2012; Bisset et al., 2014). Two PCR methods were employed: 
single species PCR and a multiplex PCR. Briefly, single species PCR was 
performed using GoTaq Flexi polymerase (Promega) according to the 
manufacturer’s instructions. The total volume of each reaction was 12.5 μl of 
which 1 μl was 1:20 DNA lysate. Primers designed to amplify the ITS2 region and 
specific to the species of interest were used. Table 2.1 shows primer sequences 
with their original reference, expected amplicon size, and TA °C. All PCRs were 
carried out using the following protocol: denaturation at 94 °C for 2 min, then 35 
cycles each of 94 °C 30 s, TA °C 30 s and 72 °C 30 s, with a final extension step of 
72 °C 10 min.
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Table 2.1: Primer sequences used to speciate strongyle larvae.  
Species Primer 
name 
Sequence TA (°C) Product size 
(bp) 
Reference 
Teladorsagia circumcincta Tc_ITS2 F: ATACCGCATGGTGTGTACGG 52 421 (Burgess et al., 
2012)   
R: CAGGAACGTTACGACGGTAAT 
  
(Burgess et al., 
2012) 
Trichostrongylus vitrinus Tv_ITS2 F: AGGAACATTAATGTCGTTACA 52 100 (Wimmer et al., 
2004)   
R: CTGTTTGTCGAATGGTTATTA 
  
(Wimmer et al., 
2004) 
Haemonchus contortus Hc_ITS2 F: GTTACAATTTCATAACATCACGT 50 321 (Redman et al., 
2008)   
R: TTTACAGTTTGCAGAACTTA 
  
(Redman et al., 
2008) 
Generic ITS2 ITS2GF F: CACGAATTGCAGACGCTTAG 54 370-398 (Bisset et al., 2014) 
Generic ITS2 ITS2GR R: GCTAAATGATATGCTTAAGTTCAGC 54 
 
(Bisset et al., 2014) 
Chabertia ovina ChovFd2 F: CAGCGACTAAGAATGCTTTGG 54 115/117 (Bisset et al., 2014) 
Cooperia curticei CocuFd3 F: TAATGGCATTTGTCTACATTGGTTC 53 252 (Bisset et al., 2014) 
Oesophagostomum 
venulosum 
OeveRv1 R: CGACTACGGTTGTCTCATTTCA 54 323-329 (Bisset et al., 2014) 
Trichostrongylus axei TraxFd2 F: GATGTTAATGTTGAACGACATTAATATC 52 186 (Bisset et al., 2014) 
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Multiplex PCR was also performed, adapted from a protocol optimised by Bisset 
et al. (2014). Briefly, each 12.5 μl reaction contained: 2.5 μl 5X GoTaq Green 
buffer, 1.25 μl MgCl2 25 mM, 0.06 μl GoTaq Flexi polymerase 5 U/μl (Promega), 
0.25 μl dNTPs 10 mM each (NEB Inc.), 0.15 μl Generic Forward primer 10 μM, 
0.15 μl Generic Reverse primer 10 μM, 0.25 μl Trichostrongylus axei Forward 
primer 10 μM, 0.35 μl Cooperia curticei Forward 3 primer 10 μM, 0.1 μl 
Oesophagostomum venulosum Reverse 1 primer 10 μM, 0.15 μl Chabertia ovina 
Forward 2 primer 10 μM (Eurofins Genomics, Table 2.1), and 6.29 μl DEPC treated 
water (Ambion). To this 1 μl of 1:20 DNA lysate was added. Touchdown PCR 
conditions were: denaturation at 94 °C for 2 min, then 12 cycles each of 94 °C 
15 s, 60 °C, decreasing by 0.5 °C each cycle, to 54.5 °C for 15 s and lastly 72 °C 
30 s. Next, 25 cycles each of 94 °C 15 s, 54 °C 15 s, 72 °C 30 s, with a final 
extension step of 72 °C for 7 min. Products were visualised with SafeView (NBS 
Biologicals) on 2% agarose gels for single species PCR and 2.5% agarose gels for 
multiplexed PCR. 
Any unidentified strongyles (i.e. positive on the multiplex PCR as a strongylid 
nematode) were amplified with Phusion High-Fidelity Polymerase (NEB) using the 
generic ITS2 primer set (Bisset et al., 2014) and sequenced by Eurofins 
Genomics. A BLAST search using NCBI was performed for identification (Altschul 
et al., 1990). Speciation results were analysed in Microsoft Excel and species 
proportions, determined by PCR, were used to estimate individual T. 
circumcincta egg counts pre- and post-treatment. A 2-sample proportion test 
was performed in Minitab to compare speciation results pre- and post-treatment 
of the FECRT performed on Farm 1. 
2.4.3 Microsatellite PCR and Analysis  
Ten microsatellites were amplified by PCR. Briefly, each 20 µl reaction 
contained: 4 µl 10% Tween 20, 1.8 µl 11.1X buffer, 1 µl Forward primer, 1 µl 
Reverse primer (Eurofins Genomics), 0.1 µl of GoTaq Flexi polymerase 
(Promega), 11.1 µl DEPC treated water (Ambion) and 1 µl 1:20 DNA lysate. Table 
2.2 shows primer sequences with their original reference, expected amplicon 
size range, microsatellite repeat sequence and TA °C. The 11.1X buffer was 
made in house, and contained 334 µl 2M Tris HCl (pH 8.8), 166 µl 1M Ammonium 
sulphate, 67 µl 1M MgCl2, 7.2 µl 100% 2-mercaptoethanol, 6.8 µl 10 mM EDTA (pH 
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8), 150 µl 100mM dATP, 150 µl 100 mM dCTP, 150 µl 100mM dGTP, 150 µl 100 mM 
dTTP and 170 µl 10 mg/ml bovine serum albumin. Aliquots were stored at -20 
°C. Thirty T. circumcincta L3 were tested per field sample population. PCR 
conditions were as follows: 94 °C for 2 min, then 40 cycles each of 94 °C for 15 
s, TA °C for 45 s and 72 °C for 1 min and a final extension step of 72 °C for 15 
min. Products were visualised with SafeView (NBS Biologicals) and the brightness 
of the visualised band compared with the same volume of a 50 µg/ml Quick-
Load® 100 bp DNA ladder (NEB). This allowed a qualitative estimation of DNA 
quantity for subsequent dilution steps. PCR products were wrapped in tinfoil and 
stored at 4 °C. Products were diluted and multiplexed as required (Table 2.2, 
footnote) and sent to the MRC PPU DNA Sequencing and Services laboratory, 
University of Dundee. An Abi Prism 3730xl Genetic Analyser (Applied 
Biosystems), with 50 cm capillaries was used to quantitatively measure the size 
of each amplified fragment. GeneScanTM 500 ROXTM dye size standard (Applied 
Biosystems) was selected.  
Results were analysed using GeneMapperTM Software v4.0 (Applied Biosystems) to 
automatically call peaks, using information including the expected tandem 
repeat size and fragment size range. Following this, peaks were manually 
checked and data exported to Microsoft Excel. TANDEM v1.09 was used to assign 
raw allele calls to tandem repeat size bins (Matschiner and Salzburger, 2009). 
Following this, data were converted into Arlequin format using the software 
Convert v1.31 (Glaubitz, 2004). Arlequin v3.5.2.2 was used to statistically 
analyse data for genetic relatedness between samples (Excoffier et al., 2005). 
Settings used can be found in Appendix 1. Results are described in section 3.3.3. 
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Table 2.2: Primer sequences for microsatellites.  
Primer 
name 
Repeat sequence Sequence Label TA 
(°C) 
Product 
size 
(bp) 
Reference 
MTG15a [GT]6GC[GT]6GGGTTTGT F: TGCAAGGAAACTGCTAAGAAGGAG 5’ FAM 58 233-275 (Grillo et al., 2006) 
R: ATCATGGAACCTTGATACCGCAAG       
MTG67a [CT]14 F: CAAGTCGTTTAGGCACGTCTGG 5’ HEX 58 172-192 (Grillo et al., 2006) 
R: CAGGGCGGAACCCAATTGATCG       
MTG68b [ACA]2[ACC]2TCG[ACA]4ACTA 
CAACCACAACTACG[ACAACC]2 
F: ATCACCAGGCGGCTGCTACG 5’ FAM 50 420-453 (Grillo et al., 2006) 
R: CGAAAAGTAGAGTATGAGC       
MTG73b [TGC]2TGTTGC[TGT]2[TGA]3T 
G[TGA]2TAA[TGA]2AAATA[TGA]2 
F: CCTTGTATAAATTCGAAG C 5’ HEX 45 148-157 (Grillo et al., 2006) 
R: GTAGTAGTGATTAACTTCCG       
Tc13604a [CAGGTA]12TAGGTACAGGCACAG F: CGATAAATGGTATTATCTG 5’ HEX  50 250-386 (Redman et al., 2015) 
R: GCTGCTATTAGAGGATAT   
 
  
Tc2066c [GGCGAGTA]9GGCGATTAGGCGA 
GAAGGCGTGTAGGTGAGTAGGCGAG 
F: GAGCAACGACTGAACCTCAC 5’ HEX 50 189-309 (Redman et al., 2015) 
R: GCTGGAAGCATATTCTGCGC       
Tc22274d [TGTA]17TGTCTGAATGT F: ACAAAGTGCTCAAGTTAG 5’ HEX 54 189-329 (Redman et al., 2015) 
R: GGGGGTTCTATATACAGTA   
 
  
Tc2467d [TTTA]15TCTATT F: AACGCTTTGAACCGTGTCGG 5’ FAM 54 149-224 (Redman et al., 2015) 
R: GCTGCCACATCAGCTTAGA   
 
  
Tc4504b [ACAT]13ACAGATACAGACA F: TTATCACACCACTTCATT 5’ FAM 50 228-276 (Redman et al., 2015) 
R: GTCTTTAAACGCTAAATA   
 
  
Tc7989c [GTCT]17GTCCGTTTGTGTG F: GATCTCACGTACTATGAA 5' FAM 50 133-232 (Redman et al., 2015) 
R: CTATTGAATGTCGTACAG       
Primers were multiplexed following PCR for fragment analysis as follows (dilutions shown in brackets); aMTG15 (1:20), MTG67 (1:20) and Tc13604 (1:20), 
bMTG68 (1:5), MTG73 (7:10) and Tc4504 (1:10), cTc2066 (1:2) and Tc7989 (1:2), dTc22274 (1:50) and Tc2467 (1:50).
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2.4.4 Pyrosequencing 
Using a method adapted from Skuce et al. (2010), BZ resistance associated SNPs 
were pyrosequenced in T. circumcincta individuals from Farm 1 (30 individuals 
per sample – see section 3.3.2.3). Eggs and L1, obtained from EHTs were used on 
day 14 post-BZ and post-IVM FECRTs. At all other time points L3 were used. Two 
regions of the β-tubulin isotype-1 gene (one region including codons 200 and 198, 
and the other including codon 167) were amplified using the Pyromark PCR kit 
(Qiagen) according to the manufacturer’s instructions. Briefly, a 25 μl reaction 
was set up using 12.5 μl 2X Pyromark Master Mix, 0.5 μl of each primer, 10.5 μl 
DEPC treated water (Ambion) and 1 μl of diluted DNA lysate. PCR conditions 
were: denaturation at 95 °C for 15 min, then 45 cycles of 94 °C for 30 s, 55 °C for 
30 s and 72 °C for 30 s, with a final extension step of 72 °C for 10 min. Two 
positive controls were included each time, one MTci2 (sensitive) and one MTci5 
(resistant). Pyrosequencing was performed on a Biotage Q96 ID instrument 
(Qiagen) according to the manufacturer’s protocol with pyrograms evaluated 
manually. The sequences analysed were: ‘CAGWAYGTYDMRTCGG’ for codons 
F200Y and E198A/L, and ‘TCATWCTC’ for codon F167Y. Primers used are shown 
in Table 2.3. A 2-sample proportion test was performed in Minitab to compare 
pyrosequencing results from samples collected pre- and post-anthelmintic 
treatments on Farm 1.
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Table 2.3: Primer sequences for pyrosequencing of the BZ resistance associated SNPs in β-tubulin isotype-1.  
Primer name Sequence TA(°C) Label Product size (bp) Reference 
Btub_SK_200 F: ACCTTACAATGCCACTCTTTCTG 55 Biotin 97 (Skuce et al., 2010) 
R: GCGGAAGCAGATATCGTACAG 
   
(Skuce et al., 2010) 
SEQ: RGAGCYTCATTATCGATR 
   
(Skuce et al., 2010) 
Btub_SK_167 F: GCATTCTTTGGGAGGAGGTA 55 
 
122 (Skuce et al., 2010) 
R: TGCACCTCGAGAACCTGTACATA 
 
Biotin 
 
(Skuce et al., 2010) 
SEQ: CGGATAGAATCATGGCT 
   
(Skuce et al., 2010) 
For each amplified region, a forward and reverse primer pair was used to amplify a fragment containing the relevant SNPs. The sequencing primer (SEQ) 
was used for the pyrosequencing reaction.  
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2.4.5  hprt-1 allele specific PCR 
Three primer pairs were manually designed using sequences aligned in Geneious 
v9.1.8, each pair specific to one of three potential alleles of the predicted 
homologue of hprt-1 (Figure 2.2). Using GoTaq Flexi polymerase (Promega) 
according to the manufacturer’s instructions, each primer pair was tested on 96 
individual MTci2 L3. The total volume of each reaction was 12.5 μl of which 1 μl 
was 1:20 DNA lysate. Table 2.4 shows primer sequences with their expected 
amplicon size, and TA °C. All PCRs were carried out using the following protocol: 
denaturation at 94 °C for 2 min, then 35 cycles each of 94 °C 30 s, TA °C 30 s and 
72 °C 30 s, with a final extension step of 72 °C 10 min. Products were visualised 
with SafeView (NBS Biologicals) on 2% agarose gels. Rationale and results are 
provided in section 6.3.7. 
Table 2.4: Primer sequences for hprt-1 alleles.  
Primer name Sequence TA (°C) Product size 
(bp) 
Tci2_hprt-1_c77 F: GAAACTCATCCACACCATAG 50 108 
 R: CCTACCATCCTTCCCTTG   
Tci2_hprt-
1_c1057 
F: AACACGTTGGTTAGTTCAATG 50 166 
 R: ACCTTTCCAGAAGTGGC   
Tci2_hprt-
1_c3165 
F: TACCGGTAAGCGCTTTCG 50 296 
 R: TTAAACTAGACGAAAACGACAG   
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Figure 2.2: Primer positions to amplify hprt-1 gene copies. The genes were extracted from the Tci2 contigs and aligned in Geneious v9.1.8. A. and B. Three 
primer sets were manually designed to amplify each gene copy individually. Primer properties were checked using OligoCalc (Kibbe, 2007) and the gene 
sequences were searched in Geneious v9.1.8 for multiple primer alignment. Exons are annotated in blue. Primer positions are indicated by lime green 
annotations. Each sequence is shown on a separate line, with a consensus sequence displayed at the top. Sequence similarity is indicated by a coloured 
bar plot between the consensus and sample sequences. Where there is complete agreement between sequences this is shown in green, with reduced 
height and varying colour from yellow to red for decreased consensus. Differences between sample sequences are highlighted by colours for different 
basepairs, while regions with no difference to another sequence (or no overlapping sequence) are shown in grey. 
A. 
B. 
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2.5 Genomic DNA Library Preparation for Next 
Generation Sequencing: ddRAD-Seq and Pool-Seq  
Next generation sequencing techniques were used as part of a genome wide 
association study investigating IVM resistance in UK field populations of T. 
circumcincta. Information about these techniques and the results obtained are 
presented in Chapters 4 (ddRAD-Seq), 5 and 6 (Pool-Seq). 
2.5.1 Whole Genome Amplification of DNA for ddRAD-Seq 
Thirty pre- and 32 post-IVM FECRT T. circumcincta L3 from Farm 2 were selected 
for whole genome amplification (WGA) and ddRAD-Seq. A maximum of eight 
larvae were processed at any one time. To decrease variation due to batch 
error, pre- and post-IVM individuals were selected in roughly equal numbers for 
each batch of samples prepared. For WGA the polymerase Phi-29 was used, 
capable of producing long stranded DNA molecules (>10 kb) via multiple 
displacement amplification at a constant temperature. Briefly, 5 µl worm lysate 
prepared as described in 2.4.1 was combined with 5 µl 1.3 M Trehalose and 
heated at 95 °C for 3 min. On ice, a master mix was prepared containing 29 µl 
REPLI-g buffer, 1 µl REPLI-g polymerase (REPLI-g Single Cell Kit, Qiagen) and 10 
µl 1.3 M Trehalose per sample and 40 µl of this was transferred to each sample. 
The reaction was heated at 30 °C for 16 h before denaturing Phi-29 at 65 °C for 
10 min. 
The WGA DNA was purified using Agencourt AMPure XP beads (Beckman Coulter 
Life Sciences) as per the manufacturer’s protocol, with a ratio of 1.8X beads to 
DNA volume. DNA was quantified using the Qubit™ 2.0 Fluorometric quantitation 
protocol (Invitrogen). WGA was assessed qualitatively using primers designed to 
amplify six core eukaryotic genes. Each gene was predicted to be located on a 
different chromosome of each of the six nematode chromosomes based on 
synteny analysis between C. elegans and H. contortus. One-to-one T. 
circumcincta homologues of the H. contortus genes were identified using the 
WormBase ParaSite BLAST (Howe et al., 2016; Howe et al., 2017). Primers were 
designed using Geneious® v9.1.8 (https://www.geneious.com) and are shown in 
Table 2.5. Primers were tested using individual larval lysates and WGA DNA. A 
qualitative difference in the relative brightness of amplicon bands was obtained 
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and WGA DNA of each individual was assessed in this way. Briefly, each PCR was 
performed using GoTaq Flexi polymerase (Promega) according to the 
manufacturer’s instructions. The total volume of each reaction was 12.5 μl of 
which 1 μl was WGA DNA, while a further sample contained 1 µl of 2:22 DNA 
lysate as a negative control (of WGA failure).  A known 1:10 WGA DNA sample 
was used as a positive control of WGA success. As always, a negative control 
with no DNA was included. The PCR conditions were: 94 °C 2 min, then 35 cycles 
of 94 °C 30 s, 55 °C 30 s and 72 °C 25 s, followed by an extension step at 72 °C 
for 10 min. PCR products were visualised on a 2% agarose gel with SafeView (NBS 
Biologicals).  
Table 2.5: Primer sequences for core eukaryotic genes.  
Primer 
name 
Sequence TA (°C) Product 
size (bp) 
C. elegans 
chromosome 
copb-1 F: CTCCATGCGGCTACGATCA 55 238 II 
 R: TGCAACGAATGGAGAATTGTC    
dyf-7 F: CCAAACTACCGAACTGCAGA 55 246/247 X 
 R: CCACCAGTCGATGCCAAC    
gspd-1 F: GAGCTTGATCTCACTTACAATG 55 345 IV 
 R: GCGTCAGGTAAACGAGTATC    
hmgs-1 F: GCGTGAAGACAGAGTTGATG 55 318 V 
 R: GCTTTTCCATTGAGTAGTTTGC    
mel-32 F: CTCGAAATTTGGACTATGCTC 55 272 III 
 R: GATCAGTGCTCCACGAGG    
smo-1 F: AGATAATGGCAGCGAAGCAC 55 265 I 
 R: AATGAAGAGACGGCAACTCC    
  
2.5.2 Double digest of WGA DNA 
In order to reduce GC bias (Aird et al., 2011; Dabney and Meyer, 2012), the 
restriction endonucleases MluCI and NlaIII were chosen. 900 ng of WGA DNA was 
digested using MluCI and NlaIII restriction endonucleases (NEB). Briefly, each 
reaction contained 9 µl 10X Cut Smart buffer (NEB), 9 µl MluCI, 9 µl NlaIII and 
900 ng WGA DNA with the total volume made to 90 µl with DEPC treated water 
(Ambion). The digestion was completed at 37 °C for 4 h. The double digest was 
purified and quantified as for 2.5.1.  
2.5.3 Adaptor ligation 
Barcoded adaptors, designed by Peterson et al. (2012), and kindly supplied by 
the Wellcome Sanger Institute (WSI), were ligated to 250 ng of digested WGA 
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DNA to ensure identification of individuals when pooled. Only if both a P1 and a 
P2 adaptor, each specific to either MluCI (AATT) or NlaIII (CATG) cut-sites, were 
ligated to a DNA fragment would sequencing occur (Peterson et al., 2012). Each 
adaptor ligation reaction contained 4 µl 10X T4 DNA ligase buffer, 0.7 µl T4 DNA 
ligase 2,000,000 U/ml (NEB), 5 µl P1 adaptor, 5 µl P2 adaptor (Peterson et al., 
2012), 250 ng digested WGA DNA and the total made to 40 µl with DEPC treated 
water (Ambion). Samples were heated at 23 °C for 30 min then at 65 °C for 10 
min. Reactions were cooled by 2 °C every 30 s until the reaction reached 19 °C. 
DNA was stored at -20 °C prior to pooling of individuals. Each pool included 15 
pre- and 16 post-IVM L3. Agencourt AMPure XP beads (Beckman Coulter Life 
Sciences) were used as in 2.5.1 to purify and gradually reduce the overall 
volume of each library to 40 µl. 
2.5.4 Size selection, Illumina Library Prep and DNA Sequencing 
Genomic DNA libraries were sent to the WSI, where 225-325 bp fragments were 
size selected using a Pippin Prep (Sage science). Illumina adapters were ligated 
and eight rounds of KAPAHiFi (KAPA Biosystems) PCR were performed, with post-
PCR SPRI bead clean-up and quantification by qPCR. Genomic libraries were 
sequenced with 125 bp paired-end reads on an Illumina HiSeq 2000v4. 
2.5.5 Preparation of Genomic DNA Libraries for Pool-Seq 
L3 pre- and post-IVM treatment from Farms 2 and 3 were also prepared for Pool-
Seq. For each of the sample populations pre- and post-IVM treatment, neat 
lysate material prepared as in 2.4.1, from 91 individually lysed L3 was pooled for 
extraction of gDNA. Farm 2 had already been used for ddRAD-Seq, so a maximum 
of 5 µl from each L3 lysate was available (half total L3 DNA). Farm 3 had 9 µl per 
L3 lysate available (~90% L3 DNA). To keep the protocol consistent between 
farms, Farm 3 gDNA was extracted in two parts; first 5 µl was pooled from each 
L3, then the remainder of the lysate was pooled separately, providing a 
technical replicate for each of the pre- and post-IVM sample populations from 
Farm 3.    
Genomic DNA was extracted as follows. Briefly, 15 µl of 10 mg/ml RNase A 
(Thermofisher) was added to the pooled lysates, before incubating at 37 °C for 
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10 min using a Techne DRI-BLOCK® DB-2A. Next, 792 µl of UltraPureTM 
phenol:chloroform:IAA (25:24:1) (Invitrogen) was added and the mixture shaken 
vigourously for 15 s, before being incubated at room temperature for 5 min, 
turning every 1 min. The solution was centrifuged at 14,000 x g for 15 min at 
room temperature and the aqueous supernatant transferred to a new Eppendorf 
tube. To remove any remaining phenol, 300 µl of chloroform:IAA (Sigma Aldrich) 
was added and the suspension inverted, before a second centrifugation step at 
14,000 x g for 15 min. The aqueous supernatant was transferred to a new 
Eppendorf tube, and measured. To this was added 0.1X vol 3M NaOAc pH 5.5, 3X 
vol 100% Ethanol Absolute Electran Molecular Biology grade (VWR Chemicals, at 
room temperature) and 2 µl of 5 mg/ml glycogen (Invitrogen), before storage at 
-80 °C to precipitate the gDNA. Following precipitation, the mixture was 
centrifuged at 14,000 x g at 4 °C for 45 min. The supernatant was aspirated and 
the pellet resuspended in 500 µl 70% ethanol. The gDNA was centrifuged at 
14,000 x g at 4 °C for 5 min and the supernatant carefully removed. A final brief 
centrifugation step of 14,000 x g at 4 °C for 30 s was applied, any remaining 
ethanol aspirated and the pellet air dried before resuspension in 10 µl of EB 
buffer (Invitrogen). The gDNA was stored at 4 °C before being sent to the WSI. 
Libraries were prepared and 75 bp paired-end sequencing was performed on an 
Illumina HiSeq 4000.  
2.6 Bioinformatics: Reference genomes 
At the end of October 2017, a draft T. circumcincta genome of length 685 Mb, 
N50 288.5 kb, in 8025 contigs and with the largest contig of size 2.08 Mb had 
been assembled by Dr. S. Doyle at the WSI (Tc_171026.fa). The genome was 
assembled using MTci2 worms and, throughout the rest of the thesis this genome 
is referred to as the ‘Tci2 genome’. Generated using PacBio methodology (Eid et 
al., 2009), corrected by Illumina reads, the genome was a significant 
improvement on the highly fragmented PRJNA72569 genome. This second 
genome is based on a susceptible NZ isolate, published on WormBase ParaSite, 
and is in 81,734 contigs (Choi et al., 2017). However, the PRJNA72569 genome 
(701 Mb, N50 46.8 kb), had the advantage of protein level gene annotations, 
although some were incomplete or incorrect. The Tci2 genome has been used as 
the main reference genome in this study.   
80 
 
Materials and Methods 
2.7 Bioinformatics: ddRAD-Seq 
Farm 2 was used for ddRAD-Seq. Following validation of the method, a pairwise 
comparison between the pre- and post-treatment samples was performed to 
identify regions of genetic differentiation. Bioinformatics methods are detailed 
below. Note that scripts used are included in Appendix 2 when relevant, and are 
also available on GitHub (https://github.com/SheepwormJM). Raw data can be 
accessed via ENA using accession numbers ERS1770619 and ERS1770620. 
2.7.1 Cleaning and demultiplexing of ddRAD-Seq reads 
Fastqc (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and 
MultiQC v0.9 (Ewels et al., 2016) were used to visually assess the quality of the 
sequencing data. Reads were de-multiplexed and sequencing barcodes removed 
by Stacks v2.0beta2 process_radtags (Catchen et al., 2013; Rochette et al., 
2019), resulting either in 120 bp or 125 bp read lengths. Each base of each read 
had been previously assigned an Illumina Phred score. This is the measure of the 
probability (P) that the base called is incorrect and is calculated as:  
Q = -10[log10(P)] (Illumina, 2011).  
Any reads which decreased in quality below a Phred score of 10, using a sliding 
window of 15% of the read length, were discarded by process_radtags. From this 
point forwards, only paired-end reads with an average base quality >10 were 
used. The quality of the reads per individual was assessed using Fastqc and 
MultiQC. 
2.7.2 Alignment of ddRAD-Seq reads to Tci2 genome 
Reads were aligned to the Tci2 genome using Burrows Wheeler Aligner (BWA-
MEM) v0.7.17, (Li and Durbin, 2009; Li, 2013), after first splitting the reads into 
batches using a custom script written by Dr. S. Doyle, in order to increase 
processing speed. Command line parameters included -Y, to use soft-clipping for 
supplementary alignments and -M to call split reads as ‘secondary’. Duplicates 
were not marked, as these are difficult to identify for ddRAD-Seq. SAM files 
generated were merged and sorted, before conversion to BAM output files using 
SAMtools v1.3 (Li et al., 2009). Read alignment was analysed using SAMtools v1.3 
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flagstats and SAMtools v1.3 stats. MultiQC v0.9 was used to visualise alignment 
success. Paired, two tailed Student’s t-tests were performed using Microsoft 
Excel, to check for statistical differences in read alignment between pre- and 
post-treatment samples, as described in section 4.3.3.  
2.7.3 Formation and filtering of RADloci 
Aligned reads were provided as input to the Stacks v2.0b module gstacks, which 
groups reads by similarity into ‘stacks’ of haplotypes and then RADloci (Catchen 
et al., 2013; Rochette et al., 2019). RADloci are genomic regions between two 
restriction endonuclease cut-sites. Haplotypes within and between individuals, 
predicted to be sequenced from the same genomic region, are labelled with 
identical RADlocus ID numbers. The gstacks SNP calling model, based on the low 
coverage model of Maruki and Lynch (2017), was requested to only retain variant 
sites and call genotypes when calculated to have a probability of being incorrect 
of ≤0.001. Following genotyping and variant calling, a populations analysis was 
performed. This module was initially run using all individuals, however following 
kinship analysis (2.7.4), two individuals (one pre- and one post-treatment) were 
removed and the populations module repeated for further analyses. The 
rationale for this is explained in section 4.3.5. RADloci retained were present in 
both the pre- and post-treatment sample populations and were sequenced in at 
least 80% of individuals in each sample (-p2, -r0.8) (Paris et al., 2017). Variant 
sites within retained RADloci were further analysed if the minor allele frequency 
for the genotype was at least 0.048 overall, and the maximum heterozygosity 
observed did not exceed 70% (--min_maf 0.048, --max_obvs_het 0.7) (Rochette 
and Catchen, 2017). Results are described in section 4.3.4. 
2.7.4 Population structure and Kinship analysis 
The software Adegenet v2.1.1 (Jombart, 2008; Jombart and Ahmed, 2011) was 
used to assess the genetic structure of the sample populations. From the Stacks 
plink output files, a plink.raw file was generated using PLINK v1.90b3v (Chang et 
al., 2015) and loaded as a genlight file in Adegenet v2.1.1 in R Studio (RStudio-
Team, 2015). A plot of individuals genotypes (0 - homREF, 1 - het, 2 - homALT) 
for each variant site was generated. Principal Component Analysis (PCA) was 
performed using Adegenet and plotted using ggplot2 v3.2.1 (Wickham, 2016). 
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Using vcfR v1.7.0 (Knaus and Grünwald, 2017), a genlight R file was produced, 
and sample group information and ploidy added. Using an Unweighted Pair Group 
Method with Arithmetic Mean (UPGMA, average neighbour method), the package 
poppr v2.8.2 was used to calculate the bitwise distance by bootstrapping (aboot, 
sampling 100 times) (Kamvar et al., 2014; Kamvar et al., 2015). A distance 
genetic tree, coloured by sample group, was plotted with ggtree (Yu et al., 
2017).   
Variant data from each individual was used to investigate genetic relatedness. 
The SNPRelate R package v1.12.0 (Zheng et al., 2012) module Kinship-based 
INference for GWAS (KING) (Manichaikul et al., 2010) was used to determine the 
proportion of variants that were identical-by-state and hence the familial 
relatedness between individuals. The KING-robust algorithm, not impacted by 
linkage disequilibrium and able to cope with population stratification, was used 
to compute kinship coefficients for each pair of individuals, allowing population 
substructure to be revealed. Results are described in section 4.3.5. 
2.7.5 Hardy Weinberg analysis 
Stacks v2.0b populations was used to calculate departure from Hardy-Weinberg 
Equilibrium (HWE) using an exact test for SNPs (Louis and Dempster, 1987; 
Engels, 2009) and a Markov Chain for RADloci haplotypes (Guo and Thompson, 
1992; Rochette et al., 2019). In addition, VCFtools v0.1.14 was used to assess 
SNPs for heterozygosity excess or deficit (--hardy) (Danecek et al., 2011). 
Results are described in section 4.3.6. 
2.7.6 Linkage disequilibrium analysis 
Prior to calculating the linkage disequilibrium (LD), the percentage of missing 
variant sites per individual was calculated using VCFtools v0.1.14 (--missing-
indv). Six individuals were removed (three from each of the pre- and post-
treatment samples) and Stacksv2.0b populations repeated with 54 individuals, 
but requesting the proportion of individuals per site in each population to be 
equivalent to the original –r80 value (Catchen et al., 2013; Paris et al., 2017). 
The new variant output file was provided to VCFtools v0.1.14 to calculate the LD 
r2 value between each variant site within contigs (--geno-r2) and between 
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contigs (--interchrom-geno-r2). Note that this compares genotypes (homozygous 
for the reference, heterozygous or homozygous for the alternate allele) rather 
than phased alleles as haplotype data are not available. The LD decay was 
calculated and plotted using an R script written by Fabio Marroni 
(https://fabiomarroni.wordpress.com/2011/08/09/estimate-decay-of-linkage-
disequilibrium-with-distance/, last accessed Jan 2019). The distance in basepairs 
to the mean intercontig LD r2 value (Cutter et al., 2006), was also obtained using 
this script. Results are described in section 4.3.8. 
2.7.7 SNP density across the genome 
The SNP density per kb was calculated using VCFtools v0.1.14 –-snpden. Results 
were calculated in distinct 1 kb windows across the genome. The first 50 contigs 
were plotted using R to visually assess SNP density. Results are described in 
section 4.3.9. 
2.7.8 ddRAD-Seq genetic differentiation analysis 
FST values were calculated for each RADmarker (SNP) using Stacks v2.0b 
populations. Note that FST is used throughout this PhD as a description of the 
degree of genetic differentiation between sample populations. It is particularly 
used to compare the pre- and post-IVM populations in the ddRAD-Seq chapter 
(chapter 4) and later for the Pool-Seq chapters (chapters 5 and 6). FST is not a 
true measure of genetic differentiation but is rather a fixation index, describing 
the degree of fixation of alleles between populations. It ranges from 1 (complete 
fixation) to 0 (each population has equal proportions of each allele - panmixis). 
FST will be low in the presence of within-population diversity, and therefore the 
relative difference between FST values are usually considered rather than 
absolute values. In addition, F'ST and DEST statistics were calculated for RADloci 
(Bird et al., 2011), as these can better account for within-population diversity. 
DEST is a true measure of genetic differentiation, while F'ST is a fixation measure 
which calculates the relative degree of allele fixation between populations given 
the within-population diversity. For each statistical dataset, RADloci and 
RADmarkers which had calculated values of genetic differentiation greater than 
three standard deviations above the mean value were considered of interest and 
were retained for further study. At the time of this analysis, the Tci2 genome 
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was not annotated. Tci2 contigs containing these RADmarkers/RADloci were 
manually annotated in Artemis v16.0.0 (McQuillan et al., 2011), using RNA-Seq 
data obtained from a NZ study (Choi et al., 2017), to identify genes up to 75 kb 
distant from the RADlocus. RNA-Seq fastq files were first checked using FASTQ 
Groomer v1.1.1 (Blankenberg et al., 2010) and subsequently aligned to the Tci2 
genome using HISAT2 v2.1.0  (Kim et al., 2015). For this, the University of 
Glasgow Galaxy server was used (Afgan et al., 2018).  
The translated nucleotide sequences of annotated genes were searched against 
the NCBI Nematode database, using BLASTP. Each alignment was considered on 
its own merit, however only predicted homologues which had an E-value of less 
than 1e-5 were retained. All C. elegans homologues retained had greater than or 
equal to 20% pairwise identity, and H. contortus homologues had greater than or 
equal to 30% pairwise identity. All equivalent proteins retained from the T. 
circumcincta PRJNA72569 BLASTP had greater than 60% pairwise identity. In 
addition, BLAST tools in WormBase ParaSite were used to further identify C. 
elegans homologues, H. contortus homologues, and to identify equivalent genes 
in the PRJNA72569 T. circumcincta genome. If no gene could be identified in the 
PRJNA72569 T. circumcincta genome then the PRJNA72569 contig with the 
lowest E-value was recorded. Where relevant, wormbase.org was used to better 
understand the possible function and interactions of genes identified. Consensus 
fasta sequences for each individual (two sequences per RADlocus per individual) 
were extracted from the Stacks v2.0b output file and visually assessed in 
Geneious® v9.1.8 (https://www.geneious.com). Due to the time taken to 
manually annotate and identify genes, RADloci within the top 50 results of two 
or more statistical methods (FST, F’ST or DEST), were prioritised. In addition, the 
top five RADloci of each method were investigated. Lastly, the use of contig 
mean LD as an indicator for IVM selection was investigated by comparing contigs 
with SNPs of high FST by their mean FST and mean LD value. Results are described 
in sections 4.3.10 to 4.3.12. 
2.8 Bioinformatics: Preliminary annotation of Tci2 
genome 
In January 2019, the Tci2 genome was annotated as part of this PhD. MTci2 RNA-
Seq data generated from three biological replicates and two technical replicates 
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each of pooled adult females, pooled adult males and pooled sheathed L3 was 
provided by the BUG Consortium. Using STAR v2.5.2 (Dobin et al., 2012), RNA-
Seq reads were aligned to the Tci2 genome. Following alignment, SAMtools and 
MultiQC were used to analyse the alignment success: between 87 and 90% of 
reads mapped successfully to the genome. The aligned reads and the Tci2 
genome were provided as input to the program BRAKER v2.0 (Stanke et al., 
2008; Hoff et al., 2016), composed of GeneMark-ET (Li et al., 2009; Barnett et 
al., 2011; Lomsadze et al., 2014), a program which annotates genes using 
aligned RNA-Seq reads, and AUGUSTUS (Altschul et al., 1990; Stanke et al., 
2006; Camacho et al., 2009), which uses the pre-annotated genes to further 
predict additional coding sequences. Results are described in section 6.3.1. 
BUSCO v3.0.2 was used to assess the gene copy number (Simao et al., 2015). The 
annotated protein dataset (produced using the MTci2 RNA-Seq data) was 
analysed using -m proteins. The Tci2 genome assembly was also separately 
analysed using the nematoda_odb9, Caenorhabditis elegans, as training material 
for AUGUSTUS. BUSCO results are provided and discussed in Chapter 7.  
2.9 Bioinformatics: Pool-Seq 
For the Pool-Seq experiment two farms were used. Farm 2 had a pre- and a post-
treatment sample. Farm 3 had two technical replicates of the pre- and post-
treatment samples. Following validation of the method, pairwise comparisons 
between the pre- and post-treatment samples were performed by farm to 
identify regions of genetic differentiation. Bioinformatics methods are detailed 
below. Note that scripts used are included in Appendix 2 when relevant, and are 
also available on GitHub (https://github.com/SheepwormJM). Raw data can be 
accessed via ENA using accession numbers ERS2487257 to ERS2487262. 
2.9.1 Alignment of Pool-Seq reads to the reference genome 
Fastqc and MultiQC were used to visually assess the quality of the sequencing 
data. Following this, reads were aligned to the Tci2 genome using the same 
script detailed in 2.7.2. For Pool-Seq, duplicate reads were marked. SAM files 
generated were merged and sorted, before conversion to BAM output files using 
SAMtools. Using the same method, reads were also aligned to the PRJNA72569 
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genome. MultiQC was used to assess the alignment success. Results are 
described in section 5.3.2. 
2.9.2 Coverage 
The genome-wide coverage depth was calculated as:  
((number of reads x 75 bp read length)/genome length) 
for each sample population. In addition, SAMtools v1.3 depth was used to 
calculate the mean mapped depth per site, requiring a minimum mean read base 
quality (BQ) of 20 (-q20). To better appreciate the spread of coverage depth 
across the genome, SAMtools v1.3 stats was used to calculate the coverage 
frequency in bins of ten, ranging from 1 to 1000 read depth (-c(1, 1000, 10), i.e. 
the first bin included genomic sites with coverage 1-10, the next 11-20 etc.. Any 
sites with coverage depth of >1000 were binned together. Lastly, bedtools 
makewindows was used to split the genome into 6145 bp regions, based on the 
average size of a gene in the published reference genome PRJNA72569 (Quinlan 
and Hall, 2010; Quinlan, 2014; Choi et al., 2017). Following this, the read count 
per 6145 bp window was calculated by bedtools multicov (-f 37E-9 -q 20), 
requiring a mapping quality (MAPQ) of 20 or more, and that each read included 
in the analysis should overlap the region by at least 37 bp (equal to half the read 
length). Results are described in section 5.3.3. 
2.9.3 Within population diversity and Tajima’s D 
An mpileup file which contained, for each genomic site, the coverage and 
sequencing quality of all mapped reads for each sample population was produced 
using SAMtools v1.3. Only reads with MAPQ > 20 and BQ > 30 were used. 
Duplicate reads were discarded. Each sample pileup was subsequently extracted 
using a custom script provided by Dr S. Doyle of the WSI. PoPoolation Variance-
sliding.pl (Kofler et al., 2011a) was used to calculate the nucleotide diversity 
(Tajima’s Pi) and Tajima’s D. These tests are explained further alongside the 
results in section 5.3.4. Distinct 10 kb windows were used, requiring a minimum 
minor allele count of two, a minimum coverage of 10 and a maximum coverage 
of 400. The minimum covered fraction of each window was 0.1. A Wilcoxon sum 
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rank test, with continuity correction, was performed in R v3.1.2, to compare 
samples, and treatment groups (i.e. all pre- vs all post-treatment samples). 
Results are described in section 5.3.4. 
2.9.4 Pool-Seq genetic differentiation analysis 
For this analysis the mpileup file (2.9.3) was used. Indels were identified using 
PoPoolation2 identify-indel-regions.pl (--indel-window 5, --min-count 2) (Kofler 
et al., 2011b). Basepairs adjacent to these were filtered (filter-sync-by-gtf.pl), 
to reduce the chance of calling false positive SNPs. After syncing the file 
(mpileup2sync.jar), PoPoolation2 snp-frequency-diff.pl was used to calculate 
major and minor allele frequencies for each variant site. The major allele 
frequencies were used to compare genetic relatedness of samples in R v3.1.2 
using cor() and the package Hmisc to calculate Pearson’s correlation coefficient 
(r). The packages ggplot2 (Wickham, 2016) and reshape2 (Wickham, 2007) were 
used to produce a correlogram using geom_tile.  
For each sample pairwise comparison (i.e. pre- vs post-treatment, within a farm) 
performed by PoPoolation2, variant site allele frequency differences were 
calculated and a Fisher’s Exact Test was performed (fisher-test.pl). In addition, 
the degree of allele fixation between sample populations for each variant site 
was calculated (FST analysis of genetic differentiation, fst-sliding.pl), and data 
were smoothed. Distinct windows of 10 kb, 50 kb and 100 kb, allowing for 
fractional coverage of each window of 1, 0.5 and 0.1 were tested. Following this 
initial assessment, a window size of 10 kb and fractional coverage of 0.1 was 
subsequently chosen. Using the first 100,000 variant sites, allele frequency and 
coverage depth parameters for the FST analysis were trialled. Minimum minor 
allele counts of 2, 5 and 10 were compared. For all analyses (FST, allele 
frequency differences and Fisher’s Exact Test), a minimum minor allele count of 
5, (across all six samples/replicates), a minimum coverage of 10 (for each 
sample) and a maximum coverage equal to the top 2% of coverage for each 
sample was chosen (range 70 – 76x).  
For all FST comparisons regions and variants of interest were defined as having 
FST values above a threshold cut-off of three standard deviations above the mean 
FST value for that comparison. Individual variant sites were considered of 
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interest if they had a significant allele frequency difference (p<0.05), between 
the pre- and post-treatment samples. Data were always filtered within farm, 
rather than between farms. Contigs containing regions of interest were 
compared to contigs containing RADloci of interest from the ddRAD-Seq analysis. 
The FST analysis was repeated for reads aligned to the PRJNA72569 genome, and 
results were compared between genomes. In addition to within farm analysis, 
genetically differentiated regions identified in each farm analysis independently 
were compared using bedtools intersect to identify genomic regions of 
differentiation common to both farms. The expected number of 10 kb regions to 
be identified in both farm analyses by chance was calculated using: 
(Number of windows in Farm 2 data x Number of windows in Farm 3 data) 
Total number of 10 kb windows (68,500) 
The expected number of windows identified on both farms was compared to the 
observed number of windows identified on both farms using a Chi-squared test in 
Excel.  
Farm 3 had two technical replicates for each sample, referred to as Pre-IVM 
Replicate A and Replicate B, and Post-IVM Replicate A and Replicate B. These 
were used to additionally filter false positive results (see Figure 2.3). Each pre-
IVM replicate was compared to each post-IVM replicate. Windows and SNPs were 
filtered so that only results identified as being of interest in all of these four 
pairwise comparisons (i.e. Pre-A vs Post-A, Pre-A vs Post-B, Pre-B vs Post-A and 
Pre-B vs Post-B), were retained. In addition, the two post-IVM technical 
replicates on Farm 3 were compared for regions of genetic differentiation. It 
was assumed that any region identified would not be related to IVM treatment 
and these regions were discarded from further Farm 3 analyses. Results are 
described in section 5.3.5 and are compared with ddRAD-Seq results in 5.3.6.  
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Figure 2.3: Schematic representation of filtering of Farm 3 data. Shown are three Manhattan 
plots. The black line indicates the threshold calculated for the pairwise comparison plotted. 
(A). Pre-A vs Post-A, (B). Pre-A vs Post-B, (C). Post-A vs Post-B. Three 10 kb windows are 
indicated with FST values greater than the threshold for the pre- to post-IVM comparison in 
plot (A). The blue dot represents a 10 kb window which is above the threshold in both (A) 
and (B), but also in (C), suggesting that it is related to inherent diversity within the sample 
population rather than indicating IVM selection. It is discarded. The green dot only appears 
to be selected in (A), and not in (B), so it too is discarded. Lastly, the orange dot is high in 
both (A) and (B), but not in (C). It is retained for further analysis. 
In addition to the above, a Cochran-Mantel-Haenszel (CMH) test was performed 
(PoPoolation 2, cmh-test.pl) to identify regions significantly (p<0.0001) and 
consistently differentiated by allele frequency on both farms. This was 
performed five times, each time comparing Farm 2 (Pre- vs Post-IVM) to a 
different Farm 3 technical replicate comparison (Pre- vs Post-IVM or Post- vs 
Post-IVM). As for the FST analysis, results were filtered for consistency across all 
Farm 3 replicate comparisons. Results were excluded when identified using the 
Farm 3 post-post technical replicates, which should not have differences related 
to IVM selection. Results are described in section 5.3.5.   
2.9.5 Identifying genes within genetically differentiated regions 
Genetically differentiated regions identified on a farm were further examined. 
The amino acid sequences of genes annotated by AUGUSTUS within, or crossing a 
window of interest were extracted using bedtools intersect. Homologues (C. 
elegans and H. contortus) and equivalent proteins (proteins identified within the 
PRJNA72569 T. circumcincta genome) were identified using the WSI farm_blast 
BLASTP. As hundreds of proteins were investigated, only the top hit was retained 
(blast_options "-max_target_seqs 1"). In some instances this may have permitted 
selection of a shorter alignment, with a lower (and hence better) E-value, than a 
more appropriate, longer alignment. However, in most cases this method was 
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expected to be successful. Results were further filtered to retain only proteins 
with E-value < 1e-05. Homologues for C. elegans were accepted if they had 20% 
pairwise identity or more, or for H. contortus if they had 30% pairwise identity 
or more. No equivalent proteins identified in the T. circumcincta PRJNA72569 
genome were retained with less than 50% pairwise identity, however most had 
greater than 80% identity. Predicted homologues or equivalent proteins which 
were common to both farms were identified. All results are provided in 
Appendices 5, 6 and 7 and are described in sections 6.3.2 and 6.3.4. 
2.9.6 Obtaining gene ontology information for identified genes 
Following identification of homologues in C. elegans and H. contortus and 
equivalent proteins in PRJNA72569 T. circumcincta, BIOMART (Smedley et al., 
2015) as hosted by WormBase ParaSite, was used to identify annotated gene 
ontology (GO) terms. GO terms were searched for in a hierarchical manner to 
attempt to obtain the maximum information possible, as many genes in the 
PRJNA72569 T. circumcincta genome are missing protein information.  
To do this, each list of proteins previously identified using BLASTP (2.9.5), was 
provided to BIOMART, beginning with the PRJNA72569 equivalent protein list. In 
addition to GO terms, homologues in H. contortus and C. elegans and the gene 
name were included in the output file. From this file, H. contortus homologues 
identified, with no C. elegans homologue, were subsequently included when the 
H. contortus protein list was provided to BIOMART. For this list, the C. elegans 
homologue was requested in addition to the GO terms and gene name. Any C. 
elegans homologues identified by BIOMART from either search were included in 
addition to the C. elegans homologue list previously identified (2.9.5) and were 
provided to BIOMART to identify GO terms. All results are provided in Appendices 
8 and 9. Genes of interest were then identified using the following search terms; 
Neuronal genes (‘neuro’, ‘nerve’, ‘axon’, ‘dendrite’, ‘synap’ and ‘channel’), 
Lipid metabolism genes (‘lipid’, ‘ligase’, ‘glycerol’, ‘glycerone’, ‘fatty’, ‘lipo’ 
and ‘cholesterol’), Male (‘male’ and ‘sperm’), Female (‘female’, ‘egg’, ‘vulva’ 
and ‘zygot’). Genes were manually checked. Results are provided in section 
6.3.2. 
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2.9.7 Identifying SNPs of high or moderate impact 
The program SnpEff (Cingolani et al., 2012), was used to assess the possible 
impact of SNPs within high FST 10 kb windows. First, a T. circumcincta database 
was created using SnpEff following which SnpEff was run for each farm 
separately, using default values. The program requires both gene annotations 
and a list of variant sites in VCF format. SAMtools v1.3 was used to produce a 
VCF file of all variant sites with MAPQ > 20 and BQ > 30. Mean depth per variant 
site was determined for each farm separately using VCFtools v0.1.14. The VCF 
file was filtered to retain only variant sites with coverage depth of between 20 
to 60x inclusive, as determined for each farm independently. These variant sites 
were used as input for SnpEff. The SnpEff annotated VCF output file was filtered 
using bedtools intersect to retain only SNPs with: (i) high FST, (ii) a significant 
allele frequency difference (p<0.05) and (iii) which were within the high FST 10 
kb windows. Lastly, each file was filtered using grep to identify those SNPs 
which were deemed to be of ‘HIGH’ or ‘MODERATE’ impact. Results are provided 
in section 6.3.3. 
2.9.8 Comparison with other GWAS 
Three recently published GWAS investigating IVM resistance in T. circumcincta 
(Choi et al., 2017), H. contortus (Sallé et al., 2019), and O. volvulus (Doyle et 
al., 2017) were compared to results obtained in the present study. In addition, 
recent work using a genetic cross of MHco3(ISE) and MHco18(UGA) to investigate 
IVM resistance in H. contortus was also compared (BUG Consortium). To compare 
between studies, the genes, SNPs or regions of interest, as identified by the 
study authors were compared with homologues of Tci2 genes identified within 
regions of genetic differentiation in the present study. Results are described in 
section 6.3.5. All results are presented in Appendices 12-14.  
2.9.9 Copy number variation 
Variation in copy number between sample populations was assessed using a 
proxy method dependent on the read count within a given window size (Xie and 
Tammi, 2009). Prior to performing this analysis a file containing only reads 
which had successfully aligned to the Tci2 genome was produced using SAMtools 
view (-F4). The resulting file was piped to a perl script to produce a ‘hits’ file as 
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required by the program CNV-seq (Xie and Tammi, 2009). Copy number variation 
(CNV) was calculated using CNV-Seq cnv-seq.pl specifying a genome size of 680 
Mb and requiring a set window size of 5 kb. Each window overlapped the 
previous window by 2500 bp. For each window, the log2(read count ratio) 
between the pre- and post-IVM samples was calculated. Results were filtered to 
retain only windows with log2(read count ratio) greater than one or less than 
minus one, which were significant at p<0.00001. Windows that had no reads in 
one sample of a comparison were discarded. For each comparative analysis, the 
post-IVM sample was compared to the pre-IVM sample. Hence, if the log2(read 
count ratio) is positive, read counts are higher in the post-IVM sample compared 
to the pre-IVM sample. A two tailed, paired t-test was performed in Excel to 
compare the pre- and post-treatment sample means. 
Based on the genome-wide average read count per window, the read count 
distribution and the median read count, the results were then further filtered as 
described in Figure 2.4. As CNV is less accurately determined using Pool-Seq data 
than for individual sequencing, filtering aimed to retain only CNV of large 
magnitude. For insertions/duplications (log2(read count ratio) >1), windows were 
only retained if the post-IVM sample had a read count greater than 1.5x the 
median post-IVM sample read count. For deletions, windows were only retained 
if they had read counts of less than half the median read count in the post-IVM 
treatment samples and had a read count greater than or equal to the median 
read count in the pre-IVM treatment sample. For Farm 3, CNV were also required 
to be present in all four pre- to post-IVM replicate comparisons. Tci2 genes were 
identified for each window retained after filtering using bedtools intersect. 
Homologues and equivalent proteins were identified using the WSI farm_blast 
BLASTP tool in the PRJNA72569, H. contortus and C. elegans protein databases. 
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Figure 2.4: Schematic diagram showing filtering of CNV regions. The green filled areas 
indicate the retained read-counts. Results were filtered as follows: for 
insertions/duplications (top), any windows with read counts >1.5x post-IVM sample median 
read count were retained. For deletions (bottom), windows retained were required to have a 
read count of <0.5x post-IVM sample median read count AND the median read count (or 
greater) of the pre-IVM sample median read count. The blue line indicates the median read 
count, the red line the cut-off.  
Windows retained were considered for potential relevance and robustness by a 
number of factors. The contigs and their corresponding gff3 data were extracted 
for visualisation with aligned reads in Artemis. Four points were then 
considered. Firstly, the length of the CNV was determined (although the sliding 
windows used were 5000 bp, the read count across the window was not 
necessarily uniform). Secondly, the MAPQ score of the reads was visually 
assessed to obtain an estimate of mapping quality over the region. Thirdly, the 
position of the CNV relative to gene annotations was considered (i.e. was it 
within an intron, exon or close to an annotated gene). Lastly, was the CNV 
region within, or covered by, a repetitive or low-complexity region by more than 
70%, which might indicate falsely aligned reads (Trost et al., 2018)? 
To identify CNV of specific P-gp genes, a BLASTP search, with no restrictions, 
using the WSI farm_blast was performed of all translated nucleotide sequences 
of genes annotated by AUGUSTUS. Using PRJNA72569 equivalent proteins, and C. 
Insertions/Duplications: log2(read count ratio) >1 
Windows with > 1.5x median post-
IVM read count were retained 
Deletions: log
2
(read count ratio) <-1 
Windows with < 0.5x median post-
IVM read count AND with > median 
pre-IVM read count were retained 
Post-IVM 
Post-IVM 
Pre-IVM 
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elegans protein homologues of P-gps, relevant results were extracted and 
manually examined to identify all Tci2 P-gps required. Where necessary, amino 
acid sequences were extracted and aligned in Geneious® v9.1.8, and 
phylogenetic trees were plotted. CNV read counts were subsequently extracted 
for the appropriate regions. Results are described in section 6.3.6.
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3 Don’t put all your eggs in one basket: The role 
of diversity in PGE and anthelmintic resistance 
on a commercial farm 
3.1 Abstract 
Commercial sheep flocks vary widely in their size, management and purpose. 
However parasitic gastroenteritis is common to all. This disease is complex with 
multiple strongyle species potentially contributing to clinical signs. Various 
management and breeding practices are known to affect the clinical outcome of 
infection. Almost all farmers will use anthelmintics to control and treat the 
disease, but efficacy can decline with use. Despite this, few farmers routinely 
test the anthelmintic efficacy of the products they use. In addition, multiple 
factors can affect the interpretation of results of such tests. I used three 
different classes of tests (in vivo – faecal egg count reduction test, in vitro – egg 
hatch test and larval development test, and molecular test – pyrosequencing) to 
investigate anthelmintic efficacy on a typical commercial farm in the UK. In 
addition, parasite abundance and species composition was assessed over time to 
gain insight into how such tests might be affected over the farming year. Lastly, 
microsatellites were used to assess for evidence of selection or change in the T. 
circumcincta population present on the farm over time. My results showed that 
despite modern farming practices, a considerable diversity of strongyle species 
can be maintained. Both the in vivo and in vitro tests of anthelmintic efficacy 
were considerably confounded by this species diversity. By using a combination 
of tests it was identified that T. circumcincta individuals were highly dual-
resistant to both BZ and IVM anthelmintics. Genotyped offspring of individuals 
surviving BZ treatment indicated survival of heterozygous resistant individuals. 
No change over time in the T. circumcincta individuals was noted using 
microsatellites, and individuals were as diverse as had been found on other 
farms in previous studies. Neither the in vivo nor in vitro tests used to detect 
IVM resistance were sensitive to the presence of a highly resistant species within 
the parasite community. A genetic test for IVM resistance, as is currently 
available for BZ resistance, would therefore greatly help research into IVM 
resistance. 
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3.2 Introduction 
Parasitic gastroenteritis (PGE) is a significant production and welfare concern for 
sheep farmers in the UK (Sargison, 2014; APHA, 2018). Various means of 
disseminating advice to farmers on managing and monitoring PGE and 
anthelmintic efficacy are available. The best developed resources are provided 
by ‘SCOPS’ (Sustainable Control of Parasites in Sheep), including a website 
(www.scops.org.uk), best practice guidelines for farmers, and a technical 
manual for veterinary surgeons (Abbott et al., 2012). Uptake of these 
recommendations varies considerably (McMahon et al., 2013c; Learmount et al., 
2016b; Jack et al., 2017) and anthelmintic resistance can still arise even with 
their use (Learmount et al., 2016a).  
Farmers monitor PGE in a variety of ways (McMahon et al., 2013c). These may 
include noting clinical signs of illness within the flock, monitoring weight gain 
over time, obtaining faecal egg counts (FECs) or receiving post-mortem reports. 
In practice, a combination of these methods is most effective in fully 
understanding the presence and impact of PGE on a farm. For example, FECs do 
not always directly correlate with intensity of infection. This may be because 
infection is not yet patent, or because there is variation between species, 
duration of infection or the host immune response (Coyne et al., 1991; Stear and 
Bishop, 1999; Saccareau et al., 2017). In the case of T. circumcincta, the density 
of infection affects the fecundity of adult females (Bishop and Stear, 2000). 
Similarly, low weight gain can be caused by many nutritional and disease-related 
factors.  
Following collection of a faecal sample, eggs are harvested and ‘strongyle eggs’ 
are counted. Strongyle eggs describe those of a similar appearance but 
encompass many different species of Trichostrongylid parasites of ruminants. 
There are five FEC methods in use with varying sensitivities: the McMaster (15 to 
50 eggs per gram (epg)) (Coles et al., 1992; Cringoli et al., 2004), FLOTAC (1 
epg) and Mini-FLOTAC (5 to 10 epg) (Rinaldi et al., 2014; Godber et al., 2015), 
FECPAK (30 epg) (Coles, 2003) and a cuvette method (1 epg, Christie and 
Jackson (1982), see Chapter 2.2.2). The Mini-FLOTAC and FECPAK are 
commercialised for use on farm. Neither require a centrifuge and the FECPAK 
can be performed without a microscope; instead an image is taken allowing 
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interpretation by an expert distant to the farm, making it highly practical for 
use by farmers. Dependent on the reason for sampling, each of these methods 
will vary in their applicability. For example, to monitor for the presence of high 
FECs requiring treatment the McMaster or FECPAK is suitable, however, to 
determine anthelmintic efficacy, it is better to use a test with high sensitivity.  
The current gold standard test to assess anthelmintic efficacy, a ‘controlled 
efficacy test’, requires sacrificing animals (Coles et al., 2006) so is rarely used. 
The faecal egg count reduction test (FECRT), described in Figure 3.1, is simple 
to perform and is the most frequently used method on farm, but it can be 
expensive and labour intensive, as it requires setting aside groups of lambs for 
use in the test. The meat (or milk) withdrawal times of the anthelmintics used in 
the FECRT must also be observed. A modification of the full FECRT is to perform 
a ‘drench test’, sampling a group of animals post-treatment only, although 
interpretation is limited even with the inclusion of an untreated control group 
(Coles et al., 2006). For both the FECRT and drench test, analysis should ideally 
be done using separate FECs for each individual, obtaining an arithmetic mean 
(Dash et al., 1988). Although a simple calculation can be used as shown, with 
variations on this (McKenna, 2006), it is also possible to calculate the FECR using 
zero-inflated Bayesian methods, which can be more robust to inherent variation 
and bias (Wang and Paul, 2017; Wang et al., 2017). It is important to realise the 
limitations in determining anthelmintic efficacy from a FECRT. In particular the 
possibility of worms remaining post-treatment, but which shed fewer eggs 
compared with before (Sutherland et al., 2003a), or the presence of 
anthelmintic resistance in only one or two particular strongyle species within the 
population (McKenna, 1997). 
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Figure 3.1: Faecal egg count reduction test guidelines adapted from Coles et al. (2006), with 
the addition of the 4-AD (Kaminsky et al., 2008) and 5-SI anthelmintic classes (Little et al., 
2011). 1If using animals older than six months of age it is important to check that the 
strongyle faecal egg count is > 150 epg. 2Note that not all L4 larvae of every species may be 
killed.    
Strongyle species identification can be performed using morphology of the L3 
larval stages (Crilly and Sargison, 2015). L3 are killed and examined under a 
microscope, in particular focusing on sheath tail length and shape, head shape, 
the presence of refractile bodies within the head, the number of gut cells and 
the overall length of the larva (Figure 3.2 A-C) (van Wyk and Mayhew, 2013). 
This can be an excellent means of identification by skilled parasitologists, but is 
time consuming and requires training. Molecular methods have been developed, 
using the internal transcribed spacer region (ITS2) of the ribosomal RNA gene. 
Worms can be identified by individual species PCR (Wimmer et al., 2004), 
multiplex PCR (Bisset et al., 2014) (Figure 3.2 D) and multiplex-tandem PCR, 
commercialised as AusDiagnostics (Roeber et al., 2012; Roeber et al., 2017) 
using eggs or larvae as template. Newer methods use next generation sequencing 
(NGS) to sample the entire ‘nemabiome’ using strongyle specific, but species 
generic primers which amplify the ITS2 region, prior to pooled sequencing and 
extrapolation of the approximate species proportions by read count (Avramenko 
et al. (2015), www.nemabiome.ca).  
FECRT guidelines: 
 
1. Identify groups of 10 or more sheep for each anthelmintic used +/- a control 
group.1 
2. Calibrate equipment (weigh scales and dosing gun) 
3. Weigh each animal individually. 
4. Collect faecal sample, ideally per rectum, of roughly 3-5 g weight. 
5. Dose each animal to their individual weight.  
6. Perform FEC. 
7. Re-sample animals 7 to 17 days later depending on the anthelmintic used: 
 1-BZ: 10 – 14 days post-treatment 
 2-LEV: 7 days post-treatment 
 3-ML: 14 – 17 days post-treatment 
 4-AD: 14 days post-treatment 
 5-SI: 14 days post-treatment2 
8. Perform FEC and calculate difference. Various equations may be used 
including: 
 
FECR % = ((FEC pre-treatment – FEC post-treatment)/(FEC pre-treatment))*100 
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Figure 3.2: Strongyle species identification methods. Morphological identification of L3: A. 
By sheath tail length, e.g. top = short tailed, Teladorsagia circumcincta type, bottom = long 
tailed, for example Chabertia ovina, B. By head shape, i.e. rounded, square, bullet shaped, 
C. Cooperia curticei head demonstrating the presence of refractile bodies (arrow). Molecular 
methods: D. Image of PCR products from a multiplex PCR reaction. The top band is the 
amplicon of the generic primers, while the lower band is species specific (Bisset et al., 
2014).  
The presence of multiple species contributing to PGE complicates both 
management and research on farm. Typically, parasites reach patency within 
three weeks following ingestion, but there is considerable variation between 
species (Roeber et al., 2013b), time of year (Gibbs, 1986a), and immune 
response of the host (Smith et al., 1985). Free-living stages pass through three 
developmental stages (egg, L1 and L2) before reaching the infective L3 stage 
(Figure 3.3). The development period and survival time of L3 on pasture is 
species specific, but is also affected by relative humidity, moisture and soil 
temperature (Gibson and Everett, 1972; O’Connor et al., 2006; van Dijk and 
Morgan, 2011; Wang et al., 2014). In the case of T. circumcincta, L3 were able 
to survive on pasture for 16 months from the time of the egg being laid (Gibson 
and Everett, 1972), and L3 can be stored at 8 °C for longer than this. 
 
A B C 
D 
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Figure 3.3: Teladorsagia circumcincta lifecycle as an example of a typical Trichostrongylid 
lifecycle. A. An infective L3 on herbage is ingested. B. The L3 exsheaths within the rumen 
(Bekelaar et al., 2018) and enters the gastric glands of the abomasum (Sommerville, 1953). 
Here it moults twice and emerges as an L5 before reaching patency as an adult. C. 
Following patency (typically estimated to take 17-21 days, although 14 days has been 
observed for T. circumcincta), eggs are shed into the faeces (Barrett et al., 1998). D. T. 
circumcincta eggs develop at temperatures above 4 °C (Crofton, 1965). E. The L1 larvae 
hatch and moult to L2, usually within the space of a few days. F. Following climatic cues, 
the infective L3 emerges from the faecal pat onto herbage (Gibson and Everett, 1972). Here 
it may move up the sward, or down into the soil dependent on local environmental 
conditions (van Dijk and Morgan, 2011). G. Close up of an opened abomasum, illustrating 
the mucosal folds (lines), with the multi-papillary raised lesions associated with an infection 
of T. circumcincta. These lesions are due to the presence of maturing L4 within the gastric 
glands, predominantly within the fundic region. Not all L4 will mature – some will be 
suppressed by the host’s immune response, others will become hypobiotic overwinter and 
re-emerge in spring. 
The determination of anthelmintic efficacy by FECRT on a farm may vary across 
the year dependent on which species are sensitive, as seasonal variation in 
species prevalence is recognised on farms (Boag and Thomas, 1977). In addition, 
the proportion of sensitive to resistant nematodes within a host at any given 
time will also affect the results of a FECRT. How readily resistant parasites are 
‘diluted’ within hosts is largely dependent on the number of sensitive parasites 
A 
B 
C 
D 
E 
F 
G 
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in refugia on farm, which the host is likely to ingest between treatments 
throughout the year (van Wyk, 2001). Monitoring anthelmintic resistance on a 
farm over time to determine treatment choice, and to understand how refugia, 
climate and management practices affect the prevalence of resistance is thus 
complicated. FECRTs are expensive, in terms of actual costs and labour time, 
but also unavoidably apply drug-selection to a subset of animals on a farm. 
Various in vitro bioassays are available to measure anthelmintic resistance (Gill 
et al., 1995; von Samson-Himmelstjerna et al., 2009a) (see Introduction, Table 
1.2), which avoid drug selection on farm. Unfortunately, these are also 
expensive, time consuming, can be technically challenging, and in most cases, 
are not commercially available.  
To overcome current limitations in resistance diagnostics there is a pressing 
need for sensitive and specific molecular tests, but these require knowledge of 
the genetic loci conferring resistance (e.g. BZ SNPs (Kwa et al., 1995; Skuce et 
al., 2010)). In order to develop such tests it is also important to understand the 
underlying parasite population structure, its diversity, and how this changes with 
time e.g. under different climatic conditions and management strategies. A 
well-established method to monitor changes in a parasite population over time is 
the use of microsatellite markers. Microsatellites are short, rapidly evolving DNA 
sequences of tandem repeat units, most commonly di- or tri-nucleotides. 
Thirteen microsatellites have been characterised in T. circumcincta and used to 
measure within and between-population diversity on UK farms (Grillo et al., 
2006; Grillo et al., 2007; Redman et al., 2015).  
The pattern of PGE and the involvement of different species over time were 
monitored on a commercial farm in Scotland. Changes in BZ resistance markers 
and neutral microsatellite markers in T. circumcincta were measured and 
compared with results from FECRTs and bioassays to determine the ease and 
effectiveness of resistance diagnosis by commonly used methods. 
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3.3 Results 
3.3.1 Management, parasite abundance and diversity over a year 
on a farm 
3.3.1.1 Study farm and flock management 
Farm 1 was a commercial, 150 acre lowland farm in southeast Scotland with 
previously diagnosed anthelmintic resistance. The farm was studied from March 
2016 to March 2017. The breeding flock consisted of approximately 370 Cheviot 
Mule ewes which were bred to Texel, Suffolk and Beltex rams. Lambs were 
finished on pasture before being sold at market in the autumn. Lambing began in 
late March, with ewes housed on straw from early January, and continued for 
approximately five to six weeks, with an average annual lambing percentage of 
180% (Table 3.1). Ewes were fed haylage (analysed for nutritional content by the 
farmer) and supplemented with sheep nuts (Davidsons; Super Ewe Rolls (20% CP) 
and EWELAC 18 Nuts (18% CP)) whilst indoors, and sheep nuts continued to be 
provided for a short period following lambing. Ewes and new lambs were 
returned to pasture within 48 hours of lambing.  
Pastures were grazed intensively by the flock, with frequent rotation of the 
small group of rams between pastures. Ewes and lambs were kept together in 
large fields, with little to no rotation until weaning in late August, when all 
lambs were re-grouped as a single flock and moved to a ‘clean’ pasture. This had 
been previously used for silage, but had been occasionally grazed by rams during 
silage growth and gimmers (young adult females which have not reproduced) had 
grazed the pasture earlier in the year. Ewes were re-sorted onto several 
pastures and in the autumn were mixed with the rams for breeding. New rams 
were bought in September 2016 and replacement ewe lambs were obtained in 
October 2016. The management observed on the farm over the year of study 
(Table 3.1) was similar to that in previous years. Occasionally, in previous years, 
when grass sward height was sufficient, pastures on the farm had been rented to 
neighbouring cattle farmers. Adult females were vaccinated with Covexin 10 
(Zoetis) in February/March 2016 and with Enzovax (MSD Animal Health) and 
Toxovax (MSD Animal Health) in the summer (Table 3.1). These vaccines protect 
against infection with clostridia, Chlamydophila abortus and Toxoplasma gondii, 
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respectively. Sheep were generally healthy although lameness was a concern - 
this was primarily noticed in the rams.  
Table 3.1: Main management events on Farm 1.  
Month Management event 
January Ewes housed 
February Ewes housed. Pregnant sheep vaccinated with Covexin 10.  
March Started lambing. Ewes put outside to pasture when lambed. 
April Finished lambing 
May  
June Lambs treated with Vetrazin (Elanco) to protect against 
blowflies. 
July  
August Weaned lambs as a single group onto silage aftermath. Ewes 
placed in several groups. Gimmers vaccinated with Enzovax and 
Toxovax.  
September New rams bought in.  
October Replacement ewe lambs bought in. Breeding began.  
November Last few lambs sold. Breeding continued. 
December  
 
3.3.1.2 Study farm anthelmintic treatments 
Anthelmintic dose was chosen by the farmer following weighing of the sheep 
estimated to be the heaviest in the group, and all sheep were subsequently 
dosed to this weight then returned to the same pasture. Dosing guns were rarely 
calibrated. The shepherd would decide to dose sheep based on clinical signs of 
scour and/or concern of potential PGE (possibly including a FEC) and would 
usually choose the anthelmintic product based on veterinary recommendation. 
The majority of the ewes were treated following parturition with MOX (Cydectin 
0.1%; persistent action against reinfection by susceptible T. circumcincta, H. 
contortus and T. colubriformis for five weeks, Zoetis), before being returned to 
pasture (Table 3.2). The shepherd aimed to treat all ewes with triplets, and 
some ewes with twins, based on assessment of need (e.g. body condition score), 
but not ewes with singles. However, in practice, treatments were more 
widespread and the medicine book recorded that 350 (out of 370) ewes were 
treated with MOX. Samples collected from ewes and lambs between lambing and 
weaning were from a group which included ewes dosed with MOX. Rams were 
treated in February using LEV, in July with IVM and following the breeding period 
in late autumn (anthelmintic unknown) (Table 3.2).  
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Following identification of Nematodirus battus eggs in the faeces of four young 
lambs in late May, lambs were treated with albendazole three times in May, 
June and July, at each time point leaving 5-10% of lambs untreated (Table 3.2). 
Although no FECRT was performed at these treatment times, FECs were 
conducted within 11 to 15 days following each treatment and at each time point 
strongyle eggs were detected. In late September, lambs were dosed with LEV by 
the farmer. In addition, FECRTs were assessed in a small group of 32 lambs at 
this time point, to assess efficacies of albendazole (Albex 2.5%, Chanelle Vet 
UK), LEV (Levacide 3%, Norbrook) and IVM (Noromectin 0.08%, Norbrook), as part 
of this study (see 2.2.5). Replacement ewe lambs and new rams were treated 
with MPTL and doramectin on arrival at the farm. The ewe lambs were kept on 
pasture for a fortnight before being moved to rented grazing. The new rams 
were integrated with other rams after 48 hours. MPTL has been used for 
quarantine treatment of new stock on this farm since at least 2013. The 
medicine record book indicates that in 2013 and 2015 replacement ewe lambs 
were dosed with MOX rather than doramectin. In 2012, LEV was used for 
quarantine treatment of ewe lambs.  
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Table 3.2: Anthelmintic treatments during 2016 on Farm 1.  
Date Anthelmintic 
(Product) 
Sheep group FECRT efficacy 
(95% HPD 
interval)1 
04/02/2016 
 
LEV (Levacide 3%) Rams ND 
01/04/2016 to 
28/04/2016 
MOX (Cydectin 
Oral) 
Lambed ewes – 
primarily triplets, 
but also some 
twin/single 
bearing ewes 
99.6% (99.5-
99.7%) 
23/05/2016 BZ2 (Albenil) Lambs (excluding 
5-10% of lambs) 
ND 
14/06/2016 and 
15/06/2016 
BZ (Albenil) Lambs (excluding 
5-10% of lambs) 
ND 
01/07/2016 IVM (Noromectin) Rams ND 
06/07/2016 and 
07/07/2016 
BZ (Albenil) Lambs (excluding 
5-10% of lambs) 
ND 
09/09/2016 MPTL (Zolvix) 
Doramectin 
(Dectomax) 
Bought in rams ND 
20/09/2016 LEV (Levacide 3%) Lambs ND 
20/09/2016 BZ (Albex 2.5%) Ten lambs 65.3% (14.5-
86.2%) 
20/09/2016 LEV (Levacide 3%) Ten lambs 80.8% (58.0-
91.1%) 
20/09/2016 IVM (Noromectin 
0.08%) 
Twelve lambs 77.2% (45.5-
91.6%) 
07/10/2016 MPTL (Zolvix) 
Doramectin 
(Dectomax) 
Ewe lambs ND 
All anthelmintic treatments given to the flock are shown. The product name, as obtained 
from the farm medicine record book, is also provided. 1For Faecal egg count reduction tests 
performed during the study the anthelmintic product name and efficacy, as calculated using 
‘eggCounts’ shiny is provided with the 95% Highest Posterior Density interval in brackets 
(Torgerson et al., 2014; Wang and Paul, 2017; Wang et al., 2017). 2BZ = Albendazole. ND = 
not done. 
3.3.1.3 Faecal egg counts over the year 
Individual FECs were conducted on approximately ten ewes every three weeks 
throughout the year from 20th March 2016. In addition, lambs were sampled 
every three weeks from 16th May 2016 to 23rd November 2016 when the last 
lambs were sold. Again, ten samples were collected at each time point excluding 
the first, when only four lambs were sampled. Arithmetic means were 
calculated. From mid-April until weaning the same pasture group of ewes and 
lambs were sampled. The aim was to sample the group generally rather than to 
follow ten individuals across the year. This was partly due to practical 
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limitations of working with a commercial flock, but also to assess the flock as a 
whole and reduce host bias. Following weaning, new groups of ewes and lambs 
were followed. As much as possible, these new groups were consistently 
followed from this point forward until housing, when a new group of ewes was 
identified and followed until lambing. The occasional sample was collected by K. 
Hamer or Prof. N. Sargison. Results of the FECs are included in Hamer et al. 
(2019). 
Overall, FECs were comparatively low, remaining below 200 epg for much of the 
year in both ewes and lambs. Ewe FECs rose from a mean of 452.1 epg on the 
20th March, to 912.0 epg three weeks later when a further ten ewes were 
sampled shortly after parturition (Table 3.3, Figure 3.4). The increase was not 
statistically significant, likely reflecting the wide range of individual counts – the 
median FECs varied less, being 409.5 and 675.0 epg respectively. A MOX FECRT 
was performed on the 7th April 2016 by the farm veterinary surgeons. The mean 
strongyle FEC decreased from 912.0 epg to only 3.4 epg, an efficacy of 99.6% 
(95% Highest Posterior Density (HPD) Interval: 99.5 to 99.7%) (Torgerson et al., 
2014; Wang and Paul, 2017; Wang et al., 2017). Individual reduction percentages 
ranged from 98.9 to 100% reduction (Table 3.2). Further ewe mean FECs 
remained low within the pasture group followed, ranging between mean 2.8 epg 
and 129.8 epg (Figure 3.4). This latter value was from a group sampled on the 7th 
June 2016 and was higher compared with other samples collected throughout 
the summer and early autumn. A rise in egg output from ewes during the autumn 
breeding period was also observed, rising from a mean 23.0 epg on the 10th 
October to 106.2 epg on the 23rd November (Figure 3.4). FECs subsequently 
reduced, such that in January, February and early March 2017 FECs were low, 
prior to rising again in late March at lambing time (Figure 3.4). 
Lamb faecal samples were collected from 16th May 2016, from just four lambs in 
the initial sampling group, when lambs would have been eight weeks old or 
younger. The initial mean strongyle FEC was only 11.8 epg, but the presence of 
N. battus eggs were noted in the faeces (Figure 3.4, Table 3.4). Following this, 
ten lambs were sampled at each time point. Mean FECs remained low, before 
rising from 40.3 epg on the 8th August to 205.9 epg on the 31st August 2016 
(median 30 epg rising to 157.5 epg, Table 3.4). Between these two dates the 
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lambs had been weaned, combined into one large group of approximately 300 
lambs and moved to silage aftermath. Following this time point, lamb FECs 
remained higher, averaging between 151.8 and 232.5 epg until the end of 
November 2016, when very few lambs were left on the farm (Figure 3.4). Only 
one sample was low during this time period, with a mean 38.9 epg, collected on 
the 10th October 2016, 20 days after a LEV treatment was given (Table 3.4).   
Table 3.3: Farm 1 ewe strongyle faecal egg counts.  
Date Number 
of ewes 
sampled 
Arithmetic 
mean strongyle 
epg 
SD strongyle 
epg 
Range 
strongyle 
epg 
Median 
strongyle 
epg 
20/03/2016 10 452.1 318.9 (2-1062) 409.5 
07/04/2016 10 912.0 822.7 (60-2484) 675.0 
21/04/2016 10 3.4 5.7 (0-15) 0.0 
16/05/2016 9 36.4 84.9 (0-261) 3.0 
07/06/2016 12 129.8 208.7 (0-711) 30.0 
27/06/2016 11 9.8 11.2 (0-36) 6.0 
18/07/2016 10 2.8 4.0 (0-11) 1.0 
08/08/2016 10 3.7 5.3 (0-16) 1.0 
01/09/2016 13 20.3 43.2 (1-162) 5.0 
20/09/2016 10 3.0 3.0 (0-8) 3.0 
10/10/2016 10 23.0 16.0 (1-51) 19.5 
01/11/2016 10 77.0 79.9 (4-207) 32.0 
23/11/2016 10 106.2 95.3 (6-270) 84.0 
14/12/2016 10 109.5 91.8 (39-297) 67.5 
04/01/2017 9 53.0 53.2 (12-180) 30.0 
27/01/2017 10 25.3 46.6 (1-153) 8.0 
26/02/2017 10 75.9 59.1 (9-195) 58.5 
16/03/2017 10 432.9 446.9 (42-1512) 354.0 
Samples collected on the 7th and 21st of April were collected per rectum as part of a MOX 
FECRT. Epg = eggs per gram. 
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Figure 3.4: Strongyle faecal egg counts over time on Farm 1. A box and whisker plot is shown for each sampling time point. In addition, each 
individual’s egg per gram is plotted at each time point (dots). Key to annotations: light blue = ewes housed, light green = lambing, purple = 
breeding, dark green = weaning, white = albendazole (BZ) drench, yellow = LEV drench. Note, MOX indicates day zero of the MOX faecal egg count 
reduction test performed by the farm veterinary surgeons. At time of LEV treatment of remaining lambs, 32 lamb FECRTs were performed (post-
treatment samples shown elsewhere).  
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Table 3.4: Farm 1 lamb strongyle faecal egg counts.  
Date Number 
of lambs 
sampled 
Arithmetic 
mean 
strongyle epg 
SD strongyle 
epg 
Range 
strongyle 
epg 
Median 
strongyle 
epg 
16/05/2016 4 11.8 15.1 (0-33) 7.0 
07/06/2016 11 31.5 34.0 (0-99) 24.0 
27/06/2016 14 25.1 30.4 (0-99) 13.0 
18/07/2016 10 5.0 8.6 (0-24) 1.0 
08/08/2016 10 40.3 42.6 (0-129) 30.0 
31/08/2016 14 205.9 179.4 (9-630) 157.5 
12/09/2016 6 232.5 149.2 (114-504) 175.5 
20/09/2016 32 172.4 158.2 (27-672) 115.5 
10/10/2016 10 38.9 32.3 (3-102) 28.5 
01/11/2016 10 151.8 175.9 (2-468) 64.5 
23/11/2016 10 203.7 86.9 (27-330) 205.5 
Samples collected on the 20th September were collected per rectum as part of a faecal egg 
count reduction test, for which post-treatment results are shown separately. Epg = eggs per 
gram 
N. battus eggs were noticed in ewe samples, but counts were always low to 
negligible (Figure 3.5). Of note was the presence of N. battus eggs in housed 
ewe samples on the 20th March 2016. N. battus eggs were found in the earliest 
lamb samples prompting treatment of the flock with albendazole (Figure 3.5, 
Table 3.5). This parasite continued to be detected at low levels in lamb faecal 
samples throughout the year, with an additional rise observed in September. 
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Figure 3.5: Nematodirus faecal egg counts over time on Farm 1. A box and whisker plot is shown for each sampling time point. In addition, each 
individual’s eggs per gram is plotted at each time point (dots). Key to annotations: light blue = ewes housed, light green = lambing, purple = 
breeding, dark green = weaning, white = albendazole (BZ) drench, yellow = LEV drench. Note, MOX indicates day zero of MOX faecal egg count 
reduction test performed by farm veterinary surgeons, at time of sampling. At time of LEV treatment of remaining lambs, 32 FECRTs were 
performed (post-treatment samples shown elsewhere). 
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Table 3.5: Farm 1 lamb Nematodirus faecal egg count.  
Date Number 
of 
lambs 
sampled 
Arithmetic 
mean 
Nematodirus 
epg 
SD of 
Nematodirus 
epg  
Range 
Nematodirus 
epg 
Median 
Nematodirus 
epg 
16/05/2016 4 180.0 104.5 (66-276) 189.0 
07/06/2016 11 0.1 0.3 (0-1) 0.0 
27/06/2016 14 0.0 0.0 (0-0) 0.0 
18/07/2016 10 0.2 0.4 (0-1) 0.0 
08/08/2016 10 2.3 2.6 (0-7) 1.5 
31/08/2016 14 14.1 33.6 (0-117) 0.0 
12/09/2016 6 3.0 4.6 (0-9) 0.0 
20/09/2016 32 22.3 47.6 (0-237) 3.0 
10/10/2016 10 0.0 0.0 (0-0) 0.0 
01/11/2016 10 5.7 11.3 (0-36) 0.0 
23/11/2016 10 0.0 0.0 (0-0) 0.0 
Samples collected on the 20th September were collected per rectum as part of a faecal egg 
count reduction test, for which post-treatment results are shown separately. Epg = eggs per 
gram. 
3.3.1.4 Strongyle species present on the farm 
Faecal examination identified ‘strongyles’, Nematodirus, Strongyloides 
(confirmed as a true infection by rectal sampling), Trichuris, Monezia and 
various species of Coccidia. Species identification of L3 strongyles by PCR 
revealed considerable variation and diversity within the strongyle population 
over time and between sheep age groups (Figure 3.6). The following strongyle 
species were identified: Cooperia curticei, Chabertia ovina, Oesophagostomum 
venulosum, N. battus, T. circumcincta, Trichostrongylus vitrinus, and 
Trichostrongylus axei (Figure 3.6). The proportions of these nematode species 
varied throughout the year and were generally different between the ewes and 
the lambs. It is important to note here that species proportions do not 
necessarily reflect abundance – species proportions when egg counts are high 
will have a very different impact to when egg counts are low. 
Generally, either T. circumcincta or C. curticei predominated. Species common 
in the ewe samples were later seen to predominate in the lamb samples. 
However, usually for a given sampling time point, the majority species was 
different for ewes and lambs. Indeed, C. curticei was not apparent in the lamb 
samples until mid-September, despite being detected in pre-lambing samples 
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and accounting for over 63% of strongyles speciated in ewes in July (Figure 3.6). 
Taking species diversity into account, the epg attributable to individual 
pathogenic species, such as T. circumcincta, was often considerably lower than 
that calculated by the overall strongyle FEC (Figure 3.6).   
In the ewes, T. circumcincta accounted for only 38 to 53% of strongyles 
speciated pre-lambing in 2016 (Figure 3.6). Post-MOX treatment, only four 
strongyle larvae were harvested post-coproculture, of which three were T. 
circumcincta and the other N. battus. In early June, coinciding with a small but 
noticeable rise in FEC, T. circumcincta accounted for 58% of strongyle L3 
speciated, but in early July, when the FEC dropped to extremely low levels, T. 
circumcincta contributed only 4.6% in the ewe sample (Figure 3.6). Subsequent 
ewe FECs were low, with negligible proportions of T. circumcincta. Despite the 
rise in FEC in the autumn, the proportion of T. circumcincta did not increase, 
remaining low, and was not detected in a ewe sample collected in early January 
2017 (Figure 3.6).  
Trichostrongylus species were detected throughout the year, but were not 
particularly prevalent in any coproculture. Although T. vitrinus was always 
detected in the lamb samples, and most of the ewe samples, it was always a 
minor species (Figure 3.6). In the lambs, T. axei numbers were negligible and 
not detected until July. Nevertheless, T. axei had been present in the ewes pre-
lambing and remained at detectable levels in all ewe samples across the year, 
increasing in proportion over the summer months, before declining in the 
autumn. In the ewe sample collected in early January 2017, T. axei accounted 
for 28.6% of the strongyles speciated by PCR (Figure 3.6).  
Two large intestinal species were apparent over time in both the ewes and the 
lambs. C. ovina was present in the ewe samples at 29.0% and 31.4% pre-lambing 
and in the July lamb sample at 37.7%. Only one ewe sample did not include C. 
ovina. Lastly, O. venulosum was present in ewe samples pre-lambing, although 
interestingly did not re-appear in either ewe or lamb samples until late 
August/early September. However, it was a minor species, so may have been 
present at low levels, undetectable by the methods used in this study. 
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Figure 3.6: Species proportions of cultured strongyle larvae on Farm 1 over time. From left to right the number of total strongyles speciated at each 
time point was; Ewes: 93, 86, 93, 88, 86, 63, 91 and 91; Lambs: 54, 53, 93, 222, 81. Note that 20th September 2016 is an average of samples cultured and 
speciated separately from the three lamb pre-treatment samples from the faecal egg count reduction test. Those speciated post-treatment are shown 
later (Figure 3.7). 
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3.3.2 Determining anthelmintic efficacy using available tests  
3.3.2.1 Faecal egg count reduction test 
In September 2016, a FECRT was performed drawing from a group of lambs 
initially chosen at random by the farmer. Based on those lambs which were 
caught first, but with the aim of roughly balancing for sex, ten, ten and twelve 
lambs were chosen. The anthelmintic classes tested were 1-BZ, 2-LV and 3-ML 
respectively (see 2.2.5). FECs were performed on days zero, seven and fourteen 
post-treatment. Resistance to all three anthelmintics (albendazole, LEV and IVM) 
was detected (Table 3.2). FECs suggested an overall efficacy of 65% (95% HPD 
Interval: 14.5, 86.2) for albendazole, 80.8% efficacy (95% HPD Interval: 58.0, 
91.1) for LEV and 77% efficacy (95% HPD Interval: 45.5, 91.6) for IVM (Table 3.2). 
Pre-treatment, strongyle speciation by PCR was performed and a diverse mix of 
strongyle species was detected (Figure 3.6 and Figure 3.7). Post-treatment, 
molecular speciation was performed for albendazole and IVM at days seven and 
fourteen. Only T. circumcincta was detected post-IVM, however T. circumcincta 
and C. curticei were detected on day seven post-BZ, with T. axei and O. 
venulosum also identified on day 14 (Figure 3.7). Post-LEV, from the day seven 
sample, larvae were selectively picked under low power to obtain T. 
circumcincta individuals for NGS work, and too few larvae were recovered in 
total to also permit an un-biased speciation of the strongyle population. 
Adjustment of the FEC to represent the proportion of larvae identified as T. 
circumcincta indicated no change in the egg output of this species following 
treatment by either BZ or IVM (Table 3.6, Figure 3.8). C. curticei epg had fallen 
to 5 epg post-BZ from an initial 148 epg on day 0 (Table 3.6, Figure 3.8). 
Overall, there was a significant reduction in egg output from strongyle species 
other than T. circumcincta (p = 0.00).  
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Table 3.6: Benzimidazole and ivermectin faecal egg count reduction tests performed in September 2016 on Farm 1.  
Sample 
ID 
N1 Mean 
Strongyle  
epg 
SD 
Strongyle 
epg 
Mann-Whitney test 
Strongyle epg2 
Proportional 
Teladorsagia 
circumcincta 
Mean epg3 
SD 
Teladorsagia 
circumcincta 
epg3 
Mann-Whitney test 
Teladorsagia 
circumcincta epg3 
Strongyle    
FECR % 
(95% HPD 
Interval)4 
Teladorsagia 
circumcincta    
FECR % 
(95% HPD 
Interval)4 
Cooperia 
curticei    
FECR % 
(95% HPD 
Interval)4 
D7 D14 D7 D14 
BZ D0 10 209 182 p=0.005 p=0.005 41.3 36 p=0.056 p=0.212    
BZ D7 8 47.1 75.4  p=0.534 21.3 34  p=0.625    
BZ D14 10 77 156   67 137   65.3% 
(14.5, 
86.2%) 
4.99% 
(0.0, 55.8%) 
91.8% 
(82.4, 
96.1%) 
IVM D0 12 202 186 p=0.003 p=0.002 51 47 p=0.976 p=0.583    
IVM D7 11 53.8 53.6  p=0.666 53.8 53.6  p=0.666    
IVM D14 12 48.4 57.9   48.4 57.9   77.2% 
(45.5, 
91.6%) 
9.17% 
(0.0, 53.2%) 
 
Arithmetic mean strongyle egg counts and proportional Teladorsagia circumcincta egg counts (adjusted by species percentage as determined by PCR) are 
reported, with strongyle faecal egg count reduction (FECR) percentages for each anthelmintic. The BZ FECR percentage has been calculated for both T. 
circumcincta and Cooperia curticei but only for T. circumcincta post-IVM treatment as all other species egg counts were zero on day 14 post-IVM. 1N = number of 
lambs sampled. On day 7 not all lambs were present or contained sufficient material per rectum for an adequate sample to be obtained. 2Comparing egg count 
medians between sampling dates using Minitab; hypothesis of ‘medians not equal’, p value reported. Numbers in bold indicate significant differences between 
sample medians. 3T. circumcincta epg calculated for each individual sample using the strongyle species proportions obtained from PCR of the ITS2 region of L3 
(D0, D7) and eggs/L1 (D14). 4FECR percentage calculated using R shiny ‘eggCounts’ (Torgerson et al., 2014; Wang and Paul, 2017; Wang et al., 2017). Bayesian CI 
(HPD.Low and HPD.High) are in brackets. HPD = Highest posterior density interval. Epg = eggs per gram. 
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Figure 3.7: Farm 1 benzimidazole and ivermectin faecal egg count reduction test strongyle 
species proportions. The proportions of strongyles as speciated by PCR of the ITS2 region 
are shown for each sampling time point (days 0, 7 and 14 of each FECRT). Key to colours: 
grey = Cooperia curticei, pink = Chabertia ovina, green = Oesophagostomum venulosum, 
black = Trichostrongylus axei, orange = Teladorsagia circumcincta, blue = Trichostrongylus 
vitrinus. From left to right the following number of total strongyles was speciated at each 
time point; BZ: 96, 62, 82; IVM: 83, 83, 42. L3 were used on days 0 and 7 but on day 14, 
individuals sampled were eggs and L1 larvae from the wells of an egg hatch test (in equal 
proportions to the percentage hatch). 
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Figure 3.8: Farm 1 benzimidazole and ivermectin faecal egg count reduction test mean 
strongyle eggs per gram by species proportion. Individual lamb faecal egg counts were 
extrapolated by L3 strongyle species proportions identified. The arithmetic mean for each 
species is shown, with the standard error of the mean plotted. Key to colours: grey = 
Cooperia curticei, pink = Chabertia ovina, green = Oesophagostomum venulosum, black = 
Trichostrongylus axei, orange = Teladorsagia circumcincta, blue = Trichostrongylus 
vitrinus. From left to right the following number of total strongyles was speciated at each 
time point; BZ: 96, 62, 82; IVM: 83, 83, 42. L3 were used on days 0 and 7 but on day 14, 
individuals sampled were eggs and L1 larvae from the wells of an egg hatch test (in equal 
proportions to the percentage hatch). 
3.3.2.2 Bioassays 
Anthelmintic resistance can also be detected using in vitro bioassays, testing 
sensitivity to the anthelmintic by free-living lifecycle stages (Coles et al., 2006). 
Throughout the season, samples were tested using an EHT for BZ resistance and 
a LDT for IVM resistance. The former used thiabendazole (TBZ) and the latter 
22,23 dihyroavermectin B1 (IVMB1a). Both were liquid tests, the former following 
the protocol defined by von Samson-Himmelstjerna et al. (2009a) written after 
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ring-testing in European labs, and the latter was adapted from work by Varady 
et al. (1996) (see 2.3.2).  
These bioassays were used both pre- and post- the BZ and IVM FECRTs performed 
in September 2016 on the farm to correlate the in vivo phenotype observed with 
the in vitro phenotype of the offspring. For the EHT, the percentage hatch in 
the DMSO control wells showed a difference between the pre- and post-BZ 
treatment strongyle populations. Pre-BZ, 79% of eggs hatched in 
control wells compared to 91% post-BZ (Table 3.7). After adjustment for the 
response in the DMSO control wells, it was determined that just 39% of eggs from 
the pre-BZ strongyle sample hatched in the EHT at the definitive dose of 
0.1 μg/ml (Coles et al., 2006). Post-BZ, 93% hatched (Table 3.8), giving a 
resistance ratio (RR) of 2.4 (% hatch post-treatment/% hatch pre-treatment). 
Calculating the ED50 also revealed a difference pre- and post-BZ treatment. Post-
BZ, 50% hatched at a higher concentration of TBZ/DMSO (0.615 μg/ml) compared 
with pre-BZ (0.048 μg/ml) (Table 3.8, Figure 3.9), a RR of 12.8 (ED50 post-
treatment/ED50 pre-treatment). The pre-IVM strongyle sample was similar to the 
pre-BZ sample, with an ED50 of just 0.043 μg/ml (Table 3.8, Figure 3.10), and a 
percentage hatch in the 0.1 μg/ml definitive dose well of 32.6% (Table 3.8). 
Post-IVM, not enough material was available to perform both a full EHT and a 
full LDT, and so only the definitive dose well was assessed post-IVM, with no 
control well used. Though imperfect, this still revealed an uncorrected 
percentage hatch of 82.4% post-IVM (Table 3.8). 
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Table 3.7: Control wells of the egg hatch tests performed with samples taken during the 
faecal egg count reduction test .  
Test Average 
percentage 
hatch 
0.5% DMSO 
Pre-BZ FECRT  
(4 plates) 
79% 
Post-BZ FECRT 91% 
Pre-IVM FECRT  
(4 plates) 
85% 
The average percentage hatch in the 0.5% DMSO control wells is reported for each sample 
population tested.  
Table 3.8: Egg hatch test results.  
Test EHT ED50 (μg/ml)1 
(95% CI) 
Percentage hatch 
in 0.1 µg/ml2 (SD) 
Pre-BZ FECRT (four 
plates combined 
analysis) 
0.048 µg/ml 
(0.045, 0.052) 
39.1% 
(8.58) 
Post-BZ FECRT 0.615 µg/ml 
(0.538, 0.730) 
93.1% 
(0.23) 
Pre-IVM FECRT 
(four plates 
combined analysis) 
0.043 µg/ml 
(0.040, 0.046) 
32.6% 
(6.06) 
Post-IVM FECRT NA 82.4%3 
(3.43) 
Effective doses (ED50) of thiabendazole required to prevent hatching of 50% of eggs are 
reported for each full test performed. The average percentage hatch in definitive dose wells 
(0.1 µg/ml) is given for each test. 1Raw data were adjusted for response in 0.5% DMSO 
control wells. 2Adjusted for response in 0.5% DMSO control wells. 3No DMSO well was 
included post-ivermectin and only two replicate wells for 0.1 µg/ml were included. This 
therefore is the uncorrected percentage hatch. The uncorrected percentage hatch in the 0.1 
µg/ml wells pre-ivermectin was 27.52% (5.0 SD). 
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Figure 3.9: Dose response curve of the egg hatch test performed using samples from the  
benzimidazole faecal egg count reduction test. The corrected egg hatch test data are 
shown, with log10(thiabendazole concentration) plotted against the proportion hatching. The 
data were modelled in R using a binomial general linear model (probit), and the regression 
line is plotted here. Pre-BZ (X, blue), four tests were performed, each with three replicate 
wells for each concentration included. Each well is plotted. On day 14 post-BZ, lambs were 
sampled and a further EHT performed. Fewer eggs were available and for some 
concentrations only one or two replicate wells were included. The proportion hatching in 
each well is shown (O, red).  
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Figure 3.10: Dose response curve of the egg hatch test performed using the Pre-ivermectin 
faecal egg count reduction test sample. The corrected egg hatch test data are shown, with 
log10(thiabdendazole concentration) plotted against the proportion hatching. The data were 
modelled in R using a binomial general linear model (probit), and the regression line is 
plotted here. Pre-treatment, four tests were performed, each with three replicate wells for 
each concentration included. Each well is plotted. Post-ivermectin data are not shown. 
Average egg hatch in the 2% DMSO control wells of the LDT was 97%. Pre-
treatment 67% of hatched larvae developed to L3 on average in the control wells 
(range 53–75%), compared to 86% post-IVM (Table 3.9). No definitive dose has 
been established for the IVM LDT used in this study, but using a GLM, the 
ED50 can be determined. Pre-IVM this was 2.43 nM (95% CI: 2.14, 2.81) and post-
IVM this rose to 4.07 nM (95% CI: 2.87, 6.36) (Table 3.10, Figure 3.11), giving a 
RR of 1.7. Pre-BZ treatment an ED50 of 2.27 nM was calculated, comparable to 
that of the pre-IVM group (Table 3.10, Figure 3.12).    
122 
 
Chapter 3 
Table 3.9: Control wells of the larval development test.  
Test Average percentage hatch Average percentage 
development to L3 
Water 2% DMSO Water 2% DMSO 
Pre-BZ FECRT, 
plate 1 
98% 97% 87% 75% 
Pre-BZ FECRT, 
plate 2 
98% 97% 85% 67% 
Pre-IVM FECRT, 
plate 1 
99% 98% 78% 58% 
Pre-IVM FECRT, 
plate 2 
96% 96% 66% 53% 
Post-IVM FECRT 95% 92% 92% 86% 
The average percentage hatch and development to L3 are shown for comparison between 
the water and 2% DMSO control wells. Samples used to perform the test were obtained 
during faecal egg count reduction tests of a benzimidazole anthelmintic (BZ) and ivermectin 
(IVM). 
Table 3.10: Larval development test results.  
Test IVM LDT ED50 (nM)1 
(95% CI) 
Pre-BZ FECRT (two plates combined analysis) 2.27 nM 
(2.05, 2.56) 
Pre-IVM FECRT (two plates combined analysis) 2.43 nM 
(2.14, 2.81) 
Post-IVM FECRT 4.07 nM 
(2.87, 6.36) 
Effective doses (ED50) of ivermectin required to inhibit 50% development of eggs to L3 are 
reported for each test performed. 1Raw data were adjusted for response in 2% DMSO control 
wells. Samples used to perform the test were obtained during faecal egg count reduction 
tests of a benzimidazole anthelmintic (BZ) and ivermectin (IVM). 
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Figure 3.11: Dose response curve of the larval development test performed using samples 
obtained during an ivermectin faecal egg count reduction test. The corrected larval 
development test data are shown, with log10(ivermectin concentration) plotted against the 
proportion developing to L3. The data were modelled in R using a binomial general linear 
model (probit), and the regression line is plotted here. Pre-treatment (X, blue), two tests 
were performed, each with three replicate wells per concentration included. Each well is 
plotted. On day 14 post-ivermectin (O, red), fewer eggs were harvested and concentrations 
were only performed in duplicate. 
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Figure 3.12: Dose response curve of the larval development test performed using the Pre-
benzimidazole faecal egg count reduction test sample. The corrected larval development 
test data are shown, with log10(ivermectin concentration) plotted against the proportion 
developing to L3. The data were modelled in R using a binomial general linear model 
(probit), and the regression line is plotted here. Pre-treatment (X, blue), two tests were 
performed, each with three replicate wells for each concentration included. Each well is 
plotted. No larval development test was carried out post-benzimidazole treatment due to a 
lack of eggs. 
Over the season the EHT was used to assess the BZ sensitivity of the lamb 
strongyle population. For each sample tested, the hatch percentage in the DMSO 
control wells, and the corrected hatch percentage of the definitive dose wells 
(0.1 µg/ml) are shown in Figure 3.13. From May to July, percentage hatch in 
both the control wells and the definitive dose wells (0.1 µg/ml) averaged greater 
that 80%, and variation between replicate wells within a test was minimal. 
However, in August and September within-test variation increased considerably, 
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especially at the definitive dose. Lower percentage hatch was recorded in 
August and September at the definitive dose, compared with earlier in the year 
(Figure 3.13). In contrast, in October, 14 days following BZ treatment, both the 
egg hatch in the control well and the definitive dose wells were very similar, and 
hatching percentages were similar to those in early summer (Figure 3.13).  
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Figure 3.13: Lamb egg hatch test results over the season. The plot shows the percentage hatch in the DMSO control wells (blue, uncorrected) and the 
definitive dose wells (0.1 µg/ml, corrected by average percentage hatch in control wells, red) of egg hatch tests performed at each sampling time point. 
Number of tests performed (each with wells included in triplicate) at each sampling time point from 16th May 2016 onwards: 1, 1, 1, 1, 1, 2, 8, 1 (the latter had 
just one DMSO well and two definitive dose wells). Individual points are shown (each point represents one well), and the X indicates the mean value. BZ = 
Lambs treated with benzimidazoles. 
BZ BZ BZ BZ 
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3.3.2.3 Pyrosequencing 
The use of a molecular test, where a genetic marker for resistance is known, 
enables the rapid and accurate detection of resistance or sensitivity to an 
anthelmintic. BZ resistance is associated with three SNPs within the β-tubulin 
isotype-1 gene in many strongyle species (Kwa et al., 1995; Silvestre and 
Cabaret, 2002; Ghisi et al., 2007), and various genetic tests are available to 
detect these SNPs. For this study, a pyrosequencing method, developed by Skuce 
et al. (2010) and subsequently used by Redman et al. (2015) in field populations, 
was used to measure BZ resistance on this farm. Over the year, 386 individual T. 
circumcincta L3 were sequenced at the 198 and 200 SNPs (single sequencing 
reaction) and 385 L3 at the 167 SNP (one individual did not amplify). Those 
classified as ‘fully susceptible’ encoded only phenylalanine at codons 200 and 
167 (P200F, P167F) and only glutamic acid at codon 198 (P198E). Individuals 
referred to here as ‘resistant’ to BZ carried at least one resistance associated 
SNP at either position 200, 198 or 167, encoding tyrosine at positions 200 or 167 
(TTC>TAC), and leucine at codon 198 (GAA>TTA). Heterozygous individuals were 
identified with codon changes at more than one position. However, no individual 
was sequenced with three codon changes.  
Of the 386 individuals sequenced, 64% were homozygous for the resistance 
associated SNP at codon 200, 28.5% were heterozygous at codon 200 and only 
7.5% were homozygous for phenylalanine at this position. Of the 110 individuals 
heterozygous at codon 200, five (4.5%) were also heterozygous at codon 167, and 
16 (14.5%) were heterozygous at codon 198. Of the 29 individuals homozygous 
susceptible at codon 200, eight (27.6%) were homozygous for the resistance 
associated SNPs at codon 198, four (13.8%) were heterozygous at codon 198 and 
one (3.4%) was heterozygous at codon 167. Only 16 (4.1%) individuals were fully 
susceptible at all three positions. In total 2.1% of all 386 individuals were 
homozygous for the resistance associated SNPs at codon 198, and 5.2% of all 
individuals were heterozygous at codon 198. All individuals with resistance-
associated polymorphisms at codon 198 encoded leucine. In addition, one 
individual encoded a stop codon at position 198 (GAA > TAA). Only 6 individuals 
(1.6%) carried a resistance associated SNP at codon 167 and all were 
heterozygous.  
128 
 
Chapter 3 
Included in these 386 individuals sequenced were 30 T. circumcincta individuals 
selected at each sampling time point of the BZ and IVM FECRTs in September 
2016, totalling 180 individuals (Figure 3.14 and Figure 3.15). Individuals 
homozygous for tyrosine at codon 200 or heterozygous at one or more codon 
were detected in all samples. Those with homozygous resistance mutations at 
codon 198 were detected on day 0 of the IVM FECRT and on days 7 and 14 of the 
BZ FECRT. ‘Susceptible’ individuals were identified on days 0, 7 and 14 of the 
IVM FECRT and on day 14 of the BZ FECRT. For both the BZ and IVM treatment 
groups no significant differences in genotype proportions were noted between 
samples before and after treatment (Figure 3.14 and Figure 3.15). 
 
Figure 3.14: Teladorsagia circumcincta offspring genotypes determined by pyrosequencing 
before and after benzimidazole treatment of lambs. At each sampling time point (day 0, 7 
and 14 of a benzimidazole faecal egg count reduction test), 30 T. circumcincta individuals 
were genotyped at the 200, 198 and 167 codons of the β-tubulin isotype-1 gene. R = 
resistant allele SNP, S = sensitive allele SNP. R/S = heterozygous.  
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Figure 3.15: Teladorsagia circumcincta offspring genotypes determined by pyrosequencing 
before and after ivermectin treatment of lambs. At each sampling time point (day 0, 7 and 14 
of an ivermectin faecal egg count reduction test), 30 T. circumcincta individuals were 
genotyped at the 200, 198 and 167 codons of the β-tubulin isotype-1 gene. R = resistant 
allele SNP, S = sensitive allele SNP. R/S = heterozygous. 
The total length of the sequence containing the 198 and 200 codons was 16 
basepairs and contained additional, synonymous SNPs surrounding the non-
synonymous SNPs associated with BZ resistance. Pyrosequencing allows 
determination of the individual’s genotype at each basepair position but does 
not allow phasing of haplotypes for each individual. Taking a highly conservative 
approach – only fully homozygous individuals, or those with no more than one 
heterozygous SNP (i.e. excluding those heterozygous at both codon 200 and 
codon 198), and ignoring the codon 167 sequence, haplotypes were examined in 
217 individuals, providing a total of 434 haplotypes (assuming two copies of the 
β-tubulin isotype-1 gene were amplified). Three ‘susceptible’ haplotypes, two 
‘resistant’ haplotypes encoding leucine at codon 198 (P198L, P200F), and five 
‘resistant’ haplotypes encoding tyrosine at codon 200 (P198E, P200Y) were 
identified. Three of the five haplotypes encoding tyrosine were commonly 
sequenced (88 to 158 sequence copies per haplotype), with two sequenced only 
five times each. One of the two haplotypes encoding leucine at codon 198 had 
18 sequences, while the other was only sequenced once, suggestive of PCR or 
sequencing errors. Of the ‘susceptible’ haplotypes, two were common (23 and 32 
sequence copies per haplotype), while the last was only sequenced twice. From 
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analysing this short 16 bp region within a subset of individuals on this farm it is 
evident that moderate diversity is present within the population. This diversity 
was maintained over the course of the season and despite the use of different 
anthelmintic treatments. Although there are a few common haplotypes these 
include two commonly sequenced sensitive haplotypes, suggesting the presence 
of sufficient refugia or survival of heterozygotes to maintain such diversity.  
3.3.3 Assessing population change over time 
Ten previously published microsatellites (Grillo et al., 2006; Redman et al., 
2008) were used to assess the T. circumcincta population on the farm over time 
and in different ages of sheep. At each sampling time point 30 T. circumcincta 
L3 were genotyped and population genetics analysis was conducted using 
Arlequin v3.5.2.2 (Excoffier et al., 2005). Two ewe samples (collected pre-MOX 
treatment, and in early June) and several lamb samples (days 0 and 14 of the BZ 
FECRT and days 0, 7 and 14 of the IVM FECRT) were tested. There was high 
within-sample diversity, with the majority of variation detected between 
individual worms rather than between sample groups - only 0.66% of all variation 
was found to be between samples (Table 3.11).  
The total number of alleles in the population per microsatellite varied from five 
(MTG73) to 44 (Tc22274). Figures were similar to those reported by Redman et 
al. (2015) (Figure 3.16), suggesting a similarly high diversity on Farm 1 as is 
present across other UK farm populations of T. circumcincta. For many 
microsatellites, the presence of private alleles unique to a sample population 
was detected across the samples tested, likely reflecting a small sample size and 
a highly polymorphic population rather than substructure. For some 
microsatellites the presence of three alleles amplified from a single individual 
was detected. These were checked for repeatability and, for that individual, all 
alleles of that microsatellite were converted to ‘nulls’ for population genetic 
analysis. This was because these were (i) uncommon and (ii) it was not possible 
to determine which two alleles would be haplotypic with other microsatellite 
alleles which were apparently diploid. As the software required diploid data, to 
remove one allele without just cause would introduce bias.  
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Overall, only one microsatellite locus, MTG73, was identified as a significant 
outlier in FST analysis between the seven sample groups tested (FST value 0.04, 
p<0.05, Table 3.12, Figure 3.17 A). Nonetheless, when repeating the analysis 
using sample subsets (either only ewe samples, only BZ FECRT samples or only 
IVM FECRT samples), no selection at this locus was apparent (Table 3.12). No 
microsatellite appeared to be under selection by IVM treatment. Some 
microsatellites appeared genetically different between the ewe or BZ FECRT 
samples (p<0.05, Table 3.12 and Figure 3.17). However, this is potentially due to 
stochastic sampling of a diverse population. Overall pairwise comparisons 
between samples also suggested significant differences (p<0.05, Table 3.13), but 
again, no consistency was observed. No obvious selection occurred due to either 
anthelmintic treatment.  
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Table 3.11: Microsatellite global AMOVA results as a weighted average over all loci.  
Source of variation Variance 
(%) 
Average F 
statistic 
over all loci 
P-value 
Among samples (FST) 0.66% 0.00658 1.00 
Among individuals within 
samples (FIS) 
48.73% 0.49052 0.00 
Among individuals within total 
population (FIT) 
50.61% 0.49388 0.00 
 
 
Figure 3.16: Microsatellite allele counts comparing Farm 1 data (blue) and data collected 
from seven UK farms by Redman et al. (2015) (red).  
Table 3.12: Individual microsatellite FST values between samples.  
Microsatellite All 
samples 
Ewe 
samples 
only 
BZ FECRT 
samples 
only 
IVM FECRT 
samples 
only 
MTG15 0.0037 -0.0017 0.0062 0.0179 
MTG67 0.0008 0.0092 -0.0215 0.0092 
MTG68 0.0164 0.0239 0.0024 0.0232 
MTG73 0.0388 -0.0046 0.0081 0.0289 
Tc13604 -0.0046 -0.0153 -0.0157 -0.0066 
Tc2066 0.0178 -0.0095 0.0336 -0.0009 
Tc22274 0.0036 0.0049 -0.0060 0.0107 
Tc2476 -0.0013 -0.0269 -0.0195 -0.0177 
Tc4504 0.0108 0.0335 0.0414 0.0015 
Tc7989 -0.0002 0.0021 0.0031 -0.0041 
Significant allele differences between samples are highlighted in bold and underlined 
(p<0.05) and may suggest genetically differentiated loci between sample groups. Negative 
values may be due to rare alleles within a population and should be interpreted as zero. 
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Figure 3.17: Sample allele proportions for Farm 1 microsatellites. A. MTG73, B. Tc2066, C. 
Tc4504, D. Tc2476. a-d denote significant FST value by pairwise comparison (p<0.05, see 
Table 3.12). Each colour represents a different allele. Colours should only be interpreted 
within a plot, not between microsatellites.  
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Table 3.13: Sample pairwise FST values for Farm 1.  
 
Ewe April Ewe June Pre-BZ day 
0 
Post-BZ 
day 14 
Pre-IVM 
day 0 
Post-IVM 
day 7 
Ewe 
April 
NA      
Ewe 
June 
0.004180 NA     
Pre-BZ 
day 0 
-0.002450 0.018800 NA  
  
Post-BZ 
day 14 
0.016270 0.011070 0.007600 NA   
Pre-IVM 
day 0 
0.003950 0.015030 0.006410 0.013550 NA 
 
Post-
IVM day 
7 
0.001710 0.011340 0.017300 0.016060 0.012650 NA 
Post-
IVM day 
14 
0.004250 0.011120 0.007050 0.021240 0.014350 0.015890 
Significant differences between samples are shown in bold and underlined (p<0.05). 
Negative values should be interpreted as zero.   
3.4 Discussion 
3.4.1 Parasite abundance and diversity on a farm today 
Despite the use of multiple new anthelmintics, the frequent use of such 
anthelmintics, and the presence of anthelmintic resistance in one or more 
species on this farm, data collected over the year from both ewes and lambs has 
suggested that the epidemiology of PGE is similar to past descriptions in the UK 
(Morgan et al., 1951; Boag and Thomas, 1977; Wilson et al., 2008). The peri-
parturient rise (PPR) in FEC at lambing was observed in the housed ewes, which 
was curtailed by an efficacious MOX treatment (Jansen, 1987; Taylor et al., 
1997). Following this, a slight rise in egg output was noted over the following 
few weeks, potentially due to T. circumcincta, demonstrating ‘tail resistance’ 
(Kerboeuf et al., 1995; Sargison et al., 2012), or the presence of other species, 
identified on this farm, against which MOX has no persistent action. Lamb egg 
output rose in late August, mirroring the rise in ewe egg output, as expected 
(Salisbury and Arundel, 1970). 
In June, a small increase in FEC in the ewes was noted before rapidly falling, 
which corresponds with the last recording of a moderately high T. circumcincta 
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prevalence in ewe coprocultures. This phenomenon of an acute change in T. 
circumcincta prevalence has been noted elsewhere (Jansen, 1987; Sargison et 
al., 2012) and potentially reflects reassertion of immunity against this parasite. 
That this is delayed until June may suggest that the persistency of MOX prevents 
resumption of immunity (Brunsdon, 1966). If so, this is a concern for farmers as 
eggs deposited in June in the UK have a much greater chance of contributing to 
infective L3 on pasture than those deposited in March (Gibson and Everett, 
1971).  
The source of infective L3 for lambs arises either from overwintered L3 on 
pasture or from the ewes, of which the major contribution arises from the PPR 
phenomenon (Jansen, 1987). In the lambs the FEC remained low throughout the 
spring and summer. This may be due to the presence of low levels of infective L3 
on pasture or the use of neosuppressive BZ treatments in the spring, despite the 
presence of several BZ resistant species. Grass sward height was short for a 
considerable period of the early spring and summer, which may have increased 
the ingestion of infective larvae by ewes (van Dijk and Morgan, 2011), reducing 
the infective larval burden present for the lambs, especially as egg output from 
ewes remained low.  
The cause for the rise in ewe FEC in November and December (Figure 3.4) does 
not appear to be due to the presence of a new species, against which immunity 
needs to be re-established. Neither does it coincide with an increased proportion 
of Trichostrongylus species which are considered to be important in late 
autumn/winter PGE in the UK (Craig et al., 2006). Hormonal changes induced by 
the shortening day length or breeding related activity, perhaps leading to 
reduced food intake or reduced immunity might be partially responsible. Such 
changes might also be related to climatic differences, perhaps resulting in 
changes in feed availability and reduced protein intake affecting the immune 
response (Sakkas et al., 2012). Nevertheless, the grass sward was not noticeably 
short, especially compared to the summer months when grass was in poor supply 
due to warm, dry weather and ewes were lactating. An overall increase in the 
larval availability on pasture may be the cause of this rise, although this is 
unlikely, as the ewes were grazing pasture which had been used by both ewes 
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and lambs earlier in the year. If this were the case, one would expect an earlier 
rise in FEC, coinciding with the rise in lamb FEC in August. 
The species diversity on the farm over the season was moderately high, with 
seven strongyle species (including N. battus), from the abomasum, small and 
large intestines identified. In addition, other internal parasites including 
Trichuris ovis, Strongyloides papillosus, Moniezia and Coccidia were identified. 
Of the strongyles detected, T. circumcincta was the predominating pathogen 
over the season. The presence of considerable proportions of C. curticei was 
interesting and this small intestinal species has been noted to rise in the early 
autumn in lambs (Boag and Thomas, 1977). Boag and Thomas (1977) had 
considered that there was just one cycle of this parasite during the season, 
however on this farm it is clear that patent infection with C. curticei is present 
in the ewes much earlier in the year, and it is not obvious as to why the 
presence of C. curticei in the lambs is so delayed. The pre-patent period is 
comparatively short, only 14-15 days (Roeber et al., 2013a), and the 
development to L3 on pasture takes about 25 days at air temperatures of 13.9 °C 
(Ahluwalia and Charleston, 1974). Local weather data (Figure 3.18) kindly 
provided by S. Leeson, (Centre for Ecology and Hydrology, NERC, Figure 3.18) 
and Cosmos (2018), indicated that favourable temperatures should have allowed 
eggs deposited in June from the ewes to develop to infective L3 within a month. 
One study investigating co-infection with T. circumcincta and T. vitrinus (a small 
intestinal parasite), noted that T. circumcincta infection reduced establishment 
of T. vitrinus (Jackson et al., 1992b). A second study reported reduced 
establishment of T. colubriformis when lambs were co-infected with this 
parasite and T. vitrinus, compared to monospecific infections (Roy et al., 2004). 
A similar phenomenon may have occurred here. Although considered a mild 
pathogen by those in the field (Abbott et al., 2012; Roeber et al., 2013a), few 
studies have investigated its effects on production (Ahluwalia and Charleston, 
1975) and its impact as part of a mixed species infection may be different. Given 
the high prevalence of this species more up-to-date information as to its 
pathogenicity in the UK may be useful.  
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Figure 3.18: Average soil and air temperature between the 1st September 2015 and the 30th September 2017 collected by S. Leeson (CEH, NERC) (Cosmos, 
2018). Purple dots indicate the daily average soil temperature. Coloured lines indicate the daily average air temperature, measured in four time periods 
throughout the day. The minimum hatching temperature for Teladorsagia circumcincta, Trichostrongylus axei and Trichostrongylus vitrinus is shown 
(Crofton, 1965).  
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Similar levels of diversity have been found on other farms in the UK, although far 
fewer species have been identified on many farms (Burgess et al., 2012; Hybu 
Cig Cymru, 2015; Redman et al., 2015). Where no anthelmintics are used, 
greater diversity is found (Craig et al., 2009; Sinclair et al., 2016). Co-grazing 
untreated animals (e.g. ewes, lambs, gimmers or rams) alongside treated sheep 
may be key to maintenance of species diversity on this farm. In addition, 
maintenance of diversity may be due to the presence of multiple BZ resistant 
species within the strongyle community. Several pasture types were present and 
these, in addition to the comparatively intensive grazing of pastures may also 
contribute to species diversity (Silvestre et al., 2000). Silvestre et al. (2000) 
found that the number of flocks of different origin originally contributing to a 
farm was an important variable in species diversity. The relevance of this factor 
on UK farms is hard to quantify. Although many farms, including this farm, are 
‘openly’ managed, with replacement breeding sheep bought each year, new 
sheep are usually treated with an anthelmintic, reducing the opportunity for 
introduction of new species onto a farm.  
In addition to larvae surviving over winter on pasture, or the presence of such 
larvae being maintained by winter grazing sheep, it was clear from this study 
that patent infection with all species was present in the housed ewes at lambing 
time, indicating overwinter survival in the host (Stadalienė et al., 2015). Given 
the absence of T. circumcincta in the FEC from housed ewes in January, the 
presence of T. circumcincta egg output at lambing was either from resumption 
of development of arrested L4 (Reid and Armour, 1975; Smith, 2007), or from 
resumption of egg laying in adults previously supressed by the ewe’s immune 
response (Jeffcoate et al., 1992; Stear and Bishop, 1999; Stear et al., 1999). It is 
clear that immunity in vivo does not equally suppress all species, given the 
difference in species composition of the ewe faecal egg output after June 
(Morgan et al., 1951). With the continuing rise in anthelmintic resistance (Kaplan 
and Vidyashankar, 2012), it may be beneficial to better understand the impact 
of diversity of strongyle infection within a host, how this affects production 
parameters (Coop et al., 1986; Giudici et al., 1999), and how it can best be 
managed or exploited for sustainable sheep production in the future. Cross-
immunity to different pathogens may be important in natural infections 
(Reinecke et al., 1980; Coop et al., 1986; Jackson et al., 1992b), and the 
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maintenance of production, when infected with multiple species, in the absence 
of anthelmintic treatment may indicate a role for diversity to regulate parasite 
burdens and egg output (Roy et al., 2004).  
Interestingly, there was a marked difference in species composition of the faecal 
egg output between the ewes and the lambs, particularly throughout July to 
November. This is an important point to consider when identifying the need for 
treatment of animals, management of parasites within the flock over the season 
and interpreting anthelmintic efficacy (McKenna, 1997). The pathogenicity 
reports of different species are usually based on single species infections and are 
relative to the overall intensity of infection. However, pathogenicity may also be 
relative to the age and reproductive status (Taylor and Pearson, 1979b; Jackson 
et al., 1988), breed (Ross, 1970; Gonzalez et al., 2008) and sex (Craig et al., 
2006) of the host. T. circumcincta (Coop et al., 1981), Trichostrongyle species 
(Coop et al., 1979; Taylor and Pearson, 1979a; Beveridge et al., 1989), N. battus 
(Crofton and Thomas, 1951) and H. contortus (Yadav et al., 1993) are considered 
highly pathogenic. In contrast, C. curticei (Ahluwalia and Charleston, 1975), C. 
ovina and O. venulosum (Roeber et al., 2013a) are only mildly pathogenic. These 
differences mean that species identification for routine FECs could add value in 
flock health planning on a farm. On this farm, the use of ewes after June to 
‘hoover up’ larvae from pasture could be beneficial. These animals would have a 
bias against output of T. circumcincta eggs onto pasture, whilst increasing the 
refugia of less pathogenic species. This may allow the judicious use of pastures 
following weaning, particularly if weaning earlier (e.g. at 12 or 14 weeks of age 
(Laws and Genever, 2015)) such that, dependent on weather and farm species 
prevalence, fields used by ewes and lambs earlier in the season may become 
useful for finishing lambs at the end of the season. 
Overall, the use of both FEC, management data and strongyle species 
information allows for a much more informed understanding of the parasite 
abundance and diversity present on a farm. However a clear caveat is the 
potential difference between egg output and worm burden (Cabaret et al., 
1998), the relationship varying between species. In particular, T. circumcincta is 
known to have a non-linear relationship between the number of adults and the 
eggs shed per adult female (Bishop and Stear, 2000). Coproculture is a useful 
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technique, however, culture conditions for each species vary, and the optimum 
temperature and time taken to develop to L3 can bias results towards particular 
species (Dobson et al., 1992; O'Connor et al., 2006).  
3.4.2 Was the anthelmintic use appropriate? 
The need to preserve anthelmintics requires that they are only used when 
necessary. On this farm FECs were rarely greater than 250 epg, which might 
indicate that treatments were unnecessary (Abbott et al., 2012). Conversely, it 
is important to realise that these low FECs may have been due to strategic 
treatments given throughout the year. 
The use of MOX to suppress the PPR has been recommended to prevent 
contamination of the pasture for growing lambs (Salisbury and Arundel, 1970; 
Taylor et al., 2016), improving lamb growth rates (Coop et al., 1982). For this 
reason, and to reduce the parasite burden in the ewes, improving lactation 
(Mavrot et al., 2015), the ewes on this farm were treated with MOX at lambing. 
The treatment was highly effective at reducing egg output, and egg counts were 
low in general over the season in ewes and lambs. Had the PPR not been 
suppressed, daily egg output from a ewe with a mean epg of 600 could have 
seeded the pasture with approximately 840,000 eggs per day (Waghorn et al., 
1999). Thus, this treatment may have been important and had the effect 
desired. However, the overall benefits of supressing the PPR have been recently 
questioned (Taylor et al., 2016; Learmount et al., 2018). It may be that the 
benefit of treating ewes varies between farming systems and years, dependent 
on hosts, feed availability, pasture larvae and spring weather. PGE risk versus 
risk of anthelmintic resistance development should be considered for each farm 
from year to year.  
One downside of MOX use on this farm may be the selection for resistant 
parasites, at a time when refugia is low (Martin et al., 1981). Lambs suckling 
treated ewes also receive MOX in the milk, exacerbating selection for 
macrocyclic lactone resistant parasites (Dever and Kahn, 2015). Use of a short 
acting product would allow curtailment of the PPR, and ewe FECs could be 
monitored for additional treatments required. On this farm, LEV may be the 
most suitable anthelmintic, due to the presence of dual IVM and BZ-resistant T. 
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circumcincta, although the efficacy of LEV against this parasite specifically 
should first be tested. Before lambing started the farmer advised that mostly 
triplets, and only some twins or single bearing ewes would be treated with MOX. 
However, the medicine book records that 350 ewes received MOX, suggesting 
that most ewes were treated, leaving few untreated ewes able to seed the 
pasture with susceptible parasites. Provided that ewes receive adequate 
nutrition, suppression of the PPR in all ewes should not be necessary, as the 
pasture larval levels should be controllable with only some ewes treated 
(Houdijk et al., 2000; Sakkas et al., 2012). On this farm, the grass sward was 
very short at the start of the season, reflecting the cold winter preceding the 
start of the study. For this reason, nutrition available to the ewes may have 
been lower than ideal, leading to increased treatment of the flock to maintain 
adequate levels of milk production and lamb growth. Nevertheless, it would also 
be likely that fewer L3 would have survived overwinter on pasture, reducing the 
need for a persistent anthelmintic.  
In the UK, unless it is possible to use a field for young lambs which has not had 
sheep on it for at least the previous two years, the presence of N. battus 
requires the pre-emptive use of anthelmintics in the spring (Thomas, 1991), 
based on NADIS parasite forecasts (https://www.nadis.org.uk/parasite-
forecast.aspx). The use of BZ anthelmintic treatments for N. battus are 
therefore justifiable as this parasite is highly pathogenic in young lambs (Crofton 
and Thomas, 1951). However, on this farm, anthelmintics were not used until 
after N. battus eggs were detected in the faeces, suggesting that some 
pathology had already occurred, restricting optimal growth rates over the 
season. In addition, by the timing of the last dose, lambs may have acquired 
some immunity towards N. battus (Taylor and Thomas, 1986; Israf et al., 1997) 
and this dose may have been superfluous, serving only to increase selection for 
BZ resistance. Anthelmintic use at this time in young lambs has the disadvantage 
of low refugia levels, and it is not surprising that several species were resistant 
to BZ, with BZ resistance associated SNPs almost fixed within the T. 
circumcincta population. The presence of dual-resistant T. circumcincta is likely 
also related in part to this management practice – i.e. BZ selection upon a 
population already comprised of a significant proportion of parasites either fully 
or partially resistant to MOX. Following treatment of ewes at lambing, MOX 
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resistant, and potentially also IVM resistant (Ranjan et al., 2002; Ménez et al., 
2016), eggs would be output by the ewes and predominate on pasture, for 
ingestion by lambs. In addition, lambs could ingest MOX via the ewe’s milk 
(Dever and Kahn, 2015), further selecting for resistant parasites. Therefore the 
strongyle community within the lambs when they were dosed with BZ would be 
likely to contain a large proportion of MOX and potentially IVM resistant 
parasites. Nevertheless, as BZ resistance is common on this farm, and the N. 
battus population appears sensitive to BZ, this was a good choice of 
anthelmintic. It reserves the use of other anthelmintic classes to treat other 
species later in the year when they are more significant. In addition, the farmer 
left 5-10% of the lambs untreated, and ewes were co-grazing with the lambs at 
this time. These untreated sheep will have continued to contribute to the 
pasture larval population, and will have been important in maintaining BZ 
sensitive parasites.  
Lamb FECs on this farm were low, and if the guidance threshold of 250 epg for a 
predominantly T. circumcincta infection was used to prompt treatment (Abbott 
et al., 2012), no anthelmintic treatments would have been provided to the 
lambs other than for N. battus. Although only one other anthelmintic treatment 
was given, its requirement is hard to justify based on the FEC and speciation 
data alone. In September, the LEV treatment when the mean FEC was 172 epg, 
with T. circumcincta contributing only 50 epg, was questionable. However, using 
a different anthelmintic class than was used earlier in the year is recommended 
(Abbott et al., 2012). Two FECs preceding the treatment revealed a mean epg 
more than four times as high as the pre-weaning FEC samples. Responding 
proactively to reduce pasture contamination from a rising FEC was wise, given 
the high proportions of T. circumcincta detected in the lamb samples previously. 
Hindsight is useful, but in practice welfare and economic concerns require 
decisions to be made in advance. Lambs in Scotland are fitted with electronic 
ear tags before they leave the farm, and using these for regular monitoring of 
lamb growth with an understanding of feed nutritional value, can allow for 
targeted selective treatment (McBean et al., 2016). This does not require 
knowledge of the FEC, or species present (assuming other causes of poor weight 
gain are not a concern), and has been shown to maintain production parameters 
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(Kenyon et al., 2013; McBean et al., 2016) which may have been of more use on 
this farm than FECs.  
3.4.3 Can we accurately and cheaply determine which 
anthelmintics will be effective?  
Probably the greatest confounding factor limiting interpretation of the FECRT 
(and the in vitro bioassays) was the species diversity. The presence of a highly 
dual-resistant population of T. circumcincta contributing only a minor proportion 
of eggs pre-treatment, allowed for the calculation of a considerably more 
effective FECR percentage than was truly observed (McKenna, 1997). The change 
in species over time on this farm requires a FECRT with species identification to 
be performed when the farmer would usually treat the sheep – with the age 
group requiring treatment. The identity of BZ resistant T. axei would allow a 
veterinary surgeon to suggest that BZ anthelmintics are avoided during the late 
autumn/winter months if ‘black scours’ was the clinical diagnosis (Craig et al., 
2006). However, ideally the FECRT would be repeated when this species was 
more prevalent. On this farm therefore, reduced anthelmintic efficacy cannot 
be correctly interpreted without species data. But species identification carries 
additional costs, and is not routinely performed in the UK. Nevertheless, where 
an anthelmintic is highly effective, such as in the case of MOX on this farm, the 
FECRT is a useful confirmation of success. It could also aid diagnosis for causes 
of weight loss, poor growth and diarrhoea or anaemia not caused by PGE by 
ruling out anthelmintic resistance, while simultaneously providing beneficial 
information to the farmer. In addition, although there are limitations to the 
interpretation of a FECRT as to the number of adults remaining within the host 
(Cabaret et al., 1998), it is an excellent indicator of the reduction in pasture 
contamination.  
The use of bioassays such as the EHT and LDT provide an understanding of the 
anthelmintic resistance phenotype of free-living stages of strongyles. Although 
these may not necessarily reflect the in vivo mechanisms of resistance (Rufener 
et al., 2009a; Barrère et al., 2012; Kotze et al., 2012), they are quicker than 
performing a FECRT, identifying anthelmintic efficacy within just 48 hours to a 
week. Bioassays only require a single faecal sample collection, and do not 
contribute to drug selection on farm. In this study, the EHT worked 
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comparatively well and identified the presence of dual-resistant parasites 
without the need to treat hosts with two anthelmintics. Over the season, the 
percentage hatch in the definitive dose well reflected recent BZ anthelmintic 
treatments, reducing as time since the last treatment increased. Variability 
between replicate wells of a test increased as the species diversity increased, 
and the abundance of T. circumcincta reduced. An exception was the test 
performed at the end of August, when there was high variability between wells, 
despite a high percentage of T. circumcincta, suggesting that there may have 
been some variation in the resistance phenotype of the T. circumcincta 
population at that time. However, without PCR speciation of eggs and L1 larvae, 
which is time-consuming and can be technically challenging post EHT, the results 
are difficult to interpret. For both tests, as for coproculture, it is important to 
remember that not all species will develop equally well at a set temperature, 
and over a set time period (Dobson et al., 1992). This was potentially observed 
in the present study, with differences in the control wells pre- and post-
treatment. This may bias results towards those species more suited to the test 
set-up, compromising interpretation of the anthelmintic efficacy. 
While the EHT appeared to detect BZ resistance reasonably well, and has been 
ring-tested in Europe using lab isolates of H. contortus (von Samson-
Himmelstjerna et al., 2009a), the LDT did not prove as useful in this study. 
There was little change in the ED50 post-IVM treatment in September (RR = 1.7), 
despite a considerable reduction in the proportion of IVM sensitive species in 
vivo. Similar RRs were also identified between IVM resistant and susceptible 
isolates of H. contortus using an agar based LDT, when IVM was the anthelmintic 
tested (Gill et al., 1995). However, larger RRs were obtained using more polar 
avermectins, and using a different avermectin as a proxy measure of IVM 
resistance may provide more informative measures of IVM phenotype (Gill et al., 
1995). In contrast, there was a marked difference between the pre- and post-BZ 
treatment populations ED50 in the EHT (RR = 12.8). In addition, although the EHT 
pre-treatment suggested a generally susceptible population, there was the 
presence of a more resistant sub-population detectable by hatching percentages 
at the 0.2 and 0.3 mg/ml concentrations (von Samson-Himmelstjerna et al., 
2009a). Collectively these results may suggest a similar genetic basis for BZ 
resistance both in vivo and in vitro in this field population. In contrast, different 
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genetic mechanisms may underlie in vitro and in vivo IVM resistance, or the in 
vitro tests may be inappropriate (George et al., 2017).  
Identifying resistance using molecular methods allows for rapid and robust 
understanding of the resistance status of a population. It can also be performed 
using eggs, greatly increasing the speed of diagnosis, provided the method is 
sensitive to extremely low quantities of DNA. For BZ, the presence of the β-
tubulin isotype-1 SNPs at codons 167, 198 and 200 have been closely associated 
with BZ resistance (Kwa et al., 1994; Silvestre and Cabaret, 2002; Ghisi et al., 
2007). While these SNPs can be detected in a laboratory setting, no commercial 
test has been developed for use on farm. In this study, we used pyrosequencing, 
a technique which provides genotype and some haplotype data for each 
individual sequenced. The results from this farm clearly indicate the importance 
of testing all three codon positions. Codon 200 was the most commonly mutated, 
as has been found elsewhere (Redman et al., 2015; Ramünke et al., 2016). 
However, in some studies, codon 198 was found to have a higher frequency of 
mutations than codon 200 within the sample population tested (Redman et al., 
2015; Esteban-Ballesteros et al., 2017). Most studies have associated leucine at 
P198 with BZ resistance in T. circumcincta, as was found here, but some have 
found alanine (Esteban-Ballesteros et al., 2017), which is more commonly 
identified in H. contortus (Chaudhry et al., 2015), or valine (Avramenko et al., 
2019). Although it may be a sequencing error (n=1), the presence of a stop codon 
was detected at codon 198 in this study. This diversity increases both the cost 
and the time taken to obtain a conclusive answer. The need to first select and 
speciate individuals restricts the use of molecular techniques. Newer 
techniques, including MiSeq, are now being used to sequence pools of strongyles 
to determine BZ resistance haplotypes, which may be extremely useful in the 
future (Avramenko et al., 2019). 
Results from this PhD and a recent study in Ireland (Keegan et al., 2017a), 
indicate that BZ resistance in T. circumcincta may be more complicated than 
just the presence of SNPs at these three codons, and that the presence of 
resistant individuals may be missed by molecular methods focusing solely on 
these. In this study, the presence of homozygous ‘susceptible’ offspring 
indicates the survival of adults hetero- or homozygous for BZ sensitive alleles. In 
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Ireland, Keegan et al. (2017a) identified the presence of adults surviving 
oxfendazole treatment, which were genotyped as heterozygous or homozygous 
‘susceptible’ at each of the BZ SNPs. Similar ideas of alternative BZ resistance 
mechanisms have been suggested previously. Originally, selection at both β-
tubulin isotype-1 and β-tubulin isotype-2 was noted in BZ resistant isolates 
compared to susceptible isolates (Beech et al., 1994; Lubega et al., 1994). It was 
suggested that BZ resistance could occur following mutation in β-tubulin isotype-
1 but that high level phenotypic resistance was possible with deletion of β-
tubulin isotype-2 in H. contortus (Kwa et al., 1993). In Caenorrhabditis elegans, 
multiple ben-1 gene variants have been associated with BZ resistant phenotypes, 
and the N2 Bristol strain, commonly used in research, was unusual in having the 
codon 200 SNP (Driscoll et al., 1989; Hahnel et al., 2018). Similar to H. 
contortus, highly BZ resistant C. elegans strains had a deletion of ben-1 (Driscoll 
et al., 1989). Resistance phenotype may also vary by codon (Silvestre and 
Cabaret, 2002) and lifecycle stage (Barrère et al., 2012; Kotze et al., 2012). In 
addition to the target gene(s), studies have reported other mechanisms which 
may increase BZ resistance or tolerance, including the multidrug transporters, 
the P-glycoproteins (Blackhall et al., 2008). It is clear from EHTs that there are a 
range of resistance phenotypes even within a single isolate population, with only 
a subset of worms able to survive at higher concentrations. This would suggest a 
range of genotypes underlying this trend, which may be more relevant in some 
field populations than others.  
Although molecular methods can be extremely useful and reliable, despite the 
potential for multiple mechanisms of resistance, they are comparatively 
expensive. For example, taking the Animal and Plant Health Agency (APHA, a 
standard lab for diagnostic testing in the UK) as a guide, a FECRT would cost a 
farmer £25.20 for a McMaster FEC for a single sheep (pre- and post-treatment), 
providing five or more animals were included. A parasitological examination of a 
single faecal sample would be £34.30. Morphological identification of L3 was 
priced at £172.30 (price data accessed July 2019). No EHT or LDT was included 
in the price list. In this study, the approximate cost of speciating 96 individual 
strongyles to identify four species by a multiplex PCR was £37.25, not including 
staff costs. The pyrosequencing assay, not including speciation prior to 
genotyping, was approximately £240 per 30 worms genotyped at all three β-
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tubulin isotype-1 SNPs. Although these costs would be offset by the size of the 
flock, and therefore the cost-benefit spread over many individual sheep, for 
many farmers the cost would be likely prohibitive, especially in the face of 
known resistance. As such, any molecular tests used in research settings need 
first to be adapted for commercial use, so that either by scale of use, or a cost-
reduction in materials, such tests become cost-effective for farmers. For BZ 
resistance in T. circumcincta, which is widespread, the uptake of molecular 
testing is unlikely. However, if resistance was not yet identified, or there was 
potential to monitor development of resistance with different management 
practices, the uptake of such tests might be more likely, for example for 
emerging resistance of N. battus (Morrison et al., 2014) or cattle parasites 
(Winterrowd et al., 2003), or for IVM resistance.  
As both the pyrosequencing and microsatellite results showed, the T. 
circumcincta population on this farm was highly diverse and did not appear to 
segregate into sub-populations at different times of year, in different age groups 
of sheep or following either BZ or IVM treatment in September. On this farm the 
presence of multiple genetic mutations associated with BZ resistance, and 
multiple haplotypes carrying these alleles, suggests that a soft sweep has 
occurred as observed elsewhere in the UK (Redman et al., 2015). This may be 
related to multiple origins of resistance within the farm, for example several 
resistant haplotypes may have been present since the establishment of the farm. 
Alternatively, the habit of replacing stock each year may have sequentially 
introduced new resistance alleles into the T. circumcincta population (Redman 
et al., 2015). In the UK, the stratified flock system, with many farms buying and 
selling stock at various times of year, may help to maintain species diversity but 
also increase the chance of resistance being introduced onto a farm. In France, 
where many farms are established and remain ‘closed’ with no new stock bought 
in, resistance was found to be linked to the number of farms of origin at 
establishment (Silvestre et al., 2000). Fewer β-tubulin isotype-1 haplotypes were 
identified in French T. circumcincta populations compared with UK populations 
(Skuce et al., 2010). Due to the practice of quarantine drenching (a necessity to 
reduce the spread of disease and resistant parasites), the likelihood of 
introducing new sensitive haplotypes, with potentially higher fitness than 
resistant parasites (if such fitness costs exist), is unlikely. In the presence of 
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such diversity, studies investigating single genes can also increase the chance of 
false positive association of a SNP with a resistance phenotype (Laing et al., 
2016; Rezansoff et al., 2016), and this may be why there is so much 
contradictory evidence regarding the mechanism of IVM resistance.  
3.5 Conclusion 
Methods used to detect anthelmintic resistance on Farm 1 were confounded by 
species diversity. Molecular tests were useful and revealed high individual 
diversity within the T. circumcincta population, and the presence of multiple 
haplotypes carrying BZ resistance associated SNP alleles. Although the EHT 
correlated with BZ resistance phenotype, the LDT was less informative. The 
genetic basis of IVM resistance is not known, and no molecular test is available. 
The following three chapters present results of a genome wide association study 
using two NGS technologies to identify genetic markers of IVM resistance. L3 
progeny of T. circumcincta field populations, selected by FECRT, are used. 
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4 One site does not fit all: difficulties in identifying 
markers of IVM resistance using a reduced 
representation sequencing method 
4.1 Abstract 
Identification of IVM resistance in field populations is currently performed using 
a faecal egg count reduction test. This test has multiple limitations and can be 
insensitive to diagnose resistance. In contrast, molecular tests of resistance are 
sensitive, specific and results can be obtained rapidly. Currently the genetic 
basis of IVM resistance in Teladorsagia circumcincta - the main pathogen of 
growing lambs in the UK - is unknown and no genetic test exists. This limits 
research into the effect of management and refugia on IVM resistance spread 
and development. To date, studies investigating single genes or gene families 
have not identified a conclusive genetic basis for IVM resistance in T. 
circumcincta. Genome wide association studies provide an unbiased approach to 
identify novel loci associated with anthelmintic resistance. The published T. 
circumcincta reference genome is large (~700 Mb) and highly fragmented (81,000 
contigs). Instead, a draft reference genome has been recently assembled (685 
Mb, 8025 contigs) and was used for this study. I used a reduced representation 
next generation sequencing method - double digest restriction-site associated 
DNA sequencing - to sequence 30 pre-treatment and 32 post-IVM treatment T. 
circumcincta individuals. These were offspring collected from adults treated 
with IVM. In total 15,912 polymorphic RADloci were used for analysis. My results 
identified multiple loci that were differentiated between the pre- and post-
treatment populations. Nevertheless, linkage decay was rapid and RADloci were 
unevenly distributed across the genome. Manual annotation of regions up to 75 
kb distant of highly differentiated RADloci using RNA-Seq from a published study 
was performed. A RADlocus containing two of the highest FST value SNPs, with 
apparent selection of the SNP alleles by IVM treatment was identified. Yet closer 
inspection failed to confirm selection by IVM over this RADlocus. No IVM 
candidate genes were present on contigs containing highly differentiated 
RADloci. Individual diversity and the reference genome used may have limited 
the usefulness of ddRAD-Seq in this field population.  
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4.2 Introduction 
Previous studies investigating anthelmintic resistance have mostly focused on a 
small number of candidate genes (Walker et al., 2001; Dicker et al., 2011b; 
Martinez-Valladares et al., 2012b). While this has proven remarkably successful 
for BZ resistance (Kwa et al., 1995), this approach has not been effective for IVM 
resistance, with studies providing conflicting conclusions on the genetic basis of 
IVM resistance (Dent et al., 2000; Njue and Prichard, 2004; Martinez-Valladares 
et al., 2012b; Rezansoff et al., 2016). However, a single microsatellite locus in 
H. contortus (Hc_8a20) has been repeatedly linked to IVM resistance (Redman et 
al., 2012; Rezansoff et al., 2016). Recently, with the increasing availability and 
decreasing cost of next generation sequencing (NGS) methods, genome wide 
association studies (GWAS) have been undertaken to identify the basis of IVM 
resistance in parasitic nematodes (Choi et al., 2017; Doyle et al., 2017; Doyle et 
al., 2019). In contrast to candidate gene studies, these GWAS are both unbiased, 
allowing novel genetic mechanisms to be identified, and have the ability to test 
multiple resistance loci in parallel. This latter aspect is especially important as 
IVM resistance is known to be polygenic in C. elegans (Dent et al., 2000; James 
and Davey, 2009) and more than one mechanism may exist in parasites (Le 
Jambre et al., 2000; Kotze et al., 2014). The size of parasitic nematode genomes 
still makes the use of whole genome re-sequencing (WGS) techniques 
comparatively expensive, however, and reduced-representation approaches - 
sequencing less than one to five percent of the genome (Altshuler et al., 2000; 
Peterson et al., 2012) - are particularly attractive in these organisms (Baird et 
al., 2008).  
In 2000, a letter to Nature described a reduced-representation shotgun 
sequencing method (RSS) for SNP analysis of the human genome. This involved 
cloning and sequencing fragments of genomic DNA from a pool of ten individuals 
after restriction digestion and size selection (Altshuler et al., 2000). The use of 
such a method increased the chance of detecting SNPs between individuals, at a 
fraction of the cost of WGS and was welcomed at a time when the human 
genome was still being assembled. Since then, various methods have been 
developed, including restriction-site associated DNA sequencing (RAD-Seq) (Baird 
et al., 2008). Originally conceived as a microarray method (Miller et al., 2007), 
the incorporation of Illumina sequencing greatly increased the scope of the 
151 
 
Chapter 4 
method (Baird et al., 2008). RAD-Seq involved digestion of genomic DNA using a 
single restriction endonuclease, ligation of P1 adaptors (modified Illumina 
adapters) to the enzyme cut-site and random shearing of the DNA. Following 
this, a second, divergent ‘Y’ adaptor (P2) was ligated to the sheared end of the 
DNA fragment. PCR amplification followed, allowing only those fragments with a 
P1 adaptor to be amplified. The region immediately adjacent to the P1 adaptor 
was sequenced, i.e. immediately adjacent to the restriction enzyme cut-site, 
and the sequence was denoted a ‘RAD-Tag’. SNPs within these loci were called 
RAD markers (Miller et al., 2007; Baird et al., 2008). While this method greatly 
increased the number of markers it was possible to sequence, and reduced the 
bias associated with microarray methods, library preparation costs limited the 
number of individuals that could be multiplexed in a single Illumina lane. 
Sequencing of loci in both directions from a cut-site also conferred some level of 
redundancy to the method. Furthermore, without the presence of a reference 
genome, many sequences were discarded as complexity could not be sufficiently 
reduced to enable robust SNP calling over sequencing errors (Peterson et al., 
2012). The use of restriction endonucleases, specific to a particular pattern 
within the DNA, by necessity requires all individuals to be homogenous at the 
cut-sites in order to retain the same DNA fragments for sequencing (Altshuler et 
al., 2000). Obviously, in nature, this is not the case, and increasing diversity 
within a population leads to increasing levels of polymorphic cut-sites, such that 
some RAD-Tags will be lost from each individual within a sample group (Rubin et 
al., 2012). While this can be used as a test of SNPs within the genome itself 
(Miller et al., 2007; DaCosta and Sorenson, 2016), it can also lead to 
heterozygous loci appearing to be homozygous, due to the loss of one haplotype.  
Peterson et al. (2012) modified the method to include two restriction 
endonucleases, a technique known as ‘double digest RAD-Seq’ (ddRAD-Seq). In 
this method, the P1 adaptor contained an inline barcode (molecular identifier), 
to increase the number of samples that could be multiplexed, therefore reducing 
library set-up costs. The P2 ‘Y’ adaptor contained a second Illumina primer site, 
allowing paired-end sequencing. ddRAD-Seq facilitated multiplexing of up to 576 
individuals within an Illumina flowcell lane. Furthermore, Peterson et al. 
removed the random shearing step, but included a size selection step. These 
changes increased both the flexibility of the method (increasing the potential for 
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fine-tuning the number of RAD-Tags likely to be sequenced), and the specificity 
of selected RAD-Tags between different individuals, increasing the chance that 
the same homologous genomic regions would be retained and amplified in each 
individual, improving the method’s efficiency per megabase of sequencing cost 
(Peterson et al., 2012). Additional benefits included the ability to increase the 
number of RAD-Tags retained, as additional complexity could be accounted for 
due to paired-end reads, and the presence of two different restriction cut-sites 
on each fragment. This also made it easier to perform SNP analysis without a 
reference genome, and Peterson et al. (2012) developed the means to analyse 
their ddRAD-Seq RAD-Tags de novo. Paired-end reads were of further benefit as 
they enabled greater confidence in calling variant sites if the reads overlapped. 
As a sequencing reaction progresses, sequencing errors increase, such that the 
bases called at the 3’ end of a read have a higher chance of being falsely 
identified than at the 5’ end. This is in part due to degradation of the DNA over 
time. By judicious use of size selection methods, DNA fragments can be chosen 
so that many will have overlapping paired-end reads. This will increase the 
sequencing depth at the 3’ end of the reads, providing two separate 
opportunities for sequencing bases at these ends, and improving genotyping 
confidence (Andrews et al., 2016). 
While the budget usually dictates the amount of sequencing possible, 
experimental design for ddRAD-Seq ideally requires knowledge of the genome 
size and the frequency of cut sites for any given restriction endonuclease in the 
organism under investigation. Further to this would be knowledge of the mean 
and range of fragment sizes produced by the digest (i.e. the number of RAD-Tags 
expected). This dictates the number of individuals that can be sequenced per 
lane to achieve the required sequencing depth. However, one of the great 
attractions of RAD-Seq is the use of the technique in non-model species for 
which there is not yet a full, or indeed, any reference genome (Hohenlohe et 
al., 2012). The published T. circumcincta genome (PRJNA72569), available 
during the design stage of this experiment, is highly fragmented (81,000 
contigs), and incomplete. Estimates of the number of times a restriction 
endonuclease might cut could be extrapolated from a similar species, or 
estimated from previously sequenced genes or regions based on the GC 
percentage, assuming a uniform GC percentage across the genome (Baird et al., 
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2008). This requires an assumption of a similar genome length and frequency of 
cutting, and this may not be as expected. For example, T. circumcincta has an 
estimated genome size of close to 700 Mb (Choi et al., 2017), yet the closely 
related parasitic nematode H. contortus has a genome size of just 280 Mb (Doyle 
et al., 2018).   
Attempting to understand the effect of population diversity on a RAD-Seq 
experiment can be complex to predict. The impact of diversity will also be 
dependent on the goals of the study. Low diversity will impact phylogenetic 
studies by requiring increased numbers of markers to obtain sufficient diverse 
markers to separate individuals and traits (Hohenlohe et al., 2010). In contrast, 
higher diversity populations may lose markers due to polymorphisms in the cut-
site (Rubin et al., 2012), but the RAD-Tags remaining are likely to have more 
informative SNPs (Paris et al., 2017), so fewer markers are required. For GWAS, 
where RAD markers are required to be linked with a causal SNP, the density of 
markers may be important. In outbred, diverse populations, such as the 
nematode Caenorrhabditis remanei, linkage disequilibrium (LD) may be low, 
requiring a large number of RAD-Tags to sufficiently capture markers under 
selection (Cutter et al., 2006). The number of individuals and markers required 
for a study to achieve sufficient power, when nucleotide diversity and (LD) is 
unknown, is thus very hard to accurately predict, and is often curtailed by the 
budget available for sequencing. Despite this, many RAD-Seq studies have been 
successfully completed (reviewed by McKinney et al. (2017)). Paired-end 
sequencing alongside comparatively low error rates in Illumina sequencing, and 
the application of Bayesian based models, permits variant calling from as low as 
3 to 10x coverage (Peterson et al., 2012; Maruki and Lynch, 2017). This enables 
sequencing resources to be spent on increasing the number of individuals and 
sites sequenced, rather than increasing sequencing depth.  
The aim of this study was to identify genetic markers of IVM resistance in UK 
field populations of T. circumcincta. To allow for an unbiased approach, with 
the potential to detect novel regions of the genome under selection by IVM, a 
GWAS was performed. As T. circumcincta is estimated to have a large genome 
size, the reduced representation method, ddRAD-Seq, was chosen for the study. 
Results describe the validation and outcome of this approach to detect genetic 
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differentiation in progeny of a T. circumcincta field population, pre- and post-
IVM treatment, from a commercial farm.  
4.3 Results 
4.3.1 Farm information and FECRT data 
A single UK farm was chosen for the analysis. Farm 2 was located in southwest 
England, and had previously diagnosed multi-drug resistance (BZ 83.7%, LEV 
92.5% and IVM 93.0% efficacy), detected by FECRT in 2013 (Glover et al., 2017). 
In August 2016 a further FECRT was performed by the farm’s veterinary surgeons 
using four groups of 20 lambs for each anthelmintic tested. BZ, LEV, IVM and 
MOX efficacies were calculated to be 87.7%, 95.4%, 87.4% and 98.6% respectively 
(Table 4.1). Little is known about how the farm is managed, however it is 
understood that two separate flocks were merged between 2013 and 2016. In 
2016, pre-treatment samples from all groups of lambs were combined for 
coproculture and post-treatment samples for each anthelmintic treatment group 
were coprocultured separately. From the 2016 samples, L3 strongyles were 
speciated by PCR using the ITS2 region, as described in 2.4.2. Of these, 69.8% 
were identified as T. circumcincta pre-treatment, and only T. circumcincta was 
identified post-IVM treatment. Extrapolation of the strongyle species 
percentages to the faecal egg count (FEC) data suggested that IVM was 81.9% 
effective against the T. circumcincta population on Farm 2 in August 2016 (Table 
4.1, Figure 4.1). 
Table 4.1: Faecal egg count reduction test results on Farm 2.  
Anthelmintic 
tested 
FECRT 2013 (%) FECRT 2016 (%) FECRT 2016 against 
Teladorsagia 
circumcincta (%) 
BZ 83.7% 87.7% ND 
LEV 92.5% 95.4% ND 
IVM 93.0% 87.4% 81.9% 
MOX ND 98.6% ND 
Overall percentage reduction in strongyle egg output following anthelmintic treatment is 
shown. The proportional reduction in Teladorsagia circumcincta faecal egg count is 
indicated for those samples where L3 larvae were speciated by PCR of the ITS2 region. ND = 
Not done.  
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Figure 4.1: Ivermectin Faecal egg count reduction test Farm 2, 2016, with eggs per gram 
attributed by species. Following coproculture, 96 pre- and 89 post-treatment L3 strongyles 
were speciated by PCR using the ITS2 region. Species percentages were used to 
extrapolate eggs per gram of faeces by each species present. Key to colours: green = 
Oesophagostomum venulosum, black = Trichostrongylus axei, orange = Teladorsagia 
circumcincta, blue = Trichostrongylus vitrinus. 
4.3.2 ddRAD-Seq read quantity and quality 
Two pools each of 31 whole genome amplified (WGA) and barcoded individual T. 
circumcincta L3 (each with 15 pre-treatment and 16 post-IVM treatment 
individuals to minimise batch effects) were sent to the WSI. Pools were 
successfully sequenced using 125 bp paired-end reads. Each pool was run in a 
separate flowcell sequencing lane and the quantity, quality and composition of 
reads was similar between lanes. Following de-multiplexing, 96.9 and 97.6% of 
reads were retained per pool.  
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Between 2.1 M and 11.1 M total read-pairs (a total of 4.2 to 22.2 M reads) were 
sequenced for each individual, with a mean of 6.4 M and a standard deviation of 
2.2 M (Figure 4.2, Appendix 3). Values were similar across pre- and post-
treatment samples. A high level of read duplication averaging 41% (28.3 to 
54.5%) was seen across all individuals. This was as expected for RAD-Seq, due to 
the same regions being sequenced many times, in contrast to WGS, when lower 
levels of duplication would be expected. There was a positive correlation 
between the total number of reads sequenced and the percentage duplication. 
Percentage duplication was always lower for the second read of a pair, likely 
reflecting DNA degradation during sequencing i.e. although duplicates (including 
PCR duplicates) will have been the same (as the reads are in a pair), the second 
read of each pair will have increased errors, reducing the detection of such 
duplicates.  
 
Figure 4.2: Total number of read pairs sequenced per individual. Blue = Pre-treatment, 
Orange = Post-ivermectin. Each individual is represented by a dot. The mean values for 
each sample population are shown by an X. 
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Overall quality was good, with all read base positions attaining an average base 
quality Phred score of greater than 30 for each individual, and most positions 
within reads had a Phred score of greater than 35. A score of 30 equates to a 
99.9% probability that the base is correct. Restriction enzyme cut-sites were 
clearly represented, and base content appeared balanced along the remaining 
read length. Per base N content was very low, being less than 0.3% for all reads. 
The GC content was normally distributed for all sets of reads, being slightly 
higher (46-47%) for reads with the CATG cut-site, as opposed to the reads 
generated from the AATT cut-site (44-45%).  
Samples had been processed in the lab in batches of eight (see 2.5.1). If there 
was no batch effect, one would expect there to be no relationship between 
individuals within a batch. However, it is clear that some bias has occurred 
between groups. The earliest processed WGA samples (Figure 4.3, red and light 
green) tended to have fewer reads sequenced, and displayed a reduced variation 
between individuals than some of the later processed samples (dark green, 
maroon), which had increased reads sequenced per individual, with greater 
variation between individuals (Figure 4.3).   
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Figure 4.3: Identification of sequenced samples by whole genome amplification batch 
number. Using MultiQC (Ewels et al., 2016), samples were identified by their WGA batch and 
the number of sequenced reads (in millions) were plotted against the percentage 
duplication. Reads to the right are those of the primary read in each pair, while those to the 
left are the second read in each pair. Batches were processed in the following order: red, 
light green, dark blue, light orange, light blue, lilac, dark green, maroon. Each point 
represents one individual. 
4.3.3 Reads aligned well to the reference genome  
Using BWA-MEM (Li, 2013), de-multiplexed reads were aligned to the draft T. 
circumcincta Tci2 genome. This genome is 685 Mb in length, with 8025 contigs, 
and an N50 value of 288.5 kb, with 642 contigs longer than the N50. The longest 
contig is 2.08 Mb long. Although a draft version, this is a considerable 
improvement on the published genome available at WormBase ParaSite, 
PRJNA72569 (Choi et al., 2017). Of the total number of sequences, on average 
82.6% of the reads mapped successfully as a pair (range 76.5 to 85.2%, Figure 
4.4). However, fewer reads mapped successfully to the genome in their pair 
together (denoted ‘properly paired’, 60.6%, range 52.1 to 70.0%). Most of the 
discrepancy between these figures is due to reads aligning to separate contigs, 
reflecting the fragmented nature of the genome (Figure 4.4). Secondary 
alignments ranged from 4.6 to 10.4% (average 7.9%).  
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The mapping quality (MAPQ) reflects the probability that a read is incorrectly 
mapped to the genome. Calculated using –10[log10(probability incorrectly 
mapped)], values of 20 suggest that there is 99% chance the read is correctly 
mapped. A MAPQ=0 is used to denote a read which maps equally well to two or 
more genomic positions, but it may align well, or poorly, to those positions. The 
percentage of total sequences mapping with a MAPQ=0 was on average 13.9% 
(range 12.4 to 15.3%, Figure 4.4). The average base quality per individual was 
35.8 (range 35.6 to 36). Average insert size per individual (overall size, in bp, of 
both reads of a pair mapped to the genome, including the gap between reads), 
was 220.43 bp (range 215.2 to 225.3). Noting that ligated adaptors will have 
been removed before alignment to the genome this insert size reflected the 225-
325 bp size selection step using the Pippen Prep (Sage Science). For all mapping 
statistics there was no significant difference between the pre-treatment and 
post-IVM sample populations, other than the percentage of total sequences 
mapped as a pair to the genome (p<0.001). For this statistic, the average for 
each of the pre- and post-treatment samples was 83.7 and 81.6% respectively. 
The average error rate (the number of mismatches per bases mapped) was 
3.44E-02 (range 3.34E-02 to 3.53E-03). 
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Figure 4.4: BWA-MEM alignment percentages per individual. Each value is the percentage of 
reads mapped to the reference genome out of the total number of reads sequenced. ‘X’ is 
the mean. From the left; orange = ‘Mapped as a pair’, light blue = ‘Properly paired’, grey = 
‘Mate mapped to another contig’, yellow = ‘MAPQ=0’, dark blue = ‘Secondary alignments’. 
4.3.4 Over 3 million RADloci identified, but very few shared 
between individuals 
In total, 3,341,180 RADloci were identified. Of these, 75,517 RADloci were 
sequenced in 80% or more of each of the pre- and post-treatment samples (Paris 
et al., 2017), sampling less than 0.03% of the genome. Most RADloci retained 
were non-polymorphic (78.9%, 59,605/75,517), with the remainder containing 
119,892 variant sites. The 15,912 polymorphic RADloci sampled less than 0.01% 
of the 685 Mb genome. Calculating the average SNP density across the genome: 
(Genome length in basepairs / Total number of shared SNPs) 
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suggested one SNP every 5.7 kb - assuming an even spacing of SNPs. The mean 
number of genotyped sites per RADlocus was 233.23 bp (standard error 0.14 bp). 
On average, 26.2/30 and 27.7/32 individuals were analysed per RADlocus, for 
each of the pre- and post-IVM treatment sample groups respectively. The 
nucleotide diversity (Pi) for variant sites was very similar for each sample group, 
being 0.223 and 0.224 for the pre- and post-IVM populations respectively. The 
genome-wide nucleotide diversity was considerably lower being 0.002 for both 
samples. Not all alleles were present in both populations. The pre-treatment 
sample had 1365 private alleles, and the post-IVM sample contained 1768 private 
alleles. The mean FST between the pre- and post-treatment samples was 0.013. 
4.3.5 A diverse population but with the presence of 
contamination: kinship analysis 
High individual diversity was apparent following genome wide population 
analysis using the R program Adegenet v2.1.1 (Jombart, 2008; Jombart and 
Ahmed, 2011). A genotype plot, displaying the SNP genotypes for all individuals 
sequenced was produced. By chance, due to random assortment of individuals by 
the software, this plot highlighted the presence of two highly similar individuals 
(Figure 4.5). Despite a high percentage of identical genotypes, the presence of a 
few notable differences between the two individuals was still apparent. One 
individual had been sampled pre-treatment and the other post-IVM. When the 
plot was re-constructed, with individuals sorted by treatment sample, no 
obvious segregation, suggestive of population sub-structuring or selection by IVM 
of SNP genotypes, was apparent (Figure 4.6).   
162 
 
Chapter 4 
 
Figure 4.5: Genotype plot of all individuals. Each row is a separate individual. Outlined by a 
dotted box are two highly similar individuals. All SNPs identified are included, with each 
column corresponding to a different SNP position. The individual’s genotype is indicated for 
each SNP by three colours; white = homozygous for reference allele (0), light blue = 
heterozygous (1), dark blue = homozygous for alternative allele (2).  
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Figure 4.6: Genotype plot of all individuals ordered by treatment sample. This is a different 
visualisation of the same information plotted in Figure 4.5. Each row is a separate 
individual. All SNPs identified are included, with each column corresponding to a different 
SNP position. The individual’s genotype is indicated for each SNP by three colours; white = 
homozygous for reference allele (0), light blue = heterozygous (1), dark blue = homozygous 
for alternative allele (2).  
Phylogenetic analysis confirmed high individual diversity, for all but the two 
previously mentioned individuals (Figure 4.7). A PCA plot revealed that 3.69% of 
the overall variation could be explained by the presence of these two 
individuals, separated along the first principal component axis from all other 
individuals. The remaining individuals were spread along the second principal 
component axis, which described just 2.09% of all variation (Figure 4.8). 
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Figure 4.7: Genetic distance tree of all 62 ddRAD-Seq individuals. An average neighbour 
method was used to cluster individuals. Key to colours: Blue = Pre-treatment, Red = Post-
ivermectin. Scale = fraction of sites which differ between individuals (bitwise.dist()). 
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Figure 4.8: PCA plot of all individuals. Adegenet v2.1.1 was used to calculate principal 
components, and ggplot2 (Wickham, 2016) was used to plot individuals, colouring by 
treatment sample. The plot shows the variance explained by the first two principal 
components. The inset shows the 61 eigenvalues, each explaining 3.69% or less of the 
overall variance. Key to colour: Blue = Pre-treatment, Red = Post-ivermectin. 
A kinship analysis was performed using KING-robust (Manichaikul et al., 2010). If 
individuals were considered to be from the same population the kinship 
coefficient would be close to zero. Figure 4.9 shows the presence of a pair of 
closely related individuals, which have a kinship coefficient of 0.497 suggestive 
of monozygotic twin familial status. However, all other individual pairwise 
comparisons had negative kinship coefficients indicating unrelated individuals, 
with some population stratification, although no sub-groupings were obvious, 
even when sample population information was provided.  
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Figure 4.9: ddRAD-Seq kinship analysis of all 62 individuals. Using the KING-robust method in R (Manichaikul et al., 2010), kinship analysis between each 
all individuals was performed. Each point represents one comparison between a pair of individuals. If the kinship coefficient is estimated at zero, there is 
no relationship between the individuals, if at 0.5, then the individuals are monozygotic twins, and if negative then the individuals are unrelated, but there 
may be population sub-structuring. IBS = Identity by State. 
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The two highly similar individuals were identified as Pre_18 and Post_19. 
Following this analysis and examination of lab records, where it was shown that 
these two were prepared in neighbouring plate wells, it was decided to remove 
both individuals from further statistical analyses. Re-plotting the PCA now 
demonstrated the presence of a single population, with each of the 59 
eigenvalues contributing 2.18% or less of the overall variation (Figure 4.10).  
 
Figure 4.10: PCA plot of 60 individuals. Following removal of the Pre-18 and Post-19 highly 
similar individuals, the PCA was repeated, and the plot shows the variance explained by the 
first two principal components. The inset shows the number of eigenvalues overall, each 
explaining 2.18% or less of the overall variance. Key to colour: Blue = Pre-treatment, Red = 
Post-ivermectin.  
4.3.6 Many sites were out of Hardy-Weinberg Equilibrium 
Hardy-Weinberg equilibrium (HWE) describes the presence of entirely random 
mating within a population and requires genotype frequencies to match those 
expected given certain allele frequencies. If the expected genotypes 
(heterozygous/homozygous ratios) are not observed then it suggests that non-
random mating has occurred, such as might be expected following selection and 
bottlenecking of the population as a result of IVM treatment. RADloci haplotypes 
were assessed for HWE using Stacks v2.0b (Rochette et al., 2019). It was 
determined that 8927 of the 15,809 variants containing RADloci (56.5%) in the 
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post-IVM sample group were significantly deviating from HWE (p<0.05). In the 
pre-treatment sample group fewer RADloci (15,773) contained variants, and 
8622 (54.7%) of these RADloci deviated significantly from HWE (p<0.05).  
Both Stacks v2.0b and VCFtools v0.1.14 (Danecek et al., 2011) were used to 
analyse SNPs. Of the 119,892 variant sites, 49.5% (59,407) were deviating from 
HWE. By sample population, 27.2% (32,622) of pre-treatment and 29.2% (35,023) 
of post-IVM variant sites were deviating from HWE. Overall, observed 
heterozygosity of variant sites was lower than expected (0.15 observed 
heterozygosity for both pre- and post-IVM, as opposed to 0.22 expected 
heterozygosity for both). Almost all variant sites deviating from HWE, (59,323), 
were considered to be in heterozygous deficit (p<0.05). Just 84 variant sites 
(0.07% of all sites), were considered to be in heterozygous excess (p<0.05).  
4.3.7 Six individuals were missing proportionally more common 
RADloci than others 
Using VCFtools v0.1.14, the percentage of missing variant sites per individual 
was calculated, compared to the total number of variant sites retained across all 
60 individuals (Figure 4.11). The individual with the lowest percentage of sites 
missing had 5.5% of variant sites missing, while one individual had as many as 
31.8% of variant sites missing from their data. On average each individual had 
10.1% missing data, however the median was lower (8.4%) due to skewing of the 
data by six individuals, shown as outliers in the inset in Figure 4.11. Comparing 
this data with the number of sequences aligned as a pair to the genome, it was 
clear that there was a negative correlation between the percentage missingness 
and the total number of sequences aligned (Figure 4.12). 
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Figure 4.11: Percentage of shared variant sites missing per individual. Six individuals were outliers (see inset), with a higher percentage of sites missing, 
such that the mean (X), is greater than the median. 
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Figure 4.12: Percentage of variant sites missing per individual compared with sequences 
aligned. Each dot represents one individual. Using Excel, a regression line (power) was 
fitted, R2=0.8669. The sequences included are those which are mapped as a pair to the 
genome, although not necessarily mapped together in their pair (‘properly paired’) in 
mapping. 
4.3.8 Linkage disequilibrium decay was rapid 
Following the removal of the six individuals with the highest percentage of 
missing sites, Stacks v2.0b populations was repeated and VCFtools v0.1.14 was 
used to calculate the LD. The squared correlation coefficient value (r2) between 
each pair of variant genotypes on a contig was chosen. The squared correlation 
coefficient, r2, is allele frequency dependent, and has a range of zero to one. It 
will only be high if both alleles are at the same allele frequency and linked. 
Otherwise, if one allele is rare, even though it is linked with the other, the value 
of r2 will always be low. This makes it a more useful measure of LD within the 
genome for this study than D’, the alternative measure of LD, as this latter 
estimate will be high if alleles are linked, regardless of their frequency within 
the population. As such, r2 will only suggest high LD if alleles are both common 
and linked (which is required for identification of genetic markers linked to a 
causal mutation), with the potential for use in other populations. 
Distances between genotype positions ranged from 1 bp to 1.55 Mbp, and the 
mean r2 value was 0.090 (range 0.000 - 1.000), while the median value was much 
lower – only 0.016. The half-decay distance was always the minimum distance 
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between positions, and so, as a more meaningful measure, the distance to the 
mean intercontig LD (0.0206) was calculated (Cutter et al., 2006), and was found 
to be 2805 bp. Although some genotypes appeared to be linked over a 
considerable distance, the majority had very low r2 values, even over short 
distances, and the linkage decay was extremely rapid (Figure 4.13). This data 
will necessarily be affected by the lengths of contigs within the Tci2 genome. 
The average contig length is only 85.5 kb, but many contigs are only a few 
thousand basepairs long. If LD was high on short contigs, but lower on longer 
contigs, this could overestimate the speed of linkage decay and underestimate 
the half decay distance. 
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Figure 4.13: Linkage decay plot. Each point represents the LD (r2) between one pair of 
variant genotypes, within the same contig. The distance in basepairs between genotype 
positions is plotted along the x-axis. The linkage decay is plotted as a black dotted line and 
falls sharply. 
4.3.9 Low and variable SNP density across the genome  
VCFtools v0.1.14 was used to assess the SNP density per kb across the genome 
and contigs 1 to 50 in the Tci2 genome were plotted (Figure 4.14). These were 
generally the longest contigs, with the first contig measuring 2.08 Mb, however, 
not all contigs in the Tci2 genome are in size order. From these plots it was clear 
that the SNP density per kb varied widely across the genome, including within a 
contig, and there were large regions where no RAD markers were present (Figure 
4.14).  
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Figure 4.14: ddRAD-Seq SNP density across the genome. The first 50 contigs are plotted, each on a separate plot. Each dot represents a 1 kb window, 
which contains at least one variant site. For each contig the first million bp are included, however some contigs shown will be shorter in length than this.  
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4.3.10 FST analysis identifies genetically differentiated 
RADloci as potential markers of IVM resistance 
A Manhattan plot of the FST values for each SNP identified a subset of highly 
differentiated SNPs but did not reveal any obvious clustering (Figure 4.15). This 
is likely to reflect the fragmented state of the genome (Doyle et al., 2019). 
Filtering the dataset using a threshold (FST = 0.0637) of three standard deviations 
above the mean FST value retained 2592 RAD markers (Appendix 4). 
 
Figure 4.15: ddRAD-Seq SNP FST Manhattan plot. All SNPs are plotted by positional index 
within the file rather than by their genomic location. However, the SNPs are in their 
positional order from the start of contig 1 (left) to the end of the last contig sampled (right). 
The dotted line indicates the threshold of three standard deviations above the mean FST. 
(Threshold = 0.0637). 
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FST values indicate the degree of fixation of an allele within a population, 
relative to another population, but any within-sample diversity greatly reduces 
FST (Bird et al., 2011). Standardization of an FST value (F’ST) to account for 
within-sample diversity can help to recognise allele selection in populations with 
high individual diversity (i.e. given the diversity present, what is the maximum 
possible FST value attainable and, of this, what is the relative FST value?) (Bird et 
al., 2011). A true measure of between-population differentiation is DEST, which is 
independent of within-population diversity (Bird et al., 2011). It was decided to 
use all three measures to identify potential loci under IVM selection. It should be 
noted that while the FST value is calculated per SNP, the F’ST and DEST values are 
calculated per RADlocus and are thus comparing RADlocus haplotypes, 
effectively acting as a local smoothing measure for SNP analysis. Although the 
smoothed AMOVA FST value (using 1 kb distinct windows) was also extracted, the 
regional spread of SNPs across the genome varied greatly and had a noticeable 
impact on the values calculated. Since the robustness of this algorithm was 
questionable in this particular analysis, it was not considered as important as the 
FST, F’ST and DEST values.  
As the genome was not annotated at the time of analysis, it was decided to 
manually annotate regions of the genome surrounding SNPs of interest. 
Annotating all contigs containing SNPs greater than the threshold was considered 
unmanageable, but there were no obvious clusters of SNPs greater than the 
threshold, which could be visually located. Therefore, RADloci were chosen for 
further investigation as described in 2.7.8. In total, 19 SNPs in 17 RADloci, each 
on a separate Tci2 contig, were investigated further. Eleven RADloci were 
located within genes (Table 4.2). Eight RADloci were within 10 kb of at least one 
gene (Table 4.3). A further 27 putative genes were annotated within 50 kb of a 
RADlocus (Table 4.4), and finally an additional seven genes were annotated 
within 75 kb of a RADlocus of interest (Table 4.5). No candidate genes previously 
associated with IVM resistance were identified.
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Table 4.2: Genes containing a RADlocus of interest identified following manual annotation of selected high FST contigs.  
RADlocus Tci2 
contig 
Teladorsagia 
circumcincta 
PRJNA72569 gene 
Teladorsagia 
circumcincta 
PRJNA72569 
contig 
Haemonchus 
contortus gene 
Caenorhabditis 
elegans gene 
Caenorhabditis 
elegans 
Chromosome 
FST value1 
349441 77 TELCIR_09574 2025 HCON_00189500 R12E2.2 (suco-1) I 0.159 
587481 146 TELCIR_11794 3246 HCON_00151030 M04G12.1 (tag-260) V 0.236 
1486836 545 TELCIR_04325 421 HCON_00074220 K01A2.11 (cbn-1) II 0.159 
1572681 598 TELCIR_06418 900 HCON_00041530 NA NA 0.141 
1759024 732 TELCIR_02631 169 HCON_00134530 R13H9.5 IV 0.155 
1967245 894 NA 4362 HCON_00102640 NA NA 0.0892,3 
2034639 953 TELCIR_04965 544 HCON_00167480 R01E6.6 (glb-20) X 0.152 
2284168 1226 TELCIR_00369 11 HCON_00160120 F08F3.10 V 0.0972,3 
2464065 1471 TELCIR_11681 
TELCIR_11682  
3169 HCON_00013050 W01A8.5 (tofu-5) I 0.157 
2581282 1680 TELCIR_01924 103 HCON_00079090 K01B6.2 (srx-45) III 0.198 
2976600 2896 TELCIR_13774 
TELCIR_13775 
4779 HCON_00034960 Y38H6C.17  
H32K16.1 (slc-36.3, 
slc-36.4) 
V, I 0.146 
These RADloci were within the top 50 FST results or were within the top 50 F’ST/DEST results. Genes were manually annotated in Artemis using RNA-Seq data 
(Choi et al., 2017), and equivalent proteins and homologues identified by BLASTP of the amino acid sequence. PRJNA72569 contigs were identified using 
TBLASTN when no equivalent protein was identified. 1The FST value of the highest ranking SNP with the RADlocus is provided. 2Selected based on F’ST 
results. 3Selected based on DEST results. 
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Table 4.3: Genes within 10 kb of a RADlocus of interest identified following manual annotation of selected high FST contigs.   
RADlocus Tci2 
contig 
Teladorsagia 
circumcincta 
PRJNA72569 gene 
Teladorsagia 
circumcincta 
PRJNA72569 
contig 
Haemonchus 
contortus gene 
Caenorhabditis 
elegans gene 
Caenorhabditis 
elegans 
Chromosome 
FST value1 
243878 50 NA 8051 HCON_00104180 C28C12.7 (spp-10) IV 0.100 
243878 50 TELCIR_13282 4361 HCON_00104170 T05G5.3 (cdk-1) III 0.100 
384468 86 TELCIR_04598 
TELCIR_04599 
477 HCON_00073720 F25B5.1 (dct-6) III 0.0643 
513975 122 TELCIR_00464 14 HCON_00160450 ZC116.3 V <0.06372,3 
643960 163 NA 4878, 132 HCON_00148790 C24G6.3 (mms-19) V 0.145 
643960 163 TELCIR_13875 
TELCIR_02259 
TELCIR_02260 
4878, 132 HCON_00148780 C24G6.6 (hpo-15) V 0.145 
1170167 373 TELCIR_01410 357, 2244, 62 NA NA NA 0.137 
1237196 404 TELCIR_05309 622 HCON_00189240 F39B1.1 (piki-1) X 0.171 
1486836 545 NA 343494 NA NA NA 0.159 
1486836 545 TELCIR_04326  421 HCON_00074210 H14N18.3 (ttr-47) V 0.159 
2464065 1471 TELCIR_11682 3169 HCON_00013040 Y60A3A.12 (chk-2) V 0.157 
These RADloci were within the top 50 FST results or were within the top 50 F’ST/DEST results. Genes were manually annotated in Artemis using RNA-Seq data 
(Choi et al., 2017), and equivalent proteins and homologues identified by BLASTP of the amino acid sequence. PRJNA72569 contigs were identified using 
TBLASTN when no equivalent protein was identified. 1The FST value of the highest ranking SNP with the RADlocus is provided. 2Selected based on F’ST 
results. 3Selected based on DEST results. 
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Table 4.4: Genes within 50 kb of a RADlocus of interest identified following manual annotation of selected high FST contigs.  
RADlocus Tci2 
contig 
Teladorsagia 
circumcincta 
PRJNA72569 gene 
Teladorsagia 
circumcincta 
PRJNA72569 
contig 
Haemonchus 
contortus gene 
Caenorhabditis 
elegans gene 
Caenorhabditis 
elegans 
Chromosome 
FST value1 
243878 50 TELCIR_09426  
TELCIR_09425 
1952 HCON_00104140 
HCON_00104160 
Y116A8C.36  
(itsn-1) 
IV  0.100 
384468 86 TELCIR_26237  
TELCIR_23945  
375630, 
205630 
HCON_00073750 
 
H26D21.1 (hus-1) I 0.0643 
384468 86 TELCIR_26347 494832 HCON_00073740 
 
T12D8.6 (mlc-5) III 0.0643 
389043 86 TELCIR_09534 2004 HCON_00148060 
 
Y32F6A.4 V 0.174 
389043 86 TELCIR_19868 15459, (3079, 
no genes) 
HCON_00148050 NA NA 0.174 
587481 146 TELCIR_15805 6898 HCON_00151040 T01D3.5 (zipt-9) V 0.236 
587481 146 TELCIR_10786 2599 HCON_00151060 R186.3 V 0.236 
643960 163 TELCIR_02258 132 HCON_00148760 C24G6.4  
(nhr-47) 
V 0.145 
1486836 545 TELCIR_01295 
TELCIR_04328 
54, 421 NA Y54F10AM.2  
(feh-1) 
III 0.159 
1572681 598 TELCIR_06417 900 HCON_00041530 NA NA 0.141 
1759024 732 TELCIR_02631 169 HCON_00134530 C39H7.1 IV 0.155 
1759024 732 NA 169 HCON_00134530 C39H7.1 IV 0.155 
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RADlocus Tci2 
contig 
Teladorsagia 
circumcincta 
PRJNA72569 gene 
Teladorsagia 
circumcincta 
PRJNA72569 
contig 
Haemonchus 
contortus gene 
Caenorhabditis 
elegans gene 
Caenorhabditis 
elegans 
Chromosome 
FST value1 
1886869 827 NA 426 NA NA NA 0.166 
1886869 827 NA NA NA NA NA 0.166 
1886869 827 TELCIR_05657 699 HCON_00178015 R148.3 III 0.166 
1886869 827 TELCIR_05658  
TELCIR_05659  
TELCIR_05660 
699 HCON_00179670 F48E3.3 F26H9.8 
(uggt-1, uggt-2) 
X, I 0.166 
1967245 894 TELCIR_06338 870 NA NA NA 0.0892,3 
1967245 894 NA 3253, 870 HCON_00096840 Y41E3.9 (fcd-2) IV 0.0892,3 
2034639 953 NA 544 NA C56E6.4 II 0.152 
2284168 1226 TELCIR_00368 11 HCON_00160130 C01G10.8 (ahsa-1) V 0.097 
2464065 1471 TELCIR_03475 280 HCON_00013030 M01E11.2 I 0.157 
2581282 1680 TELCIR_17075  
TELCIR_02329 
138 HCON_00091250 
 
K08E3.5 III 0.198 
2748445 2050 TELCIR_12625 
TELCIR_12624 
3834 HCON_00066190 Y50D7A.4 (hpo-29) III <0.06372 
2976600 2896 TELCIR_18588 11602 HCON_00153600  
 
F47G9.4 V 0.146 
3071877  3471 TELCIR_07163 1119 HCON_00071130 Y53G8AR.8 III 0.159 
3071877 3471 TELCIR_07164 1119 HCON_00071130 ZK688.8 (gly-3) III 0.159 
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RADlocus Tci2 
contig 
Teladorsagia 
circumcincta 
PRJNA72569 gene 
Teladorsagia 
circumcincta 
PRJNA72569 
contig 
Haemonchus 
contortus gene 
Caenorhabditis 
elegans gene 
Caenorhabditis 
elegans 
Chromosome 
FST value1 
3071877 3471 TELCIR_07165 
TELCIR_14502 
5449, 1119 HCON_00071140 C29E4.5 (tag-250) III 0.159 
These RADloci were within the top 50 FST results or were within the top 50 F’ST/DEST results. Genes were manually annotated in Artemis using RNA-Seq data 
(Choi et al., 2017), and equivalent proteins and homologues identified by BLASTP of the amino acid sequence. PRJNA72569 contigs were identified using 
TBLASTN when no equivalent protein was identified. 1The FST value of the highest ranking SNP with the RADlocus is provided. 2Selected based on F’ST 
results. 3Selected based on DEST results. 
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Table 4.5: Genes within 75 kb of a RADlocus of interest identified following manual annotation of selected high FST contigs.  
RADlocus Tci2 
contig 
Teladorsagia 
circumcincta 
PRJNA72569 gene 
Teladorsagia 
circumcincta 
PRJNA72569 
contig 
Haemonchus 
contortus gene 
Caenorhabditis 
elegans gene 
Caenorhabditis 
elegans 
Chromosome 
FST value1 
349441 77 TELCIR_06342 872 HCON_00189530 B0395.1 (nhx-1) X 0.159 
389043 86 TELCIR_05913 759 HCON_00148110 NA NA 0.174 
643960 163 TELCIR_08013 1395 HCON_00148730 T05C3.5 (dnj-19) V 0.145 
1170167 373 TELCIR_08843 
TELCIR_18188  
1715, 10765 HCON_00106310 
 
T06E4.1 V 0.137 
1170167 373 NA NA NA NA NA 0.137 
1170167 373 TELCIR_19422  13874 HCON_00101380 M03F4.2 
T04C12.4 
T04C12.6 (act-1, 
act-3, act-4) 
X, V, V 0.137 
2034639 953 TELCIR_03238 
TELCIR_06860 
TELCIR_08734 
177, 1025, 
789, 244, 
1672 
HCON_00046190 ZK20.6 (nep-1) II 0.152 
These RADloci were within the top 50 FST results or were within the top 50 F’ST/DEST results. Genes were manually annotated in Artemis using RNA-Seq data 
(Choi et al., 2017), and equivalent proteins and homologues identified by BLASTP of the amino acid sequence. 1The FST value of the highest ranking SNP 
with the RADlocus is provided.
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4.3.11 RADlocus 587481 had the highest FST value SNP, yet 
on closer inspection did not appear to be under IVM 
selection.  
The SNP with the highest FST value (0.236) was located within RADlocus 587481 
on Tci2 contig 146. Close to this SNP, within the same RADlocus, was a second 
SNP, also estimated to have a high FST value. In addition, this RADlocus was 
within the top 14 RADloci assessed by both F’ST and DEST. Despite this, these two 
SNPs were not in the top 50 smoothed AMOVA FST results. The RADlocus was 
found to reside within the 9th intron of a ten exon annotated gene (Table 4.2), 
with genomic location Tci2 contig 146:44804-49573, the contig being 1.22 Mb in 
length (Figure 4.16).   
  
Figure 4.16: RADlocus 587481 position. Using RNA-Seq data (Choi et al., 2017), genes were 
annotated in Artemis and the RADlocus was found to reside within the 9th intron of a gene 
on contig 146 as shown. The exons are coloured blue, the RADlocus is white.  
The highest FST SNP had either an adenine or a guanine encoded, and these 
alleles were in roughly equal proportions in the pre-treatment sample (47 and 
53%). In the post-IVM sample just 9% of alleles were guanine, with the remaining 
91% encoding adenine, suggesting positive selection of this allele.  
Following extraction of the consensus sequenced RADtags for each individual for 
this locus, these were aligned in Geneious v9.1.8 (https://www.geneious.com), 
and the two SNPs with the high FST values were located. It became clear that 
these SNPs separated a common haplotype (containing guanine at position 50 
and thymine at position 94) from other, less common, haplotypes within the 
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sample groups (Figure 4.17). Nevertheless, most individuals encoding this 
common haplotype were in the pre-treatment sample, with a diverse range of 
haplotypes present in the post-IVM sample. These multiple diverse haplotypes, 
present in both sample groups, encoded adenine at position 50 and cytosine at 
position 94 within the RADlocus. It therefore seemed unlikely that this RADlocus 
was under selection by IVM in this farm population. 
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Figure 4.17: A Neighbour-Joining tree of the consensus fasta sequences of RADlocus 
587481. of all 60 individuals. Key to colours: blue = pre-treatment, red = post-IVM. Those in 
bold font, above the dashed line, encode guanine at the highest FST SNP. Those below the 
line encode adenine. Genetic distance model: Tamura-Nei, Outgroup: FL1_1_Pos_01. 
SNP allele = GUANINE 
SNP allele = ADENINE 
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Plotting additional variants along Tci2 contig 146 showed that this RADlocus was 
unusual in displaying a higher level of SNP allele fixation between the pre- and 
post-treatment samples (Figure 4.18). Although there were other variant sites 
along the contig, none were as significant as these two SNPs, or had as high FST 
values. In addition, the majority of the other variant sites within the RADlocus, 
or close to it, had quite low FST values. Analysing the LD along the contig found 
it decayed as rapidly as the genome wide estimate of LD, and the distance in 
basepairs to the mean intercontig equilibrium was only 1958 bp. 
 
Figure 4.18: Contig 146 variant sites. All variant sites as provided by Stacks v2.0b were 
plotted by basepair position along contig 146. The FST threshold (three standard deviations 
greater than the mean) is indicated by the dot-dashed line. Each variant site represented is 
coloured by -(log10[p-value]). Lighter colours are more significant.
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4.3.12 Linkage disequilibrium across high FST contigs 
Following analysis of RADlocus 587481 an alternative standard to judge whether 
or not to further investigate a genetically differentiated RADlocus was looked 
for. It was decided to assess whether any SNPs above the FST threshold were 
found on contigs of extensive LD. It was considered that such contigs might 
indicate selection by IVM and would be worth more intensive investigation. Data 
for contigs containing SNPs of FST value greater than the threshold were 
extracted. The LD decay was rapid for this subset of contigs, with the distance 
to the mean intercontig LD, 2831 bp, very similar to the genome-wide value.  
For these contigs, the mean r2 value was plotted against the mean FST value for 
each contig (Figure 4.19). Each was coloured and scaled such that the mean 
distance between SNPs on the contig was also visualised. From this it became 
clear that there was no correlation between contig mean FST value and contig 
mean r2 value, making it an unhelpful indicator to use for following up F-statistic 
analysis. Although this makes it unlikely that large regions are under selection by 
IVM, it does not rule out the presence of smaller regions within these contigs, 
especially within longer contigs, or misassembled contigs, when diversity around 
the RADlocus would reduce both contig mean FST and r2 values. Nevertheless, it 
was realised that contig 146 had both a comparatively low mean r2 and a low 
mean FST value. 
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Figure 4.19: Contig mean FST value compared with mean r2 value. Each of the contigs 
containing a RADlocus with a high FST value, greater than three standard deviations above 
the mean FST were extracted. The mean linkage disequilibrium r2 value was obtained for 
each contig, and the results are plotted here. For each contig the mean distance between 
base pairs used to calculate the linkage disequilibrium is represented both by the size of the 
plotted point, and by the colour, with larger distances being shown by larger, lighter 
coloured points. Contig 146 is shown in red. 
4.4 Discussion 
The aim of this experiment was to identify markers of IVM resistance in a field 
population of T. circumcincta. As we were working with a commercial farm, 
offspring of adults exposed to IVM were collected pre- and post-IVM treatment as 
part of a FECRT. A reduced representation method was chosen to allow an 
increased number of individuals to be sequenced within budget limitations. This 
generated individual genotypes with which we were able to assess population 
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structure, estimate LD and analyse samples for genetically differentiated 
variants, which could be used as markers of IVM resistance.  
4.4.1 Pre- and post-IVM sample populations appear as a single 
population 
The ddRAD-Seq confirmed the presence of a largely homogeneous population 
present on a UK commercial farm, as was expected from previous microsatellite 
analysis of T. circumcincta UK populations (Grillo et al., 2007; Redman et al., 
2015). Kinship analysis allowed identification of potential contamination of one 
individual by another, or duplication, enabling removal of these two samples. 
The remaining individuals appeared to potentially have some population 
substructure, but were considered otherwise unrelated, and no distinct sub-
populations were identifiable. This indicates that offspring in the post-IVM 
sample were as individually diverse and with similar genome-wide nucleotide 
diversity as those in the pre-treatment sample. IVM selection pressures are 
therefore unlikely to occur over a large genomic region.  
The pre-treatment sample was likely, due to the study design, to include 
individuals resistant to IVM. If IVM resistance is a dominant trait (Le Jambre et 
al., 2000; Sutherland et al., 2002), heterozygous adults could survive IVM 
treatment, with sensitive alleles retained. Therefore, the post-IVM sample could 
include individuals susceptible to IVM as the L3 were not directly selected by 
IVM. This might dilute resistance associated alleles, reducing the ability to 
detect regions of IVM selection. However, the lack of a distinct subset of 
individuals post-IVM indicates that allele frequencies of genomic regions 
unrelated to IVM sensitivity are unlikely to significantly change following 
treatment, unless linked by genetic hitch-hiking. This aspect should enhance the 
ability to detect markers linked to IVM resistance. 
4.4.2 The sample size chosen was too small 
The post-IVM sample had more private alleles than the pre-treatment sample, 
suggesting that the sample size was too small, or that sub-sampling of the 
overall population had occurred. The F-statistic, FST, was chosen to measure the 
degree of genetic differentiation between samples, by the degree of allele 
fixation between sample populations. This is commonly used in GWAS but it is 
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beneficial to smooth the data, reducing noise (Beissinger et al., 2015). Although 
smoothing was attempted within this study, RADlocus SNPs were not always 
smoothed efficiently. This was because, while some regions had high SNP 
density, other windows included a single SNP. Individual SNPs can have high FST 
values, hence the output was biased towards low SNP density regions, with 
highly differentiated SNPs. Instead it was decided to use individual SNP FST 
values, in addition to RADlocus haplotype diversity measures of F’ST and DEST. 
The RADlocus on Tci2 contig 146, 587481, appeared of interest in all three 
statistical analyses. In addition, the allele frequency change of two SNPs with 
high FST values within the RADlocus, with one SNP changing from roughly equal 
allele proportions pre-treatment to 90:10 post-IVM, was suggestive of strong 
positive selection at the locus. Unfortunately, following assessment of fasta 
sequences for each individual in Geneious v9.1.8 it became apparent that 
diversity increased at this locus following IVM treatment. The apparent positive 
selection of the SNPs appeared to be by chance, as they were present on many 
different genetic backgrounds, with an increased number of haplotypes present 
post-IVM compared with pre-treatment. Although true selection may have 
occurred at this locus, with multiple haplotypes carrying the allele conferring 
IVM resistance, this could not be concluded from these results. This also 
indicated that the sample size needed to be larger to detect selection by IVM 
using ddRAD-Seq. 
4.4.3 Shared RADloci were far fewer than identified RADloci 
More than 3.3 M RADloci were identified by the gstacks module. Nevertheless, 
the number of informative RADloci retained comprised a tiny percentage – less 
than 0.5% of all 3.3 M RADloci. Shared RADloci covered less than 0.3% of the 
genome, and those with polymorphisms covered less than 0.1% of the genome. 
With even spacing of RADloci, one could expect to find an informative SNP every 
5.7 kb. This would suggest sampling of the genome frequently enough to easily 
detect selection as the average gene length in the PRJNA72569 genome is 6145 
bp (Choi et al., 2017). However, as the SNP density plots showed, SNPs are 
unevenly spread across the genome reducing the chance to detect narrow 
regions under selection. There are two main reasons for fewer shared RADloci 
compared to the total number of identified RADloci. Firstly, there may be 
differences in RADloci identified due to unequal amounts of DNA sequenced 
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between individuals. Secondly, different RADloci may be produced in different 
individuals during the digestion step. Possible causes of these two reasons will 
be discussed. 
4.4.3.1 Unequal amounts of DNA sequenced 
Individuals with a greater proportion of missing (shared) variant sites, had fewer 
reads aligned to the genome. This indicates that these individuals did not have 
fewer RADloci in common with others, which were sequenced to the same (or 
greater) depth, but rather were sequenced less overall.  
Variation in the production of sequencing libraries between individuals could 
have contributed to a loss of shared RADloci. Unequal quantities of DNA were 
almost certainly included in the pools for sequencing, potentially due to an issue 
with the Qubit whilst generating the libraries. This is suggested by the variation 
in total sequenced reads between individuals, which correlates, in part, to the 
WGA batch the samples originated from. As several hundred nanograms of DNA 
were present in each microlitre post-WGA, errors in quantifying and pipetting 
would be likely to have considerable impact. The high quality of the sequenced 
reads suggests that differences between individuals arose prior to the 
sequencing step (Maroso et al., 2018). However, during sequencing unequal 
contributions of DNA would have led to some RADloci being sequenced in all 
individuals, with other RADloci missing from some individuals. This would mean 
that fewer than 80% of the individuals within a population would contribute to 
many RADloci, and these RADloci would be removed. 
Differences in fragment size may also have biased selection of DNA quantity 
between individuals. For example, if some individuals had proportionally more 
DNA fragments that fell outside the 225-325 bp size range than others, then the 
fraction of their DNA in the pool could have been disproportionately reduced. 
This is unlikely to be a major factor as the population appears generally 
homogenous and therefore one would expect a similar size distribution in all 
individuals. 
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4.4.3.2 Different RADloci may have been produced between individuals  
Diversity between individuals may have both generated new RADloci and 
reduced shared RADloci. Over 50% of variant sites in each of the pre- and post-
IVM populations were considered to be out of HWE, largely due to an excess of 
homozygosity which is suggestive of allele loss. This phenomenon could have 
occurred due to positive selection by IVM, but due to the scale, is more likely 
related to polymorphisms in the restriction endonuclease cut-sites, leading to 
allele drop out (Miller et al., 2007). Although the variant site nucleotide 
diversity was comparatively high (0.22), the genome-wide nucleotide diversity 
was only 0.002, similar to the selfing model nematode C. elegans (Cutter, 2006). 
This was much lower than expected, and probably indicates a considerable loss 
of variable sites, rather than a realistic measure of T. circumcincta population 
nucleotide diversity. That RAD-Seq underestimates nucleotide diversity has been 
recognised before (Arnold et al., 2013), due primarily to polymorphisms within 
the restriction enzyme cut-sites causing allele loss (Cariou et al., 2016). Equally, 
RADloci likely to be shared between individuals within a diverse population are 
perhaps more likely to be selected from genomic regions of lower nucleotide 
diversity. 
Size selection of fragments using the Pippen Prep was efficient, based on the 
average insert size of reads aligned to the genome. Inefficient size selection is 
thus unlikely to have considerably reduced shared RADloci in this study (DaCosta 
and Sorenson, 2014), although it may have excluded some RADloci, or alleles, 
containing large structural indels within certain individuals.  
Other reasons for loss of RADloci may be due to bias during WGA or PCR 
amplification during the generation of sequencing libraries. The multiple 
displacement amplification reaction (WGA) using Phi29 polymerase is much more 
efficient than PCR techniques. Nevertheless, amplification bias of DNA regions 
still occurs although considerably reduced compared with PCR (Dean et al., 
2002). WGA bias could lead to a reduction in sequencing of some RADloci within 
an individual’s genome. This artefact is exacerbated with low amounts of input 
DNA, with some bias noted when 0.5 ng of human DNA was used in one study, 
but with considerably increased bias when DNA quantity was reduced to <0.1 ng 
(Dean et al., 2002). A single L3 has <1 ng of DNA, and only half of this was used 
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as input for WGA, therefore the risk of bias was a concern. The use of trehalose 
within the protocol should have partially reduced this bias (Pan et al., 2008), 
whilst simultaneously increasing DNA yield overall (Tsai et al., 2014) providing 
sufficient WGA DNA for ddRAD-Seq. As a crude measure of amplification 
uniformity, six core eukaryotic genes were chosen and PCR amplified pre- and 
post-WGA, as described in 2.5.1. Results indicated that each gene was 
successfully amplified in each individual subsequently used for ddRAD-Seq. 
Despite this, synteny between species may not be conserved, such that all six 
chromosomes may not be represented by these genes. In addition, relative 
amplification was only qualitatively assessed based on band brightness, and it is 
possible that some regions of the genome were better amplified in some 
individuals than others, leading to a loss of shared RADloci. 
Finally, it is also possible, due to the use of a fragmented, partially assembled 
genome, that haplotypic diversity within the Tci2 genome has not yet been 
resolved. If so, allelic reads of individuals could be falsely split across multiple 
RADloci. This is difficult to detect without gene annotations. However, it is 
another potential explanation for the high number of invariant RADloci, the 
large number of variant sites out of HWE and the low percentage of RADloci 
shared between individuals.  
The number of RADloci retained reduced considerably if they were required to 
have been sequenced in all individuals. Conversely, more RADloci were retained 
if fewer than 80% of individuals were required. Less than 0.03% of the 685 MB 
Tci2 genome was represented across all 75,517 RADloci, and less than 0.01% 
across those containing variant sites. Using the same sequenced data, it could be 
beneficial to sample a greater proportion of the genome, by allowing retained 
RADloci to be shared by fewer individuals. Relative differences in FST values are 
recognised when differing numbers of individuals are included in an analysis 
(Choi et al., 2017). If the number of individuals with shared RADloci was 
reduced, this would increase the variation in the number of individuals per 
RADlocus (e.g. some RADloci would have only 60% of individuals, others would be 
sequenced in all individuals). This would necessitate multiple separate analyses, 
which might not be directly comparable. Furthermore, given the diversity of the 
population and the low sample size to begin with, this did not seem appropriate. 
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Therefore, only RADloci present in 80% or more of individuals were examined in 
this study. 
4.4.4 Linkage disequilibrium decayed rapidly 
Identifying markers of IVM resistance requires either the marker to be causative, 
or to be consistently linked to a causative variant. LD was found to rapidly 
decay, such that the distance to the half maximal r2 value was always the 
minimum distance between variant sites tested. To try to obtain a more 
meaningful estimate, the distance to the mean intercontig LD was obtained. This 
was calculated to be only 2805 bp. To put this in context, the average gene size 
in the T. circumcincta PRJNA72569 genome was 6415 bp (Choi et al., 2017). 
When the SNP density per kb was extracted and plotted it was clear that RADloci 
retained were unevenly spread across the genome, with large regions with no 
variant sites within them. This could greatly reduce the chance of identifying 
markers of IVM resistance in such an outbred population, where the genomic 
footprint of a resistance locus might be small (Smith and Haigh, 1974). Recent 
work in H. contortus laboratory and field isolates has identified a large locus 
under IVM selection, in a region of low recombination (Redman et al., 2012; 
Rezansoff et al., 2016; Doyle et al., 2019; Sallé et al., 2019), which would be 
likely to be detected using a RAD-Seq approach. However, it would appear the 
architecture of resistance may differ in field populations of T. circumcincta. 
Alternatively the IVM locus may be in a highly fragmented region of the 
assembly, or was simply not sampled in this study.  
It is known that recombination rates and nucleotide diversity vary across a 
genome, and even along a chromosome (Doyle et al., 2018). This could allow 
some regions of low recombination, and high LD, to prove useful, even with low 
SNP density (McKinney et al., 2017). Furthermore, if IVM resistance had been 
recently selected within a population, which might have occurred on this farm 
based on the FECRT history, larger regions of low diversity and high LD might be 
present surrounding IVM resistance loci. This could allow the detection of IVM 
resistance markers even with low LD genome-wide (Catchen et al., 2017; Lowry 
et al., 2017). To determine whether any contigs with highly differentiated 
RADloci also had high LD, contigs containing RADloci with high FST variants were 
extracted. Despite the presence of SNPs of high FST, suggesting potential 
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selection pressure by IVM, LD decay appeared similar to genome-wide estimates. 
No association between mean contig FST and mean contig LD was present in the 
study data. Although interpretation of this result is limited by variation in contig 
lengths (longer contigs may have short regions of both high LD and high FST), and 
SNP density, it lends support to the theory that genetic footprints of IVM 
resistance are narrow, or that the genetic basis has arisen, or is currently 
located, on multiple genetic backgrounds. 
4.5 Conclusion  
Overall, this ddRAD approach was of limited value for the detection of IVM 
resistance loci in a UK field population of T. circumcincta. This was due to a lack 
of shared data between individuals and an insufficient SNP density across the 
genome to compensate for low LD. However, additional limitations were found 
in the use of the Stacks v2.0b program which, at the time of writing, has been 
updated nine times since it was used for this study. Nevertheless, from this 
analysis we were able to determine the need to sample more individuals to 
attain a better estimate of allele frequency within a population. We could also 
calculate the approximate LD and we obtained haplotypic sequencing data from 
a considerable number of individuals which could be useful later.  
As the T. circumcincta genome assembly improves, this analysis, using an 
updated version of Stacks, or similar software/pipelines, could be repeated and 
may provide improved outcomes. With a more assembled reference genome, 
ddRAD-Seq or similar techniques may become more useful. The large genome 
size still prevents WGS of individuals, particularly when high levels of genetic 
diversity necessitate large numbers of individuals for sufficient power. Instead, 
other options are available, including pooled sequencing of individuals, allowing 
both a larger sample size, and an increased fractional coverage of the genome, 
whilst maintaining comparatively low sequencing costs. Based on the results of 
this study, WGS with a larger sample size may be a more appropriate approach 
to study IVM resistance in this species.
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5 A tale of two farms: validation of a Pool-Seq 
technique to investigate IVM resistance in UK 
field populations 
5.1 Abstract 
The IVM locus associated with resistance may be small in UK field populations of 
Teladorsagia circumcincta. If IVM resistance is dominantly inherited, diversity 
of, or around the specific genes or variants under selection by IVM may still be 
comparatively high even following direct selection with IVM treatment. High 
individual diversity can complicate identification of suitable markers with small 
sample sizes. However, sequencing sufficient numbers of worms individually is 
expensive.  Using a whole genome re-sequencing approach, I sequenced pools of 
91 larvae obtained from adults treated with IVM, pre- and post-IVM treatment. 
Two geographically separated UK farms were used and were treated 
independently throughout the study. Despite diversity within the population, it 
was assumed that alleles conferring, or associated with IVM resistance would be 
enriched in the post-IVM samples. In contrast, neutral regions of the genome 
were likely to be similar between pre- and post-IVM sample populations. 
Population genetics analysis identified multiple regions of the genome to be 
potentially under selection by IVM. To identify whether a common genetic basis 
between farms exists, I included two UK farms in this genome wide association 
study. Genetically differentiated regions were predominantly specific to each 
individual farm; however, sixteen 10 kb windows were identified to be 
potentially under IVM selection on both farms. No single large locus was 
identified to be under IVM selection.  
5.2 Introduction 
Whole genome re-sequencing (WGS) of pooled individuals (Pool-Seq) can provide 
a highly cost-effective approach for population genomic analysis. Pool-Seq has 
been used to detect population substructure (Phair et al., 2019), changes in 
populations over time (Phillips et al., 2016), somatic variants in cancer studies 
(Ding et al., 2012) and in genome wide association studies (GWAS), linking a 
variant to a phenotype of interest (Ehrenreich et al., 2010). When sequencing 
individuals separately, many sequencing reads used to determine a genotype at 
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a genomic site are surplus to requirements. This reduces the cost-benefit of the 
sequencing performed. In contrast, using Pool-Seq, most individuals within the 
pool are usually sequenced less than once, such that each read contributes to 
the overall estimation of allele frequency (Futschik and Schlotterer, 2010). For 
example, using a model for diploid individuals, Gautier et al. (2013a) found that 
for half the sequencing cost, twice the number of individuals could be pooled 
providing a more accurate estimation of the population allele frequency 
compared with sequencing individuals separately.  
WGS also allows for much wider sequencing coverage of the genome than 
reduced representation library methods (e.g. ddRAD-Seq, exome sequencing, 
RNA-Seq). This provides several benefits, including: the increased ability to 
identify small footprints of genetic selection, to obtain a more accurate 
estimate of the nucleotide diversity, to identify the presence of indels and 
transposable elements and to include low complexity regions within the 
sequenced results. In an outbred population, with high nucleotide diversity and 
rapid decay of LD, as was found in this study, WGS can therefore provide many 
benefits over reduced representation methods for a GWAS. For example, Barnes 
et al. (2017) were able to confirm a hard sweep around the CYP6P9a gene, in 
populations of Anopheles funestus using Pool-Seq. This corresponded to intense 
use of pyrethroids since 2002, such that the 2002 and 2014 samples displayed 
high genetic differentiation at this locus. Cheeseman et al. (2015) used Pool-Seq 
to confirm the presence of a soft sweep in Plasmodium falciparum. Multiple 
haplotypes were selected around the kelch gene, associated with artemisinin 
resistance in this species. Although the authors were able to detect the locus, 
using FST, various other neighbouring loci had higher FST values – a factor which 
may be important in the present study. In contrast, using microsatellites, 
Redman et al. (2012) identified that the marker, Hc_8a20, was linked with H. 
contortus IVM resistance phenotypes, but were unable, particularly with an 
incomplete genome assembly, to identify which genes were associated with IVM 
resistance. More recently, using WGS, a region containing many genes on 
Chromosome V has since been identified (Doyle et al., 2019). 
The benefit of Pool-Seq to determine genome-wide nucleotide diversity allows 
for calculation of Tajima’s Pi and Tajima’s D for each site or region (Kofler et 
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al., 2011b). These statistics provide a measure of diversity for a population, 
which can provide evidence of fixation of alleles due to a reduction in diversity 
over that region (Tajima, 1989). This measure can therefore be useful to confirm 
regions under selection (Doyle et al., 2019), or to identify regions of fixation. 
As found in the ddRAD-Seq experiment, the use of a selective reduced 
representation technique was not the best option for the highly polymorphic T. 
circumcincta field population. Rapid decay of LD also reduced the ability to 
detect regions of selection across the genomes within the population. It was 
decided to perform WGS to sequence the entire genome, using a larger sample 
to improve the accuracy of the population allele frequencies obtained. To 
perform WGS of individuals was prohibitively expensive. Instead, Pool-Seq would 
enable an increased sample size, with a better allele frequency determination 
for the same budget. In addition, the amount of DNA required for Pool-Seq is less 
than for ddRAD-Seq. This allows gDNA of pooled L3 to be used directly, without 
the need for whole genome amplification, reducing library preparation costs. In 
addition, by requiring fewer library preparation steps prior to pooling of 
individuals, variation between individuals within and between pools is likely to 
be reduced. If IVM resistance is dominant as suggested in adult T. circumcincta 
(Sutherland et al., 2002) and in H. contortus (Le Jambre et al., 2000), or 
partially dominant as suggested in L3 of T. circumcincta (Sutherland et al., 
2003b), then survival of heterozygous adults may occur following IVM treatment. 
Offspring used in this study could therefore contain heterozygous or homozygous 
susceptible individuals. These haplotypes and genotypes could dilute signals of 
IVM selection, although the region under selection should still be visible. If, 
however, SNPs or haplotypes related to IVM resistance reach fixation, the 
selection of the farm population used will be critical. Regions of fixation within 
a population can have very low minor allele frequencies, which also produce low 
FST values and makes identifying such regions difficult as, both before and after 
treatment, most individuals will be homozygous for the variant.  
Pooled sequencing can be performed using barcodes to identify and separate 
individuals or groups post-sequencing, potentially providing additional useful 
data (Wong et al., 2013), however this can rapidly increase library preparation 
and labour costs. Alternatively, sequencing can be performed as a mixed pool 
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(Pool-Seq), with no ability to separate and identify individual DNA sequences 
post-sequencing, which is considerably cheaper, but brings with it specific 
concerns as to unknown bias within the data, which cannot always be accounted 
for (Futschik and Schlotterer, 2010; Gautier et al., 2013a). A primary concern for 
many researchers is that of biased allele frequencies, both in terms of actual 
allele frequencies within the sample, and in degrees of variation between 
samples. Bias could occur following pooling of unequal amounts of input DNA 
from individuals within the pool (Zhu et al., 2012), or variation in sequencing 
coverage between individuals at a locus (Anderson et al., 2014). PCR 
duplication, if PCR was used in library preparation, can bias allele frequencies 
and estimates of the effective population size (Futschik and Schlotterer, 2010). 
Other, more generic sequencing errors, which affect both individual and pooled 
approaches, include either dependent (repeatedly the same nucleotide 
substituted, e.g. A, A, A instead of T), or independent (different nucleotides 
substituted, e.g. A, G, C instead of T) errors which can confound SNP calling, 
particularly in pooled samples if the minor allele read count is low (Futschik and 
Schlotterer, 2010). 
The power of a sequencing study is its ability to successfully detect true positive 
variants (low Type II error). In other words, a highly powerful study has a low 
chance of accepting the null hypothesis of no difference when it should, in fact, 
be rejected. When sequencing individuals, raising the coverage provided can 
allow an increase in power to detect true SNPs and also determine false 
positives, especially if errors are independent, although this is less effective for 
dependent errors (Futschik and Schlotterer, 2010). Various simulations and real-
life experiments have determined that Pool-Seq can easily detect such variants, 
as well as selective sweeps, often at coverage considerably lower than that 
required for individuals. For example, Boitard et al. (2012) suggest, from 
simulations, that coverage of 0.5x per chromosome is sufficient to determine the 
allele frequency spectrum in a pool of 200 chromosomes. They were able to 
detect known regions of selection along the X-chromosome using pools of 
Drosophila melanogaster, sequenced at approximately 1x per individual (Boitard 
et al., 2012). Several guidelines are important to follow however: firstly, to 
ensure that sufficient individuals are sequenced within the pool, with each 
individual contributing equal amounts of DNA (Zhu et al., 2012; Gautier et al., 
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2013a; Anderson et al., 2014; Rode et al., 2018). Minimum cut-offs for the minor 
allele count should reflect the expected sequencing error and coverage depth 
(Kofler et al., 2011a). The library preparation technique appears less important 
than the coverage (Kofler et al., 2016b). Increasing coverage of pools containing 
554 to 736 Drosophila from 30 to 50x, improved estimates of allele frequencies 
within a population, with differences in allele frequency estimation reduced by 
27% (a difference in frequency estimate of 0.016) (Kofler et al., 2016b). Despite 
this, the degree of variation in coverage across a genome was not found to 
greatly affect results, providing the model used accounted for this (Boitard et 
al., 2012). Lastly, using technical replicates can greatly improve confidence in 
results (Robasky et al., 2014).  
Again using progeny of adults treated with IVM as part of a faecal egg count 
reduction test (FECRT), I used Pool-Seq to identify regions of the genome 
potentially under selection by IVM. In addition to Farm 2 (also used for ddRAD-
Seq) I also selected an additional UK farm (Farm 3) for the Pool-Seq study. Farm 
2 and Farm 3 were geographically separate populations. They had different IVM 
FECR T. circumcincta percentages (comparatively high efficacy on Farm 2, low 
efficacy on Farm 3). Each farm was analysed separately - identifying regions of 
genetic differentiation between the pre- and post-treatment populations. 
Following within farm analysis, results of loci potentially under selection by IVM 
on each farm were also compared based on the hypothesis of a common locus 
conferring IVM resistance. Results describe the validation and outcome of this 
technique on these two farms.   
5.3 Results 
5.3.1 Farms used and FECRT data 
Two UK farms were chosen for the analysis, referred to here as Farms 2 and 3. 
Farm 2 has been previously described in 4.3.1 and a summary of the FECRT is 
repeated in Table 5.1 for comparison with Farm 3.  
Farm 3 is in southeast Scotland and in July 2015 a FECRT was performed by 
colleagues at the Moredun Research Institute (MRI). Anthelmintic efficacies were 
-34.4%, 96.0% and 22.4% for BZ, LEV and IVM respectively (Table 5.2). Pre-
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treatment egg counts were 135.8 epg and 181.0 epg for BZ and IVM treatment 
groups respectively. All L3 strongyles provided by the MRI and speciated by PCR 
pre- and post-IVM were T. circumcincta, and all but one post-BZ L3 were also T. 
circumcincta. A further two groups of lambs were used to test the combined 
efficacy of co-administering BZ and IVM, and LEV and IVM. These demonstrated 
improved anthelmintic efficacies compared with BZ or IVM given as a single 
active alone, reducing egg output by 54.5% and 89.1% respectively (Morrison, 
pers comm, Table 5.2). 
Table 5.1: Faecal egg count reduction test results on Farm 2, 2013 and 2016.  
Anthelmintic FECRT 2013 
(%) 
FECRT 2016 
(%) 
FECRT 2016 efficacy against 
Teladorsagia circumcincta (%) 
BZ 83.7% 87.7% ND 
LEV 92.5% 95.4% ND 
IVM 93.0% 87.4% 81.9% 
MOX ND 98.6% ND 
Overall percentage reduction in strongyle egg output following anthelmintic treatment is 
shown, with the proportional reduction percentage of Teladorsagia circumcincta indicated 
for those samples where L3 larvae were speciated by PCR of the ITS2 region. ND = Not 
done. 
Table 5.2: FECRT results on Farm 3, 2015.  
Anthelmintic FECRT 2015 (%) FECRT 2015 efficacy against Teladorsagia 
circumcincta (%) 
BZ -34.4% -32.5% 
LEV 96.0% ND 
IVM 22.4% 22.4% 
BZ and IVM 54.5% ND 
LEV and IVM 89.1% ND 
Overall percentage reduction in strongyle egg output following anthelmintic treatment is 
shown, with the proportional reduction percentage of Teladorsagia circumcincta indicated 
for those samples where L3 larvae were speciated by PCR of the ITS2 region. ND = Not 
done. 
5.3.2 A smaller percentage of reads aligned post-treatment 
compared with pre-treatment 
Read quality was good, with an average Phred score of greater than 38 for the 
first read of each pair and an average score of greater than 30 (99.9% chance 
that the base called is correct), for the second read in each pair. Post-IVM 
samples on Farm 3 appeared to have a subset of reads with higher GC content 
compared with other samples (see arrows, Figure 5.1). This may have been due 
to bacterial contamination, with a higher GC content (Barbu et al., 1956). 
201 
 
Chapter 5 
Results of a Kraken report (Wood and Salzberg, 2014) produced by the WSI 
suggested approximately 10% of reads were proteobacteria for each sample 
sequenced. However, these results did not provide evidence of species or 
abundance differences in the post-IVM samples on Farm 3 to explain the GC 
results. Average GC content varied between 47 and 49% (Table 5.3), similar to 
that expected for T. circumcincta (Choi et al., 2017). Read duplication was 
reasonable with, at most, 14.5% of reads duplicated. 
 
Figure 5.1: Pool-Seq read GC content distribution. Plotted by MultiQC (Ewels et al., 2016),  
orange lines indicate the GC percentage content distribution as a percentage of all reads 
sequenced for a sample. Each sample has two lines, due to paired-end sequencing. Blue 
arrows indicate the Farm 3 post-IVM samples. 
Between 60.6 and 70.1% of reads aligned to the genome (Table 5.3), with fewer 
reads mapping in their pair to the genome (48.5 to 56.4%). The majority of reads 
which were mapped, but not properly paired, were included in the number of 
reads with a mate mapping, with good quality score, to a different scaffold, 
which reflected the fragmented nature of the reference genome. As for ddRAD-
Seq a lower percentage of reads in the post-IVM samples mapped to the genome 
compared with the pre-IVM samples. 
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Table 5.3: Summary of Pool-Seq alignment.  
Sample Name Reads 
Mapped (M) 
Reads 
Mapped (%) 
Reads 
‘properly 
paired’ in 
mapping1 (%) 
Pre-
alignment 
mean GC 
content (%) 
Farm 2 Pre-
treatment 
451.8 M 70.1% 56.4% 47% 
Farm 2 Post-IVM  437.4 M 66.0% 52.6% 47% 
Farm 3 Pre-IVM 
replicate A 
470.9 M 68.4% 54.5% 47% 
Farm 3 Pre-IVM 
replicate B 
460.3 M 68.7% 54.8% 47% 
Farm 3 Post-IVM 
replicate A 
418.3 M 60.6% 48.5% 49% 
Farm 3 Post-IVM 
replicate B 
422.9 M 61.6% 49.4% 49% 
Reads aligned to the reference genome for each Pool-Seq sample are shown. 1Reads which 
are ‘properly paired’ are those which have been mapped in their pair, rather than with the 
pair split over a considerable distance, or to a separate contig.  
In total, between 17.7 and 17.8% of the total number of aligned reads had a 
MAPQ=0 for each sample. The mapping error rate output by SAMtools stats was 
similar across all samples ranging from 2.94E-02 to 2.99E-02 (Li et al., 2009).  
5.3.3 Coverage varies between pre- and post-treatment samples 
The average mapped coverage across the genome as a whole, 
((number of reads x 75 bp read length)/genome length), 
varied from 45.7x to 51.5x (Table 5.4). The coverage frequency calculated by 
SAMtools v1.3 stats, revealed that pre-treatment samples tended to have a 
greater number of sites with higher coverage depths of 60x or more compared 
with post-treatment samples, which had a greater proportion of sites with 
coverage depth <40x (Figure 5.2). This reflected the total number of reads 
aligned to the reference genome, with more reads aligned per pre-treatment 
sample than post-treatment sample (Table 5.4). Most genomic sites had a 
coverage of 100x or less. Bedtools v2.17.0 multicov (Quinlan and Hall, 2010; 
Quinlan, 2014) was used to calculate the coverage in distinct windows across the 
genome, equivalent to the average gene size in the PRJNA72569 T. circumcincta 
genome (Choi et al., 2017). Each sample had extremely similar patterns of 
coverage across the genome. Data from the Farm 2 pre-treatment sample is 
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provided as an example, highlighting the variability in coverage along the 
genome (Figure 5.3). The mean mapped depth per site, as calculated by 
SAMtools v1.3 depth, filtering for mean BQ of >20 was lower than the average 
coverage per site calculated, ranging from 35.5x to 39.2x (Table 5.4).  
Table 5.4: Pool-Seq genome-wide mapped coverage per sample.  
Sample Name Reads mapped (M) Mapped coverage 
across the genome 
as a whole (685.9 
Mb genome)1 
Mean mapped 
depth per site2   
Farm 2 Pre-
treatment 
451.8 M 49.4x 39.2x 
Farm 2 Post-IVM  437.4 M 47.8x 36.3x 
Farm 3 Pre-IVM 
replicate A 
470.9 M 51.5x 38.9x 
Farm 3 Pre-IVM 
replicate B 
460.3 M 50.3x 37.5x 
Farm 3 Post-IVM 
replicate A 
418.3 M 45.7x 35.5x 
Farm 3 Post-IVM 
replicate B 
422.9 M 46.2x 35.7x 
1The coverage was calculated by the following equation: ((N reads in millions*75)/685.9). 
2Note the depth per site was calculated by SAMtools, and awk was used to extract the mean 
depth per site for each sample.   
 
Figure 5.2: Coverage depth site frequency. All genomic sites were binned by coverage 
depth, using bins of coverage range ten, i.e. the first bin has sites with coverage depth 1-10, 
the next 11-20 etc. Pre-treatment samples are coloured lighter (and to the left) than post-
treatment samples (to the right). Only bins of up to 150x coverage depth are shown. 
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Figure 5.3: Read count in 6145 bp windows along the genome. Data plotted are for Farm 2 
pre-treatment. A. All windows are plotted sequentially, from contig 1 on the left, to contig 
8025 on the right, which is roughly in contig size order from longest to shortest. B. Enlarged 
plot of the first 2500 windows, showing only those with read count up to 50,000.   
5.3.4 Sample pools are diverse, with some evidence of selection 
by IVM 
Biallelic SNPs were used to assess sample relatedness. Pearson correlation 
coefficients were calculated for the major allele frequencies at each SNP, and 
samples were found to be diverse. Although technical replicates were slightly 
more similar to one another (r = 0.73), correlation between samples varied 
between 0.67 and 0.69 (Figure 5.4). There did not appear to be any grouping of 
samples by farm or by treatment time point.  
A 
B 
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Figure 5.4: Pearson correlation coefficients of genome-wide allele frequencies. Biallelic 
SNPs were used to calculate correlations between samples. A heatmap is shown, with 
positive correlations in red, and the correlation coefficient given for each pairwise 
comparison. 
Tajima’s Pi (the nucleotide diversity, (π)) was calculated for each sample using 
PoPoolation v1.2.2 (Tajima, 1989; Kofler et al., 2011a) using distinct 10 kb 
windows. Tajima’s Pi is a measure of the number of pairwise differences 
between sequences. The greater the number of pairwise differences, the higher 
the value of Pi. However, Tajima’s Pi has a tendency to underestimate the 
presence of rare mutations, and will be influenced by the alignment of reads to 
the reference genome. Genome-wide Tajima’s Pi was similar across all sample 
populations, averaging 0.024 for each sample tested (0.01 standard deviation). 
This would suggest a 2.4% chance of a mutation at any given site within the pool 
of individuals. Median values of nucleotide diversity were almost the same as the 
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mean values for each sample. Samples were directly compared using a Wilcoxon 
rank sum test in R v3.1.2, with continuity correction. No significant differences 
in genome-wide nucleotide diversity were identified between samples (Figure 
5.5), or by treatment status (Figure 5.6).  
 
Figure 5.5: Tajima's Pi by sample. A boxplot of the genome-wide Tajima’s Pi values is 
shown. 
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Figure 5.6: Tajima's Pi by treatment time point. A boxplot of the genome-wide Tajima’s Pi 
values is shown. Samples are grouped by treatment time point. 
Tajima’s D is a measure estimating the difference between the number of total 
segregating sites and the number of pairwise differences between DNA 
sequences (Tajima, 1989). Directly following a selection event, dependent on 
the severity of such an event, there may be very few rare alleles and Tajima’s D 
may be positive. Over time, as new mutations occur, rare alleles will increase 
and Tajima’s D will become negative. As the population breeds, alleles will be 
redistributed becoming more common, and Tajima’s D values will return towards 
zero.  
For each sample population, PoPoolation v1.2.2 was used to calculate Tajima’s D 
using distinct 10 kb windows along the genome. The mean value for all samples 
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was close to -0.7, with the median value for each slightly more positive, ranging 
from -0.62 to -0.67 (Figure 5.7). Tajima’s D varied considerably across the 
genome for each sample (Figure 5.9 and Figure 5.10). Interestingly, all post-IVM 
samples were slightly, but significantly, less negative compared to the pre-
treatment samples (p<<0.001, Wilcoxon sum rank test, Figure 5.7 and Figure 
5.8), suggesting fewer rare alleles within these samples. Most regions had 
Tajima’s D values of between 0 and -1, indicating that any selection pressure on 
the populations has not occurred genome-wide, as usually only values of greater 
or less than 2 and -2 would be considered to suggest significant deviation 
(Tajima, 1989). Although several regions had values between -2 and -3 (Figure 
5.9 and Figure 5.10), these were difficult to assess visually. They may represent 
just one or two fragmented loci, or many separate loci. Moderately negative 
regions tended to be the same between technical replicates (Figure 5.10, A & 
B), although some differences were apparent, particularly on shorter contigs. If 
highly negative regions were the same in both pre- and post-treatment samples 
(highlighted in colour, Figure 5.9 and Figure 5.10), post-IVM samples were less 
negative than pre-treatment samples. One region stood out on Farm 2 as having 
a greater number of highly negative post-IVM windows, with few pre-IVM 
windows in the same region (near positional index 25,000). However, there were 
still a few windows in this region with highly negative values in the pre-
treatment sample, and due to the scale it is difficult to confirm whether these 
points represent a single region, or many. A similarly positioned window was also 
present on Farm 3 but was more negative in the pre-IVM samples than the post-
IVM samples. 
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Figure 5.7: Tajima's D by samples. A boxplot of the genome-wide Tajima’s D values is 
shown. Samples were compared using a Wilcoxon sum rank test in R as shown. The 
medians of all pairwise comparisons indicated (***) were significantly different p<<0.001. 
 
*** 
*** 
*** 
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Figure 5.8: Tajima's D by treatment time point. A boxplot of the genome-wide Tajima’s D 
values is shown. Samples are grouped by treatment time point. The medians are 
significantly different (p<<0.001). 
  
*** 
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Figure 5.9: Farm 2 genome-wide Tajima's D. Each point represents one 10 kb window. The 
1000 most negative windows are coloured. Key to colours: Pre-treatment = blue, Post-IVM = 
red. 
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Figure 5.10: Farm 3 genome-wide Tajima's D. Each point represents one 10 kb window. The 
1000 most negative windows are coloured. A. Farm 3 Pre-IVM replicates, B. Farm 3 Post-IVM 
replicates. For A and B, replicates are distinguished by colour. C. Farm 3 all samples (Pre-
IVM = blue, Post-IVM = red). 
A B 
C
A
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5.3.5 Identification of differentiated genomic regions between pre- 
and post-treatment samples 
Regions of genetic differentiation between the pre- and post-IVM treatment 
sample populations were identified using a fixation index measure: FST (Hartl and 
Clark, 2007; Kofler et al., 2011b). Parameters used to calculate pairwise FST 
values are detailed in the methods (section 2.9.4). FST is a measure of how fixed 
an allele is between samples within a population (Bird et al., 2011). As seen in 
Chapter 4, individual SNP FST values can often be quite high, but without any 
selection at the surrounding locus. The ddRAD-Seq data were too sparse to allow 
effective smoothing of the data, but Pool-Seq increased the coverage across the 
genome enabling confident smoothing of SNPs using distinct 10 kb windows to 
account for diversity and overinflated SNP FST values. Initially window sizes of 
100 kb, 50 kb and 10 kb were tested (Figure 5.11 and Figure 5.12). As the 
window size reduced, more of the genome had potential to be included in the 
analysis (87.7 to 99.3%). Requiring complete coverage of a window returned no 
data, as all windows were excluded. The number of windows included in the 
analysis was greater for a window fractional coverage of 0.1 than 0.5, 
potentially due to variable coverage across a contig, either in absence of reads 
aligning, or in their depth. In addition, this reflects the number of contigs with 
total length less than 5 kb. The final window size of 10 kb, and the minimum 
window fractional coverage of 0.1 (i.e. 1000 bp), were chosen to maximise the 
number of contigs included in the analysis, whilst still permitting some 
smoothing of the data to account for diversity. 
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Figure 5.11: Farm 2 Manhattan plots comparing different distinct window sizes and 
fractional coverages. All compare the pre-treatment sample with the post-ivermectin 
sample. A, C and E are 0.5 fractional coverage; B, D and F are 0.1 fractional coverage. A and 
B are 100 kb windows, C and D are 50 kb windows and E and F are 10 kb windows. Windows 
are plotted along the x-axis in order from the start of contig 1 to the end of the last contig 
for which values were calculated; contig 1 is the longest contig, and with some exceptions, 
contigs generally reduce in size from left to right.  
 
A B 
C D 
E F 
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Figure 5.12: Farm 3 Manhattan plots comparing different distinct window sizes and 
fractional coverages. All compare the pre-ivermectin sample with the post-ivermectin 
sample. A, C and E are 0.5 fractional coverage; B, D and F are 0.1 fractional coverage. The 
average FST value across all four replicate pre-post pairwise comparisons is plotted. A and 
B are 100 kb windows, C and D are 50 kb windows and E and F are 10 kb windows. Windows 
are plotted along the x-axis in order from the start of contig 1 to the end of the last contig 
for which values were calculated; contig 1 is the longest contig, and with some exceptions, 
contigs generally reduce in size from left to right.  
Following FST analysis of the full dataset, using the MAPQ ≥ 20 and BQ ≥ 30 
filters, the results showed similar median FST values for each of the farm pre- to 
post-IVM pairwise comparisons, both using distinct 10 kb windows along the 
genome (Figure 5.13), and for individual SNP values (Figure 5.14). The mean and 
median values were lower for the SNPs than for the 10 kb window data. 
However, maximal values were considerably higher for SNPs than for the 
smoothed 10 kb windows. Values calculated for the Farm 3 post-IVM replicate A 
A B 
C D 
E F 
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vs post-IVM replicate B pairwise comparison were lower than for the pre- to 
post-IVM comparisons, as expected.  
 
Figure 5.13: 10 kb window FST pairwise comparisons. All pairwise comparisons performed 
are shown. The thresholds used for filtering differentiated regions are indicated. For all pre- 
to post-treatment comparisons (Farm 2 samples and Farm 3 replicate samples), the dot-
dash line indicates the threshold above which windows were retained for further 
investigation. For each comparison this was very similar, and so just one line, at 0.06, is 
shown. The Farm 3:Post-Post technical replicate comparison had a lower threshold (0.05), 
indicated by the dotted line. Regions present as outliers in the Farm 3:Post-Post technical 
replicate comparison were excluded from further Farm 3 analyses as potential false 
positives.  
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Figure 5.14: SNP FST pairwise comparisons. All pairwise comparisons performed are shown. 
The thresholds used for filtering genetically differentiated SNPs are indicated. For all pre- to 
post-treatment comparisons, the dot-dash line indicates the threshold above which SNPs 
were retained for further investigation. For each comparison this was very similar, and so 
just one line, at 0.12, is shown. The Farm 3:Post-Post technical replicate comparison had a 
lower threshold (0.10), indicated by the dotted line. SNPs present as outliers in the Farm 
3:Post-Post technical replicate comparison were excluded from further Farm 3 analyses as 
potential false positives. 
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For each pairwise comparison a threshold was calculated, equivalent to an FST 
value of three standard deviations greater than the mean FST for that comparison 
(Table 5.5). SNPs and windows greater than the threshold were retained for 
further investigation. The presence of diversity within the population produces 
noise within the data and so for Farm 3, data were further filtered using the 
technical replicates as described in 2.9.4 (Robasky et al., 2014). Manhattan plots 
appeared similar for the pre- to post-IVM replicate comparisons on each farm 
(Figure 5.15). Outlier regions were distributed across the genome, and no single 
large locus under IVM selection was evident. There was no obvious difference in 
the 10 kb outlier FST values between farms (Figure 5.15).   
Table 5.5: Pool-Seq FST thresholds.  
 10 kb window FST Threshold SNP FST Threshold 
Farm 2 pre-treatment vs 
post-IVM treatment 
0.059770 0.116409 
Farm 3 pre-IVM rep A vs 
post-IVM rep A 
0.059739 0.117296 
Farm 3 pre-IVM rep A vs 
post-IVM rep B 
0.059374 0.116733 
Farm 3 pre-IVM rep B vs 
post-IVM rep A 
0.060321 0.118530 
Farm 3 pre-IVM rep B vs 
post-IVM rep B 
0.060064 0.118046 
Farm 3 post-IVM rep A vs 
post-IVM rep B 
0.050054 0.102495 
For each pairwise comparison between pre- and post-treatment samples the threshold FST 
value, used to filter data to retain only the most highly differentiated regions and SNPs is 
shown. The threshold was calculated as three standard deviations above the mean FST value 
for that comparison. 
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Figure 5.15: Manhattan plots of Farm 2 and Farm 3 Pool-Seq data A. Farm 2; pre-treatment 
compared with post-IVM sample. B. Farm 3; pre-IVM replicate B vs post-IVM replicate B 
pairwise comparisons are plotted. For each dataset the threshold used for filtering regions 
of interest is shown by a black line. Threshold is three standard deviations above the mean 
FST value.  
A. Farm 2 
B. Farm 3 
220 
 
Chapter 5 
Regions of selection were difficult to visually determine using the Manhattan 
plots due, in part, to the large, fragmented and unordered genome assembly. 
Values calculated for each farm were plotted against each other to compare 
data between farms (Figure 5.16). When plotting each of the Farm 3 technical 
replicate comparisons against the Farm 2 data, it was evident that there were 
differences as to which windows were genetically differentiated on both farms. 
Also, differences were present between technical replicate comparisons. For 
clarity, just one technical replicate comparison is plotted in Figure 5.16, 
however points are coloured according to whether the FST value was considered 
high in all four technical replicate comparisons for Farm 3 or was only high in 
some. From this point forward, for Farm 3 analyses, only those windows 
considered of note in all four pre-post pairwise comparisons, and below the 
Farm 3:Post-Post technical replicate comparison threshold will be considered.  
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Figure 5.16: Farm 2 vs Farm 3 10 kb window FST values. The Farm 3 pre-IVM replicate B vs post-IVM replicate B comparison is plotted. Each point is a 10 kb 
window. The threshold for each farm is indicated. Tci2 contig IDs are given. (B. is enlarged detail of A.) Key to colours: Purple = Window genetically 
differentiated on Farm 2 and in all Farm 3 replicate comparisons (but not in the Farm 3:Post-Post replicate comparison), Red = Window genetically 
differentiated on Farm 2 and in the plotted Farm 3 replicate comparison, Yellow =  Window genetically differentiated on Farm 2 only, Blue = Window 
genetically differentiated in all Farm 3 replicate comparisons (but not in the Farm 3:Post-Post replicate comparison), Green = Window genetically 
differentiated in the plotted Farm 3 replicate comparison.  
A B 
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In total, sixteen 10 kb windows had values greater than the FST thresholds for 
both Farm 2 and Farm 3 (Table 5.6, Appendix 5). Most of these windows were on 
separate contigs, however three were on contig 2028, spanning a region from 50 
to 90 kbp (50-60 kbp, 70-90 kbp). The number of windows expected to be 
differentiated on both farms by chance was one (p<<0.001).  
Considering Farm 2 alone, a total of 576 10 kb windows were above the FST 
threshold, identified across 435 contigs (Table 5.6, Appendix 6). Several of these 
windows were adjacent to one another. Although no single large genetically 
differentiated region was apparent, contig 118 had 11 windows with raised FST 
values, with the longest consecutive region measuring 30 kb in length. The 
widest region overall was found on contig 422, measuring 40 kb, with a 
neighbouring differentiated region of 20 kb (separated by just 10 kb). All 
windows were ranked by decreasing FST value, and two of these 10 kb windows 
on contig 422 were within the top ten (Appendix 6).  
A total of 91 10 kb windows were retained following filtering of Farm 3 data 
(Table 5.6, Appendix 7). These windows were distributed across 76 contigs. 
Again, several of these windows were adjacent to each other. However, in 
comparison to Farm 2, the maximum number of windows identified on a single 
contig was four (contig 129), and these were distributed such that the longest 
consecutive region was 20 kb in length, although a third window was identified 
10 kb distant from this, suggesting that the overall region of selection might be 
40 kb (Appendix 7).  
The total number of SNPs retained with FST values higher than the threshold was 
considerably greater for Farm 2 (636,541) than Farm 3 (24,052, Table 5.6). Only 
1901 SNPs were genetically differentiated in both farm datasets. A Fisher’s Exact 
Test of the allele frequency difference between the pre- and post-treatment 
populations was performed using PoPoolation2 v1.201. Filtering SNPs to retain 
only those with a significant difference (p<0.05), retained over a million SNPs on 
Farm 2, but only 52,426 SNPs on Farm 3. When filtering SNPs using both FST 
values and allele frequency differences just 4.08% and 0.05% of all of those SNPs 
retained by FST alone were kept for Farm 2 and Farm 3 respectively. Excluding 
all SNPs not within a 10 kb window of high FST value further reduced this number 
(Table 5.6). It also changed the relative proportion of SNPs retained on each 
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farm, with 0.11% of SNPs of high FST value retained in the Farm 2 dataset, and 
0.01% retained in the Farm 3 dataset. No SNPs were identified which had both a 
high FST value and a significant allele frequency difference in the sixteen 10 kb 
windows identified on both farms (Table 5.6). In addition to the FST analysis, a 
Cochran-Mantel-Haenszel test was performed (Kofler et al., 2011b; McDonald, 
2014). Only a single SNP (on contig 331) was identified with a consistent allele 
frequency difference between both farms (p<0.0001). This SNP was not found 
within a 10 kb window of interest.     
Table 5.6: Counts of genomic regions and SNPs identified as being of interest on each of 
Farms 2 and 3.  
  Farm 2 Farm 3 Both 
farms 
Total No. of 10 kb windows above the FST 
threshold (Tci2 contigs) 
576 (435) 91 (76) 16 (14) 
Total No. of SNPs above the FST threshold 636,541 24,052 1901 
Total No. of SNPs with significant allele 
frequency difference 
1,131,099 52,426 3298 
Total No. of SNPs with both a high FST and a 
significant allele frequency difference 
26,002 11 1 
Total No. of SNPs with both a high FST and a 
significant allele frequency difference found 
within the high FST 10 kb windows 
676 2 0 
Thresholds used were three standard deviations above the mean value of the pairwise 
comparison and are detailed in Table 5.5. 
5.3.6 Comparison with ddRAD-Seq results 
Contigs containing ddRAD-Seq SNPs identified in the previous experiment 
(Chapter 4), were compared to the contigs containing genetically differentiated 
10 kb regions in the Pool-Seq experiment (Appendix 8 and 9). For both 
experiments, regions or SNPs compared were those with FST values of greater 
than three standard deviations above the mean FST. In total, 131 contigs were 
identified as potentially under selection by IVM on Farm 2 in both experiments. 
However, when comparing the ddRAD-Seq Farm 2 data with the Pool-Seq Farm 3 
data, just 21 contigs appeared under selection. Just one RADlocus in the Farm 2 
data was found within a Pool-Seq window. No RADloci were identified within 
Pool-Seq windows on Farm 3.  
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Of those manually annotated in 4.3.10, very few were also identified in the Pool-
Seq experiment. On Farm 2 four contigs which had been annotated previously 
were identified by Pool-Seq. These were contigs 77, 86, 163 and 827. 
Comparison of the relative distance between the RADlocus, and the Pool-Seq 10 
kb window revealed that all four contigs had 80 kb or greater distance between 
the SNP and the Pool-Seq region. Thus, the manual annotation of the contigs, 
extending only approximately 75 kb distant from a RADlocus would not have 
identified genes within the Pool-Seq regions. Contig 163 was the only manually 
annotated contig identified in both experiments for Farm 3. The Pool-Seq 
window identified on contig 163 in the Farm 3 data was the same as in the Farm 
2 data, and was approximately 80 kb distant from the RADlocus identified on 
Farm 2. However, the gene manually annotated at 75 kb distance from the 
RADlocus did not overlap with the Pool-Seq window. The Pool-Seq window 
contained a gene with sushi-domain, which may suggest involvement in 
extracellular recognition. The gene had an H. contortus homologue predicted by 
BLASTP but no C. elegans homologue.  
5.4 Discussion 
To identify markers of IVM resistance, Pool-Seq was performed using T. 
circumcincta progeny obtained pre- and post-IVM treatment as part of a FECRT. 
Two geographically separated farms, with differing reductions in T. circumcincta 
egg output post-IVM were selected. The genetic basis of IVM resistance in H. 
contortus appears similar across many different isolates (Doyle et al., 2019; 
Sallé et al., 2019), and the aim was to identify genetic markers which could be 
used diagnostically on many farms. For this reason, farm FST results were 
compared. However, many differences may exist between isolated populations 
unrelated to IVM selection (Sarai et al., 2014; Doyle et al., 2019; Sallé et al., 
2019) and so comparisons to identify genetically differentiated regions of the 
genome, potentially under selection by IVM, were conducted within each farm 
population separately.  
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5.4.1 Whether a single locus, or multiple loci, contribute to IVM 
resistance on each farm is difficult to discern 
Multiple 10kb windows appeared genetically differentiated between the T. 
circumcincta pre- and post-treatment populations on each farm. However, the 
relative genomic location of these windows, within the draft, fragmented Tci2 
genome is not known. As such it is not possible to determine whether regions 
correspond to a single locus, or many loci. For example, Doyle et al. (2019) 
plotted their FST data (comparing a backcrossed, IVM-selected strain, with a 
susceptible isolate), on three separate versions of the H. contortus genome, 
assembled in various stages of completion from over 23,000 contigs (with an N50 
of 83 kb and with 1,151 contigs longer than this length), to just eight scaffolds. 
As the genome assembly improved, it became possible to determine peaks of 
selection, whereas, with the same data, this was not possible on the original 
assembly.  
FST analysis indicated that only 160 kb, in total, was genetically differentiated on 
both farms, corresponding to regions on 14 different contigs. These results may 
indicate that the major mechanism of IVM resistance falls within those regions 
identified on both farms. Compared to the number of windows expected to be 
identified on both farms by chance (<1), the observed number of windows (16) is 
significantly greater. This would add support to the theory of a single dominant 
locus conferring IVM resistance in adult worms of T. circumcincta. In H. 
contortus, a region on Chromosome V has been identified in multiple studies 
comparing IVM susceptible and resistant isolates (Sallé et al., 2019), or genetic 
crosses (Laing, pers comm, Redman et al., 2012; Doyle et al., 2019). This region 
is divided into two main peaks, spanning 5 Mb and 3 Mb. In contrast, 910 kb 
across 76 contigs appeared genetically differentiated on Farm 3 and 5.76 Mb 
were genetically differentiated on Farm 2, spread across more than 400 contigs. 
If IVM resistance in parasitic nematodes is polygenic, as is the case in C. elegans 
(Dent et al., 2000; James and Davey, 2009; Page, 2018), the genetic basis of IVM 
resistance may differ between farms, consistent with work on field populations 
of Onchocerca volvulus (Doyle et al., 2017). Genetically differentiated regions, 
which did not appear to be selected on both farms, often had stronger signals of 
selection than those that were common to both. This may indicate that the locus 
conferring IVM resistance lies within the higher FST regions – with a different 
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genetic basis of resistance on each farm. Alternatively, due to the dominant 
phenotype expected, the regions with lower FST, but common to both farms may 
be more important. This is because dominant phenotypes could allow 
maintenance of heterozygosity within the population, maintaining some diversity 
at the IVM resistance locus. It would be expected to be detected due to 
enrichment of alleles conferring resistance within the post-IVM population, but 
would not necessarily be the highest FST locus. Alternatively, multiple variants 
within the same gene may confer resistance to IVM, which would also maintain 
diversity – as was noted in BZ resistant C. elegans (Hahnel et al., 2018) and 
artemisinin resistant Plasmodium falciparum (Cheeseman et al., 2015).  
In addition to the large region of selection on Chromosome V (Doyle et al., 2019; 
Sallé et al., 2019), other loci appear to be under IVM selection in H. contortus 
populations treated at half-doses of IVM (Laing, pers comm). On these farms it is 
entirely possible that multiple IVM resistance mechanisms have been selected 
over time. For example, from under-dosing of sheep (Sargison, 2011), or from 
selection of mechanisms which support multi-drug resistance and may be 
selected by multiple anthelmintics, such as the P-glycoproteins (Raza et al., 
2016b). Furthermore, in the UK, with high levels of sheep movement between 
farms, each farm may have multiple origins of IVM resistance, increasing overall 
genomic diversity and producing soft selective sweep patterns, rather than 
harder sweeps. This has been observed for BZ resistance previously (Redman et 
al., 2015). This may be especially relevant on Farm 2, which is known to have 
recently merged two flocks. 
As IVM has multiple targets (e.g. GluCls, GABA receptors, FXR etc) and affects 
multiple different pathways in a diverse range of organisms (Holden-Dye and 
Walker, 1990; Jin et al., 2013; Ballesteros et al., 2016; Gallardo et al., 2018; 
Ménez et al., 2019), it is possible that more than one protective mutation may 
arise which confers some resistance to IVM in diverse field populations. In 
addition, different mechanisms of resistance may be important at different 
lifecycle stages – all of which may experience some selection pressure in field 
populations. Lastly, aside from genome wide diversity naturally occurring 
between populations, the presence of adaptive mutations, in the face of a 
necessary, but perhaps deleterious mutation conferring IVM resistance, may be 
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additionally selected for independently. Such mutations may overcome any 
fitness cost and increase genetic diversity (and apparent selection by IVM) within 
and between populations (Levin et al., 2000). 
5.4.2 Post-IVM samples are still highly diverse, but populations 
are less diverse than expected 
The genome-wide mean nucleotide diversity (Tajima’s Pi), was very similar 
between all samples and did not suggest considerable selection of a particular 
sub-population of individuals on either farm. In addition, allele frequency 
correlations (Pearson’s correlation coefficient), suggest that all samples are 
equally diverse, without grouping of samples within farm or by treatment. 
Clearly individuals that are IVM resistant are as diverse within their sub-
population as those which are susceptible. It is therefore unlikely that extensive 
LD over a region large enough to affect genome wide diversity measures has 
occurred by IVM selection. Alternatively, initial selection pressure on the 
population by IVM treatment may have occurred sufficiently distantly in time to 
allow subsequent outbreeding of any selected region within the population as a 
whole (both by recombination and by new mutations arising within the locus), 
supported by genome wide patterns of Tajima’s D.  
When comparing the Tajima’s Pi estimates of T. circumcincta sample 
populations in this study with genome-wide estimates of several lab isolates of 
H. contortus (Doyle et al., 2019), T. circumcincta appears to be slightly more 
conserved than perhaps might be expected for such a highly diverse outbred 
population. Resistant strains of H. contortus (MHco4(WRS) and MHco10(CAVR)), 
and the susceptible inbred strain MHco3(ISE), had mean autosomal wide 
estimates of nucleotide diversity of between 0.022 and 0.038 (Doyle et al., 
2019), comparable to or higher than the genome-wide mean estimates of T. 
circumcincta presented here (0.024). Nevertheless, the mean nucleotide 
diversity of the X chromosome of H. contortus was markedly lower, being at 
most 0.017 (MHco10(CAVR)), and as a minimum, only 0.008 (MHco3(ISE)) (Doyle 
et al., 2019). As the T. circumcincta genome is not assembled to chromosome 
level, it is not possible to tease out the differences relating to this disparity 
within the data, and the mean autosomal diversity may be higher than the 
genome-wide diversity calculated here. In addition, if some reads did not align 
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due to high diversity then this could artificially lower the genome wide Tajima’s 
Pi. 
5.4.3 Why might fewer reads have aligned post-treatment 
compared with pre-treatment?  
Pre-treatment populations on both farms had an increased number of sites with 
coverage depth greater than 60x compared with post-treatment populations, 
which had a greater proportion of sites with coverage depth less than 40x. This 
correlated with both a reduced percentage of reads aligning, and fewer reads 
aligned in total, in these post-IVM samples. Interestingly, a slightly smaller 
percentage of reads also aligned to the genome for the Farm 2 post-treatment 
ddRAD-Seq experiment compared with the pre-treatment sample (4.3.3). This 
may reflect an increased genetic difference between the post-IVM populations 
and the MTci2 population used to assemble the reference genome. MTci2 was 
isolated from the field before IVM was licensed and is fully susceptible to a 
standard dose of IVM (Skuce et al., 2010). Although the sample size is small, it is 
interesting to speculate if this phenomenon is related to genetic differentiation 
(Kofler et al., 2016b), rather than merely stochastic chance, as it could indicate 
a loss of data, perhaps one or two alleles, specifically relating to IVM resistance. 
Although the extent of such an effect depends on how much of the genome is 
affected by IVM selection, a loss of diversity in the post-treatment populations 
due to a reduction in reads aligning, would still be likely to produce a signal.  
In addition to the lower percentage of reads aligning in these post-treatment 
samples, the mean and outlier Tajima’s D values were always slightly less 
negative, indicating fewer rare alleles in the post-treatment samples compared 
with the pre-treatment. This might imply selection upon these populations by 
IVM. Alternatively, this effect may have been caused by certain alleles not 
aligning to the MTci2 genome in these samples.  
5.4.4 Sample coverage was lower than expected – and may have 
affected sample size, increasing differences between 
technical replicates 
In order to increase the chance of truly sampling allelic diversity within the 
population, and obtain accurate allele frequencies, we aimed to use Pool-Seq 
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with as many individuals as possible, while keeping the numbers of individuals 
used for each pool consistent within and between farms. The cost-benefit of 
Pool-Seq increases as the number of individuals included in the pool increases 
(Gautier et al., 2013a) and variation in DNA input quantity between individuals is 
reduced (Rode et al., 2018). In this study, we were able to use three times as 
many worms for each sampling time point as for the ddRAD-Seq experiment. 
Ninety-one individuals were used per pool and a coverage of ~100x aimed for 
(Rode et al., 2018), based on the expected genome size. This level of coverage 
would have allowed each individual to be sequenced once, providing a coverage 
per chromosome (2n = diploid) of 0.5x. In reality, between 70.4 to 75.4x 
coverage of each pool was obtained. However, following alignment of reads to 
the genome, actual coverage was much lower, ranging from 45.7 to 51.5x 
genome wide, with variability in coverage across the genome such that the mean 
mapped depth per site was between 35.5 and 39.2x (Table 5.4). This raises two 
concerns. Firstly, due to the actual pool coverage (0.27x per chromosome), as 
opposed to the expected coverage (0.5x), the sample size is much smaller than 
hoped. In a highly diverse population this could reduce the ability to accurately 
determine allele frequencies and hence detect selection. Secondly, it could have 
increased differences between technical replicates. These were included for 
Farm 3 and proved useful in reducing noise generated by false positive signals 
unrelated to IVM selection (Robasky et al., 2014). Although the Pearson’s 
correlation coefficient was higher between technical replicate samples than 
between different biological samples, it was still only about 0.73. By reducing 
the sample size sequenced, the chance of stochastically sampling chromosomes 
within the pool, and limiting selection of allele frequencies within a sample, 
could increase differences between technical replicates. That the strength of 
IVM selection was strong enough to overcome this potential variation was 
evidenced by the reduced median FST values identified, and threshold 
calculated, for the Farm 3:Post-Post technical replicate comparison compared 
with the Pre-Post comparisons. 
Reasons for the reduced relative to the expected coverage include 
contamination within the sample, suggested by the Kraken report and the subset 
of high GC reads within the Farm 3 post-IVM samples (Barbu et al., 1956). As 
mentioned above, the potential for diversity between MTci2 and the field 
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populations could lead to reduced numbers of reads aligning – only between 60 
to 70% of reads aligned overall for each sample. Conversely, it is possible that 
part of the reason for these reads not aligning is that sections of the T. 
circumcincta genome could be missing from the Tci2 assembly. Lastly, of those 
reads which aligned, almost one fifth had a mapping quality of zero, indicating 
they aligned equally well in more than one position. This may indicate the 
presence of haplotypic regions within the draft genome, spreading reads over 
multiple contigs, which should instead be aligned in just one region. This would 
both reduce mean coverage across the genome and could also affect FST analysis.  
5.5 Conclusion 
This study has validated a Pool-Seq method to detect regions of differentiation 
across the genome in outbred UK field populations of T. circumcincta. Despite 
using very low quantities of input DNA, sequencing was successful, and quality 
was good. Coverage could have been higher, which has limited sample size. 
However, due to the draft nature of the genome, artefactual haplotypic 
diversity may still be present within the genome. Dependent on the extent of 
this, genome-wide sequencing coverage may be higher than that observed, and 
could therefore increase as the genome assembly improves. High nucleotide 
diversity, similar to that of H. contortus, was observed. Although slightly lower 
than perhaps expected, values calculated support the concept of a small 
genomic footprint of selection by IVM, with maintenance of a diverse population. 
No single strong signals of selection were detected, although these may have 
been masked by the fragmented state of the genome. Nevertheless, several 
regions appeared differentiated on both farms, suggesting that a common 
genetic basis of IVM resistance may reside within them. Alternatively, many 
regions of genetic differentiation were identified on each farm individually, 
which may support a multigenic basis of IVM resistance. All regions require 
further analysis as it is not possible to determine those which are selected by 
IVM from those selected by genetic hitch-hiking, or false positive signals of 
selection. 
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6 Sifting the wheat from the chaff: Identifying 
genes which might be associated with IVM 
resistance  
6.1 Abstract 
Genome wide association studies can identify many regions that are 
differentiated, without always providing a clear indication of which regions are 
the most clinically relevant. Using results obtained following Pool-Seq of pre- 
and post-treatment Teladorsagia circumcincta offspring collected from two UK 
farms, I performed further bioinformatic analyses to investigate regions 
potentially under IVM selection. I annotated the draft Tci2 T. circumcincta 
reference genome using MTci2 RNA-Seq data provided by the BUG Consortium. 
The lipophilic drug IVM induces a flaccid somatic paralysis and can induce 
starvation and inhibit development associated with pharyngeal paralysis. In 
addition, IVM suppresses egg output of sensitive strongyle nematodes. I 
identified multiple regions containing neuronal genes, including one glutamate 
gated chloride channel, glc-3 - although this was only identified on one farm. 
Some genes were predicted to be specific to males or females within highly 
differentiated regions. Multiple metabolic genes were identified, including those 
involved with lipid metabolism. In addition to within-farm analysis, regions 
identified as under selection were compared between farms. When separate 
Tci2 annotated genes were differentiated on each farm but the same homologue 
was predicted for both Tci2 genes, these genes were noted. My results were 
compared with other published GWAS of IVM resistance to identify whether 
genes were commonly selected across species. Lastly, copy number variation 
was assessed to specifically investigate P-glycoproteins, which have previously 
been indicated in anthelmintic resistance as a multi-drug resistant mechanism. 
Although many genes identified within regions of differentiation could 
potentially be associated with IVM resistance, no candidate genes were strongly 
linked with IVM treatment. In addition, evidence of multiple gene copies, 
representing technical artefacts within the available reference genomes was 
apparent. Results should therefore be carefully interpreted as the extent to 
which this artefactual duplication, and the fragmented state of the reference 
genome might impact upon this analysis is unknown.   
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6.2 Introduction 
In the previous chapters, genetically differentiated regions were identified 
between progeny of pre- and post-IVM T. circumcincta populations on two 
separate farms. These regions were spread throughout the fragmented Tci2 
genome and it was not possible to determine whether one or many loci were 
differentiated (Doyle et al., 2019). There were too many regions for detailed 
functional validation using molecular techniques. This chapter describes work 
investigating these genomic regions using bioinformatic analyses, highlighting 
regions that may be suitable for further study, based on the current literature.  
Once genes of interest are identified, there are now many tools available for 
comparative genomics. An excellent database (WormBase) containing genes, 
proteins, phenotypes and gene interaction information for the closely related 
model nematode C. elegans is available (Howe et al., 2016). This can be used 
with WormBase ParaSite (Howe et al., 2017) to identify putative homologues of 
parasitic nematode genes and their potential function. In addition, WormBase 
ParaSite provides genomic and transcriptomic data for many related parasites, 
including the newly completed chromosomal assembly of H. contortus, PRJEB506 
(MHco3ISE_4.0). A published T. circumcincta genome, PRJNA72569 
(T_circumcincta.14.0.ec.cg.pg), is also available on WormBase ParaSite, which, 
although highly fragmented (81,734 scaffolds), has gene annotations and some 
protein information (Choi et al., 2017).  
In January 2019, MTci2 RNA-Seq data generated by the BUG Consortium was used 
to annotate the Tci2 draft genome. Using WormBase, WormBase ParaSite and 
the literature, annotated genes within genetically differentiated regions were 
explored for potential relevance to IVM resistance. In addition, other recently 
published GWAS investigating IVM resistance in T. circumcincta (Choi et al., 
2017), H. contortus (Sallé et al. (2019) and unpublished work by the BUG 
Consortium), and Onchocerca volvulus (Doyle et al., 2017) were compared with 
the present study. The aim was to identify consistent patterns, and genes or 
gene families, which may be important in understanding IVM resistance.  
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6.3 Results 
6.3.1 Preliminary annotation of the Tci2 genome 
MTci2 RNA-Seq data, of good quality, was provided by the BUG Consortium. This 
was used to guide annotation of the Tci2 genome as part of this PhD project. 
Approximately 87 to 90% of the reads aligned successfully and, in total, 55,014 
putative genes were annotated by BRAKER v2.0 (Stanke et al., 2006; Stanke et 
al., 2008; Lomsadze et al., 2014; Hoff et al., 2016), with 60,450 transcripts in 
total. In contrast, the published T. circumcincta PRJNA72569 genome has 25,572 
coding genes annotated (Choi et al., 2017), while the H. contortus chromosomal 
assembly, PRJEB506, (Howe et al., 2017) has 19,430 coding sequences and 
20,707 gene transcripts. C. elegans (PRJNA13758, Howe et al., 2016) has 20,213 
coding genes annotated, with a further 25,050 non-coding genes and over 61,000 
gene transcripts in total. Many of the Tci2 annotated genes were fragmented or 
were missing start or stop codons. These results are as expected with a 
fragmented and haplotypic draft assembly within which genes may be split over 
multiple contigs and multiple alleles of the same gene may be present. It is 
therefore expected that multiple Tci2 annotated genes may be identified as 
homologues of the same gene in H. contortus or C. elegans or to be multiple 
copies of the equivalent gene in PRJNA72569. The published T. circumcincta 
genome is itself highly fragmented with many genes incompletely annotated, 
and some genes are known to be missing from the assembly.   
6.3.2 Individual farm analysis identifies many genes of potential 
interest in IVM resistance 
Regions of genetic differentiation were identified using 10kb distinct windows 
along the genome, allowing for potentially 68.5 million windows to be analysed. 
In total just 576 windows were above the FST threshold on Farm 2, and just 91 on 
Farm 3. Fewer were identified in the Farm 3 data due to an increased stringency 
of filtering using technical replicates (see section 2.9.4 for more detail). Genes 
were present within 438 of the 576 10kb windows above the FST threshold on 
Farm 2 (‘genetically differentiated’) and within 68 of the 91 genetically 
differentiated windows on Farm 3 (Table 6.1). A BLASTP search (Altschul et al., 
1990) with the translated nucleotide sequences was used to identify homologues 
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in C. elegans and H. contortus and equivalent proteins (i.e. the same protein or 
a closely related paralogue) in PRJNA72569 as described in 2.9.5.   
In total, 603 Tci2 genes were identified within these windows in the Farm 2 
data, and for 526 of these, homologous or equivalent proteins were identified in 
at least one database (Table 6.1). Just over a third of these appeared to be 
parasite specific, with no homologue identified in C. elegans. Just over 2% of 
proteins were solely identified in the T. circumcincta PRJNA72569 database.  
In total, 85 Tci2 genes were identified on Farm 3, and 73 of these equated to 
proteins identified in at least one database. A greater proportion of these were 
parasite specific (42.3%) compared with Farm 2, however none were solely 
identified in the T. circumcincta PRJNA72569 database.
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Table 6.1: Numbers of Tci2 annotated genes and their predicted proteins within genetically 
differentiated regions.  
  Farm 2 Farm 3 
10 kb windows above the FST threshold (Tci2 contigs) 576 (435) 91 (76) 
Tci2 genes identified within these windows 
(transcripts) 
603 (690) 85 (89) 
Tci2 genes with at least one homologous or equivalent 
protein predicted 
526 
(87.2%) 
73 
(80.2%) 
Teladorsagia circumcincta PRJNA72569 reference 
genome proteins predicted (% of all Tci2 genes) 
324 
(57.5%) 
42 
(50.6%) 
Haemonchus contortus proteins predicted (% of all Tci2 
genes) 
455 
(84.1%) 
69 
(81.2%) 
Caenorhabditis elegans proteins predicted (% of all 
Tci2 genes) 
283 
(52.7%) 
35 
(43.5%) 
Tci2 genes for which proteins were predicted in all 
three datasets (% of all Tci2 genes) 
255 
(42.3%) 
28 
(32.9%) 
Tci2 genes for which parasite proteins were predicted, 
without a predicted homologue in Caenorhabditis 
elegans (% of all Tci2 genes); putatively parasite-
specific genes 
212 
(35.2%) 
36 
(42.3%) 
Tci2 genes for which proteins were identified solely in 
the PRJNA72569 database (% of all Tci2 genes); 
putatively Teladorsagia circumcincta-specific genes 
12 (2.0%) 0 (0.0%) 
Tci2 genes for which no protein was identified (% of all 
Tci2 genes) 
77 
(12.8%) 
12 
(14.1%) 
10 kb windows with no Tci2 gene (% of all windows) 138 
(24.0%) 
23 
(25.3%) 
 
To ascertain protein function, gene ontology (GO) terms were extracted for the 
526 proteins identified in the Farm 2 analysis, and the 73 proteins identified in 
the Farm 3 analysis, as described in 2.9.6. It was assumed that the GO term 
annotations would be most complete in the C. elegans genome assembly. For 
parasite-specific genes, GO terms were preferentially identified in H. contortus 
homologues rather than PRJNA72569 equivalent genes, if available.  
Following extraction of GO terms and gene descriptions, search terms were used 
to identify genes of interest in the following categories; neuronal (42 genes in 
the Farm 2 data (Table 6.2) and three genes in the Farm 3 data (Table 6.3)), 
lipid metabolism (39 genes in the Farm 2 data (Table 6.4) and seven genes in the 
236 
 
Chapter 6  
Farm 3 data (Table 6.5)), female (13 genes in the Farm 2 data (Table 6.6) and 
three genes in the Farm 3 data (Table 6.7)) and male (seven genes in the Farm 2 
data (Table 6.8) and just a single gene, snf-10, in the Farm 3 data (Table 6.9)). 
These categories were chosen because of the known effects of IVM on 
locomotion (Demeler et al., 2010a), feeding (Alvarez-Sanchez et al., 2005b) and 
reproduction (Sutherland et al., 2003a). The category of lipid metabolism was 
chosen as IVM is lipophilic (Sutherland and Campbell, 1990) and can affect lipid 
storage (Smus et al., 2017). It is also possible that due to starvation induced by 
IVM, altered lipid metabolism and storage of lipids may be important in survival 
in the presence of IVM (Laing et al., 2012). Fewer genes were identified in these 
categories in Farm 3 data than in Farm 2 data, reflecting the smaller number of 
genes overall. The complete GO term results for all genes identified within 
regions of genetic differentiation are presented in Appendices 10 and 11. 
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Table 6.2: Farm 2 predicted homologues annotated with GO terms associated with neuronal tissues or processes.  
Gene stable ID Gene name Gene description or GO term 
WBGene00000054 acr-15 Acetylcholine Receptor   
WBGene00000056 acr-17 Acetylcholine Receptor   
WBGene00022104 acsd-1 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase   
WBGene00011258 best-15 Bestrophin homolog 15   
WBGene00206487 best-19 Bestrophin homolog   
WBGene00012779 cdkl-1 Cyclin-dependent kinase-like 1   
WBGene00000528 clh-1 Chloride channel protein   
WBGene00014054 dbt-1 Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase 
complex, mitochondrial   
WBGene00000951 deg-3 Acetylcholine receptor subunit alpha-type deg-3   
WBGene00000955 des-2 Acetylcholine receptor subunit alpha-type des-2   
WBGene00001519 gar-3 Muscarinic acetylcholine receptor gar-3   
WBGene00001593 glc-3 Glutamate-gated Chloride channel; Glutamate-gated chloride channel subunit   
WBGene00001664 gpa-2 Guanine nucleotide-binding protein alpha-2 subunit   
WBGene00001665 gpa-3 Guanine nucleotide-binding protein alpha-3 subunit   
WBGene00010593 gsnl-1 Gelsolin-like protein 1   
WBGene00006504 kcc-1 K+/Cl-Cotransporter   
WBGene00002234 kqt-2 Potassium channel, KvQLT family   
WBGene00022283 lgc-27 Ligand-Gated ion Channel   
WBGene00017314 lgc-39 Ligand-Gated ion Channel   
WBGene00008022 lgc-41 Ligand-Gated ion Channel   
WBGene00021437 lgc-42 Ligand-Gated ion Channel   
WBGene00003029 lin-44 Abnormal cell lineage protein 44   
WBGene00003058 lov-1 Location of vulva defective 1   
WBGene00015478 mapk-15 Mitogen-activated protein kinase 15   
WBGene00003404 mpz-1 Multiple PDZ domain protein   
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Gene stable ID Gene name Gene description or GO term 
WBGene00017437 nmgp-1 Neuronal Membrane Glycoprotein   
WBGene00003909 pag-3 Zinc finger protein PAG-3   
WBGene00003878 pept-3 Peptide transporter 3   
WBGene00004032 pkc-1 Protein kinase C-like 1B   
WBGene00004212 ptl-1 Microtubule-associated protein   
WBGene00019891 R05F9.7 Sensory perception of chemical stimulus 
WBGene00006476 rhgf-2 RHo Guanine nucleotide exchange Factor   
WBGene00008183 rin-1 RIN (Ras/Rab Interactor) homolog   
WBGene00011392 sbt-1 Seven B Two (Mammalian 7BT prohormone convertase chaperone) homolog   
WBGene00004902 snf-3 Sodium- and chloride-dependent betaine transporter   
WBGene00004926 snt-6 Synaptotagmin   
WBGene00005713 srv-2 Serpentine receptor class gamma   
WBGene00011326 T01D3.1 Motor neuron axon guidance 
WBGene00006615 trp-2 TRP (Transient receptor potential) channel family; TRP homologous cation channel protein   
WBGene00006768 unc-32 Probable V-type proton ATPase 116 kDa subunit a   
WBGene00021305 zig-11 2 (Zwei) IG domain protein   
HCON_00090710 NA Neurotransmitter:sodium symporter activity 
All genes were identified using GO terms returned by the BIOMART tool (Smedley et al., 2015) in WormBase ParaSite. Caenorhabditis elegans genes were 
the preferred choice for identifying function, and all Teladorsagia circumcincta PRJNA72569 equivalent genes and Haemonchus contortus homologues 
were first used to identify C. elegans homologues in BIOMART. Those for which no C. elegans homologue could be found were identified by H. contortus 
GO term annotations.  
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Table 6.3: Farm 3 predicted homologues annotated with GO terms associated with neuronal tissues or processes.  
Gene stable ID Gene name Gene description or GO term 
WBGene00002976 lev-9 Synapse related 
WBGene00003878 pept-3 Peptide transporter 3   
WBGene00004909 snf-10 Transporter 
All genes were identified using GO terms returned by the BIOMART tool in WormBase ParaSite. Caenorhabditis elegans genes were the preferred choice 
for identifying function, and all Teladorsagia circumcincta PRJNA72569 equivalent genes and Haemonchus contortus homologues were first used to 
identify C. elegans homologues in BIOMART.  
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Table 6.4: Farm 2 predicted homologues annotated with GO terms associated with lipid metabolism or storage.  
Gene stable ID Gene name Gene description or GO term 
WBGene00000020 abt-2 ABC Transporter family   
WBGene00007112 B0035.13 Lipid metabolic process 
WBGene00015544 C06E8.5 Lipid binding 
WBGene00008291 C54C8.3 Hexosyltransferase   
WBGene00000509 cka-1 Choline Kinase A   
WBGene00000837 cul-2 Cullin-2   
WBGene00000838 cul-3 Cullin-3   
WBGene00014054 dbt-1 Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase 
complex, mitochondrial   
WBGene00006483 dgk-4 Diacylglycerol kinase   
WBGene00017373 F10G7.10 Ubiquitin protein ligase activity 
WBGene00009237 F28H7.3 Lipid metabolic process 
WBGene00018175 F38B6.6 Protein O-mannosyl-transferase TMTC1   
WBGene00019029 F58B6.1 Lipid metabolic process 
WBGene00011321 fil-1 Fasting Induced Lipase   
WBGene00001511 fzy-1 WD repeat-containing protein fzy-1   
WBGene00019612 gpcp-1 Putative glycerophosphocholine phosphodiesterase GPCPD1 homolog 1   
WBGene00003478 mtm-6 Myotubularin-related protein 6   
WBGene00020679 ogdh-1 2-oxoglutarate dehydrogenase, mitochondrial   
WBGene00003877 pept-1 Peptide transporter family 1   
WBGene00004032 pkc-1 Protein kinase C-like 1B   
WBGene00004076 pod-2 Fatty acid biosynthetic process 
WBGene00004205 psr-1 Bifunctional arginine demethylase and lysyl-hydroxylase psr-1   
WBGene00004259 pyr-1 CAD protein Glutamine-dependent carbamoyl-phosphate synthase Aspartate 
carbamoyltransferase dihydroorotase  
WBGene00011040 R05H5.5 Sphingolipid metabolic process 
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Gene stable ID Gene name Gene description or GO term 
WBGene00011935 scrm-1 Phospholipid scramblase   
WBGene00004926 snt-6 Synaptotagmin   
WBGene00020393 T10B5.7 Lipid metabolic process  
WBGene00020784 tat-4 Phospholipid-transporting ATPase   
WBGene00006739 ulp-4 Ubiquitin-like protease 4   
WBGene00020962 W02H5.8 Glycerone kinase activity 
WBGene00022532 ZC155.4 Glycerophosphodiester phosphodiesterase activity 
HCON_00053760 NA Ubiquitin protein ligase activity 
HCON_00130960 NA Lipase   
HCON_00156530 NA Glycerophosphodiester phosphodiesterase activity 
TELCIR_04843 NA Triacylglycerol lipase   
TELCIR_05535 NA DAK2 domain protein   
TELCIR_13687 NA Diacylglycerol kinase accessory domain protein   
TELCIR_16739 NA Dehydrogenase E1 component   
TELCIR_21800 NA Oxoglutarate dehydrogenase (succinyl-transferring) activity 
All genes were identified using GO terms returned by the BIOMART tool in WormBase ParaSite. Caenorhabditis elegans genes were the preferred choice 
for identifying function, and all Teladorsagia circumcincta PRJNA72569 equivalent genes and Haemonchus contortus homologues were first used to 
identify C. elegans homologues in BIOMART. Those for which no C. elegans homologue could be found were identified by H. contortus GO term 
annotations, or if they had only an equivalent gene identified in PRJNA72569, they were identified by the PRJNA72569 GO term annotations.  
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Table 6.5: Farm 3 predicted homologues annotated with GO terms associated with lipid metabolism or storage.  
Gene stable ID Gene name Gene description or GO term 
WBGene00012019 dkf-2 Serine/threonine-protein kinase dkf-2   
WBGene00017084 E01A2.1 Glutamate-cysteine ligase complex 
WBGene00018620 F48G7.9 Positive regulation of glutamate-cysteine ligase activity 
WBGene00003670 nhr-80 Nuclear Hormone Receptor family   
WBGene00003877 pept-1 Peptide transporter family 1   
WBGene00004259 pyr-1 CAD protein Glutamine-dependent carbamoyl-phosphate synthase Aspartate 
carbamoyltransferase Dihydroorotase  
TELCIR_14993 NA Glutamate-cysteine ligase catalytic subunit binding 
All genes were identified using GO terms returned by the BIOMART tool in WormBase ParaSite. Caenorhabditis elegans genes were the preferred choice 
for identifying function, and all Teladorsagia circumcincta PRJNA72569 equivalent genes and Haemonchus contortus homologues were first used to 
identify C. elegans homologues in BIOMART. Those for which no C. elegans homologue could be found were identified by H. contortus GO term 
annotations, or if they had only an equivalent gene identified in PRJNA72569, they were identified by the PRJNA72569 GO term annotations.  
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Table 6.6: Farm 2 predicted homologues annotated with GO terms associated with female related terms.  
Gene stable ID Gene name Gene description or GO term 
WBGene00000430 ceh-5 Homeobox protein ceh-5   
WBGene00000837 cul-2 Cullin-2   
WBGene00000868 cyb-3 G2/mitotic-specific cyclin-B3   
WBGene00001377 eya-1 Eyes absent homolog 1   
WBGene00002295 let-19 Mediator of RNA polymerase II transcription subunit 13   
WBGene00003017 lin-31 Abnormal cell lineage protein 31 
WBGene00003029 lin-44 Abnormal cell lineage protein 44   
WBGene00003367 mix-1 Mitotic chromosome and X-chromosome-associated protein mix-1   
WBGene00003638 nhr-48 Nuclear hormone receptor family member nhr-48   
WBGene00004013 pha-4 Defective pharyngeal development protein 4   
WBGene00004930 sod-1 Superoxide dismutase [Cu-Zn]   
WBGene00006771 tln-1 Talin   
WBGene00006768 unc-32 Probable V-type proton ATPase 116 kDa subunit a   
All genes were identified using GO terms returned by the BIOMART tool in WormBase ParaSite. Caenorhabditis elegans genes were the preferred choice 
for identifying function, and all Teladorsagia circumcincta PRJNA72569 equivalent genes and Haemonchus contortus homologues were first used to 
identify C. elegans homologues in BIOMART.  
Table 6.7: Farm 3 predicted homologues annotated with GO terms associated with female related terms.  
Gene stable ID Gene 
name 
Gene description or GO term 
WBGene00003670 nhr-80 Nuclear Hormone Receptor family   
WBGene00003794 npp-8 Nuclear Pore complex Protein   
WBGene00007413 pro-2 Nucleolar complex protein 2 homolog   
All genes were identified using GO terms returned by the BIOMART tool in WormBase ParaSite. Caenorhabditis elegans genes were the preferred choice 
for identifying function, and all Teladorsagia circumcincta PRJNA72569 equivalent genes and Haemonchus contortus homologues were first used to 
identify C. elegans homologues in BIOMART. 
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Table 6.8: Farm 2 predicted homologues annotated with GO terms associated with male 
related terms.  
Gene stable ID Gene name Gene description or GO term 
WBGene00000837 cul-2 Cullin-2   
WBGene00000868 cyb-3 G2/mitotic-specific cyclin-B3   
WBGene00003029 lin-44 Abnormal cell lineage protein 44   
WBGene00003058 lov-1 Location of vulva defective 1   
WBGene00003605 nhr-6 Nuclear hormone receptor family 
member nhr-6   
WBGene00007733 smz-1 Sperm Meiosis PDZ domain containing 
proteins   
WBGene00020661 smz-2 Sperm Meiosis PDZ domain containing 
proteins   
All genes were identified using GO terms returned by the BIOMART tool in WormBase 
ParaSite. Caenorhabditis elegans genes were the preferred choice for identifying function, 
and all Teladorsagia circumcincta PRJNA72569 equivalent genes and Haemonchus 
contortus homologues were first used to identify C. elegans homologues in BIOMART. 
Table 6.9: Farm 3 predicted homologues annotated with GO terms associated with male 
related terms.  
Gene stable ID Gene 
name 
Gene description or GO term 
WBGene00004909 snf-10 Transporter 
All genes were identified using GO terms returned by the BIOMART tool in WormBase 
ParaSite. Caenorhabditis elegans genes were the preferred choice for identifying function, 
and all Teladorsagia circumcincta PRJNA72569 equivalent genes and Haemonchus 
contortus homologues were first used to identify C. elegans homologues in BIOMART. 
6.3.3 SNPs predicted to have high or moderate impact within 
regions of genetic differentiation 
I hypothesised that genes containing SNPs that affected transcription of a 
protein or caused a codon change were more likely to be under IVM selection. In 
addition, I considered whether genes within a certain distance from a SNP might 
also be the SNP might also be under IVM selection. SnpEff (Cingolani et al., 
2012), which estimates the effect of variants, was provided with variant sites of 
interest (as defined in 2.9.7) and the preliminary gene annotations. Only 
preliminary annotations are present on the Tci2 genome, and the length of 
untranslated regions (UTRs) for T. circumcincta genes are unknown. In addition, 
it is not known whether regions distant from a gene can regulate its 
transcription. For this reason, SNPs within 5 kb of a gene (SnpEff default 
setting), were considered to potentially modify a gene.  
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On Farm 2, 636,541 SNPs had FST values greater than the threshold of 0.116, and 
1.13 million SNPs had a significant allele frequency change between the pre- and 
post-treatment populations (p<0.05). In total, 26,002 SNPs were retained which 
had an FST value greater than the threshold and a significant allele frequency 
difference. Of these, 676 were within the top 10 kb windows for Farm 2. Lastly, 
these 676 SNPs were filtered to obtain a list of SNP positions with mean depth of 
between 20-60x coverage in the Farm 2 data. This dataset of 212 SNPs was 
provided as input to SnpEff to obtain a list of SNPs, filtered by the above 
criteria, and which were also putatively predicted to have either a high or 
moderate impact phenotypically.  
No SNPs were predicted to have a high impact on Farm 2. In total, four SNPs 
were predicted to have a moderate impact upon four Tci2 genes, with 
modification of a fifth (Table 6.10). The equivalent PRJNA72569 genes and 
homologues in H. contortus and C. elegans are shown in Table 6.11 and Table 
6.12. Each SNP was non-synonymous, introducing an amino acid change in the 
Tci2 annotated proteins G540.T1, G10328.T1, G15772.T1 and G43444.T1, 
G43444.T2 (Table 6.10). g540.t1 had no identifiable proteins in any of the three 
protein databases (Table 6.11). g10328.t1 was predicted to be an 
aminopeptidase. The transcript g15772.t1 was identified as TELCIR_03383, a 
transposable element (TEs: reverse transcriptases, transposases, 
endo/exonucleases), with a homologue also identified in H. contortus. Lastly, 
g43444 was identified as the DNA repair protein rev-1 (Table 6.11). In addition, 
the SNP within this gene was predicted to be a downstream gene variant of the 
transcript g43445.t1. Note that this is arbitrary – any SNP within 5 kb of a gene 
will be annotated as either an upstream or downstream variant (Cingolani et al., 
2012). This transcript had only one homologue identified, HCON_00177350, a TE 
(Table 6.12).  
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Table 6.10: Farm 2 moderate impact SNPs predicted by SnpEff, which were present within genetically differentiated 10 kb windows.  
Tci2 
Contig 
SNP QUAL1 Annotation2 Tci2 
Transcript 
5 180615 999 Missense variant  
(g540.t1|protein_coding|1/4|c.23C>A|p.Pro8His|23/348|23/348|8/115||) 
g540.t1 
140 229875 211 Missense variant  
(g15772.t1|protein_coding|1/1|c.328G>A|p.Gly110Arg|328/570|328/570|110/189||) 
g15772.t1 
1305 28503 999 Missense variant  
(g43444.t1|protein_coding|3/12|c.2000G>A|p.Arg667Gln|2000/2997|2000/2997|667/998||)  
Missense variant  
(g43444.t2|protein_coding|3/12|c.2000G>A|p.Arg667Gln|2000/2985|2000/2985|667/994||)  
Downstream gene variant  
(g43445.t1|protein_coding||c.*3756G>A|||||3756|) 
g43444.t1 
g43444.t2 
g43445.t1 
5194 11514 999 Missense variant  
(g10328.t1|protein_coding|8/8|c.908T>C|p.Ile303Thr|908/990|908/990|303/329||) 
g10328.t1 
Note that all SNPs were identified as having a high FST value, a significant allele frequency change between the pre- and post-ivermectin samples (p<0.05) 
and were sequenced to a mean depth of between 20-60x in the Farm 2 data. In addition they were present within 10 kb regions with FST values greater than 
the threshold. 1QUAL reflects the confidence in the variance seen at the SNP position (-10log10[probability that the alternate allele is wrongly called]). 
2Annotations include: variant type, transcript, transcript-type, exon-with-SNP/total-exons, HGVS.c - the SNP and it’s position within the cDNA sequence, 
HGVS.p - the amino acid change and it’s position within the protein sequence, cDNA position/total cDNA length, protein position/total protein sequence 
length, distance to first/last exon if upstream/downstream variant.
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Table 6.11: Farm 2 gene transcripts containing SNPs of moderate impact.  
Tci2 
Transcript 
ID 
T. 
circumcincta1 
PRJNA72569 
gene 
T. 
circumcincta1 
PRJNA72569 
genomic 
location2 
H. contortus3 
gene 
H. 
contortus3 
genomic 
location4 
C. 
elegans5 
gene 
C. elegans5 Gene 
stable ID 
C. elegans5 
genomic 
location4 
Gene 
description 
g540.t1 NA NA NA NA NA NA NA Unknown 
g10328.t1 TELCIR_08194 1466:52385- 
62418 
HCON_00142190 V:15962912- 
16009730 
Y42A5A.1 WBGene00012776 V:11088154-
11097970 
Amino-
peptidase 
g15772.t1 TELCIR_03383 265:87651-
88220 
HCON_00170720 X:11864855-
11865637 
NA NA NA TE 
 
g43444.t1 TELCIR_02997 210:159381- 
163463 
HCON_00104960 IV:11508359
-11509732 
ZK675.2 
(rev-1) 
WBGene00014066 II:7900647-
7904636 
DNA repair 
protein 
REV1 
g43444.t2 TELCIR_02997 210:159381- 
163463 
HCON_00104960 IV:11508359
-11509732 
ZK675.2 
(rev-1) 
WBGene00014066 II:7900647-
7904636 
DNA repair 
protein 
REV1 
1Teladorsagia circumcincta 2Contig:nucleotide range 3Haemonchus contortus  4Chromosome:nucleotide range 5Caenorhabditis elegans. TE = Transposable 
element.  
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Table 6.12: Farm 2 gene transcripts putatively impacted by a SNP of moderate impact in a nearby gene.  
Tci2 
Transcript 
ID 
T. 
circumcincta1 
PRJNA72569 
gene 
T. 
circumcincta1 
PRJNA72569 
genomic 
location2 
H. contortus3 
gene 
H. 
contortus3 
genomic 
location4 
C. 
elegans5 
gene 
C. elegans5 Gene 
stable ID 
C. elegans5 
genomic 
location4 
Gene 
description 
g43445.t1 NA NA HCON_00177350 X:23863014-
23865806 
NA NA NA TE 
1Teladorsagia circumcincta 2Contig:nucleotide range 3Haemonchus contortus  4Chromosome:nucleotide range 5Caenorhabditis elegans. TE = Transposable 
element. 
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In total, 24,052 SNPs of high FST value were retained following filtering of the 
Farm 3 data (see 2.9.4). Twice this number of SNPs (52,426) had a significant 
difference in allele frequency between the pre- and post-IVM samples (p<0.05). 
Eleven SNPs were present in both datasets. Of these, two were found to reside 
within the genetically differentiated windows identified on Farm 3. Both had 
coverage depth between 20 and 60x but neither were deemed to have high or 
moderate impact by SnpEff. 
6.3.4 Comparison of results from both farms identified some 
common regions potentially under selection by IVM  
Sixteen genetically differentiated windows were identified on both farms, 
containing 19 Tci2 genes (Table 6.13). Two of these 16 windows had no 
annotated genes, although one of these, on Tci2 contig 2028, was adjacent to a 
differentiated window that did contain a gene. Six of these genes were 
identified as TEs (Table 6.14). Additional predicted proteins, identified by 
BLASTP search of the Tci2 amino acid sequences, were common to both farm 
analyses – yet the Tci2 genomic regions were different in each farm analysis. 
This could indicate that the two (or more) Tci2 genes could represent different 
genes within the same gene family, or paralogues. By identifying genes under 
selection on both farms in this way, it may be possible to determine gene 
families potentially important in IVM sensitivity on both farms. Alternatively, a 
gene under IVM selection on both farms may be represented by two or more 
allelic sequences in the draft Tci2 genome. Read alignment to these alleles 
could be different on each farm. For this reason, protein lists generated by 
BLASTP searches of C. elegans, H. contortus and the T. circumcincta 
PRJNA72569 protein databases were compared between farms. A further ten 
proteins potentially under selection by IVM on both farms were identified in this 
way (Table 6.15). These included PGP-3, which was identified as the homologue 
of four separate Tci2 proteins within genetically differentiated windows. Eleven 
Tci2 genes, identified in the Farm 2 analysis, were predicted to be the same 
PRJNA72569 equivalent gene, a TE. Three of the proteins identified on both 
farms were predicted to be peptide transporters (PEPT-1, PEPT-2 and PEPT-3). 
Both Cel-pept-2 and Hco-pept-3 were homologues of the same Tci2 gene. 
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Table 6.13: Numbers of Tci2 annotated genes and predicted proteins within genetically 
differentiated regions which were identified in both farm analyses.  
  Number 
detected on both 
farms 
10 kb windows above the FST threshold (Tci2 contigs) 16 (14) 
Tci2 genes identified within these windows (transcripts) 19 (21) 
Teladorsagia circumcincta PRJNA72569 reference genome 
proteins predicted (% of all Tci2 genes) 
9 (47.4%) 
Haemonchus contortus proteins predicted (% of all Tci2 
genes) 
15 (73.7%) 
Caenorhabditis elegans proteins predicted (% of all Tci2 
genes) 
6 (31.6%) 
Tci2 genes for which proteins were predicted in all three 
datasets (% of all Tci2 genes) 
4 (21.1%) 
Tci2 genes for which parasite proteins were predicted, 
without a predicted homologue in Caenorhabditis elegans 
(% of all Tci2 genes); putatively parasite-specific genes 
9 (47.4%) 
Tci2 genes for which proteins were identified solely in the 
PRJNA72569 database (% of all Tci2 genes); putatively 
Teladorsagia circumcincta-specific genes 
0 (0.0%) 
Tci2 genes for which no protein was identified (% of all Tci2 
genes) 
4 (21.1%) 
10 kb windows with no Tci2 gene (% of all windows) 2 (12.5%) 
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Table 6.14: 10 kb windows of the Teladorsagia circumcincta Tci2 draft genome identified on both Farm 2 and Farm 3 with FST values greater than all 
comparison thresholds.  
Tci2 
genomic 
position1 
Tci2 
transcript 
name 
T. 
circumcincta2 
PRJNA72569 
gene 
T. 
circumcincta2 
PRJNA72569 
genomic 
position1 
H. contortus3 
gene 
H. contortus3 
genomic 
position4 
C. 
elegans5 
gene 
C. elegans5 
genomic 
position4 
Gene 
description 
4:1220000-
1230000 
g522.t1 
g522.t2 
TELCIR_11371 2975:898-
54044 
HCON_00015810 I:22624698-
22655013 
F36H2.3 I:9251838-
9261657 
Complement 
C3d receptor 2 
41:780000-
790000 
g2978.t1 TELCIR_13612 4637:257-937 HCON_00047360 II:19224350-
19224700 
NA NA Unknown 
(single exon) 
41:780000-
790000 
g2977.t1 TELCIR_10574 2485:16509-
36197 
HCON_00168150 X:7239913-
7241341 
NA NA TE 
41:780000-
790000 
g2976.t1 TELCIR_01154 47:11070-
11630 
HCON_00187972 X:40329402-
40335075 
NA NA TE 
163:800000-
810000 
g16889.t1 NA NA HCON_00193670 II:41464399-
41483472 
NA NA Unknown 
382:270000-
280000 
g24918.t1 TELCIR_03613 307:55728-
119232 
NA NA ZK20.6 
(nep-1) 
II:11654214-
11657172 
Neprilysin-1   
703:100000-
110000 
g33104.t1 NA NA HCON_00193210 II:30974948-
30990518 
T22C8.2 
(chhy-1) 
II:8614546-
8617603 
Hyaluronidase   
970:160000-
170000 
g38597.t1 NA NA HCON_00174350 X:18160059-
18160850 
NA NA TE  
1041:30000-
40000 
g39761.t1 NA NA HCON_00052580 II:28633156-
28635145 
NA NA TE 
1359:16000
0-170000 
g44198.t1 NA NA NA NA NA NA NA 
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Tci2 
genomic 
position1 
Tci2 
transcript 
name 
T. 
circumcincta2 
PRJNA72569 
gene 
T. 
circumcincta2 
PRJNA72569 
genomic 
position1 
H. contortus3 
gene 
H. contortus3 
genomic 
position4 
C. 
elegans5 
gene 
C. elegans5 
genomic 
position4 
Gene 
description 
1476:90000-
100000 
g45559.t1 TELCIR_07851 1337:8475-
27067 
HCON_00025940 I:36693463-
36695728 
K04G2.1 
(eif-2β) 
I:8026606-
8028752 
Eukaryotic 
translation 
initiation 
factor 2 
subunit 2   
476:90000-
100000 
g45560.t1 NA NA HCON_00000560 I:665765-
672922 
NA NA TE 
1476:90000-
100000 
g45562.t1 NA NA HCON_00066030 III:1736614-
1737678 
NA NA TE 
1476:90000-
100000 
g45561.t1 NA NA NA NA NA NA NA 
1646:20000-
30000 
g47181.t1 NA NA NA NA NA NA NA 
2028:50000-
60000 
g50265.t1 TELCIR_143236 5289:2069-
9396 
HCON_00063720 II:44978432-
44996563 
NA NA NAB region 2 
domain   
2028:70000-
80000 
g50266.t1 TELCIR_01040 42:20306-
32459 
HCON_00067270 III:3717209-
3720584 
T28B4.3 
(ttr-6) 
X:6596425-
6597121 
Transthyretin-
Related family 
domain   
2028:80000-
90000 
NA NA NA NA NA NA NA NA 
2170:30000-
40000 
g51079.t1 
g51079.t2 
TELCIR_07563 1244:13623-
84320 
HCON_00010920 I:14733034-
14747180 
C06G8.2 
(pept-2) 
IV:10790598
-10794597 
Peptide 
transporter 
family 
6280:0-
10000 
NA NA NA NA NA NA NA NA 
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Tci2 
genomic 
position1 
Tci2 
transcript 
name 
T. 
circumcincta2 
PRJNA72569 
gene 
T. 
circumcincta2 
PRJNA72569 
genomic 
position1 
H. contortus3 
gene 
H. contortus3 
genomic 
position4 
C. 
elegans5 
gene 
C. elegans5 
genomic 
position4 
Gene 
description 
6442:0-
10000 
g11819.t1 NA NA NA NA NA NA NA 
Included are those homologues and PRJNA72569 equivalent genes identified by BLASTP of the translated nucleotide sequence. These were identified 
using the WSI farm_blast. If no homologue was identified by this BLASTP for the Tci2 translated nucleotide then NA is written. 1Contig:nucleotide range. 
2Teladorsagia circumcincta 3Haemonchus contortus 4Chromosome:nucleotide range. 5Caenorhabditis elegans.  6Identified by Choi et al. 2017 in a T. 
circumcincta multi-drug resistance genome wide association study (see section 6.3.5.1). TE = Transposable element.
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Table 6.15: Proteins predicted to be homologues or equivalent PRJNA72569 proteins of Tci2 genes located within separate regions of differentiation in 
each farm analyses.  
C. 
elegans1 
gene 
C. elegans1 gene 
stable ID 
C. elegans1 
genomic 
location2 
H. contortus3 
gene 
H. 
contortus3 
genomic 
location2 
T. 
circumcincta4 
PRJNA72569 
gene 
T. 
circumcincta4 
PRJNA72569 
genomic 
location5 
Gene description 
C09H10.8 
(glb-4) 
WBGene00007502 II:11109584-
11111169 
HCON_00063260 II:44063590-
44076404 
TELCIR_01028 40:407974-
4523736 
Globin related 
D2085.1 
(pyr-1) 
WBGene00004259 II:8651109-
8658808 
HCON_00008370 I:10891644-
10913956 
NA NA CAD protein 
Glutamine-dependent 
carbamoyl-phosphate 
synthase Aspartate 
carbamoyltransferase 
Dihydroorotase 
T20B3.7 
(phy-3) 
WBGene00004026 V:16833316-
16839141 
NA NA NA NA Proline Hydroxylase 
E01B7.1 
(usp-50) 
WBGene00008441 V:17924916-
17934225 
HCON_00144310 V:19589136-
19603459 
TELCIR_07375 1183:11919-
19623 
Ubiquitin Specific 
Protease 
ZK455.7 
(pgp-3) 
WBGene00003997 X:11352136-
11357094 
HCON_00042800 II:11890313-
11916024 
NA NA Multidrug resistance 
protein pgp-3 
NA NA NA HCON_00050050 II:24598380-
24658474 
NA NA WD40 repeat domain 
(tcab-1) 
NA NA NA HCON_00121860 IV:37733818
-37736775 
TELCIR_07666 1274:16307-
16852 
TE 
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C. 
elegans1 
gene 
C. elegans1 gene 
stable ID 
C. elegans1 
genomic 
location2 
H. contortus3 
gene 
H. 
contortus3 
genomic 
location2 
T. 
circumcincta4 
PRJNA72569 
gene 
T. 
circumcincta4 
PRJNA72569 
genomic 
location5 
Gene description 
NA NA NA HCON_00133270 V:2943852-
2948958 
NA NA Oxidoreductase 
(C14E2.4) 
NA NA NA HCON_00176880 X:22986334-
22988317 
TELCIR_12769 3936:2914-
3336 
TE 
NA NA NA HCON_00178645 X:26119795-
26179301 
NA NA Peptide transporter 
family (pept-1) 
Homologues and equivalent proteins were predicted for Tci2 genes within genetically differentiated regions on each farm by BLASTP of the translated 
nucleotide. Shown in this table are homologues/equivalent genes common to both farm analyses, but which were identified using the WSI farm_blast for a 
different Tci2 gene in each farm analysis. If no homologue was identified by this BLASTP for the Tci2 translated nucleotide then NA is written. 
1Caenorhabditis elegans 2Chromosome:nucleotide range 3Haemonchus contortus 4Teladorsagia circumcincta 5Contig:nucleotide range. 5C. elegans.  6Choi 
et al. (2017) identified four SNPs approximately 200,000 bp distant from this gene (using ddRAD-Seq) which were potentially under selection by IVM (see 
section 6.3.5.1). TE = Transposable element.  
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6.3.5 Comparison of results with other GWAS 
Four GWAS investigating IVM resistance in parasitic nematodes have been carried 
out to date. Genes identified in the present study were compared to data from 
prior studies with the purpose of identifying common genes found to be under 
selection by IVM across studies, isolates and species. A T. circumcincta study 
using Pool-Seq to compare a susceptible strain and a multidrug resistant strain 
(Choi et al., 2017), was considered first. Two H. contortus studies were also 
considered, one using WGS to compare individuals of geographically separated 
field isolates (Sallé et al., 2019), and the other using Pool-Seq and RNA-Seq to 
investigate IVM resistance in a genetic cross (BUG Consortium, unpublished). 
Lastly, a study investigating IVM resistance using clinical isolates of the filarial 
nematode, O. volvulus, was considered (Doyle et al., 2017). For each GWAS, 
genes compared were those identified by the authors as being of potential 
interest.    
6.3.5.1 T. circumcincta New Zealand study 
A NZ study produced an inbred susceptible strain (Sinbred), using an anthelmintic 
susceptible lab isolate, originally obtained in the 1950s before widespread 
anthelmintic use (Choi et al., 2017). In 1996, a triple resistant (BZ, LEV and IVM) 
population was isolated from the field and this was passaged for five 
generations, treating each generation with all three anthelmintics 
simultaneously to generate a strain that was highly resistant to all three drugs. 
Subsequently, this strain was crossed with the Sinbred strain via surgical transfer 
of approximately 300 immature female susceptible worms and 300 mature adult 
male resistant worms. In total, three surgical crosses interspersed by 
interbreeding of siblings for five generations each, and multidrug selection (BZ, 
LEV and IVM) were performed to produce the triple resistant RS3 strain. The 
authors then performed two experiments. Firstly, they compared the Sinbred to 
the multi-drug treated RS3 strain using Pool-Seq of mixed-sex adults (300-500 
worms per pool). They also performed ddRAD-Seq using the F2 generation of the 
first intercross (F21). For this, two groups, each of nine goat kids, were infected 
with F21 and one group was treated with IVM. From these 18 goats, 24 IVM 
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treated male T. circumcincta and 24 untreated males were selected for ddRAD-
Seq.   
The Choi study identified 18 genes of interest that were present in both their 
Pool-Seq and ddRAD-Seq experiments. However, none of these were identified in 
the present study. The comparison was extended to include all genes within 
highly differentiated regions (z-score 4.5) in the introgression Pool-Seq analysis, 
which also contained a ddRAD-Seq locus (of any score) on the same contig (Choi 
et al. (2017) table S13). Just one gene (TELCIR_01265) within Choi’s study was 
also predicted to be under selection by IVM on Farm 2, with no genes identified 
in the Farm 3 data. This gene does not appear to have a C. elegans homologue; 
it has a macin domain and may be involved in the defense response.  
A comparison of SNP data was also undertaken. ddRAD-Seq SNPs with data from 
at least ten individuals in each sample population, and with an FST z-score of 2 or 
greater (the lowest score reported by Choi; SNPs with no z-score reported were 
discarded) were selected, providing 149 SNPs to compare with the present study. 
As Choi et al. had aligned their data to the PRJNA72569 genome, the SNPs could 
not be directly compared to the Tci2 data. Instead, these 149 SNPs were 
compared with the PRJNA72569 contigs containing the equivalent Tci2 genes 
identified in each farm analysis. Both farms had just one PRJNA72569 gene 
containing a ddRAD-Seq SNP. This gene was TELCIR_14323 on PRJNA72569 contig 
5289, the equivalent gene of g50265 on Tci2 contig 2028 (Table 6.14). This gene 
is predicted to have transcriptional regulatory activity and contains a NAB co-
repressor domain. The C. elegans homologue of this gene, mab-10, is widely 
expressed in the worm, and is involved in the moulting cycle (Harris and Horvitz, 
2011) and reproductive morphology (Hodgkin, 1983). Although no other ddRAD-
Seq SNPs were identified within PRJNA72569 genes on either farm, ddRAD-Seq 
SNPs on PRJNA72569 contigs shared between the studies were identified 
(Appendix 12). Of these, three PRJNA72569 contigs were of particular interest. 
In total, four ddRAD-Seq SNPs were identified between PRJNA72569 contig 
40:220119-220176, roughly 200,000 bp from TELCIR_01028, predicted to be the 
homologue of the C. elegans gene glb-4, identified in both farm analyses (Table 
6.15). Of the four SNPs, all had a z-score >2.5, with one displaying a high z-score 
>4.5. Secondly, a ddRAD-Seq SNP on PRJNA72569 contig 1274 was identified. 
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This SNP was 3859 bp from the gene TELCIR_07666, which is a single exon of 
unknown function (most likely to be a TE), and was also identified in both farm 
datasets. Lastly, two ddRAD-Seq SNPs were present on PRJNA72569 contig 43. In 
the Farm 2 dataset, four PRJNA72569 equivalent genes were identified on this 
contig with the following C. elegans homologues; mpz-1, mnk-1, rhgf-2 and lgc-
27. The closest gene to a SNP was Tci-rhgf-2, approximately 49 kb away.  
6.3.5.2 H. contortus studies 
Comparisons of H. contortus samples from across the globe 
A very interesting analysis comparing H. contortus isolates across and within 
continents was reported by Sallé et al. (2019). As part of this work, WGS of IVM 
susceptible (NAM, ZAI and AUS.2) and IVM resistant (STA.1, STA.3 and AUS.1) 
isolates were compared within continent by pairwise XP-CLR analysis. This is a 
cross-population composite likelihood ratio test. Both the allele frequency 
differentiation relative to the reference population (under assumptions of 
neutrality within the reference population), and the extent of LD are combined 
to locate regions of recent selection within the genome (Chen et al., 2010). 
Genes of interest within 2000 bp of a selection hit were searched for, with six 
genes identified as putatively under selection by IVM: aex-3, B0361.4, glc-4, pgp-
11, snf-9 and unc-24 (Sallé et al., 2019). None of these genes appeared in either 
the Farm 2 or Farm 3 analyses, but members of the same gene classes were 
detected. pgp-3 appeared to be under selection on both farms, while snf-3 and 
snf-10, members of the neurotransmitter:sodium symporter family, were 
identified on Farms 2 and 3 respectively. On Farm 2 only, the GluCl gene, glc-3, 
and the gene unc-32, were identified as potentially under selection by IVM.  
H. contortus genetic cross (BUG Consortium) 
A study using a laboratory cross between the drug-susceptible H. contortus 
isolate MHco3(ISE) and the triple resistant isolate MHco18(UGA), resistant to BZ, 
LEV and IVM, identified a large region of differentiation by FST on Chromosome V 
associated with IVM selection (Laing, pers comm). This region was in two main 
peaks: V:37-38 Mbp and V:45-48 Mbp. Corresponding regions had been detected 
by Doyle et al. (2019) in two laboratory backcrosses under IVM selection 
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(MHco3(ISE)xMHco4(WRS) and MHco3(ISE)xMHco10(CAVR)) and also by Sallé et al. 
(2019) as described above. The BUG Consortium generated a genetic cross 
between female MHco3(ISE) and male MHco18(UGA); F1 progeny were crossed 
with their siblings to provide the F2 generation, which was treated with IVM. 
Pool-Seq was performed on 200 F3 L3 obtained pre- and post-IVM treatment of 
the F2 generation. In addition to this, RNA-Seq was performed using the F2 IVM-
treated adult worms and untreated F2 controls. H. contortus genes were 
compared with H. contortus homologues of Tci2 genes in the present study.  
On Farm 2, five Tci2 genes were identified as homologues of four H. contortus 
genes located within the Chromosome V region identified by the BUG consortium 
(Table 6.16). The H. contortus gene HCON_00154992 is a predicted 7TM-GPCR 
serpentine receptor of class R with no C. elegans homologue. HCON_00155250 is 
a homologue of two Tci2 genes (on separate Tci2 contigs) within the Farm 2 
data. It is predicted to encode an uncharacterised oxidoreductase, with a C. 
elegans homologue E02C12.19. HCON_00155250 was downregulated in expression 
in both male (-0.73 log2 fold change, p<0.001) and female (-1.09 log2 fold 
change, p<0.01) IVM treated H. contortus (Laing, pers comm). A third gene, 
HCON_00161360 is a homologue of the C. elegans gene, phat-1. phat-1 contains 
a ShKT domain and is expressed in the pharyngeal gland cells, which are thought 
to be equivalent to mammalian salivary glands (Smit et al., 2008). The last gene 
identified in both studies was HCON_00162680, the homologue of ape-1, a gene 
involved in negative regulation of p53-induced apoptosis in C. elegans 
(Bergamaschi et al., 2003). No genes identified within the Farm 3 data were also 
found within the Chromosome V region identified by the BUG Consortium. 
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Table 6.16: Genes shared between Farm 2 and Chromosome V peak of the BUG Consortium Haemonchus contortus genetic cross.  
Tci2 genomic 
location1 
Tci2 
transcript 
Haemonchus 
contortus gene 
Haemonchus 
contortus 
genomic 
location2 
Caenorhabditis 
elegans gene 
stable ID 
Caenorhabditis 
elegans gene 
Gene description Differentially 
expressed?3 
441:0-100004 g26855.t1 HCON_00154992 V:37059054-
37061784 
 NA NA 7TM-GPCR, 
serpentine 
receptor class R 
(Str) 
No 
30:620000-
640000 
g2278.t1 HCON_00155250 V:37333743-
37339458 
WBGene00271797 E02C12.19 Uncharacterised 
oxidoreductase 
Dhs-27 
Yes; males 
and females 
(p<0.01) 
708:120000-
140000 
g33217.t1 HCON_00155250 V:37333743-
37339458 
WBGene00271797 E02C12.19 Uncharacterised 
oxidoreductase 
Dhs-27 
Yes; males 
and females 
(p<0.01) 
357:310000-
320000 
g24147.t1 HCON_00161360 V:45284232-
45287187 
WBGene00016732 C46H11.8 
(phat-1) 
 
Pharyngeal gland 
Toxin-related, 
ShKT domain 
protein   
No 
83:80000-
90000 
g12991.t1 HCON_00162680 V:47133046-
47147156 
WBGene00000146 F46F3.4 
(ape-1) 
Apoptotic 
enhancer 1 
protein 
No 
H. contortus homologues located within regions of genetic differentiation in the Farm 2 data were compared with H. contortus genes identified within a 
region of high FST on Chromosome V following Pool-Seq comparing progeny of F2 treated adults pre- and post-IVM. 1Contig:nucleotide range. 
2Chromosome:nucleotide range. 3RNA-Seq for differential expression of genes between F2 generation H. contortus adult worms treated with IVM and 
untreated controls. Males and females were compared separately. 4This window is rank 1/576 in Farm 2 data. However, Tci2 contig 441 is not present in the 
Farm 3 data. 
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Following comparison with the Chromosome V region, data were compared with 
the H. contortus BUG Consortium RNA-Seq experiment. Genes found to be 
significantly differentially expressed within the RNA-Seq dataset (3660 genes, 
p<0.05) were compared with the genes within high FST windows in this study. A 
total of 106 H. contortus genes, with differential expression values ranging from 
-3.21 to 4.44 log2 fold change, were identified as homologues of Tci2 genes 
within the Farm 2 dataset (Appendix 13). Noteworthy was reduced expression of 
Hco-pgp-3 in IVM-selected H. contortus males (-0.72 log2 fold change) and 
females (-1.45 log2 fold change) compared with the IVM naïve controls. A K+/Cl- 
Co-transporter, kcc-1, showed increased expression in IVM selected H. contortus 
males (0.22 log2 fold change). Several genes involved in metabolism pathways 
were also present, in both datasets, including some involved in lipid metabolism.  
Of the genes shared by Farm 2, the third greatest increase in expression (by 
decreasing rank order), in IVM selected H. contortus adults was a LGIC, lgc-42 
(2.14 log2 fold change in males). An acetylcholine receptor (AChR) subunit, acr-
17, also showed increased expression in IVM selected H. contortus males (1.03 
log2 fold change). Only two H. contortus genes showed increased expression 
greater than lgc-42 in IVM selected adults relative to controls; HCON_00142620, 
a nematode gene of unknown function, putatively a peptidase, and 
HCON_00102660, also of unknown function (4.08 and 4.44 log2 fold change 
respectively, males). The gene with the greatest down-regulation in IVM 
selected adults in the Farm 2 data was the predicted homologue of ZC155.4, a 
gene involved in lipid metabolism (-3.21 log2 fold change, females). Another 
gene, a complement receptor, previously identified on both Farm 2 and Farm 3 
in the FST analysis, F36H2.3, was also reduced in IVM selected females (-1.98 log2 
fold change) but was increased in males (0.37 log2 fold change).  
Farm 3 had 12 H. contortus homologues identified as differentially expressed 
between the H. contortus F2 generation IVM treated and untreated adults. These 
are shown in Appendix 13. The gene with the greatest reduction in expression in 
the IVM selected females was F36H2.3, followed by pgp-3. Those with increased 
expression included snf-10, a member of the sodium:neurotransmitter symporter 
family (0.44 log2 fold change, males), and lev-9, important in clustering of AChRs 
at synapses (Gendrel et al., 2009), (0.70 log2 fold change, males). The gene with 
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the greatest increase in expression was a protein tyrosine phosphatase, T28F4.3, 
with 0.85 log2 fold change in H. contortus males.   
6.3.5.3 Onchocerca volvulus 
Doyle et al. (2017) investigated the genome of the human filarial nematode O. 
volvulus for regions under selection between sub-optimal responders (SOR) and 
good responders (GR) to IVM treatment from clinical subjects in Ghana and 
Cameroon. From their QTL analysis, 403 O. volvulus genes were identified as 
being within regions of genetic differentiation between the SOR and GR worms. 
Using the BIOMART tool in WormBase ParaSite, homologues of these genes were 
identified in C. elegans, H. contortus and T. circumcincta PRJNA72569 genomes. 
In total, homologues were identified for 229 genes (Appendix 14). 
Farm 2 had five Tci2 genes shared with the dataset of Doyle et al. (2017) (Table 
6.17). These included two genes with H. contortus homologues (HCON_00142180 
and HCON_00142190), which lie adjacent to each other on Chromosome V, 
between 15.93-16.01 Mbp. Farm 3 had only a single gene with a homologue 
identified within the O. volvulus dataset (Table 6.18). This was a TE, which in H. 
contortus was positioned within an intron of the gene HCON_00191600, a 
dehydratase, a homologue of C. elegans R107.2.  
Doyle et al. (2017) also categorised genes as being within pathways of interest 
potentially related to IVM sensitivity. Each farm dataset was manually searched 
for these genes, using the descriptive part of the C. elegans gene name (e.g. 
‘unc’) to find members of the same gene class. These included those associated 
with (i) IVM, (ii) neurotransmission, (iii) LIN-12/Notch signalling, (iv) muscle 
assembly/myosin organisation and (v) lipid synthesis and storage/stress. Nine 
Farm 2 genes were identified, one of which was identified previously in the O. 
volvulus comparisons (nrfl-1, Table 6.17). The other eight were in the same 
gene class as O. volvulus genes and included klp-18, unc-32, acs-7, tat-4 and 
four LGIC (Table 6.19). However, the function of these genes may not 
necessarily correspond to the same descriptions as provided for the O. volvulus 
genes by Doyle et al. There were no equivalent genes identified in the Farm 3 
analysis.  
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Table 6.17: Genes within genetically differentiated regions in Farm 2 data with potential homologues also identified in an Onchocerca volvulus ivermectin 
study.  
Tci2 transcript Teladorsagia circumcincta 
PRJNA72569 gene 
Haemonchus contortus 
gene 
Caenorhabditis 
elegans stable ID 
Gene Description 
g10328.t1 TELCIR_08194* HCON_00142190* Y42A5A.1 Metalloaminopeptidase activity 
g26501.t1  
g26501.t2 
TELCIR_13613 HCON_00119540 C01F6.6 
(nrfl-1)1 
Mammalian Na/H exchange regulatory 
factor like 
 
g5596.t1 TELCIR_00201 HCON_00135630 F25B3.3 (rgef-1) Rap Guanine nucleotide Exchange 
Factor homolog 
g37707.t1 TELCIR_12798 HCON_00142180 Y42A5A.4 (cdkl-1) Cyclin-dependent kinase-like 1 
g42704.t1 TELCIR_10244 HCON_00111520 Y56A3A.13 (nft-1) Nitrilase and fragile histidine triad 
fusion protein NitFhit Bis(5'-adenosyl)-
triphosphatase Nitrilase homolog 
Homologues of genes identified within genomic regions of high differentiation between sub-optimal responders and good responders of female O. volvulus 
filarial worms treated with ivermectin were compared with genes identified on Farm 2. An asterisk (*) indicates that a different homologue was identified by 
BIOMART. The gene identified by a BLASTP search of the Tci2 translated nucleotide sequence is provided here. 1Note that this gene was within a pathway 
of interest identified by Doyle et al. as containing more than one gene within QTL regions (see Table 6.19)   
Table 6.18: Genes within genetically differentiated regions in Farm 3 data with potential homologues also identified in an Onchocerca volvulus ivermectin 
study.  
Tci2 
transcript 
Teladorsagia circumcincta PRJNA72569 
gene  
Haemonchus contortus 
gene 
Caenorhabditis elegans 
stable ID 
Gene Description 
g34923.t1 TELCIR_25085 HCON_00192370 NA TE 
Homologues of genes identified within genomic regions of high differentiation between sub-optimal responders and good responders of female O. volvulus 
filarial worms treated with ivermectin were compared with genes identified on Farm 3. TE = Transposable element. 
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Table 6.19: Farm 2 Caenorhabditis elegans homologues with similar description to 
Onchocerca volvulus genes.  
Caenorhabditis elegans 
gene  
(this study) 
Onchocerca volvulus 
gene 
(Doyle et al., 2017) 
Pathway/Functional 
characteristic 
klp-18 klp-11 IVM-associated 
lgc-27 
lgc-39 
lgc-41 
lgc-42 
lgc-46 
lgc-47 
Neurotransmission 
unc-32 unc-44 
 
unc-17 
unc-31 
unc-26 
 
unc-82 
IVM-associated 
 
Neurotransmission 
 
 
Muscle assembly/myosin 
organisation 
nrfl-1 nrfl-1 Neurotransmission 
acs-7 
tat-4 
acs-16 
tat-2 
Lipid synthesis and 
storage/stress 
The pathway or functional characteristic is given for each of the O. volvulus genes. These 
genes were identified by Doyle et al. within QTL peaks and were predicted to have 
functional characteristics or pathways in common with other genes identified in QTLs in the 
data from Ghana or Cameroon. Genes of the same ‘gene class’ were identified in the Farm 2 
data. Nevertheless, it is important to note that these genes may not have the same function 
as those identified by Doyle et al. 2017. 
6.3.6 P-glycoproteins did not show copy number variation 
between pre- and post-treatment samples  
Differences in copy number of genes or genomic regions can arise between 
individuals or populations following duplication, or deletion, of a gene or 
genomic region within a genome. If whole genes are duplicated, these are known 
as paralogues, and it has been suggested that increased copy number of Tci-pgp-
9 is associated with IVM resistance (Choi et al., 2017; Turnbull et al., 2018). In 
contrast, deletion of genes or genomic regions has been associated with BZ (Kwa 
et al., 1993) and LEV (Barrère et al., 2014) resistance. To investigate whether 
any copy number variants (CNV) were associated with IVM resistance on these 
farms, the program CNV-Seq (Xie and Tammi, 2009), was used to compare 
aligned read counts between the pre- and post-IVM treatment samples for each  
farm (Figure 6.1). As CNV is less accurately determined using Pool-Seq data than 
for individual sequencing, data were filtered as described in 2.9.9. For each 
comparative analysis, the post-IVM sample was compared to the pre-IVM sample. 
Hence, if the log2 (read count ratio) is positive, read counts are higher in the 
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post-IVM sample compared to the pre-IVM sample from the same farm. It is 
important to note that the mean read counts for all post-IVM samples were 
significantly lower (p<0.05) than for all pre-treatment samples (Table 6.20).  
 
Figure 6.1: Farm 2 copy number variation. Each point represents one 5 kb window. Those 
coloured in blue are significant at p<0.00001. The dashed lines indicate log2 (read count 
ratio) of 1 and -1. Farm 3 pairwise comparisons were similar in appearance. 
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Table 6.20: Mean and median read counts per 5000 bp window for each sample.  
Sample Mean read count per 
window 
Median read count per 
window 
Farm 2 Pre 2983 2689 
Farm 2 Post 2880 2592 
Farm 3 Pre_A 3100 2803 
Farm 3 Pre_B 3033 2741 
Farm 3 Post_A 2759 2494 
Farm 3 Post_B 2793 2523 
Read counts reported by CNV-Seq after first filtering out unmapped reads. 
No deletions were identified in the post-IVM samples following filtering. A 
narrow, 98 bp intronic region within a cation transmembrane transporter gene 
was identified to have increased CNV on Farm 2 (log2(read count ratio) 3.6).   
However, apart from this stack of reads, the region generally had few reads 
mapping, and it is important to note that although the post-IVM read count was 
greater than 1.5x the sample mean, the pre-treatment read count was reduced 
(0.25x sample mean). The region was located within the first intron of a 10-exon 
gene (Table 6.21). 
CNV regions identified on Farm 3 were frequently larger than those on Farm 2, 
ranging from just under 2 kb to almost 15 kb wide. Four CNV regions had the 
majority of reads aligning with MAPQ >20 (Table 6.21). One CNV region located 
on Tci2 contig 209 appeared to cover most of g18981, a predicted homologue of 
HCON_00078870. Two other regions were within introns of genes on contigs 382 
(g24918) and 755 (g34397). C. elegans homologues of these genes were 
predicted to be nep-1 and drh-3. Two-stage RNAi of nep-1 in dgk-1 mutants 
confers resistance to paralysis in the presence of the acetylcholinesterase 
inhibitor, aldicarb (Sieburth et al., 2005). This nep-1 homologue, g24918, was 
previously identified within a genetically differentiated region common to both 
farms (Table 6.14). The fourth CNV region at the 5’ end of Tci2 contig 2721, was 
approximately 5 kb in width and separated from the rest of the contig by a long 
string of NNNs. No genes were present within the region.  
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Table 6.21: Genes and their predicted homologues/equivalent PRJNA72569 genes within or containing a region of altered copy number by read count.  
Tci2 contig 
CNV window1 
Average 
log2 read 
count 
ratio 
(Post:Pre)4 
Tci2 
gene 
Teladorsagia 
circumcincta 
PRJNA72569 
gene 
Haemonchus 
contortus gene 
Caenorhabditis 
elegans gene 
Gene description Actual 
CNV 
length 
Notes 
209:532501-
5375002 
1.28-1.33 g18981 NA HCON_00078870 NA SET domain 5185 bp Almost 
covers 
Tci2 gene 
annotated.  
382:262501-
2675002 
1.24-1.30 g24918 TELCIR_03613 NA ZK20.6 (nep-1) Endothelin 
converting enzyme 
12746 bp Within an 
intron 
(3/4)5 
755:307501-
3125002 
1.19-1.44 g34397 TELCIR_18240 HCON_00009250 D2005.5 (drh-3) DExD/H-box 
helicase 58 
3808 bp Within an 
intron 
(7/14)5 
755:125001-
1325003 
3.63 g34388 TELCIR_06296 HCON_00127120 ZK185.5 Cation 
transmembrane 
transporter activity 
98 bp Within an 
intron 
(1/9)5 
Comments are provided based on visualisation of aligned BAM files in Artemis. 1Contig:nucleotide range. 2Region identified on Farm 3, all pairwise 
comparisons. 3Region identified on Farm 2. 4The range is provided for Farm 3 regions. 5Denotes (intron containing CNV / total number of introns) TE = 
Transposable element. 
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Tci-pgp-9 (g25235) was predicted to be single-copy in the Tci2 genome following 
identification of Tci2 equivalent genes of the four pgp-9 homologues identified 
in the PRJNA72569 genome by Choi et al. (2017) (Figure 6.2, Appendix 15). 
g25235 was located on Tci2 contig 391:57466-77288. This contig was not present 
in any of the CNV-Seq results previously filtered. To understand why pgp-9 was 
not present in the filtered CNV results, data for this region were extracted, 
including regions 391:57350-77300. Differences between pre- and post-treatment 
samples appeared minimal (log2(read count ratio) 0.15 to -0.21), and for most 
windows, read count ratios were non-significant. Nevertheless, the mean read 
count over g25235 was higher than the mean read count for each sample, which 
might indicate increased copy number of pgp-9 within the population as a whole 
relative to MTci2, or the presence of falsely collapsed paralogues within the 
genome. 
Another P-glycoprotein, pgp-3, had been previously identified by FST analysis of 
both Farm 2 and Farm 3 data. In addition, changes in expression of Tci-pgp-3 had 
been described in a study comparing a sensitive and a multi-drug resistant 
isolate of T. circumcincta (Dicker et al., 2011b). Nevertheless, pgp-3 was not 
present in the filtered CNV data. Read CNV data were extracted for each of 
g6221, g18187, g20732 and g39213, identified as full or partial homologues of 
pgp-3 (Figure 6.2 and Figure 6.3, Appendix 15). Overall there was considerable 
variation across the length of the genes as to whether the log2(read count ratio) 
was increased or reduced. Values tended to vary between -0.5 and 0.5 for all 
four genes examined indicating only small differences and most were not 
deemed to be significant. In comparison to pgp-9, the mean read count for each 
gene was either the same or lower than the mean read count for each sample, 
which likely reflects the multiple pgp-3 haplotypes remaining in the Tci2 draft 
genome, in contrast to pgp-9, which was assembled as a single gene. In 
conclusion, there is no evidence of selection for CNV of pgp-9 or pgp-3 with IVM 
treatment in this study. 
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Figure 6.2: A Neighbour-Joining tree of P-glycoprotein amino acid sequences. Using 
Geneious® v9.1.8, the amino acid sequences of the top two PRJNA72569 proteins 
(TELCIR_19955 and TELCIR_20127) identified as partial homologues of CEL-PGP-3, were 
compared with those identified as PGP-3 within the Tci2 genome (G6221.T1, G18187.T1, 
G39213.T1, G20732.T1 and G18181.T1). A partial sequence of TCI-PGP-3 by Dicker et al. 
(2011b) was also included for comparison. CEL-PGP-4 was included as Dicker et al. 
suggested that the partial sequence had similarity to both CEL-PGP-3 and CEL-PGP-4. Both 
PGP-9 isoforms identified in Tci2 are shown (G25235.T1 and .T2), with the PRJNA72569 
PGP-9 proteins (TELCIR_13812, TELCIR_19247, TELCIR_19884 and TELCIR_08885) and the 
Caenorhabditis elegans PGP-9. Genetic distance model: Jukes-Cantor, no outgroup was 
used.   
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Figure 6.3: Alignment of amino acid sequences of Tci2 gene copies of PGP-3. Using Geneious® v9.1.8, the amino acid sequences of CEL-PGP-3, the partial 
PGP-3 sequence identified by Dicker et al. (2011b), and the two identified PRJNA72569 partial proteins predicted to be partial homologues of PGP-3 were 
compared to the five putative Tci2 PGP-3 proteins. Each amino acid sequence is shown in black where there is full consensus, grey where there is not 
consensus. Gaps in alignment are indicated. The consensus sequence is at the top. Sequence similarity is indicated by a coloured bar plot between the 
consensus and sample sequences. Where there is complete agreement between sequences this is shown in green, with reduced height and varying colour 
from yellow to red for decreased consensus. 
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6.3.7 Investigation of multiple gene copies in the Tci2 genome 
During the course of the analysis it became apparent that the Tci2 genome 
contained multiple copies of genes that were annotated as single copy genes in 
the PRJNA72569 genome. During alignment of reads to a genome, it is possible 
that reads are falsely split between different gene copies, if these are 
haplotypes rather than paralogues. This affects the overall coverage depth and 
allele frequencies and can generate false positive or negative results. 
To compare coverage of genes identified in the analysis to determine whether 
they were allelic copies or paralogues, a standard, β-tubulin isotype-1, was 
chosen for comparison. The β-tubulin isotype-1 gene is expected to be single 
copy, and has only a single copy, TELCIR_01271, in the PRJNA72569 genome. 
However, in the Tci2 genome two gene copies of β-tubulin isotype-1 were 
identified. These were adjacent on the same Tci2 contig, separated by a short 
region. The read coverage over each of these genes was no different to the 
mean read coverage over the genome. This was concerning, as it could indicate 
that many genes are duplicated, with read coverage split. Although there was no 
difference in the amino acid sequences, the gene sequences had only 97.7% 
pairwise identity, primarily differing within the first two introns (Figure 6.4).  
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Figure 6.4: Pairwise alignment of the two copies of Tci2 β-tubulin isotype-1 genomic sequence. Nucleotide sequences from the first to last exon, including 
introns, of the manually annotated gene copies were aligned using the ‘geneious alignment’ tool in Geneious® v9.1.8. Exons are indicated by blue 
annotations. Each sequence is indicated on a separate line, with a consensus sequence displayed at the top. Sequence similarity is indicated by a coloured 
bar plot between the consensus and sample sequences. Where there is complete agreement between sequences this is shown in green, with reduced 
height and varying colour from yellow to red for decreased consensus. Differences between sample sequences are highlighted in black, with gaps 
indicated (i.e. indels relative to another sequence). Regions with no difference to another sequence (or no overlapping sequence) are shown in grey. 
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A gene close to TELCIR_01271, a homologue of Cel-hprt-1, had three copies 
within the Tci2 genome, whereas within the PRJNA72569 genome it only had one 
copy, with a further two partial copies of two exons each. This gene is 
frequently used as a normalising gene for qPCR (Stephens et al., 2011; Żyżyńska-
Granica and Koziak, 2012). The Tci2 hprt-1 copies were similar over the exonic 
regions (96.4% pairwise identity), with similar translated nucleotide sequences 
(Figure 6.5) but were very different when the full-length gene sequences were 
compared (42.2% pairwise identity, Figure 6.6). A simple PCR was designed to 
experimentally assess the number of gene copies of hprt-1 in 95 individual Tci2 
L3. Primers were designed to amplify only one of each of the Tci2 hprt-1 gene 
copies as described in 2.4.5. All primer sets produced amplified products. 
Nevertheless, a maximum of two amplicons were present in each of the Tci2 L3 
tested, as expected for a single gene in a diploid organism.  
It was decided to align reads to the PRJNA72569 genome to compare results with 
the Tci2 analysis. Due to the more fragmented nature of this genome, and 
because of time constraints, a full analysis of the data was not performed. The 
mean read depth over TELCIR_01271 was twice that of the Tci2 β-tubulin 
isotype-1 gene copies (~33-40x to ~73-80x). Nevertheless, the genome wide 
mean depth of coverage was similar for both genomes, suggesting that each had 
the potential for similar proportions of artefactually duplicated genomic regions. 
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Figure 6.5: Alignment of HPRT-1 with orthologues. The amino acid sequences of HPRT-1 were obtained from WormBase ParaSite for each of 
Caenorhabditis elegans (Y105E8B.5.1) and Haemonchus contortus (HCON_00005150) and aligned in Geneious® v9.1.8 with the amino acid sequences as 
annotated by AUGUSTUS (BRAKERv2.0) of the three Tci2 HPRT-1 copies (Tci2 contigs 77, 1057 and 3165). Each sequence is indicated on a separate line, 
with a consensus sequence displayed at the top. Sequence similarity is indicated by a coloured bar plot between the consensus and sample sequences. 
Where there is complete agreement between sequences this is shown in green, with reduced height and varying colour from yellow to red for decreased 
consensus. Differences between sample sequences are highlighted in grey within the sequence, while regions with no difference to another sequence (or 
no overlapping sequence) are shown in black. Deletions are indicated as gaps in the sequence. 
 
Figure 6.6: Three Tci2 gene copies of hprt-1 aligned. The genes were extracted from the Tci2 contigs and aligned in Geneious® v9.1.8. Exons are annotated 
in blue. Primer positions are indicated by lime green vertical lines. Each sequence is shown on a separate line, with a consensus sequence displayed at the 
top. Sequence similarity is indicated by a coloured bar plot between the consensus and sample sequences. Where there is complete agreement between 
sequences this is shown in green, with reduced height and varying colour from yellow to red for decreased consensus. Differences between sample 
sequences are highlighted in black within the sequence, with gaps indicated (i.e. indels relative to another sequence). Regions with no difference to 
another sequence (or no overlapping sequence) are shown in grey. 
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6.3.8 Comparison of genes identified within each genome 
alignment analysis 
Results obtained following alignment to each of the T. circumcincta genomes 
were compared. Genes within regions of genetic differentiation by FST analysis 
for each alignment were extracted and compared. Nine equivalent genes were 
identified in both Farm 2 alignment analyses (Table 6.22). Two of these genes in 
the Farm 2 comparison were LGICs; lgc-39 and lgc-42. The gene TELCIR_05875, 
identified as the equivalent gene of both Tci2 g2278 and g33217, was predicted 
to be a homologue of HCON_00155250, an oxidoreductase (Table 6.22). This 
gene is located centrally within the Chromosome V locus of genetic 
differentiation, which appears to be under selection by IVM treatment in H. 
contortus (Laing, pers comm). A single gene was identified in Farm 3 data, gcy-
22, a receptor-type guanylate cyclase (Table 6.23).  
Comparison of the PRJNA72569 alignment analysis performed in this study with 
the NZ study by Choi et al. (2017) revealed that no genes within regions of 
differentiation were identified in both studies. No ddRAD-Seq SNPs identified by 
Choi et al. (2017) were found to reside within the high FST 10 kb windows in this 
study. However, one PRJNA72569 contig contained a ddRAD-Seq SNP identified 
by Choi et al. (2017) and also contained a high FST 10 kb window in the Farm 2 
data. The ddRAD-Seq SNP was PRJNA72569 contig 93:73526 and the 10 kb 
window in this study was located at 93:130000 – 140000 bp. No gene was 
annotated within this window. Two contigs were identified which contained a 
differentiated region in the Farm 3 PRJNA72569 alignment data and a SNP in the 
ddRAD-Seq data of Choi et al. (2017). The ddRAD-Seq SNPs were PRJNA72569 
contig 1:1171769, with a 10 kb window located at 1:210000 - 220000 bp, 
containing a TE, and PRJNA72569 contig 29:339261, with a 10 kb window located 
at 29:500000 - 510000 bp. The latter window was covered by a 17-exon gene, of 
unknown function. 
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Table 6.22: Consensus regions potentially under ivermectin selection identified on Farm 2 following alignment to both Teladorsagia circumcincta reference 
genomes.  
Tci2 genomic 
location1 
Tci2 
transcript 
Teladorsagia 
circumcincta 
PRJNA72569 
gene 
Teladorsagia 
circumcincta 
PRJNA72569 
genomic 
location1 
Haemonchus 
contortus gene 
Caenorhabditis 
elegans gene 
Gene description 
5446:0-10000 g10689.t1 TELCIR_16059 7206:233-
26210 
NA  NA Rho guanyl-nucleotide 
exchange factor activity 
6704:0-10000 g12034.t1 TELCIR_16059 7206:233-
26210 
HCON_000549502 K07D4.7 (ephx-1)2 Ephexin (Eph-interacting GEF) 
homolog 
6871:0-10000 g12159.t1 TELCIR_13217 4303:7822-
25124 
HCON_00101310 F36H1.6 (alh-3) 10-formyltetrahydrofolate 
dehydrogenase 
229:0-10000 g19789.t1 
g19789.t2 
TELCIR_15799 6890:483-
18301 
HCON_00089890 Y39A3B.2 (lgc-42) LGIC 
30:620000-
640000 
g2278.t1 TELCIR_05875 756:104825-
112625 
HCON_00155250 E02C12.19 CHK kinase-like, 
uncharacterised oxidoreductase 
Dhs-27 
708:120000-
140000 
g33217.t1 TELCIR_05875 756:104825-
112625 
HCON_00155250 E02C12.19 CHK kinase-like, 
uncharacterised oxidoreductase 
Dhs-27 
797:130000-
140000 
g35340.t1 TELCIR_14359 5320:17976-
24085 
HCON_00125890 F29B9.4 (psr-1) Bifunctional arginine 
demethylase and lysyl-
hydroxylase 
928:180000-
190000 
g37932.t1 
g37932.t2 
g37932.t3 
g37932.t4 
TELCIR_14226 5200:152-
24827 
HCON_00145000 F09G2.5 (lgc-39) LGIC   
1242:150000-
160000 
g42660.t1 TELCIR_13482 4516:9020-
30978 
HCON_00121072 R06F6.4 (set-14) SET domain-containing protein 
14  
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Tci2 genomic 
location1 
Tci2 
transcript 
Teladorsagia 
circumcincta 
PRJNA72569 
gene 
Teladorsagia 
circumcincta 
PRJNA72569 
genomic 
location1 
Haemonchus 
contortus gene 
Caenorhabditis 
elegans gene 
Gene description 
1242:150000-
160000 
g42661.t1 TELCIR_13482 4516:9020-
30978 
HCON_00121072 R06F6.4 (set-14) SET domain-containing protein 
14 
76:420000-
430000 
g5091.t1 TELCIR_09340 1909:54809-
65032 
HCON_00142160 H19N07.1 (erfa-3) Eukaryotic Release Factor 
homolog 
2498:80000-
90000 
g52925.t1 TELCIR_11587 3104:34-34009 HCON_00144870 T01D3.1 Calcium ion binding. Motor 
neuron axon guidance 
Reads were aligned to both available Teladorsagia circumcincta reference genomes. Tci2 genes identified within regions of genetic differentiation were 
BLASTP searched for equivalent genes in the PRJNA72569 genome. Those identified were compared to the list of PRJNA72569 genes within regions of 
genetic differentiation in the PRJNA72569 alignment analysis. 1Contig:nucleotide range. 2Note, these are the predicted orthologues of TELCIR_16059. 
However, they were not identified during BLASTP search using the WSI farm_blast for G10689.T1.
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Table 6.23: Consensus regions potentially under ivermectin selection identified on Farm 3 following alignment to both Teladorsagia circumcincta reference 
genomes.  
Tci2 genomic 
location1 
Tci2 
transcript 
Teladorsagia 
circumcincta 
PRJNA72569 
gene 
Teladorsagia 
circumcincta 
PRJNA72569 
genomic location1 
Haemonchus 
contortus gene 
Caenorhabditis 
elegans gene 
Gene description 
155:330000-
340000 
g16586.t1 TELCIR_04718 496:50000-60000 HCON_00131630 T03D8.5 (gcy-
22) 
Receptor-type guanylate 
cyclase gcy-22 
 
Reads were aligned to both available reference genomes. Tci2 genes identified in the first analysis were BLASTP searched for equivalent genes in the 
PRJNA72569 genome. Those identified were compared to the list of PRJNA72569 genes within regions of genetic differentiation in the PRJNA72569 
alignment analysis. 1Contig:nucleotide range.
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6.4 Discussion 
Many studies have explored IVM resistance in laboratory isolates and field 
populations of different nematode species, with no clear consensus to date. Of 
the genes identified, most have been experimentally examined in either C. 
elegans or H. contortus with only a few also investigated in T. circumcincta. The 
aim of this study was to identify potential markers of IVM resistance using WGS. 
Following bioinformatic analysis, over 600 genes were identified within regions 
of genetic differentiation on both farms. Some regions were the same in each 
farm analysis, however most were different. Genes potentially related to IVM 
resistant phenotypes were identified and are discussed below. Note that a 
ranking is indicated for certain genes, relating to the FST value of the 10 kb 
window containing the gene. Although this provides one opportunity to 
determine how important a gene may be for IVM resistance, it does not 
necessarily correspond directly. For example, in P. falciparum populations, the 
kelch gene has undergone a soft sweep, with multiple alleles containing non-
synonymous SNPs selected by artemisinin treatment, reducing FST values relative 
to nearby genes (Cheeseman et al., 2015). All ranking data can be found within 
Appendices 6 and 7. 
6.4.1 Neuronal genes 
Key IVM candidate genes include the GluCl receptors (Dent et al., 1997; Dent et 
al., 2000). A single GluCl gene was identified in this study, a predicted 
homologue of Cel-glc-3 (rank 172 and 200/576, Farm 2 analysis). A related gene, 
glc-4, was recently identified when comparing IVM sensitive and resistant H. 
contortus individuals (Sallé et al., 2019). Cel-glc-3 was originally identified as an 
IVM sensitive GluCl, when it was shown to form a homomeric receptor in the 
Xenopus oocyte expression system (Horoszok et al., 2001). A response to IVM was 
elicited at IVM concentrations of > 0.1 µM, but not at 0.01 µM. In C. elegans this 
gene appears to be involved in regulating both locomotion (Cook et al., 2006) 
and searching behaviour (Chalasani et al., 2007), with both deletion mutants or 
increased expression of glc-3 affecting this behaviour. It is expressed in the AIY 
interneurons, part of the pathway controlling normal searching behaviour and 
duration (Wenick and Hobert, 2004; Chalasani et al., 2007). In H. contortus, a 
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small increase in expression of glc-3 was reported in a triple resistant (BZ, LEV, 
IVM) isolate (UGA/2004), compared to a drug susceptible isolate (US/HcS) 
(Williamson et al., 2011). glc-3 may therefore be of interest in IVM resistance, 
but its role is difficult to interpret, as it has not been identified consistently in 
other studies and was not identified in the Farm 3 analysis. Other Tci2 genes 
potentially involved in chemosensory pathways were identified, including acr-15 
(Sellings et al., 2013), deg-3/des-2 (Yassin et al., 2001), snf-3 (Peden et al., 
2013), and R05F9.7 in the Farm 2 analysis and snf-10 (Yemini et al., 2013) in the 
Farm 3 analysis.    
Other LGIC have been associated with IVM resistance including GABA receptors in 
H. contortus (Blackhall et al., 2003) and lgc-54, for which the ligand is unknown 
in T. circumcincta (Choi et al., 2017). Analysis of Farm 2 data identified two 
LGICs, predicted to be lgc-39 (rank 322/576) and lgc-42 (rank 285/576). 
Importantly, these were identified following alignment of reads to either T. 
circumcincta genome. SNPs above the Farm 2 ddRAD-Seq FST threshold were 
identified ~80 kb distant to lgc-39 (FST 0.1, odds ratio 0.1), and ~320 kb distant 
to lgc-42 (FST 0.1, odds ratio 0.1). If these contigs have been correctly 
assembled, this may suggest a wider region of selection surrounding these genes. 
Furthermore, increased expression of Hco-lgc-42 in IVM resistant male H. 
contortus (2.14 fold) has been observed compared to untreated individuals 
(Laing, pers comm). Little information is available regarding these two LGICs in 
the literature, however both are predicted to be GABA or glycine receptors. 
Therefore, although these genes may be correlated with IVM resistance on Farm 
2, their role in IVM sensitivity is difficult to predict.  
A third LGIC identified as part of the Farm 2 analysis was lgc-27 (rank 66/576). 
This also had a ddRAD-Seq SNP identified ~300 kb distant (FST 0.18, odds ratio 
13.8). Comparison with Choi’s study identified two SNPs on the same 
PRJNA72569 contig as the equivalent gene (Choi et al., 2017), however lgc-27 
was not identified when Farm 2 reads were aligned to the PRJNA72569 genome. 
Cel-lgc-27 is not well characterised. RNAi of lgc-27 extended the lifespan of 
mutant dauer larvae, which would usually be expected to die after 10-12 days 
following rapid hydrolysis of lipid stores (Xie and Roy, 2012). This gene may play 
a role in prolonging survival during periods of starvation, which might occur 
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following exposure to IVM. A fourth Tci2 gene was predicted to be Cel-lgc-41 
(rank 549/576). However, this gene is more likely to be a homologue of Hco-unc-
49. In C. elegans, the protein UNC-49 is a GABA receptor subunit for which IVM 
was previously identified to be a ligand (Hernando and Bouzat, 2014). Expressed 
in L1 muscle cells, IVM appeared capable of antagonising the effect of both 
GABA and piperazine on muscle, apparently irreversibly, but did not act as an 
agonist itself. Although this gene has a comparatively low ranking by FST, it does 
have a clearer association with IVM than many others and may be of interest for 
further study. No LGICs were identified in the Farm 3 analysis.  
IVM resistance in C. elegans has been demonstrated with mutations in three 
genes affecting pharyngeal pumping (Dent et al., 2000). In parasites, two in 
vitro tests are available to assess IVM phenotype which rely upon the action of 
IVM to induce pharyngeal paralysis and starvation (Gill et al., 1995; Alvarez-
Sanchez et al., 2005b). Two neuronal genes related to pharyngeal pumping were 
identified, which may be involved in IVM resistance. gar-3, a muscarinic AChR, 
was identified in the Farm 2 analysis (rank 55/576) (Hwang et al., 1999; Park et 
al., 2003). gar-3 appears to play an important role in enabling sufficient time for 
filling of the pharyngeal terminal bulb with food (Steger and Avery, 2004). A 
gene predicted to be a homologue of the neprilysin Cel-nep-1 was identified in 
both farm analyses, although the exact homology is uncertain. This gene was 
within the highest ranked region by FST in the Farm 3 analysis. Neprilysins are 
transmembrane zinc metalloendopeptidases which catalyse hydrolysis of 
peptides expressed on the extracellular plasma membrane, turning off signalling 
events (Turner et al., 2001). In C. elegans, 26 neprilysin genes are listed on 
WormBase and there are several neprilysin genes with differing roles present in 
humans (Turner et al., 2001). Expression of Cel-nep-1 was found within the 
pharyngeal cells in all life stages, and also in a single head neuron in adults 
(Spanier et al., 2005). In Cel-nep-1 knockout mutants, a nine-fold reduction in 
pharyngeal basal activity was identified by electropharyngeogram compared with 
wildtype worms. Evidence for a link with IVM comes from studies on filarial 
worms, where following exposure to 100 nM IVM in vitro, a reduction in 
expression of Bma-nep-1 of -3.92 log2 fold was apparent in adult female Brugia 
malayi compared to unexposed worms (Ballesteros et al., 2016). Choi et al. 
(2017) detected an increase in expression of TELCIR_03613 (log2 ratio 3.22) in 
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their triple resistant strain compared to their Sinbred strain. TELCIR_03613 is the 
predicted equivalent gene of the Tci2 neprilysin identified in both farm analyses. 
In contrast, in H. contortus RNA-Seq studies a reduction in expression of a 
neprilysin, Hco-nep-22 (-0.26 to -0.68 fold change), was reported in IVM treated 
adults (Laing, pers comm). A CNV within an intron of the Tci2 nep-1 homologue 
was identified in the Farm 3 analysis. In total, five neprilysins were identified in 
the Farm 2 ddRAD-Seq and Pool-Seq analyses. The mode of action of IVM on 
these genes is unclear, but they may be of interest for further study. 
lev-9, a secreted protein essential in C. elegans for clustering of AChRs at 
synapses, and which is expressed in body wall muscle cells (Gendrel et al., 
2009), was one of only three ‘neuronal’ genes identified by GO terms in the 
Farm 3 analysis. It is possible that alteration of this protein may affect 
expression or clustering of AChRs and the worm’s response to anthelmintics. 
However, AChRs are associated primarily with LEV resistance (Fauvin et al., 
2010; Boulin et al., 2011; Barrère et al., 2014; Blanchard et al., 2018) and MPTL 
resistance (Kaminsky et al., 2008; Rufener et al., 2009b; Turnbull et al., 2019). 
AChR subunit genes associated with LEV resistance and MPTL resistance are in 
distinct groups (reviewed by Holden-Dye et al. (2013)). Three of the four AChR 
subunit genes found in the Farm 2 analysis (acr-17, deg-3 and des-2) belong to 
the group associated with MPTL resistance. Both deg-3 and des-2 are expressed 
neuronally, within the PVD neuron and chemosensory neurons of the head region 
(IL2 and FLP cells), and within cell bodies of the tail region (Treinin et al., 1998; 
Yassin et al., 2001). Mutations in deg-3 in C. elegans can result in neuronal 
degeneration (Treinin and Chalfie, 1995) and uncoordinated movement (Chalfie 
and Sulston, 1981; Chalfie and Wolinsky, 1990). The fourth AChR, acr-15, is 
involved in chemosensory responses to nicotine in C. elegans (Sellings et al., 
2013), and also affects body size and locomotion (Yemini et al., 2013). Both deg-
3  (Treinin and Chalfie, 1995) and acr-15 (Sellings et al., 2013) are potential 
homologues of a mammalian α7 nAChR subunit. IVM has been shown to bind 
these subunits as an allosteric modulator, enhancing the binding of the ligand 
choline when functionally expressed in X. laevis oocytes (Krause et al., 1998; 
Collins and Millar, 2010). Mutations in the transmembrane domain of deg-3 
limited the effect of IVM, while other mutations facilitated inhibition by IVM of 
the receptor (Collins and Millar, 2010). Although IVM resistance has not been 
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associated with AChRs in nematodes, a recent study identified that abamectin 
was capable of antagonising nicotinic AChRs from Oesophagostomum dentatum 
when expressed in Xenopus oocytes (Abongwa et al., 2016). Interestingly, the 
response varied with drug concentration. At low doses, abamectin was 
antagonistic, however at higher doses (> 0.3 µM), this antagonism reduced. In 
addition, IVM induced profound inhibition upon the frequency of channel opening 
of levamisole AChRs in C. elegans (Hernando and Bouzat, 2014). 
IVM is also known to effect reproduction (Duke et al., 1991; Scott et al., 1991; 
Sutherland et al., 2003a). gar-3 is involved in protraction of the C. elegans male 
spicule protractor muscles and male mutants were shown to have reduced 
persistence in vulval penetrating behaviour compared with wild type worms (Liu 
et al., 2007). A second gene, lov-1, identified within the Farm 2 analysis was 
also predicted by GO term annotation to affect male mating behaviour. In the 
Farm 3 analysis, a gene predicted to be snf-10 (rank 37 and 59/91) may be 
involved in reproduction. Sallé et al. (2019) also identified a snf gene in their 
GWAS. Sodium:neurotransmitter symporters are proteins which co-transport 
sodium with another molecule, for example GABA, recycling neurotransmitters 
and terminating synaptic transmission (Bröer and Gether, 2012). Cel-snf-10 
appears important for sperm activation within the male (Fenker et al., 2014). 
Although mating between a male and a hermaphrodite C. elegans did not show 
immediate differences in numbers of progeny, over time the snf-10 mutants 
showed reduced numbers of progeny (Fenker et al., 2014). Two other 
sodium:neurotransmitter symporters were identified, both in the Farm 2 
analysis. snf-3 (rank 59/576) is a betaine transporter (Peden et al., 2013). snf-3 
may have an interaction with acr-23, the AChR subunit that confers MPTL 
resistance in C. elegans (Kaminsky et al., 2008), as betaine was toxic to snf-3 
mutants but not to snf-3;acr-23 double mutants (Peden et al., 2013). C. elegans 
snf-3 mutants have locomotory defects and retarded larval development (Peden 
et al., 2013). snf-3 is expressed in the excretory canal and tail hypodermal cells, 
the epidermis and vulval epithelial cells, and in several neurons, including 
sensory neurons of the head (Peden et al., 2013). The second snf gene in the 
Farm 2 data (rank 239/576) had an H. contortus homologue predicted but no C. 
elegans homologue was found. This gene family may be involved in IVM 
resistance, however the Tci2 genes and their predicted identity differed 
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between farms and there is no evidence of IVM interacting with these symporters 
in the literature. 
6.4.2 Metabolic and transporter genes  
IVM is known to induce starvation via cessation of pharyngeal pumping (Gill et 
al., 1995; Alvarez-Sanchez et al., 2005b). Survival may be dependent upon lipid 
stores and metabolism of these (Laing et al., 2012; Smus et al., 2017). Multiple 
genes were predicted to be involved in lipid metabolism in the present study. 
These included acs-7, a fatty acid CoA synthetase, a gene in the same class as 
acs-16 identified by Doyle et al. (2017). Genes in this family were reported to be 
upregulated by Laing et al. (2012) following exposure of an IVM resistant C. 
elegans strain (DA1316) to IVM.  
In other organisms, associations between drug resistance and ubiquitination have 
been identified. For example, in P. falciparum, artemisinin induces 
ubiquitination and resistant parasites have decreased ubiquitination and delayed 
onset of cell death (Dogovski et al., 2015). IVM has been shown to induce 
ubiquitination of P21-activated kinase 1 (PAK1), resulting in autophagy of breast 
cancer cells (Dou et al., 2016). On both farms, homologues of the C. elegans 
gene usp-50 were identified in the loci under IVM selection. usp-50 is a ubiquitin 
specific protease expressed in intestinal cells (Huynh et al., 2016). RNAi of usp-
50 in C. elegans embryos increased ubiquitination of the multi-drug resistance 
MRP-4 protein 7.7 fold (Huynh et al., 2016). P-gp half-life was reported to be 
increased following prevention of P-gp ubiquitination in a mammalian cancer 
cell line (Ravindranath et al., 2015). It is therefore possible that these Tci2 
homologues of usp-50 may be selected as part of a mechanism of survival, 
related to detoxification or reduced uptake, in the presence of IVM. Other genes 
also predicted to be within ubiquitination pathways by their GO terms included 
F10G7.10, ulp-4 and HCON_00053760 in the Farm 2 analysis.   
H. contortus and C. elegans produce glycosidated metabolites of BZ 
anthelmintics when exposed in vitro (Cvilink et al., 2008; Laing et al., 2010). 
Increased quantities of these metabolites were reported following selection of 
an IVM resistant strain (ISE-S) from the parental isolate, MHco3(ISE) (VokŘÁL et 
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al., 2012). In a bacterial system (Saccharopolyspora erythraea), it has been 
shown that both the mono- and disaccharides of IVM accept a glycosyl group, a 
reaction catalysed by a constitutively expressed glycosyltransferase (Schulman 
et al., 1993). In the present study a predicted homologue of Cel-ugt-49, a UDP-
glycosyltransferase, was identified in the Farm 3 analysis (rank 35 and 74/91). 
However, as no IVM glycoside metabolites were identified in an experiment 
involving H. contortus and C. elegans (Laing, 2010), the relevance is unclear. It 
may be that ugt-49 is related to survival during starvation, as downregulation of 
genes in this class in IVM-exposed C. elegans DA1316 was reported previously 
(Laing et al., 2012). 
Predicted homologues of the enzyme CEL-PYR-1 were identified in both farm 
analyses (rank 195/576 and 81/91). Cel-pyr-1 mutants have a shorter (~17%) and 
thicker pharyngeal isthmus compared with wild type worms (Franks et al., 2006), 
and disorganised actin filament structure is apparent. If parasites predominantly 
uptake or ingest IVM through pharyngeal structures, changes to this may play a 
role in IVM phenotype.  
The ability to rapidly excrete IVM may be a survival advantage in vivo in the host 
or in faeces. Several studies have associated P-gps with anthelmintic resistant 
phenotypes (Blackhall et al., 2008; Bartley et al., 2009; Sarai et al., 2013). In 
this study only pgp-3 was identified as differentiated between pre- and post-IVM 
samples. Tci-pgp-3 was previously identified to be significantly upregulated in 
eggs (3.90 fold, p<0.05) of the multi-drug resistant MTci5 isolate, and 
significantly downregulated in L4 (0.68 fold, p<0.01) compared with the MTci2 
isolate, as determined by qPCR (Dicker et al., 2011b). In contrast, pgp-9, which 
is more strongly associated with anthelmintic resistance in T. circumcincta 
(Dicker et al., 2011b; Turnbull et al., 2018), was not identified, either by FST or 
by CNV, unlike in Choi’s GWAS (Choi et al., 2017). This may suggest that pgp-9 is 
already increased in copy number within the field populations examined in this 
study, and is more important as a multi-drug resistance mechanism rather than 
an IVM specific mechanism. Other transporters were also noted within the 
results. These included abt-2 and kcc-1 in the Farm 2 analysis, and members of 
the peptide transporter family in both farm analyses.  
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Two oxidoreductases were identified, one of which, identified only in the Farm 2 
analysis, was predicted to be a homologue of the H. contortus gene 
HCON_00155250. This gene is located within the Chromosome V peak, and a 
reduction in expression in IVM treated H. contortus adults (-0.73 and -1.09 log2 
fold, in males and females respectively) was reported (Laing, pers comm). 
Importantly, this gene was also identified in the Farm 2 analysis following 
alignment of reads to the PRJNA72569 genome. The association with IVM 
resistance of these genes is unclear, however increased expression of genes 
related to ‘oxidoreductase activity’ and reduction in expression of genes related 
to ‘oxidoreductase’ were reported by Laing et al. (2012), following exposure of 
C. elegans DA1316 to IVM. 
6.4.3 Regulatory genes and transposable elements 
Multiple genes were predicted to have regulatory function in both farm analyses, 
including genes of the ‘abnormal cell lineage’ class. One of these, identified in 
the Farm 2 analysis, is predicted to be a homologue of Cel-lin-44, part of the 
WNT signalling pathway that can be important during development. This 
pathway has been reported to be inhibited by IVM in a study of colorectal cancer 
(Melotti et al., 2014). Other regulatory genes included nuclear hormone 
receptors. A nuclear hormone receptor, nhr-8, was recently suggested to play a 
role in IVM tolerance in C. elegans (Ménez et al., 2019). Two genes in the Farm 2 
analysis, predicted to be homologues of Cel-mab-10, a transcriptional co-factor 
(Harris and Horvitz, 2011), were identified (rank 4 and 219/576 and 351/576). Of 
these, one was also identified in the Farm 3 analysis. The PRJNA72569 
equivalent of this gene contained a ddRAD-Seq SNP in the NZ study by Choi et al. 
(2017). Originally identified in male mutants incapable of mating, which had 
slightly swollen bursas (Hodgkin, 1983), Cel-mab-10 has since been characterised 
as important in regulation of moulting in C. elegans. Mutants synthesise an extra 
adult cuticle, which males subsequently moult, but which hermaphrodites often 
fail to shed (Harris and Horvitz, 2011). Expressed in pharyngeal cells, vulval 
precursor cells, seam cells, gonads and hypodermal nuclei (Harris and Horvitz, 
2011), the link with IVM resistance is not clear. Potentially, alterations in the 
cuticle might enhance the ability of worms to survive IVM treatment due to 
restricting IVM entering the worm (e.g. failure to shed a cuticle might impair 
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uptake via ingestion/amphids/phasmids). Alternatively, it may be important in 
regulatory pathways associated with IVM resistance. 
Several genetically differentiated regions identified in both farm analyses 
contained TEs. These are DNA sequences with the inherent ability to self-
replicate, altering their genomic position and inducing structural changes within 
a genome (reviewed by Bourque et al. (2018)). Of the total number of proteins 
identified to be present in both farm datasets approximately a third were 
predicted to be TEs. These results may reflect true selection, or confounding 
appearance of selection due to misalignment of reads over the Tci2 TE, without 
necessarily reflecting the genomic position of the TE(s) within the field 
populations (Laing et al., 2011). Also, some TEs may coincidentally appear 
within a region of genetic differentiation due to a general abundance within the 
genome, without being the cause of selection in the region. TEs were previously 
demonstrated to play a role in insecticide resistance in Drosophila melanogaster 
(reviewed by Rostant et al. (2012)). Here, the presence of strong selection 
around a retrotransposon, Accord, inserted into the 5’ UTR of the cyp6g1 gene 
was associated with DDT resistance (Daborn et al., 2002; Schlenke and Begun, 
2004). In Drosophila simulans, a Doc long terminal repeat retrotransposon in the 
3’ UTR of the gene upstream of cyp6g1 was also associated with DDT resistance 
(Schlenke and Begun, 2004). These insertions were shown to increase 
transcription of the cyp6g1 gene (Schlenke and Begun, 2004), presumably 
enhancing metabolism of DDT. In contrast, an insertion of Doc1420 TE into the 
second exon of a choline kinase gene CHKov1, changed the transcription pattern 
from a single transcript to two transcripts within an individual D. melanogaster 
(Aminetzach et al., 2005). The presence of this TE was associated with 
resistance to an organophosphate, azinphos-methyl-phosphate (Aminetzach et 
al., 2005). TEs are abundant within the related nematode H. contortus, with 
differences in insertion patterns evident between isolates and to a certain 
extent also between derived strains and their parental populations (Hoekstra et 
al., 2000). That some of these TEs are still active has been demonstrated by the 
presence of TEs within RNA-Seq data of H. contortus (Laing et al., 2011). TEs 
may be involved in IVM resistance in T. circumcincta, however analyses more 
suited to exploration of TE differences are required before conclusions could be 
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drawn (Kofler et al., 2016a; Bourque et al., 2018), and would require an 
improved reference genome. 
6.4.4 Multiple gene copies have potential to confound analysis 
The presence of Tci2 genes with many-to-one homology with genes in C. elegans 
was noticed during the course of the analysis. These included genes that might 
be expected to have paralogues, such as pgp-3, but also genes which were 
expected to be single copy. If genes were truly paralogues, the presence of 
multiple gene copies would be real, and should be minimal in their effect on the 
analysis. However, if haplotypic copies of genes were retained as part of the 
Tci2 draft assembly, such that multiple copies were technical artefacts, the 
analysis could be severely impacted. Instead of reads aligning in a single stack 
(true alignment), reads would be split over the multiple gene copies by 
similarity to the haplotype, such that alleles identified for a copy of the gene 
would not reflect true population allele frequencies, or even sample 
frequencies. This would have an effect on all downstream analyses and might 
help to explain some of the differences noted between genome alignments in 
the present study.  
Support for multiple gene copies was provided by the high percentage (~17%) of 
reads with MAPQ=0, as reported in 5.3.2. Due to the filtering performed in this 
study, reads with MAPQ=0 were removed. This is likely to have affected 
coverage over technical haplotypes. Variant sites with <20 mean depth within a 
sample were not included in the SnpEff analysis, and some may have been lost 
due to low coverage following filtering of these MAPQ=0 reads. 
Investigation of read depth over β-tubulin isotype-1 in each genome alignment 
identified two copies of β-tubulin isotype-1 to be present. Nevertheless, this 
seems unlikely, as many previous studies have investigated BZ resistance using 
this gene, and have not reported multiple gene copies of β-tubulin isotype-1 in 
T. circumcincta (Skuce et al., 2010; Redman et al., 2015). A gene close to β-
tubulin isotype-1 in the PRJNA72569 genome also appeared to be multiple copy 
in the Tci2 genome, and to have partial copies in the PRJNA72569 genome. This 
gene, hprt-1, is also expected to be fairly conserved. PCRs failed to identify 
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more than two alleles of this gene in any MTci2 individual. Thus, although the 
presence of multiple gene copies cannot be excluded, the PCR results do not 
provide evidence for more than one gene copy within the T. circumcincta 
genome, despite the low percentage identity. This highlights the dramatic 
degree of diversity present within a population and the difficulties in assembling 
a truly representative reference genome. The extent of this issue within the Tci2 
draft genome is unknown, but it is concerning as it indicates that both false 
positive signals could be identified, while other regions under selection by IVM 
could be missed. 
Interestingly, the gene pgp-3 had four or five Tci2 gene copies identified, with a 
read count over the gene equivalent to the genome-wide mean read count or 
lower. In contrast, pgp-9 had only one copy, yet had increased read count over 
the gene in both the pre- and post-IVM populations in all samples compared to 
the median read count for each sample. These results suggest two possibilities. 
Firstly, if Tci2 genes are correct, Tci2 has multiple paralogues of pgp-3 but only 
a single copy of pgp-9. Dicker et al. (2011b), identified a significant increase in 
expression levels of pgp-9 mRNA in all lifecycle stages in MTci5 compared to 
MTci2, but did not identify the same differences when studying pgp-3. The Tci2 
copy number identified in the  genome would help to partially explain these 
results if MTci5 had increased copy number of pgp-9 compared to MTci2 
(Turnbull et al., 2018), but similar copy number of pgp-3. There are four copies 
of pgp-9 identified in the PRJNA72569 genome, based on a NZ isolate, and 
although Choi et al. (2017) suggested increased pgp-9 copy number in the triple 
resistant NZ strain used in their study, they did not identify pgp-9 by FST 
analysis. It may be that the results identified in these studies reflect inherent 
differences between T. circumcincta populations rather than those directly 
related to anthelmintic resistance. Alternatively, the pgp-3 gene copies could be 
technical artefacts, as the read count over the gene is the same or less than the 
mean read count and pgp-3 may or may not be important in IVM resistance. Of 
course, if the pgp-3 copy number in the field samples is less than in MTci2, then 
reads would be split over paralogous loci. It is also possible that the single copy 
Tci2 pgp-9 represents falsely collapsed paralogues, and hence has increased 
coverage.   
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6.5 Conclusion 
Overall, this genome wide analysis has indicated several genes that may be 
important in IVM resistance, but with low numbers of genes identified in both 
farms or that are consistent with other IVM GWAS. In addition, only a few genes 
were identified in both genome analyses, highlighting the impact of the genome 
assembly. Interpretation of the results is complex and should be performed with 
care due to the possibility of multiple technical gene copies and the fragmented 
state of the genome assemblies. However, the sequencing data and analysis 
pipelines remain a high quality resource and will warrant re-analysis when the 
Tci2 genome is complete
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7 Discussion: Identifying the genetic basis of IVM 
resistance proved extremely challenging 
The primary aim of this PhD was to identify genetic markers of IVM resistance in 
field populations of T. circumcincta. This proved extremely challenging. Field 
populations sampled differed in their IVM resistance status, and mixed species 
infections were common, reducing the correlation between the FECRT results 
and the IVM efficacy against T. circumcincta. As a result, locating a suitable 
farm to use in the genome wide association studies (GWAS) took longer than 
anticipated. The prevalence and severity of IVM resistance on UK farms is 
increasing (Sargison et al., 2005; Hybu Cig Cymru, 2015) and the first farm 
chosen proved to have potentially ‘fixed’ IVM resistance, with no detectable 
efficacy of the anthelmintic against T. circumcincta. Other farms tested varied 
between comparatively high efficacy (80% reduction in FEC) and low efficacy 
(20% reduction in FEC), or no efficacy against T. circumcincta. None were 
identified with a moderate efficacy of 50-60%. Unlike H. contortus, FECs of T. 
circumcincta infections are often comparatively low (Gibson and Parfitt, 1977). 
It was extremely difficult to identify a field population which had sufficient 
numbers of T. circumcincta L3 both pre- and post-IVM which also displayed an 
appropriate IVM efficacy for a GWAS. If IVM resistance was too high, detection of 
IVM resistance markers by FST comparison of pre- and post-treatment L3 was 
thought to be unlikely. In contrast, field populations against which IVM was still 
comparatively effective had limited numbers of L3 available post-IVM, restricting 
the number of larvae available for sequencing. Eventually, two field populations 
were chosen: one had a high IVM efficacy (80%, Farm 2) and the other a low IVM 
efficacy (20%, Farm 3). These populations were considered the best available for 
the experiment. However, there were additional factors which made the 
interpretation of results more challenging. Sub-sampling of the overall T. 
circumcincta population within the sheep hosts could have occurred at any given 
time point. Such that, rather than sampling individuals representative of the 
entire population treated with IVM at each time point, a sub-population was 
selected for Pool-Seq for each of the pre- and post-treatment samples. This 
could have occurred due to changes within the parasite community and in the 
faecal egg output of adult worms over time and following IVM treatment (Bishop 
and Stear, 2000; Sutherland et al., 2003a). The ddRAD-Seq results, however, 
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suggest that sub-sampling has not occurred on Farm 2, and the allele frequency 
correlations using the Pool-Seq data also suggest that no sample has a greater 
degree of differentiation to any other. An ideal sample would be comprised of 
an entirely homogenous population, with a subset of individuals resistant only to 
IVM, however both farms had multi-drug resistance. Indeed, it would be 
impossible to locate a UK farm without some resistance to BZ (McMahon et al., 
2013b; Hybu Cig Cymru, 2015). Whether individual T. circumcincta were dual-
resistant or multi-drug resistant was not known, but was likely, especially based 
on the results observed on Farm 1 and by the dual product FECRTs performed on 
Farm 3. Several genes identified on these farms have associations with LEV 
(Fleming et al., 2009; Gendrel et al., 2009), MPTL (Kaminsky et al., 2009; 
Rufener et al., 2009b) or derquantel activity (Puttachary et al., 2013; Abongwa 
et al., 2016), suggestive of prior exposure to these classes of drug. Farm 
management practices, such as those observed on Farm 1, may preferentially 
select for multi-drug resistant parasites with proportionally few individuals 
mono-resistant, alongside susceptible parasites. This could therefore increase 
differences between pre- and post-treatment samples, unrelated to IVM 
resistance. These unrelated loci could confound interpretation, especially as IVM 
has a broad spectrum of activity, and multiple gene families have been 
previously suggested to be associated with tolerance, target action, 
detoxification and resistance in the literature.  
Although it was expected that Farm 2 would display greater genetic 
differentiation (by FST), compared with Farm 3, between the pre- and post-IVM 
populations, due to a greater drug efficacy in this population, this was not 
observed. A potential reason for this discrepancy could be increased diversity on 
Farm 2 due to the recent merging of two flocks, which may both have carried 
IVM resistant worms. This could have increased diversity of, and around, IVM 
resistance loci, reducing relative FST. A different farm, with similar IVM efficacy, 
but which did not buy in new stock each year would have been desirable for 
testing, but was not available. 
ddRAD-Seq was trialled as a reduced representation method and has since been 
published as a tool to investigate IVM resistance in T. circumcincta (Choi et al., 
2017) and validated as an experimental method in Schistosoma japonicum 
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(Shortt et al., 2017). Given the large genome size (PRJNA72569, ~700Mb), 
ddRAD-Seq was an economically attractive option. Unfortunately, the high 
diversity encountered resulted in fewer RAD markers than desired. This was 
likely explained by a combination of allele drop out, due to polymorphisms in 
the restriction enzyme cut-site (Arnold et al., 2013; Gautier et al., 2013b), and 
haplotypic copies of genes in the genome affecting read alignment. 
Nevertheless, it was useful in determining linkage decay in the genome and has 
provided an excellent resource for future use when the genome assemblies are 
improved. ddRAD-Seq may have been affected by multiple haplotypic copies of 
genes or regions to a greater extent than Pool-Seq, due to the method of 
filtering. In Pool-Seq, regions were filtered by MAPQ and read depth. However, 
in ddRAD-Seq, filtering included both the number of individuals contributing to a 
RADlocus, and the number of samples. Therefore, an increased chance of 
discarding regions which had decreased read alignment, due to allelic copies 
elsewhere in the genome, would have occurred. 
Pool-Seq proved vastly more beneficial in these outbred, diverse field 
populations than ddRAD-Seq. By increasing the regional coverage of the genome, 
multiple narrow regions of genetic differentiation and potential IVM selection 
were identified. It also allowed increased sampling of the diversity within the 
population as a whole. Sample size was limited by the number of L3 available 
from the farms; however, increasing the number pooled would have led to 
decreased sampling per individual within the constraints of the sequencing 
budget. Thus, the actual number sampled would likely have remained very 
similar and would have reduced the benefit of including technical replicates. 
The coverage obtained following Pool-Seq was unfortunately less than expected, 
reducing the desired sample size. It was only after annotation of the genome 
using MTci2 RNA-Seq data that a clear explanation for this was identified as the 
draft genome itself. Although a considerable improvement upon the published T. 
circumcincta genome, the Tci2 draft genome remains in more than 8000 contigs. 
In addition, it was realised that it contains haplotypic copies of genes expected 
to be single copy. The full extent of this upon the present analysis is unknown, 
however very few genes within regions of genetic differentiation were identical 
when reads were aligned to both T. circumcincta genomes. Unfortunately, 
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similar issues exist in the published genome and the increased fragmentation 
(81,000 contigs) reduces the ability to determine regions of IVM selection. 
To fully interpret the sequencing data generated in this study, it is vital that the 
Tci2 draft genome assembly is improved and that haplotypic contigs and allelic 
genes are reduced. The uncertainty relating to this issue is undoubtedly one of 
the greatest limitations of the study. It is also the point on which any future 
investigations rely for correctly identifying allele frequencies. Until this has been 
improved, or ascertained, there is less scope for improving or further developing 
GWAS. Using both PacBio long read sequences (Eid et al., 2009) and short read 
Illumina sequences, the current version of the Tci2 genome used in this PhD was 
assembled using FALCON-Unzip (Chin et al., 2016) and Redundans (Pryszcz and 
Gabaldón, 2016). The latter software aims to reduce haplotypic diversity within 
the genome (falsely duplicated contigs or genes) by percentage identity 
alignment of contigs one to another. In addition, the pre-library preparation 
technology, 10X genomics (Zheng et al., 2016), was employed to assist in 
identification of haplotypic regions for short read data. While this was an 
excellent start, the present draft assembly still retained artefactual duplication 
of many genes. As part of the BUG Consortium project, various methods are 
underway to improve the genome and overcome the high levels of haplotypic 
diversity inherent within T. circumcincta populations. Due to the small size of T. 
circumcincta adults and the low quantity of DNA that can be isolated from an 
individual worm, the DNA libraries sequenced for the current draft assembly of 
the Tci2 genome were produced from pools of up to 250,000 MTci2 L3. However, 
this has complicated the assembly process and may have introduced 
considerable diversity into the draft genome. The MTci2 isolate was originally 
obtained from the Central Veterinary Laboratories, Weybridge, in 2000 (Skuce et 
al., 2010), and no attempts have been made to inbreed, although the population 
may have experienced some changes over time following multiple passage within 
farm laboratory settings. In contrast, the original WSI H. contortus genome was 
produced following further inbreeding of the inbred susceptible isolate, 
MHco3(ISE), using a single adult of each sex to produce MHco3(ISE).N1, followed 
by sequencing of a single male worm (Laing et al., 2013; Sargison et al., 2017). 
This genome has since been improved upon using updated bioinformatics and 
third generation sequencing technologies (Tracey, pers comm). For this reason, 
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an attempt to inbreed the MTci2 population by the BUG Consortium, using 
offspring from single females as starter populations, is ongoing. In the future, to 
check whether a reduction in diversity has been achieved, microsatellites could 
be used to compare the inbred Tci2 with the MTci2 isolate population in a 
similar manner to previous work with H. contortus (Sargison et al., 2017).  
There are various ways to identify multi-copy genes and some options could be 
applied to the currently available Tci2 genome. Firstly, the genome assembly 
was recently analysed (as part of this PhD) using BUSCO v3.0.2 (Benchmarking 
Universal Single-Copy Orthologues), to identify genes expected to be single 
copy, and determine current copy number (Simao et al., 2015; Waterhouse et 
al., 2017). This provided a better, genome-wide estimate of the current level of 
potential haplotypic duplication present within the Tci2 genome. Using the 
proteins annotated by AUGUSTUS, trained using the MTci2 RNA-Seq data, over 
23% of genes in the BUSCO nematoda_odb9 dataset were identified to be 
duplicated. The genome assembly was re-annotated using the C. elegans gene 
set within the nematoda_odb9 dataset. Almost 20% of genes were identified to 
be duplicated, while 8% were not detected within the genome. Secondly, an 
attempt to reassemble the current genome could be made using the software 
Purge Haplotigs (Roach et al., 2018), which uses a slightly different method of 
identifying haplotypic sequences to Redundans (Pryszcz and Gabaldón, 2016). It 
first identifies potentially haplotypic contigs by the relative coverage of reads 
aligned to the genome. Following this, these contigs are compared to the rest of 
the genome, using Minimap2 (Li, 2018), and those appearing to be haplotypes of 
one another are identified as ‘haplotigs’. The shorter contig is removed, being 
retained as part of a separate ‘haplome’ and the remaining contigs are used to 
assemble the genome. Roach et al. (2018), found some improvement in genome 
assembly for three of the four species tested (a coral fungus, a grapevine and 
the Zebra finch), compared to assembly using Redundans. The fourth species, 
Arabidopsis thaliana, a model diploid plant, showed similar BUSCO statistics 
using either Purge Haplotigs or Redundans (Roach et al., 2018).   
To improve the Tci2 genome assembly overall, the BUG Consortium is performing 
several additional experiments in collaboration with the WSI. The first is based 
on the successful sequencing and assembling of a 266 Mb mosquito genome, 
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using PacBio SMRT methodology, starting with amounts of DNA that were 
previously considered sub-optimal – 100 ng from a single individual (Kingan et 
al., 2019). The amount of DNA obtainable from a single worm is at best one 
tenth of this amount and it is unknown whether this will be successful, but if so, 
this method could provide excellent data. Secondly, the use of a technology 
known as Hi-C (Belton et al., 2012), which utilises the in vivo conformation of 
the genome to identify chromatin interactions, is also being trialled. In essence, 
the method allows identification of regions that are frequently spatially 
adjacent within the nucleus, indicating that they are likely to be close together 
within a linear genome (Belton et al., 2012). However, data obtained from such 
an experiment could also provide important functional information, as genes 
distantly located within a linear genome, but close within a cell, may be co-
regulated. Thirdly, using a novel 10X genomics single cell method, an assembly 
using haploid genomes of T. circumcincta sperm cells may be possible. Unlike 
the original linked reads method (Zheng et al., 2016), which provided haplotype 
data, the newer method traps single cells, barcoding all DNA within the cell, 
before pooling DNA for sequencing (Andor et al., 2018). This is currently being 
trialled using H. contortus sperm, and, if successful, will be attempted with T. 
circumcincta. It should provide information as to the copy number of each gene 
within an individual male. Alternatively, individual unfertilised eggs could be 
used instead, with the caution that MHco3(ISE) unfertilised eggs have been 
identified to be diploid or aneuploid based on microsatellite analysis (Sargison, 
2009). Triploid microsatellites were identified in Farm 1 T. circumcincta L3 
individuals, and have been indicated previously in T. circumcincta populations 
(Grillo, 2005). They may reflect the presence of non-specific primer binding to a 
second region of the genome rather than triploidy of a locus. However, if 
triploids (whether euploidy, or more likely aneuploidy in nature) do exist, this 
may significantly complicate genome assembly and identification of gene copy 
number. Triploids may also provide an enhanced ability of a population to 
rapidly adapt to selection pressure so could play a role in the development of 
IVM resistance. For example, in human cancer cell lines, tetraploidy was 
associated with multi-drug resistance compared with parental cell lines 
(Kuznetsova et al., 2015). H. contortus polyploid individuals exist (Doyle et al., 
2018), although it is unknown whether these are viable to infect sheep.  
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Whether a single locus, as suggested by in vitro testing of F1 and F2 generations 
of a H. contortus genetic cross (Le Jambre et al., 2000), or many loci, as 
suggested by work in C. elegans (Dent et al., 2000), are selected by IVM is not 
possible to determine using the current genome assemblies. Indeed, Doyle et al. 
(2019), demonstrated the marked improvement made to interpretation of NGS 
data by each refinement of the H. contortus genome assembly. Three studies 
have identified a large region on Chromosome V under IVM selection in H. 
contortus (Laing, pers comm, Doyle et al., 2019; Sallé et al., 2019). It is unclear 
whether the same large locus is syntentic in the T. circumcincta genome, 
however few homologues of the roughly 400 genes in the H. contortus locus 
appear to be under IVM selection in the T. circumcincta populations in this 
study. In the H. contortus genome, the large region of selection encompasses a 
region of reduced diversity and reduced recombination within the MHco3(ISE) 
population (Doyle et al., 2018; Doyle et al., 2019). In contrast, a similar large 
region of reduced haplotypic diversity, associated with IVM selection, was not 
detected within the data presented in the present study.  
Nevertheless, when comparing between farms as part of this PhD, rather than 
within farms, a different set of genes appeared to be differentiated, including a 
single, large region surrounding the β-tubulin isotype-1 locus. This region 
correlated with regions identified by Choi et al. (2017) when the authors 
compared a triple resistant T. circumcincta isolate and an inbred susceptible 
isolate. A potentially homologous region on Chromosome I was also identified by 
Sallé et al. (2019), when geographically separated populations of H. contortus 
were compared. Importantly, Choi et al. (2017) could only identify a region of 
selection around the BZ locus as it extended on a single contig. By using both 
assemblies, as described in this thesis, the extension of this region to include 
genes on three PRJNA72569 contigs was possible (Figure 7.1). This demonstrated 
that the gene acr-11, identified by Choi et al. (2017) as potentially involved in 
LEV resistance, lies very close to β-tubulin isotype-1. As such, acr-11 may be 
selected by genetic hitch-hiking with the β-tubulin isotype-1 gene (related to 
selection by BZ), rather than associated with LEV sensitivity itself. Many of the 
genes identified in this study are likely indirectly selected by IVM treatment. 
Although closely linked genes could be used as genetic markers of IVM 
resistance, recombination could render them ineffective.  
  
  298 
 
Discussion 
 
Figure 7.1: Relative position of contigs within the Teladorsagia circumcincta genome. The 
schematic shows the relationship between three PRJNA72569 contigs (672, 53 and 306, dark 
blue) and four Tci2 contigs (18, 1057, 77 and 866). These positions were determined using 
evidence of differentiation (light blue) over the Tci2 regions when comparing between Farm 
2 and Farm 3 populations, and the identification of their equivalent genes in the 
PRJNA72569 genome. Note that contigs 77 and 1057 also contain undifferentiated regions 
(red). These regions contained genes which did not map to PRJNA72569 contig 53. A 
selection of genes are annotated. 
Why might a wide region of reduced diversity arise around the BZ locus, but does 
not appear to have occurred around the (unknown) IVM locus? Several reasons 
are possible. Recombination rate varies both between and along chromosomes 
(Doyle et al., 2018), and between species (Stapley et al., 2017). The 
recombination rate surrounding the BZ locus in the T. circumcincta genome may 
be reduced compared with the IVM locus. Thus, the potential for linked loci to 
reach fixation is higher (Smith and Haigh, 1974). The difference in dominance of 
the resistance associated SNPs may have increased selection of BZ homozygous 
resistant individuals (an incompletely recessive trait in H. contortus (Sangster et 
al., 1998)), compared with IVM, (a dominant trait in T. circumcincta (Sutherland 
et al., 2002) and H. contortus (Le Jambre et al., 2000)). The frequency of 
selection may also vary: farmers used to be told to treat neo-suppressively, 
which can rapidly select for just a few haplotypes, as was observed when 
Anopheles funestus was subjected to intense selection by pyrethroids (Barnes et 
al., 2017), but fewer will do so now. BZ is an older drug and is more commonly 
used in this way even today for N. battus.  
672 53 306 
18 1057 866 
77 
hprt-1 
Macin gene  
acr-11 
β-tubulin isotype-1 
ttbk-7 
665 kb 
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Missing from current knowledge is how anthelmintics from different classes may 
influence selection upon other anthelmintic resistance mechanisms. For 
example, one study noted apparent selection upon BZ resistance associated SNPs 
by IVM when IVM resistant isolates were compared with IVM susceptible isolates 
of H. contortus, including comparison of derived strains with their parental 
isolate (de Lourdes Mottier and Prichard, 2008). Although one IVM resistant 
strain with BZ associated SNPs identified was derived from a BZ naïve isolate, 
with no individuals containing F200Y SNPs identified in this parental isolate, only 
27 worms were genotyped from each. Indeed, individuals within the parental 
isolate population were noted to contain F167Y SNPs. It is possible that P200 BZ 
SNPs were already present within the parental isolate population and that the 
apparent selection observed related to the presence of dual-resistant 
individuals. To distinguish between the selection of dual-resistant individuals, 
and selection by one anthelmintic upon the specific genetic locus conferring in 
vivo resistance to a second drug class, is important. The former is affected by 
management and is largely dependent on past treatment history. The latter 
might enhance selection of resistance to both anthelmintic classes, independent 
of management factors, each time the anthelmintic is used. This selection could 
occur either by the same mechanism for both drugs, or via genetic linkage 
(hitch-hiking) between two separate mechanisms (Smith and Haigh, 1974). Until 
we know the genetic basis of IVM resistance and observe if this is linked with 
other anthelmintic resistance loci, we cannot fully answer these questions. 
Despite this, the present study has not found evidence of selection upon BZ 
associated SNPs by IVM. Indeed, differentiation over the β-tubulin isotype-1 
locus was only identified when different farm populations were compared, which 
may relate to decreased within-population nucleotide diversity at this locus. 
Similarly, P-glycoproteins have been suggested to be an IVM resistance 
mechanism, but apart from a tentative link with pgp-3, this study failed to 
identify an association between P-gps and IVM resistance. It is possible that this 
gene family presents a multi-drug resistance mechanism, rather than an IVM 
specific mechanism. For example, P-gps also appear to be associated with 
exposure to MPTL (Raza et al., 2016a), resistance to LEV (Raza et al., 2016b), 
and resistance to BZ (Blackhall et al., 2008) in H. contortus isolates. As 
mentioned previously, the sample populations could have contained dual- or 
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multi-drug resistant individuals so it is also possible that any P-gp mediated 
resistance was already present in the pre-treatment populations due to an 
involvement in, for example, BZ resistance. Conversely, some genes identified in 
this study (e.g. AChRs) could be associated with other anthelmintics used on 
these farms. 
Future adaptations to genome sequencing methodologies, as described above, 
will allow improvements to the genome, and, at that point, reads generated in 
this study will be re-aligned and re-analysed. FST windows could be filtered by 
SNP density, excluding those with very few or a large number of SNPs as was 
used by Cheeseman et al. (2015) to reduce false positives within their Pool-Seq 
data. This could help to reduce noise within the Farm 2 data in particular. 
Rather than just using smoothed FST, the significance of any allele frequency 
difference could be smoothed also (Kofler et al., 2011b), and this additional 
statistic used to investigate results. To allow the use of a larger window size, 
the new genome could be subdivided by contig size, dependent on the state of 
the assembly, into two smaller ‘genomes’ following read alignment. In this way 
longer contigs could be separately examined using larger sliding windows, while 
shorter contigs could be analysed with 5 or 10 kb windows. Coverage along the 
genome in the present study was found to vary, even within a contig. To assist in 
a reasonable sub-sampling protocol, the average coverage of genes identified as 
single copy by BUSCO (Simao et al., 2015) could be determined, particularly over 
exons. Regions of coverage similar to single gene coverage could be analysed 
separately to those of lower or higher coverage, which may help with allele 
frequency sampling bias.  
Even with improvement of the genome, it is likely that there will still be a 
considerable number of genes identified as potential markers of IVM resistance. 
For example, the region in H. contortus identified on Chromosome V contains a 
considerable number of genes (Doyle et al., 2019; Sallé et al., 2019), despite 
expectations of a single dominant locus conferring resistance (Le Jambre et al., 
2000). Even in relatively outbred clinical isolates of O. volvulus (Doyle et al., 
2017), multiple genes were identified as potentially under selection, although in 
this species resistance may be polygenic. It is also not necessarily the case that 
the resistance mechanism will be identified within the highest FST window, or 
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with a single, strongly selected SNP. For example, Cheeseman et al. (2015) 
identified the kelch gene, expected to be a key determinant of artemisinin 
resistance in P. falciparum (Ariey et al., 2014) within their main locus of 
selection by FST. Yet other nearby genes had higher FST values than the kelch 
gene, because multiple haplotypes of the kelch gene, containing different non-
synonymous SNPs, were associated with resistance phenotypes (Cheeseman et 
al., 2015). Each of these SNPs contributed only a small FST value. Similarly, 
although BZ resistance is primarily conferred by changes in the ben-1 gene in C. 
elegans, multiple variants conferring a resistance phenotype are possible 
(Hahnel et al., 2018). If multiple SNPs are capable of conferring IVM resistance 
in T. circumcincta, and are present within these farm populations, then each 
SNP may have only a small FST value relative to more common SNPs nearby. 
Therefore, although we have identified many interesting genes within regions of 
genetic differentiation by FST, and these have a rank based on their FST value, 
the rank may not correlate with their importance in IVM resistance. Some, such 
as those predicted to be LGIC homologues, have lower ranked values, but are of 
greater interest, than other genes predicted to be related to the cuticle, for 
example.  
Targeted sequencing of additional populations may eliminate genes present 
within this study due to genetic hitch-hiking and help to identify markers 
common to many UK farms, useful for diagnostic testing or research. 
Nevertheless, multiple markers may exist, with some important on one farm, 
and different markers useful to a second flock as is noted with different SNPs 
within the β-tubulin isotype-1 gene and BZ resistance (Redman et al., 2015), and 
with different haplotypes of Tci-mptl-1 and MPTL resistance (Turnbull et al., 
2019). Unfortunately, sequencing of individual worms is limited by the total 
amount of DNA available (< 1 ng from a T. circumcincta L3). Array technology 
(Gabriel et al., 2009; Bumgarner, 2013) could allow the development of a 
customised SNP panel, as has been produced for other parasites, e.g. P. 
falciparum (Tan et al., 2011). The panel would include selected and neutral 
SNPs and could be used to test many farm populations at relatively low cost. 
While the quantity of DNA required for a SNP array is much greater than that 
obtained from a single worm, population-level data are likely to be more useful 
for diagnostic purposes. Therefore, one option would be to use Illumina 
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GoldenGate technology, which allows pooling of barcoded individuals for SNP 
arrays and has been used to study insecticide resistance (Weetman et al., 2018). 
Other studies have used whole genome amplification of parasites to obtain 
sufficient DNA for array based technologies (Doyle et al., 2017), however this 
could be prohibitively expensive. The use of targeted sequencing of specific 
genomic regions of interest using MiSeq with pools of individuals is showing great 
promise within the ruminant nematode community. It has been used both to 
identify species abundance within a sample (Avramenko et al., 2015) and to 
detect BZ resistance associated SNPs (Avramenko et al., 2019). With this 
technology it is possible to barcode and pool up to 96 samples for a single 
sequencing reaction, with a sequencing cost in the region of £2000. Based on 
gDNA quantities obtained for Pool-Seq in the present study, it should be possible 
to obtain sufficient quantities of DNA from pools of 200 L3 to perform 35 MiSeq 
reactions.  
If IVM resistance carries a fitness cost then individuals may be penalised in the 
absence of drug as was noted in Aedes aegypti following removal of pyrethroids 
(Chang et al., 2012; Vera-Maloof et al., 2019). A study by Leathwick et al. (2015) 
suggested some reduction in IVM resistance of T. circumcincta field populations 
after five years without IVM treatment. However, improvement year-on-year for 
each farm was inconsistent, and to date, no studies have confirmed a fitness 
cost of anthelmintic resistance in ruminant strongyles (Hodgkinson et al., 2019). 
Nevertheless, for a long time, the use of anthelmintics by farmers has been 
frequent (Burgess et al., 2012; McMahon et al., 2013a), and it is possible that 
fitness costs have not been observed due to the relative advantage conferred to 
parasites by this management practice. Indeed, if dual-resistance is common, as 
might be expected with frequent dosing using alternating or combination 
products, then a complete absence of anthelmintics might be necessary to 
observe fitness costs.  
The ready availability of highly efficacious anthelmintics has allowed farmers to 
maintain production with sheep that otherwise would be susceptible to parasitic 
gastroenteritis. However, more recently, with increasing anthelmintic 
resistance, UK farmers are actively breeding for resistant or resilient animals 
(Fairlie-Clarke et al., 2019). In addition, climate is changing, affecting strongyle 
  
  303 
 
Discussion 
communities (Kenyon et al., 2009b; Rose et al., 2016). In the future, these 
management and climatic changes may identify hitherto unrealised fitness costs 
of anthelmintic resistance in parasite populations. To exploit these, or actively 
maintain a susceptible population in refugia, we need to know the genetic basis 
of IVM resistance to identify optimal management practices. Once IVM resistance 
markers are available, it may be possible to use targeted re-sequencing of 
populations, for example using MiSeq, to monitor changes in IVM resistance 
markers in a population over time. Experiments could investigate the impact of 
refugia, of management practices such as targeted selective treatment (Kenyon 
et al., 2009a; Kenyon et al., 2013), and the effect of other anthelmintic classes 
upon selection of IVM resistance markers (or vice versa). The latter may be of 
particular importance for MOX treatments, which may or may not select for IVM 
resistance (Sargison et al., 2012). Using MiSeq, multiple loci could be amplified, 
using the same T. circumcincta samples. Although moderately expensive, and 
with an intensive initial labour input, such experiments would produce a huge 
amount of novel and interesting data and would have the potential to answer 
several research questions at once. 
7.1 Conclusion 
Identifying markers of IVM resistance proved extremely challenging. It is possible 
that, due to the draft state of the Tci2 genome, regions of IVM selection may 
have been missed, while other regions have been falsely implicated. 
Nevertheless, an interesting and compelling set of neuronal genes were 
identified within genetically differentiated loci, as were others involved in 
metabolism generally and lipid metabolism specifically. Other gene types were 
also common in the analysis, including genes with suggested regulatory functions 
and transposable elements. A recent paper implicated changes in the function of 
a nematode nuclear hormone receptor, Cel-nhr-8, in IVM tolerance in C. elegans 
(Ménez et al., 2019), and it may be that in the field, certain genes are selected 
for tolerance rather than resistance. IVM causes pharyngeal paralysis and thus 
induces a period of starvation in larvae (Gill et al., 1995). If the same 
phenomenon occurs in partially resistant adult worms, but worms are not 
directly killed by IVM, genes related to metabolism and fat storage may be 
crucial in worm survival (Laing et al., 2012). A number of genes appeared to be 
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associated with pharyngeal structures and chemosensation. It may be that IVM 
indirectly induces inhibition of feeding via chemosensory pathways, or that 
resistance mechanisms involve reduced uptake of IVM via the oral route. 
Experimental studies have previously suggested IVM resistance to be dominant in 
T. circumcincta (Sutherland et al., 2002) and the findings of this PhD support 
that. No single region appeared strongly differentiated by FST in comparison to 
BZ resistance markers identified in other studies (Laing, pers comm, Choi et al., 
2017; Sallé et al., 2019), or the recessively inherited oxamniquine resistance 
marker (Valentim et al., 2013). Although the analysis has proven challenging, 
and future re-analysis of the data using improved reference genomes will be 
beneficial, some excellent field population NGS resources have been produced 
and protocols suitable for use in future studies have been validated. 
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Appendices 
All appendices can be found on the USB stick within the envelope at the end of 
this thesis. 
Appendix 1 Arlequin parameters chosen.docx 
The parameters selected for the microsatellite analysis. 
Appendix 2 Bioinformatics Scripts.docx 
The relevant bioinformatics scripts used. These will be uploaded onto GitHub in 
the future. 
Appendix 3 ddRAD-Seq de-multiplexed summary statistics.docx 
The Stacks process_radtags summary statistics for the Farm 2 individuals 
sequenced using ddRAD-Seq. 
Appendix 4 ddRAD-Seq data (Farm 2).xlsx 
The FST, F’ST and DEST results from the ddRAD-Seq analysis. Only those results 
greater than each threshold are included.  
Appendix 5 Pool-Seq High 10 kb windows identified on both Farms 2 and 
3.xlsx 
The 10 kb regions identified as genetically differentiated on both farms in the 
Pool-Seq analysis. 
Appendix 6 Pool-Seq High 10 kb windows identified in the Farm 2 
analysis.xlsx 
Appendix 7 Pool-Seq High 10 kb windows identified in the Farm 3 
analysis.xlsx 
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These contain the Pool-Seq data (FST, genes and predicted proteins) for each 
farm analysis. Only those 10 kb windows greater than the thresholds are 
included. 
Appendix 8 Comparison of ddRAD-Seq Farm 2 SNPs with Pool-Seq Farm 2.xlsx 
Appendix 9 Comparison of ddRAD-Seq Farm 2 SNPs with Pool-Seq Farm 3.xlsx 
These contain the results after comparing the ddRAD-Seq Farm 2 data with the 
Pool-Seq data. 
Appendix 10 Farm 2 GO analysis BIOMART output.xlsx 
Appendix 11 Farm 3 GO analysis BIOMART output.xlsx 
The information extracted using BIOMART is presented, with the four gene 
categories shown (neuronal, lipid, male and female related terms). 
Appendix 12 Comparison of Pool-Seq with Choi et al 2017.xlsx 
Includes the results of the analysis comparing the Pool-Seq data from each farm 
with the results presented by Choi et al., 2017.  
Appendix 13 Comparison of Pool-Seq with H. contortus data provided by Dr R 
Laing.xlsx 
Includes the results of the analysis comparing the Pool-Seq data from each farm 
with the H. contortus MHco3(ISE)xMHco18(UGA) results provided by Dr R Laing 
(unpublished data).  
Appendix 14 Comparison of Pool-Seq with O. volvulus Doyle et al 2017.xlsx 
Includes the results of the analysis comparing the Pool-Seq data from each farm 
with the results presented by Doyle et al., 2017.  
Appendix 15 CNV logfiles for pgp.docx 
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Includes additional information regarding the identification of the pgp-3 and 
pgp-9 Tci2 genes. 
Appendix 16 Published paper (open access) 
McIntyre, J., et al. (2018). "Hidden in plain sight - Multiple resistant species 
within a strongyle community." Vet Parasitol 258: 79-87.  
Note, this is not included in the electronic appendices on Enlighten, but can be 
found using the following DOI: https://doi.org/10.1016/j.vetpar.2018.06.012 
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